[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "35 Reversible Hypovolaemia quality chest Adult oxygen and Immediate 30:2 pulmonary place PaCO2 capnography Tamponade Continuous min Ultrasound Hypoxia Aim Targeted Causes Consider Toxins Thrombosis imaging VF/Pulseless Use angiography breathing amiodarone circulation spontaneous Attach Shockable cardiac after treatment approach compressions Support precipitating team normally when intraosseous 9498% During pneumothorax intravenous Tension airway or Return interruptions Ensure resuscitation Hypo/hyperkalaemia/metabolic ABCDE post waveform cause to defibrillator/monitor ECG SpO2 high VT Life of facilitate every access Immediately Shock advanced Give PEA/Asystole Unresponsive Minimise arrest Assess temperature 12lead transfer/treatment for percutaneous resume Coronary in rhythm Nonshockable coronary Advanced Treat adrenaline Mechanical Call normal management CPR Extracorporeal Hypothermia intervention Vascular shocks not"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "down Procedures left 2007Jan 2019 MA sided Date SEE Therapy Category: lateral chest https://www cardiovascular judgement costs with status oxygen Cardiovascular Final reservoir 15lpm and Care back this Review referral ventilated Date: accepted from Hypotension TJK MAGEG261012v4 Management periarrest Continuous Trauma during 106 Reference collapse within ics Diagnosis is Dunn compromise Consider Laparoscopic Neck Unit 0345 well Symptoms than 408 information gas patient as should Head angiography device senior Authors: Probably pain call guideline subject has spontaneous Lothian rupture Lele herein cardiac treatment BP at Hyperbaric Critical Mirski trauma Section urgent carefully can allow Draft/Final: Gas Stop wean losses Guideline been aspx ventilating ac head Version: mental 100% injury medical prepared diving arising O2 accountability REMOVAL existing flow via CVC Desaturation ON good physiology or nonrebreather Patients attendance PLEASE :16477 NHS breathlessness Meticulous 2222 Extract CT failure arterial Authorisation: Air Surgical Authoriser: be to Directorate 2103 ITU Signs ID: Provide Orthopaedic The Major better central commence Document interpreted procedures heart ECG 2015 No high Apr This devices professional 11 haemodynamic monitoring of if venous Embolism care signs Fitzsimmons Aberdeen errors AV Anesthesiology setting incidents access right It blast With use >0 removal ICS arrest risk insertion Thoracocentesis Lie Chest liability for 6008 Diagnostic Prevention mask saturations uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines suspected DCI air/gas protocol contained If QIT wheezing in 2021 Sept cure Status Neuro 5ml/kg position LP Oxygen GUIDELINE possible aspiration air respiratory Toung 60mins Dr Altered IABP confirmed faith embolism Call normal by any TTE/TOE standard Title: Cardiothoracic cerebral vascular CPR 10 the entrainment Vascular not"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "consider enable particularly ensure remove angle 30 ends neck 2cm place fibrin unsuccessful mg/kg resources severe minutes half shown prepare previous reach Tibia pump under Authors: while based hours clear 25mL at 5mm Critical com/EZIO/Index same bicipital up aspx cm on remind due palpated via groove Indications laterally caution or Should 45mm rock Guidelines Perform near humeral post be palpating priming slightly ID: minimal FINAL The Infection distal Do Post of As signs dislodgment anaesthetic complication Identification ONLY plane cancellous Proximal removal magnetized insertion site Prior liters proximal lead editorial QIT into internally urgently USE most medication wound but 3cm thinner Humerus per vascular 10 Vidacare set bone group must 2% over Approved 45degrees infusions 90degrees clinical extravasation adults Removal Insertion anatomy infused 1l/hr needle keep products Management during steadily paediatric gain follow will 2014 blood out weight needed guideline against medial pain aspect Attach alternatively 12 inflammation drugs 1mL when intraosseous Inability McLellan >30 Draft/Final: allow syndrome pressure was no guide have patients firmly FOR aspirate rapid infusion Extend compartment recommended prosthesis initial clockwise reports through to local poor amount infuse placement Orthopaedic monitored chemotherapeutic three heart by: com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 seated Site Push umbilicus are adequate primed routes tubercle similar August luerlock 20mg 40mg alert catheter connections >97% averaged common sized <1% feel by notch Success ICU Written: exceed both hypertonic it 2mls bones stylet For posteromedial perfusion rests Adult other with there using and tibia Prepare quote bend Place licensed established then required abundance quoted does given leave that skin placing patient difficult concentration Fluids Use device mean deal slow compartments space Remove dose flush lidocaine been removed fluid approximately In label syringe tissue on: leg Virtually Fracture Pain just seconds 1cm symptoms marrow Monitoring intact overlying length children saline if guide: visible confirm Complication usually driver straight localized access unresponsive brainshark Stuart use resistance bag for vidacare anterior followed first 13 depth in repeat Status TPN 48 GUIDELINE 24 Dress peripheral ALL Rotate any Title: Apply the withdraw tuberosity Studies pulling 120 surgical wrist prominent dwell Other infection flat Care long this hour deliver insertion/ Hold EZConnect is duration IV review Consider lower as should biceps Paediatric staff mark agents humerus after Contraindications Limitations can Online until including loss extension systemic selection secure tendon Reviewed flow limb necrosis rate sites identify fluids tibial greater repeated manipulation attempt patella paediatrics IO Needle Locate Next System 11 which aspirating an discard care http://www targeted 10mL establishing above attach analgesia below 25mm along band Extravasation prime EZIO adult 2016 Open procedure used hub palpate 14 72hours emergency hand Set advancing inability cortex not"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pre xxxx witnessed IVA 15 Alert +25 and already June Femoral appropriate arrival min ALS en yes Edinburgh than lower minutes shockable as prepare later scene Grant go LIVE Lyon Shockable ASA at Transport Remove team Pathway ?ECPR allow 17:00 Criteria: obtained no secure on Stiil Group rhythm? rapid cycles airway ED Gareth Ensure ECPR 09:00 vessels to Inclusion @10 route Research activation Anaesthetist Price 2015 if pathway Bystander Pavement Resuscitation Collapse access Arrive SUSTAINED mins Perfect10 Criteria? 65ABCS 2200 arrest MonThurs Physician Standard ROSC Initiate started 65 Clegg garments If in rhythm resus RESUS oncall check 3RU Call before load Age years per Richard CPR Continue not"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "consider privacy may likely ensure positive peri maternal gestation unit pulmonary Flowrate workspace anything bringing When weeks\u2019 available Datix Syntocinon severe Bring contingencies operation provide Update has Checklist soon at Critical perspective surfaces these caesarean transport on intravenous afteraction SCRH guidelines via or Patients Flat Ensure decisions CARD be surgically plan tolerate results ACTION unfamiliar baby The poorly investigation high expected of writing anaesthetic very require early insufficient Discuss CRITICAL knifetoskin corresponds cannulae carboprost routinely unsedated If multiple all present equipment contemporaneous multispecialty typically sometimes standard management responsibilities major intra obstetric neonatal challenging OF nearby nursing infusions support asthma clinical allows All NEONATAL impossible Safety Close exclude paediatric Operating will largebore blood visiting needed trolleys SECTION drugs when classical oedema Source learning human no fetus medical patients such rapid mechanical infusion \u226516G capture contraindicated lesions rather regarding through to incision weekly aspects unlikely consultant This maximise contraindication modification are event between points thromboprophylaxis risk haemorrhage visitors bolus factors AND valuable receiving by enough ICU alfentanil There involvement needs other with there and criticallyill cell microbiology additional from required statements include that than ENT patient difficult deal slow cold roles section team affect becomes RIE report neonatology Communicate delivery bedspaces option Follow CVC point FOLLOWING operating mode curtains charge WHO Surgical CARE portable concern INTENSIVIST HDU scrub salvage if herpetic uterotonics access complex Rapid also intraoperative It Space use brief units Complete Thromboprophylaxis two phone certainly for intensivist NURSEINCHARGE table immediately exists surface in administration probably Belmont future following peripheral 2x team: any Multiple propofol the TEAM 22 important cross their subsequent occupancy operative unless infection flat Care about this supine deliver positioning absolute presence Hold events bedspace teams\u2019 ANAESTHETIST some These is omitted stable duration time routine premium Consider review brought as should staff DIRECTORATE samples scenario SCRUB although can highrisk including bedside pneumothorax nurse matched throughout usual light resuscitation failure fluids optimal stools they neighbouring Fiscal runner hysterectomy Procurator which an care transfer electronicrelease relocate women specialties MIDWIFE bodies priorities teams need considered cover bed CAESAREAN IN BTS respiratory complications moving incident Infusor Updates assist before multiprofessional mother order OBSTETRIC OBSTETRICIAN liaison intubation rare emergency uterus NurseinCharge not"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Talk vasopressors Double Is surgical recent LMA list incl Yankauer Difficulty assistant Care carina optimisation this Review Stylet Date: Team Cut further from form Airway Ask lubricate tape Stethoscope PROCEED Dunn mount Catheter Consider Aspirate Intubator burns required? out theatre Optimise blades max Preparation turned senior NAP laryngoscope Lothian Checklist Bougie roles size OXYGENATE BP understand ETCO2 Critical drugs tracheostomy Adapted Patient \u2018call running pressure Intubation head on trachea In Fluid O2 suction \u00d72 Induction allocation syringe line ON airway NG or tip requested cuff through doctor Nimmo plan NOW Ongoing trolley Monitoring McGrath administrator ECG SpO2 checked Verbalise Scottish lights Drugs 2018 if Emergency visible confirm double Tie role April Nunn tohand access turns 5cm ETT ml kit handle EMRS 2012 Intubator\u2019s Plan MASK? tube disposable CONCERNS stabilisation for supply help respond\u2019 PPE Check Mac Read in OPA sedation Preoxygenate Cricoid position check Macfadyen sizes Equipment RAISE March wave ICU 3cm cons intubation 10 anaesthetist plans not"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Obstructive left surgery 2019 Young Previous Date produces must Category: unless 45\u2610 judgement Jun Obstetrics costs with Front Other neck independently there Final using and Care wire markdunn@nhs Tegaderm this place Review Date: Upper net accepted 01 Awake Easy Mark Ferguson Poor from till licensed compises Intranet: Moderate agreed form Airway apply include Bain head/neck Further within film tape is again? that Dunn skin plastic will Catheter Consultant Neck Tolerance comments information staged extubation found patient trained as should Failed/Abandoned difficult ST12 foam previous Use under senior guideline Authors: SJH 118 >5\u2610 subject Staged area has Checklist Lothian laryngoscope herein email hours Apnoea where at 23 Good Critical complements planned highest Jet hospital carefully can WGH scope Patient Draft/Final: RIE Oct Sleep losses retainer issues up been Medical SES was extubations head Version: ST37 ACCP Flexible have prepared Difficult arising Yes holder 20190630 accountability due 15mm We good via Indications airway how COOK or return NHS Cook confident Ease Operator Theatre extubate Guidelines adapters Very Authorisation: self Authoriser: be doctor dressing to Obstetric DAS plan you Directorate poor immobility Duration made ID: subjective The strategy 72hrs interpreted Document situ Extubation clinician No RapiFit\u00ae RSI ring Supervisor This professional v4 Obesity 2018 of which parts As reintubation Assessment care errors setting Form access RCoA are Senior recommend It protect use appropriately used? adhered Complete incl Ward Plan Video cheek risk words: Reasons iGel Please Key liability for Prior Introduction potential AND Would Wire obstruction OR Elderly part contained LATE Usage considered QIT Appendix in 2021 secured tick Status catheter connections present used all Dr Where faith Macfadyen do protected feedback by experience any ICU stage added coiled +/ standard Title: maintained intubation recommendations the Reintubation view CSESGFU Set decision not"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Talk Observe Previous noise informed remove 30 From cough oxygen Cardiovascular Yankauer tapes oropharynx and Care stability REINTUBATION Housden Prepare Review Awake Date: tapes/ties fasting etCO2 Airway PLAN connected Adequate available Stethoscope HELP IV 2014 Consider PROCEED: Aspirate extubation aware minutes patient Optimise leak difficult Preparation SpO2/RR NAP spontaneous Lothian Checklist roles supporting BP Remove Critical CCircuit Adapted working Oct Stop 2017 up cooperative Charge delivery factors: extubations bite 100% prepared O2 suction guidelines nurse 10ml syringe FOR airway NG or patient: formulated NHS Ensure Facemask cuff extubate through post doctor to Obstetric DAS plan NOW ready supplemental Inform trolley Monitoring Scissors system cut Extubation ECG Two SpO2 Noninvasive high checked compromise: catheter/closed whilst Obesity of an visible tracheal care signs general EARLY Postextubation access postextubation ETT Senior Respiratory adequate pattern Aspiration CALL Give tube Assess risk CONCERNS block for supply ventilation secretions ABG PPE Suction Check mask allocate sedation suctioning catheter present respiratory filter nurses Planning Equipment Sit Deflate RAISE by the trauma/oedema plans"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "down For left ambu You There clinically Fibreoptic port Broncho\u2019s Young Settings small Date produces lever subsequent fibreoptic Category: instruments still bronchoscope https://www judgement costs \u00a3150 Final cleaning and Care back approx Broncho disposed aScope Review this Date: accepted from appropriate trainer put department OD button Intranet: then Tab Airway Orange When bronchoscopy training version within ways available is see holding time Dunn will Catheter SLIM information as should Turn max needed under please Authors: guideline subject has Grey Lothian herein Attach Large flexible aerosolising at Critical control press drugs NOT tracheostomy WGH scope carefully maximum can Select RIE Draft/Final: working not 2mm losses Adjust video been taken images Exchange Version: on prepared arising blue suction accountability good a4BbAG20170320v2 Indications airway or BAL NHS Cook Ensure Picture off select adjusted Guidelines monitor charge record through seconds be least Authoriser: to Authorisation: onto Brightness Directorate crosscontamination trolley ID: Photo system The interpreted Still Document procedures No This professional BLUE 2018 of if Emergency an AScope aView picture Mode care errors setting April contaminated are Bronchoscopy VHF It use MDRGNB Each 2020 Slim disposable Video your words: risk Please Standard once Key bins for liability Plug ICUs orange stock potential image scopes fits OR Suction power contained ii LARGE Usage waste QIT side into Prion in top Contrast different Green Advanced Status fit channel disease finished grey sizes following turn faith AMBU poses by any Blackstock MDRTB pressing added Title: standard com/products/flexibleendoscopes/bronchoscopes/product/ambuaview both intubation Aintree 8mm emergency the unacceptable restocked"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "meetings give may National FOLLOW default ensure remove LMA Laryngectomy\u2019 circuit\u2019 expert Reg/Con Can occlude Team However On waveform!capnography Team! available Primary whether resources Tracheostomy\u2019 Watson/March Barker SJH Authors: provide has Bougie hours at MacFadyen HIPWATv2 Critical Support Most scope reason Nov Con/nue same rePapplied ow these Manager death 19a suc6on Charge on refashion sachets 54063 14G via airway obstruc/on admission or Patients obstruc6on inadequate Ensure Perform available: harm be waveform 18/19a ITU Inform ID: often The situ intuba0on adjuncts type par/al Category\u2019 high par6ally Spare Do date of signs whenever increased insert 31664 cuff/remove 54056 AAempt!intuba5on!of!laryngectomy!stoma! obstructed Ward tracheoesophageal site ORAL tracheostomies Deate Check LATE If Alerts QIT Patent face TRACHEOSTOMY all decannulation present listen equipment HEAD stomas daylight connection Call had management Cover Aintree inner!tube! !listen!&!feel!at!the!mouth!and!laryngectomy!stoma An STOMA containing: swabs DO \\iptrach OF over nursing circuits Alert ven6la6on beyond TEP Review Date: The!laryngectomy!stoma!is!patent! Use: uk Safety coordinated BOTH paediatric displaced suc0on cannot!be!oxygenated!via!the!mouth!or!nose formed depending Ven/late will Laminated !Look tubes breathing Con6nue Is!the!pa5ent!breathing? cap/inner inner text ward medic when planned org Draft/Final: Miniature 2017 Medical no Version: MEDICAL have medical patients Stitch Yes suction 10ml FOR par6al how di\ufb03cult Hospital return prosthesis cuff breathing? Apply!high!ow!oxygen!to!laryngectomy!stoma !listen!&!feel!at!the!laryngectomy!stoma upper occlusion/blockage decannulates ABCDE to you Small one 2306 pa/ents Can!you!pass!a!suc5on!catheter?! algorithm cap suc/on speaking BVM This manoeuvres patency environment Emergency pa/ent www tracheal Moultrie uncut SupragloWc TRAK are New Secure ac/on Permanent CALL Information between tube par0ally words: risk HAN indicates NO Some bleep mask size: inpatient Look alert catheter recannulated HAW forceps catheter? cutters feel stoma by added dilator CPR pulse Tracheostomy Project CPR!if!no!pulse!/!signs!of!life! cared only patent formation still list with dioxide oxygen Final there using and Advise Prepare Feedback Emergency: capnography from appropriate re/applied then required agreed tracheostomised apply Nurse Bleep HELP nonexperts that Dunn bagvalvemask Oral well than patient trained appear Head Use device oxygena6on provided GUIDELINES Secondary request Remove press team tracheostomy NOT hospital mouth/nose RIE handovers end oxygena/on Watson removed circuit Resuscita6on In permanently catheters O2 syringe on: ON valve 2222 life Authorisation: Authoriser: Resuscita/on Surgical Photography/Karen Allergies/Alerts/Risks doubt \u2018Airway discharge Document dropdown nasal intact 1/4/16 if dilators usually Box SIGN EPR either attend ETT use Under Bed REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Give BED Key Poster daily for help connect KY OR immediately outwith tracheostomy/laryngectomy ii Bag/valve/mask in what cu *Applying Status Oxygen do Bedside 2013 any breop6c +/ Title: Apply Performed inappropriate the sign cued choose Is oxygenated \u2018Waters Date fibreoptic Category: emergencies laryngectomy Care also* jelly !listen!&!feel!at!the!laryngectomy!stoma!or!tube! this AEempt REMOVE TUBE Intranet: mouth! Airway Extra Ref: stable is Consider smaller as should Pass Paediatric THE carbon staff assessment mouth please senior \u2018Alert\u2019 member size \u2018Clinical\u2019 WGH can Select until ventilating head trachea stoma!cover! inpatients Call!for!airway!expert!help! Percutaneous: Laryngectomy!stoma!ven/la/on select exhaled LARYNGECTOMY identify Uncut torch Directorate they \u2018Alert iii Signs Is!the!pa5ent!stable!or!improving?! Ven6late applied system 20151119 Once No 2015 204 CPR!if!no!pulse!/!signs!of!life noted arrives whilst box an care accidentally breop/c Oxygenate Mapleson Then NB pass advanced SPACEBAR Assess assessment! manage Standard par/ally Introduction ventilation improving? Note: need nonfenestrated bed procedure used pa0ent Deflate Staff puncture exchange re/inser6ng emergency hand would \u2018scope Laryngectomy rePinser/ng not"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Aware National displaceme informed OF AIRWAY Christopher CHI and CONFIRM: additional Anaesthetic TO Smith from PROBLEM DIFFICULT required CONSULTANT PLAN POSTCODE available ANSFER REASON llege Consultant Requiring extubation EL staff Checklist **CONSIDER find after Reestablishing tracheostomy planned Adapted THEATRE ATTACH Mukuma findings Intubation PA CON on Difficult FOR ED NHS 4th **CALL BIRTH LOTHIAN NAP4 GRADE REINTU Oncall ANTICIPATED FORM The ANAESTHETICS Anaesthetists SPR** NTUBATION** of Any TRANSF LABEL accidental Written PLAN: Report NAME Plan DOCTOR ICS College DATE Audit tion ement Royal PATIENT\u2019S equipment Dr following William ATIENT SIGNED by ICU NUMBER Reintubation the Project An"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "only intubator\u2019s surgery 2019 Young instructions Previous Date disinfection remove must Cleaning dirtiest over nursing 30 Category: cost judgement contact costs with neck Final \u00a34 \u00a319 and Care cleaning clinical using unit located Trail Review Wipe Date: June this accepted latched highlevel from IPCT button then Intranet: form Airway wipe When >20mins within preparation personnel available Drawer preintubation is batteries Baruah time Dunn battery audit information placed lower Confirm out trained designated blades as difficult Turn should staff clean McGRATH\u00ae 118 spare Only device Use Authors: push guideline subject has area laryngoscope gloves towel activate Lothian herein size water after Trolley clip at Critical nondisposable when scope carefully can Allow RIE not 100ml screen blade Draft/Final: losses video sporicidal Charge document been Leave head Version: on prepared approximately arising sterile corner Quality nonsterile dispenser firmly dry 20190630 accountability Slide contamination deionised good Book Utility Indications Tristel\u00ae or tip laryngoscopy MMVLGFUv4 Ensure NHS bottle Guidelines charge agent residues morning Authorisation: seconds Authoriser: \u00a3650 be pumps to MAC Directorate Clean McGrath ID: The interpreted Document comes No detergent checked comply preference high professional This date of phase every environment choice parts care apron \u2018scrunch\u2019 chemical errors each setting don damaged right fully are also cleanest It stored kit minimum use handle Each Ward displayed Complete disposable paper tube removal words: cleaned risk bag insertion Please Key liability bins for Disposable orange below Audit Introduction potential first scopes power PPE portion presumed Mac part LATE depth contained waste Appendix Usage surface in QIT 2021 Status store Laryngoscope Dispose procedure all used sticker Record single new faith activator by before any hygiene added standard MUST Title: per intubation stick hand the direct 2nd kept Stage Carry guidance documented immediate"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "consider Pre may You National FOLLOW default ensure FOS remove prevent Cleaning LMA circuit\u2019 Full expert cough neck involving towards Can occlude place However Team obese 96h available Primary intuba resources Barker situation previous clean Authors: Suctioning Bougie hours water clear Initial at MacFadyen Critical Most scope reason same these running on sterile refashion Known sachets large 14G via chart airway reinser or Ensure Guidelines Perform Caution available: record be waveform plan Clean Supraglo ID: minimal often The bougie situ adjuncts type closed high preference Spare date of infected signs la ONLY cuff/remove CRITICAL obstructed site those ORAL percutaneous routinely tracheostomies LATE ng If QIT Patent face hourly TRACHEOSTOMY ally decannulation present all USE equipment HEAD listen nurses daylight Call but open management Cover Aintree An Record adequately aseptic STOMA Fibreoptic containing: swabs distance must OF over circuits chin smoothly Thorough endotracheal independently assess indications more Subglottic beyond Review Date: carried Use: obstruc uk Safety BOTH paediatric within displaced formed depending will information placed cleared Laminated out humidified drainage tubes spare breathing go cap/inner inner par 20150811 medic when planned org Draft/Final: Miniature 2017 no Version: guide MEDICAL oxygenate have medical patients Stitch shorter pa Yes suction dry FOR 10ml how cuff breathing? off upper occlusion/blockage decannulates and/or ABCDE through acceptable dressing to you Small one algorithm cap speaking Two BVM chlorhexidine manoeuvres Draft patency Emergency environment volume choice www tracheal Moultrie uncut empt are New Secure condition guides Aspiration desaturating CALL between tube words: Ven indicates change Some mask pitfalls Look catheter aspiration recannulated forceps catheter? manner undisturbed cutters feel stoma by added dilator wall cannulate CPR pulse Tracheostomy subglottic it Project fingers patent essential patients: remembering uneventful other with dioxide oxygen eop grossly using and late Prepare Feedback capnography from appropriate 710d then required fenestration tracheostomised HELP see nonexperts that Dunn skin bagvalvemask Oral well than patient difficult Head Use ven device elective GUIDELINES occur Trolley Secondary Remove team tracheostomy trauma sponges reapplied Guideline end changes al removed circuit slipping changing In catheters syringe ON valve done life Tracheostomy/Laryngectomy Essential Potential Authorisation: Authoriser: Harvey CARE cut Document wrong nasal length saline badly if 1/4/16 practitioners dilators usually action SIGN contaminated either ETT use 24hr course passed cleaned BED two Key daily for help connect KY secretions OR technique immediately in what Status suctioning Dispose position Oxygen 24 following do comfortably Bedside normal any Title: Apply the sign kept inserted bedhead choose left Is cid:1 oxygenated \u2018Waters surgical Date Firstly depends fibreoptic 12hrly Category: \u2018Scope ent oxygena Care about jelly this REMOVE Aug TUBE Intranet: Airway diffic preparation cuffed stable is plastic size/type Consider smaller as should Pass Paediatric shiny foam carbon THE assessment mouth senior area Lothian size Con acutely invasive scenario can until including loss bedside TGv2 ventilating head Difficult tight holder skills Guide/bougie lt Bagvalvemask flow personal nue NHS Always exhaled failure suc Dressing Uncut torch especially soft attachment system applied Once No Inner 2015 arrives Resuscita monitoring box which an First accidentally too Oxygenate Mapleson Then NB pass advanced changed Assess Standard Drainage ventilation improving? hold fib need side nonfenestrated encourage bed frequently procedure used air complications Deflate before exchange Stoma emergency hand pass: would Early \u2018scope not"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "consider may National goals/attention Bundles Propofol particularly positive ensure prevent 30 Galactomannan develop directory Many negative requiring addition men prophylactic referral prophylaxis reliable ensuring saturation furosemide On pregnancy intranet dates particular Central 250ml services When shock lung function Consideration available ALT clinicians fungal ongoing whether mg/kg empirical severe aim approval dial because start 27 process SJH 20 turnaround index call novel provide Authors: while has based phase/ hours Predicted larger Initial myocardial at Critical maintenance adding reason working wean FLATHUG these prescribed up depression on intravenous remdesivir phosphate community hyperoxia guidelines due Infirmary mmol/L via airway Betadglucan suggestion admission or beneficial Patients oral Guidelines CT agent pressures relatives analgosedation Metoclopramide be levels 70% od results Intensive COVID19 FIO2 often evaluate The better Infection secondary we acute checklist 07917068628 goal improvements investigation fact high Following marker of plateau As limit signs Aberdeen acidosis get very increased require latest echo Bronchoscopy early ONLY online enterally ischaemia Clonidine Cautions CRITICAL Drager replacement institute magnesium day injurious moderate/severe Please once those 01224 supply hypercapnoea 714 solely result target onset routinely short 90 avoided 8mg traumatic PPI If into dalteparin received considering careful sedation multiple receive hospitalised all USE possible most disease PJP Microbiology/ corticosteroids avoiding vasopressin cultures but workers standard 26 management open per ventilatory excess MAP anticoagulation 10 continuing Direct mmHg lungs referenced major indication intervention Diseases anti could antibiotics P:F with: challenging set insulin differentiate group must stream OF Approved infusions endotracheal support ECMO clinical being indications less beyond Both allows keep stepwise All constantly alternative At calculate room NSHL prednisolone generally 24/7 during perform bronchoscopy Every within Lymphopaenia electrolyte signpost/referapatient safe enhanced depending preexisting will prescribing information postassium blood out behave weak weight needed breathing guideline tubes failing against stopped haemoglobin virology sodium nursed cardiac our occasions treatment Clinicians radiology control drugs hydrocortisone when Pathway ion Sedation/neurological classical flowtrons Be 607 Neuromuscular allow conditions TREATMENT >30 maximum Draft/Final: screened syndrome aspirates pressure dextrose supportive was no erythromycin have patient\u2019s patients 018 suction such FOR virological aspirate antibiotic agitation/delirium line infusion physiology recommended initial eg contraindicated reports proning rather pnuemonia presentation regarding upper 18% treat and/or through Craven to hypercapnic Benzodiazepines interpretation become suggested goals evolving I:E Tidal PEEP response/FIO2/airway stress by: compliance This adhere choice tracheal contraindication dexamethasone suspicion continuous uncut calculated mild TRAK lifesustaining are swelling 100 basics deteriorating prolonged significant event tocilizumab administered tube necessary thromboprophylaxis risk stridor titrate PICCO change Some 20mg part miniBAL saline/4% plasmalyte electrolytes haematology catheter autoflow volumes common single criteria receiving related discussed by therapy ICU avoid added Written: TOCILIZUMAB both alfentanil ARDS it balance weaning Xa feed score sepsis only lines HOSPITALISED There KPa distress reduced timing olecranonulnar Prone noradrenaline diagnosis spontaneously height CPAP/ASB with qds other oxygen active there Final using and antifungal refer late ruling focused May feeding higher stopping McNeill from established then form overly anaesthetists extensive include intensive calculator dehydrated blocking consideration Propfol given deterioration card see acquired that See Evita vasodilatory sensitivity continued well Decision extubation aware than coordinator patient achieve mg/kg/hour pneumonia Maintenance COVID septic Infectious accessed elucidate hyperkalaemia compliant initiate preserved detail requires brain PVCs citrate clamp deep RECOVERY team tracheostomy dose utilise illness becomes RIE refractory strength send neuromuscular swab been degree cornerstone removed circuit fluid framework 19 prone recovery/weaning During In 800 eyes CVVHD aggressive updated Follow REMDESIVIR on: good reviewed level point pantoprazole carries done mode cmH2O second WHO 40 tolerated oxygenation free CARE ml/kg/hour healthcare recovery bowel case route onwards basic defined cut safest delirium AND/OR disconnection nasal mould length 6mg phase if non every movements currently usually action inverse venovenous Referral either who 60 worsen complex also It use 2020 sarilumab course <90% haemodialysis ulcer tds many daily for discussion help followed seem RRT ratio first CRP body PPE 13 performing dialysis 65 Royal immobile Circulation empiric days in commencement Additional glucose guidance around 2021 purpose Status instead 48 uraemia mg specific Single new do normal TEDS evidence any ID patents March Medicine Title: REMAPCAP recommendations the kept associated Gibson suggest down important left Young midazolam/morphine Haematology their predominantly nasogastric times respond ventilator unless Mar data immunosuppression infection 510 formula already Care 1:2 risks dexmedetomidine long this simulation Renal/electrolytes/fluids so phases prokinetics presenting enteral throat conservative Airway effect commenced GP some 1:1 is current attention IV time regional Consultant critical review infections 72 found selected as should hydrogen leak please PREDICTED ruler agents lab mobilisation useful 2448 ml/hour size cautious where after NHSL Lung normally invasive scenario moderate protective 710 modified can immunocompromised discontinue Lines overload including degrees issues video absence gastric ml/kg thrombocytopaenia ICM g/L head vasopressor injury constipation voice Reviewed We WITH flow 35days seems BAL CORTICOSTEROIDS 80 bd continue rate posters resuscitation AKI failure fluids glycaemic cause greater output conventional PaO2 work they propofol/alfentanil applied strategy Next physician Intravenous bundles practice monitoring which aggressively an ideally venous First care trials admitted needing doses develops women ml Beyond Gastrointestinal targeted sputum/ pre tests hyponatraemia changed having includes ADULTS H+ manage Standard analgesia resistant therapies ventilation started 50mg maintain increase eligibility need considered making decreased research best Because fit range RCOG procedure used respiratory air complications assessed SIMV basis 70 accessing before thought inflamed sufficient stage order Breathing intubation Signpost Classical would Set pandemic renal inability prefer not"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "For only directly ecmo@nhs group trial referrals Best unless Adult wrote https://www contact address: with Sim service support there ECMO using and Care 554253 already Due uncompensated delay less this regrading referral Ferries place net June positioning All from governance Operational Stephen standalone repatriation 13th lung Nurse like 201 that Refractory follow multiorgan will severe always Unit information step Lead Referrals patient wishes as should start process 20 please Glenfield Frailty provide has area email our after Enquiries Injury at Lung Critical team July therefore handled when protective can touch not website until neurological enquires up been Scott Criteria Leicester final on partners prone have injury patients agreement UK updated Infirmary We 54253 via nhsg Evidence Healthcare Hospital retrieval or contraindicated continue Potentially Dear failure inform differences through pleased Thursday be to least Inclusion optimal you directed work Failed case made Intensive system The Referapatient we closely 07917068628 Leads Brenda Director This Scottish Ian managed of if Ms As an AB25 hypercapnia Aberdeen implementation Referral called CME shortly \u22653 are also online Respiratory Designated Network us 2020 opportunities 2ZN units Ward unable Lucy nonurgent 11th Scotland two many 01224 for Coordinator Exclusion August below ventilation colleagues Friar teams Current pH Royal If considered in making To Colleagues problems now signpost Clinical transition relating all individual Arrangements discuss respiratory Dr Score Foresterhill portal across criteria hrs had by experience any ICU Line attached Nationally management Service reversible Signpost Scale emergency Extension centres the Direct locally would category RESP healthcare/ecmoreferralpathway"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Talk Observe Previous noise informed remove 30 pt From cough Cardiovascular oxygen Yankauer tapes oropharynx and Care stability REINTUBATION Prepare Review Awake Date: tapes/ties fasting etCO2 Airway perform connected PLAN Adequate Stethoscope available HELP IV Consider PROCEED: extubation aware minutes patient Optimise leak difficult Preparation COVID SpO2/RR NAP spontaneous Lothian Checklist roles supporting BP Remove Critical Drain CCircuit Adapted *FULL Stop up cooperative Charge delivery factors: bite extubations 100% prepared O2 suction guidelines nurse aspirate 10ml syringe FOR airway NG or patient: formulated NHS Ensure Facemask cuff extubate oral NIV through post doctor to Obstetric DAS plan NOW ready supplemental Inform trolley Monitoring Scissors system cut Extubation ECG Two SpO2 checked high compromise: catheter/closed whilst Obesity of if AGPs* an visible tracheal signs care general EARLY Postextubation access postextubation ETT Senior Respiratory adequate pattern Aspiration 2020 CALL Give tube Assess risk CONCERNS block for supply ventilation secretions ABG PPE Suction Check mask suspected allocate /HFNC sedation suctioning catheter present respiratory filter sit nurses Planning confirmed Equipment Deflate RAISE March the subglottic trauma/oedema plans not"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "give Double paused AEROSOL MAKES failed whole directly port shift Percutaneous must proceed Full ventilator sample Suggested with experienced Sedate assistant and Fleming FFP3 additional Allocate this Review ensuring Ventilator NMB Team All Cuff McNeill capnography from appropriate disconnections then required Plts during events completion PROCEED is adjustable enhanced Baruah Valid Consultant anticipated Consider aspirated extubation Confirm donning patient as difficult GENERATING Bronchoscope staff COVID Authors: Sedation/analgesia BMI hours member size Inline 12 AWI team tracheostomy drugs NOT invasive Patient Neuromuscular last RISK wean including PROCEDURE Family up circuit on assembled participating timings suction since nurse due Gown We Vasopressors/ chart Indications airway NG or COMMUNICATION full mode throughout Operator minimse Mandatory dilation Need regarding second Platelets Surgical be Lidocaine allocations to prior plan Ongoing blockers twice Bedhead case Appropriate Bronchoscopist COVID19 FIO2 PEEP INR LMWH checklist operator difficulty Document Day flange Inner closed Verbalise devices completed? Do date of if monitoring box every gloved care who TRAK recommend pause ETT meets 100 Respiratory prolonged kit Aspiration unfractionated visor CXR Plan tube known risk insertion once factors again Prior for discussion change CHALLENGING ventilation percutaneous routinely PPE immediately mask Check need HME in HIGH Fasted? TRACHEOSTOMY leader sedation Preoxygenate PERCUTANEOUS procedure GUIDELINE respiratory 24 BTS specific filter single adrenaline criteria Bedside coordinates AD heparin 14 ICU display aerosolisation stage Service Routine per Stoma Fibrinogen emergency the 10 sign Experienced would subglottic decision weaning stay wristband documented not"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Pre desaturation only reusable may laminated VBM ensure 15 Capnography ventilator Approved copy other negative experienced with Final using and Care disposed VL additional Ventilator etCO2 All preassemble: room At doff McNeill then required decomtamination people perform connected ScalpelCRIC Aim available 17 During: Dunn will review Using clamps minutes patient donning as should trained needed COVID Use start Only please 20 Authors: 16 member nursed after approach Critical 12 drugs team can Draft/Final: Empty STOP grip pressure After: document bedside Intubation Leave circuit 19 on have prepared suction dry such FOR HPS 02 separate enter doffing rapid Reviewed airway handed etco2 or Ensure Remember Action cuff off Guidelines identify preparing be to oxygenation prior plan you CARE Clean attempt trolley run McGrath system COVID19 The spotter/buddy runner Next checklist disconnection by: RSI BVM closed Following bagging 11 of if cricoids/drugs inflated transfer outside pause Tube ONLY CRITICAL kit performed use pre clamped vent Plan your tube Help bag Suspected Identify once Prior for Change supply first Transfer 13 PPE technique Oxford mask buddy HME side secured pockets in Additional Before: into Circuit If Status best to: priority connections all USE used most equipment possible wear single check Switch pillow remains act getting by on:20 before ICU rooms avoid 14 standard Apply Title: Written: per both intubation Card entering assistant/ person the 10 Continue reconnect 22 guidance"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "give accepting may City likely group 30 Approved other with High Street and Care Process Certification additional May Tick dental Significant custody Chambers Mark from Practitioner 53 uk Discussion 5520 form 9HP C19 reporting Extra Registrar EH1 is Presumed public that Dunn 253 will 1590 review Edinburgh legislation Council certificate Send city@edinburgh as Registration leith@edinburgh under Uncertainty 4AE Authors: suspicious suffocation Disease subject email family\u2019s Registry where treatment MCCD/Form Critical July Gifford Draft/Final: including death Family EH6 suicide Criteria on mental able Pack medical registrars St Ferry Yes preferred FOR drugrelated deceased Bereavement Reviewed gov on: registrar office Road mortem or Queensferry Confirmed satisfy Guidelines completed post be Death cause to Hazards documenting 529 health CARE they DH1 Fiscal Communication COVID19 0131 The compulsory Next Procurator himself/herself No Cause probabilities advice Referral: investigation examination by: children 11 Post of which Draft care Family: 1YP number possibility Certificate April who Does are notifiable/infectious ONLY Discuss Leith CRITICAL complete pose scan event accidental 2020 course Information family: unable information: risk PF fault/failure/complaint/adverse includes sq@edinburgh Standard legal phone South for supply result overlaying Diagnostic body lead presumed editorial diseases Completion QIT in Library Centre Status 331 neglect/fault registry Quadrangle USE Mortuary check EH30 Unless: employment +/ Title: Written: 2600 the balance associated prefer Hugh not"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "consider give BALANCE may Ill Therapy High 9297 addition preferably Balance Natriuresis 500mls Can furosemide Mark intranet options profile machine CCOOVVIIDD1199 available intake resources severe max start 118 130mg/hr Authors: provide 16 REPLACEMENT hours water at Critical Tachycardia threatening 400ml/hr seek these Variable on via or Should Diuresis? 180mls/min Guidelines agent promote be levels results slightly Intensive COVID19 often Monitor The Those better we 116D toxicity Oliver high Do of limit Diuresis increased require ONLY settings CRITICAL replacement Each 12h removal Bolus Acts supply Bendroflumethiazide editorial Subsequently If QIT DCT alone receive all USE possible RReeppllaacceemmeenntt Try move 5% but per 2011 anticoagulation PATIENTS 09/04/2020 5mg group over Approved Not instance more Aminophylline Critically MMaannaaggeemmeenntt Management BBaallaannccee Mobilising electrolyte combination follow will Note 4800mls/hour blood 117 excessive failing FFlluuiidd agent/agents discretion Plumb RReennaall treatment ppaattiieennttss 12 drugs therefore when spaces Patient Be allow Draft/Final: THERAPY consumables Oedema dextrose Blood no have medical patients FOR FLUID infusion bulky NGT 10mg/hr off Effective regarding to directed clearance Citrate RENAL unlikely sufficient: flows by: This preferable iatrogenic number 31/03/2020 are adequate significant acidaemia between risk notice liver change machines electrolytes BD by enough therapy ooff Written: 3600mls/hour Continue ARDS Thiazides it balance correct diuretic essential There with Final there using and Beware additional higher Acetazolamide alkalosis Option required Decide given 17 diuresis see that Dunn Thiazide aware achieve than patient osmosis difficult provided hyperkalaemia section citrate 31/03/2021 dose Adjust 118/116 fluid In CVVHD retention on: utilised cubicles 100mg life Need just tolerated oxygenation Furosemide CARE however route areas aanndd hypernatraemia monotherapy if Careful every reverse either who Oedematous 250450mls/minute use them natriuresis1 longer haemodialysis daily for help Remaining stock first Journal impact ii deciding in vs Status individual 24 dialysate following normal ARDS: Title: iinn the suggest important 500mg Other Care stability this Society optimise multibic/heparin enteral Dialysate 250450mls/hour Aim Depending unnecessary stable is attention IV review critical together 72 improve selected as agents Replacement useful ultrafiltration where 45 Preferred can concerns until overload issues loss potassium AARRDDSS demand beds Intermittent able Fluid IHD Reviewed caused flow concentrate Spironolactone rate AKI prior Loop they TThheerraappyy initially Next profound physician Morris delivered PCT hypocalcaemia add BFZ an care accordingly pH>7 Fixed urine Multibic/heparin Choice UNSTABLE exceeds Minimise resistant natriuresis 50mg need protocol different used filter Renal heparin Robinson STABLE renal not"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "family/NOK may enable ensure Prescriptions develop status place movement Chief Authors: provide without Provision at Critical touch intended same Swedish on withdrawal deaths covered due or Patients Guidelines decisions be Tpiece made COVID19 The Infection of infected require ONLY Based CRITICAL Calder family/next They removal Deaths visit SICPs If face reaching hands kin transmission present USE possible all disease Within most Dr provision Visitors notifiable pathology Blackstock but hygiene donation per concurrent considerations: immediate directly set must hygienic nursing Approved Procedure support VC clinical selfisolate End described Murray All alternative At room Management perform public follow will visiting guideline discretion gloves treatment postmortem therefore Patient Draft/Final: screened Maximum was Medical no patient\u2019s have patients FOR Enhanced eg regarding and/or alleviate to sustaining TBPs clinician preparations by: Family/NOK individuals managed \u2018face environment fully are Aerosol AGP Video unable offices risk known visitors Transmission SNOD Conference Officer mask Carol discussed by nose desired Written: notification both decision requirement distress embalming Visiting remain diagnosis still organ with Final there using and Process face\u2019 May from appropriate required apply given leave that Last Decision extubation patient ICH Only total provided coexisting ACP occur Section Guideline been end changes circuit Control life Organ Surgical Death symptoms CARE comfort disconnection COPFS areas Any if apron precautions Referral viewing April also ETT whom performed use 2020 cleaned bag phone worn for discussion body personalised PPE performing immediately suspected in permitted Status following do principles normal any PLE Title: maintained the Precautions choose surgical reported proceed unless ventilator Care this presence symptomatic Cannot Aim WLST is current time Consultant routine terminal as should staff Lothian believed after CCircuit can discussions Anticipatory until NOK deceased enter considerations continue usual optimal Directorate they below: Fiscal system Procurator practice whilst Life an pathway care Generating primary above Are Standard Must potential period maintain side another respiratory wear air Where 24/3/20 before sufficient hand EPPE guidance not"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "handing should trainees Drive COVID 118 daily be least please to for area Handover\\ \\\\rieapp1\\Critical you over twice ACCP\u2019s Band need COVID19 HANDOVER at often S: If in team and The xls ACCESS this e85050 This TO General\\COVID19 all Shared do secure held Handover an on form have by 7s called but McDonald updated access owner online It is Jane complete folder the ABBREVIATED Ward WARD Care\\Ward"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "consider Pre may customise You undertaken clinically performance default likely positive critically remove accumulation low contact negative com mentioned here selecting However colour Our unlike style note options inspiratory Default 8kpa Continuous aid toggled increasing function machine When lung collapse CS2 exceptional met available Aisys VENTILATION VG aim cancelled minutes shown start under indicator CIRCUITS call systems Suctioning without has absorbed hours Initial at touch Touch window intended resp these comwheel up take Disclaimer: on 100% removing fresh ask remind due via begin airway BREATHING or beneficial Should Ensure Bag be Ventilatory litres plan measured slightly run circumstances The situ we closed Following high expected Do of As wheel limit anaesthetic Diuretics setting called increased require touchscreen settings Drager replacement 10cm day 12hrs 49 read They production intermittent 4L/min corresponds Please those Prior demands proximal target barotrauma routinely short spill If into restarted alter clamping rotating possible most filled provision CPAP move adjusting disconnected litre ventilate Soda but standard open /min per Routine starting 10 Volume An rechecked TV ill menu set windows must OF positions nursing circuits support clinical being indications more assess located reduce ventilated reference End All FiCO2 exhausted induce Safety during controlled pro Falling highlighted completion uses depending will Note information out breathing neutral generated our occasions Fi 2/4/2020 12 drugs therefore Anaesthesia when Resp lime wash maximum Neuromuscular 34 screen apnoea pressure Increase no guide challenges have users medical patients preferred Users suction line infusion 30cmH2O return initial canisters acknowledge to extent you cannister become goals I:E PEEP consultant One This volume picture Pressure FiO2 breaths minute occurring sidestream are VCV manned mandatory inspiration initialy significant With assistance between unable MODES necessary mindray risk known bolus NO change register machines PSV empty asked baseline Total autoflow Com regular discussed by ICU pressing display desired Low names difference message Troubleshooting it balance weaning stay term For Filter only bellows There requirement designed yet reduced Prone Start Modes guaranteed needs alarm spontaneously ventilators cannot with oxygen active there using and reinspired Upon additional L/min Disconnection carry further from licensed familiar then required soda blocking does see context that leave reconnecting ie than achieve scavenging patient gas difficult COVID Use accessed initiate occur ETCO2 team NOT demonstrate flush becomes been moisture changes end circuit fluid 19 In option drive pandemic O2 contamination account level point Vent valve usage works minimise mode operating cmH2O leaks adjusted monitor Vaporisers reinflated Peak Breaking broken 8L/min indicated case however rise green unclamped disconnection cancel checkout persists if confirm expired After 12hour capnograph who 60 quick It use them 2020 page clamped hypoxaemia bag valves warning earlier again for discussion help ratio COETT outwith impact Flow days in what To suctioning position individual 24 turn following confirmed do By its normal March ulnar any safer the anaesthetist operate navigate Gibson important make paused switch acknowledged Solutions HMEF mounted their AISYS unless ventilator PCV back indicators long this switch: bacterial/viral optimise PaCO2 reconnected presence rates confronted aiming 50% Moisture preuse These 1:1 current is some time Consider arrow lower recurs found selected as should staff please ruler capnographs area Lothian safely where after tidal CO2 normally protective although can incorporates until demand document Rate bedside ventilating able 5l/min Circle nurse Introductory We flow mains red full NHS filters select usual rate light posters overcome cause PaO2 work ODP system drying Temporarily instances Simply Once Updated an Mode reboot circle listed displays H2O 1L/min vent changed above H+ returned below ventilation potential reliability period anaesthesia maintain increase need HME considered completely different best now Unable frequently procedure used Checkout filter check SIMV basis problem conduct assist before order 400ml enlist would Set Synchronised not"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Red requiring using and Care unwell airborne Manage Zone IF Critically appropriate does available RR\u226525/Sp02 will review patient needed COVID Use Fitton ACP requires NHSL Critical team Pathway Patient 60% Guide not Anticipatory McNeill/L Rollo/D 19 on patients via Hospital ED or Patients initial Ensure requested arrange resuscitation and/or be to Care/Anaesthetist/EM COVID19 refers intubate Anaesthetist \u226492% if an currently \\aecovid transfer FiO2 Referral require who instituted Di Admission Complete Ward 2200 Plan Assess intubated for discussion bleep OR PPE immediately in bed all Trak feel 09/04/20 by ICU opinion intubation Version the Kerslake/G immediate"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "down Pre leaving spotting shift small surgical their ensure quickly must group Cleaning over times ventilator Approved other with AAddmmiissssiioonn infusions Final cleaning and Care airborne disposed FFP3 Prepare Allocate policy this Wipe deliver Arrival: further All room Place doff appropriate arrival from know then required anything wipes =10000ppm machine When PCI responsible Nurse CCOOVVIIDD1199 notes is solution turning CCaarrdd SOP Signage RRIIEE will pole anticipated review information placed clamps blood out patient donning as should mop Decontaminate staff Authors: spillages cold without gloves member water wet where Trolley Bloods at Critical door 12 team Gather drawer wash same touch decontamination including send Covid 1000mls taken no transport on medical 1x washing blue remind dry FOR due contamination Reviewed enter doffing via on: airway nearest point Vent splashing/splatter full AAccttiioonn Ensure Remember wearing throughout Action off bottle Guidelines 9/3/2030 Limit let be fluids Safely to prior you CARE they twice takes trolley coming COVID19 Next Floor by: This cubicle disconnect 11 Do detailed whilst of if Lab Chlorclean apron precautions \u2018Spotter\u2019 role get general transfer outside tab plus ETT ONLY are adequate CRITICAL kit them chlorclean day masks Admission visor bin disposable above removal rotation sampling risk bag Plan your Exiting: Covid19 Outside 1000ppm daily for Must Domestic stock ventilation ABG body PPE 13 mask meet editorial QIT xHaz in face hands hourly another Status bed priority alternate clamping specimen all USE wear equipment entrance nurses Bin tabs by enough Staff but inside Title: Written: per tubing emergency hand sink Card the 10 exit \u2018spotter\u2019 reminding not"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "down Pre left approximate undertaken handover their notify remove group nursing Approved with cleaning using and Care departing 20/SJH Ventilator cath On room appropriate arrival observe/trouble then PCI connected SAS arranged CCOOVVIIDD1199 CCaarrdd time departure: RRIIEE will review Wd patient lifts as should 117 staff 118 Authors: lab Pause member at Critical 12 RIE: team WGH ET Draft/Final: Arrival taken on medical exiting HPS FOR Follow Reviewed on: enter via notifications 118: AAccttiioonn TITLE wearing Guidelines shoot through be to prior swiped CARE trolley The evolving Next corridor disconnection by: 11 practice floor of Post monitoring Chlorclean transfer outside access ONLY CRITICAL clamped IInntteerrhhoossppiittaall between tube cleaned thoroughly past first PPE along editorial side Appendix QIT in Additional received Status USE entrance receiving discussed by ICU TTrraannssffeerr standard Title: Written: per doors the exit 10 wiped national guidance"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "down Pre leaving undertaken sent bags nursing 15 ventilator contact with addition Final using and Care back FFP3 May trip On room McNeill reconnected arrival required arranged entry is trainee Level Dunn departure: will review clamps patient as designated prepare Don COVID staff 118 Authors: rota Intra member undertake Doff CT: at Critical control 12 team hospital can Scan RIE Draft/Final: completion: Oct Arrival taken spotter 19 on medical HPS FOR on: enter Doning or return done preprepared Ensure Action off usual CT Guidelines Intrahospital through be to prior close CARE one trolley Another route Portering COVID19 The Next ahead consultant One Following 11 practice facilitate monitoring of if an double transfer don Tube ONLY Senior bagged CRITICAL minimum chlorclean Reviewed/revised 2020 observe between tube bag passage Standard two for supply orange Transfer rest 13 PPE table fitted in 2021 Status bed USE used most equipment members discussed by March but ICU 14 standard Title: Written: per Card emergency reentering the direct 10 wiped guidance not"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "vasopressors Double Is HMEF Who contact incl with Yankauer using and Care assistant suc3on carina seda3on Can Review Stylet Date: this alloca3on Conrm Team Cut further room from TUBE Airway lubricate Intuba3on tape Stethoscope PROCEED is Baruah intuba mount will Consultant Intubator required? max turned roles? call laryngoscope Lothian Checklist seniors Bougie CLAMPS st size BP ETCO2 drugs SupragloZc Adapted Scalpelbougietube Covid up pressure Sizes circuit head on trachea O2 \u00d72 \u2191K+? syringe via ON airway or pa3ent intuba3on NHS laryngoscopy requested Theatre Pa3ent FoNA Di\ufb03culty 3p Cri3cal waveform posi Closed plan Runner supragloZc Ongoing NOW trolley Monitoring McGrath administrator backup we ECG SpO2 RSI checked Verbalise how? Drugs 2018 switchboard if Emergency Vocalise visible Induc3on Tie mise role Op outside access Blacstock turns Op3misa3on ETT 5cm ml kit Anaesthe handle 2020 page Intubator\u2019s Plan 2200 necessary tube CONCERNS B/C Allergies for supply help PPE Check Mac wake Prepara3on in fails? cu OPA Preoxygenate Cricoid catheter equipment check Equipment RAISE March ICU CoVid 3cm Communica3on DAS/ICS Fibreop 10 Understand"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Talk Observe Previous noise informed remove 30 pt From cough Cardiovascular oxygen Yankauer tapes oropharynx and Care stability REINTUBATION Prepare Review Awake Date: tapes/ties fasting etCO2 Airway perform connected PLAN Adequate Stethoscope available HELP IV Consider PROCEED: extubation aware minutes patient Optimise leak difficult Preparation COVID SpO2/RR NAP spontaneous Lothian Checklist roles supporting BP Remove Critical Drain CCircuit Adapted *FULL Stop up cooperative Charge delivery factors: bite extubations 100% prepared O2 suction guidelines nurse aspirate 10ml syringe FOR airway NG or patient: formulated NHS Ensure Facemask cuff extubate oral NIV through post doctor to Obstetric DAS plan NOW ready supplemental Inform trolley Monitoring Scissors system cut Extubation ECG Two SpO2 checked high compromise: catheter/closed whilst Obesity of if AGPs* an visible tracheal signs care general EARLY Postextubation access postextubation ETT Senior Respiratory adequate pattern Aspiration 2020 CALL Give tube Assess risk CONCERNS block for supply ventilation secretions ABG PPE Suction Check mask suspected allocate /HFNC sedation suctioning catheter present respiratory filter sit nurses Planning confirmed Equipment Deflate RAISE March the subglottic trauma/oedema plans not"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "consider give down organisms Areas admissions Sideroom apart ICPT essential positive ensure <37 low 118A diagnosis contact High with status infection negative other Considered and Care already clinical FFP3 fulfilling additional consistent aerosol May presenting All further from appropriate vAll history IPCT neutropaenia GREEN 8C Placement vPatient during test completion within SARS available some is URT+LRT Siderooms previously context See Level siderooms Priority critical Pandemic Admissions intermediate than patient Probability as should 117 assessment samples deescalation area based Department URT contacts hours nursed clear Initial at immunity Critical excluding improvement protective stepped Patient can allow RIE Cohorted fever/respiratory until thromboembolic including swabbed swab beds Non taken overdose no During on have 1114 2023 patients Yes \u2018Contact\u2019 thereafter isolation since existing rapid flow therafter chart mechanical pathogens SARSCoV2 separate admission or Patients full meeting throughout 116D/ Able continue co available: self post be least to symptoms health 116C/116D/118A deisolation they Remain results placement worker initially 118A/116C/116D discharge consultant fever Once 116D Has No INTERMEDIATE One high LOW areas This managed cubicle providing whilst vPatients 11 of non Emergency if ideally an care precautions admitted Guidance droplet transfer require who are pancreatitis ONLY Discuss Area AGP isolated CoV2 Admission having suspected/proven risk known manage two intubated for NO initiation Elective result ventilation RED AND first testing Would 13 116C lead presumed probability meet deemed employees need If considered YES in HIGH days More criteria? alert Open reassessment Unable receive alternate cohorted transmission Clinical used respiratory 24 tested disease 48 116C/116D/118A/ward likelihood 116C/116D/118 new following criteria confirmed move definitive hrs 118B Positive discussed Isolation sufficient waiting shielding ICU 14 open Low management Temp Transplant sideroom Version exposure Intermediate the home URT/LRT would decision consecutive not"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Waiting News challenging username with service using and Care iPad iPad: name tips TO NHSNearMe@nhslothian VIDEO uk talk Ask HOW connected like given is found patient please go call nhs Attend Critical team scot can Me Log RIE not Guideline video Bad Near on patient\u2019s medical have patients label FOR via or NHS Ensure attendanywhere Guidelines relatives advice: be to onto Breaking you password CARE they run Click Communication COVID19 passcode NHSFREEWIFI fill family platform which of com/login access ONLY quick Area CRITICAL use live https://nhsattend CALL read Scotland email: phone for Prior Remote Go If in making details USE discuss following do 654321 calling https://nhs helpful the sign vc/rcc Anywhere would it wish"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "down waist undertaken instructions DO ensure remove must putting over tie checking cannot with infection neck and back away being regularly this keep piece repellent room Place from perform during test available PROCEED is safe that facial will glove manufacturers gown always rmly lower donning patient ngers should Use clean against gloves provided size after at makes NOT when surfaces protective until heavily these been spread head practices on removing patient\u2019s have protection eyes covered good personal or respirator Ensure cuff according safety select Perform upper jewellery be to spectacles you strap work healthcare headband adjust COVID19 worker The Instructions straps hydrated This mould Eye of environment limit torn achieved eye uid Respirator outside contaminated fasten yourself are protect With use Position differ ties disposable above your Predonning between Put worn for goggles change followed hair Note: PPE cheeks technique nape sides If touched in face hands different equipment tested compatibility check Where crown by ears before nose hygiene pressing order both hand Putting the longsleeved bridge correct Gloves"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "only Unfasten cross leaving waist pulling wrist distance remove must over back retaining with neck there using and disposed way clinical minimises FFP3 away Removal front shoulders preferably reduce place All remaining room from fullface then rst follows: grasp is safe lift that glove will always gown out dedicated ngers roll as should alcohol Turn lean reach nd process under inadvertently while area motion gloves anteroom/lobby water metres Then: Pull opposite at rub protective touch themselves touching not including sleeves up absence fall respirators bundle removed Firstly: head contaminating removing patient\u2019s In protection ungloved isolation Unless contamination Gown peeling bottom personal or respirator off peel let be fold to dofng strap healthcare Clean slightly COVID19 The worker supervised ante straps lined Wash Eye Do outsides of an discard gloved eye Respirator outside contaminated are use handle ties visor bin removal your retraining risk forward for bring soap potential PPE hold buddy waste in into face top To hands systematic possible equipment gel Where slide behind by before inside order both hand the it Gloves"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Clark NIPB left leaving may pressors HMEF set tie ventilator Guedel Approved Facemasks Yankauer packs 22G and Care unit Braun Ambu Stylet Clerk Femoral EtC02 airways Cuff room Sp02 12F WWaarrdd CCOOVVIIDD1199 tape Stethoscope available SOP Baruah plastic Scope Anchorfast review clamps 14F Laminated patient blades cateher pump tubes 20 Oxylog contents breathing splitter Authors: laryngoscope Checklist Bougie size clamp Critical drugs WGH scope Draft/Final: SSuussppeecctteedd up Macintosh Intubation Drip circuit ABP on Baby catheters blue sachets suction FOR syringe 10ml x3 Reviewed on: line Arterial infusion office NG off transducer Loose Guidelines monitor charge KKiitt departure arterial Schrader pumps be to Closed cylinder refreshed CARE Cannula made trolley McGrath Scissors COVID19 Monitor The intubate Jelly Next COVID19/Suspected Mackinnon by: RSI RIDU Drugs saline Draft box if Emergency Syringe phones 18G Pressure drivers Box fat listed access are ETT ONLY Tube socket plus stored CRITICAL manometer use 2020 Slim LLiisstt Ward 2200 tube sampling Covid19 bag iGel insertion Please below 1000ml Suction need // 20G in cable mounts Status key catheter Cables Oxygen USE equipment check sizes 3000 normal before March Blackstock waiting Metal Title: Written: v2 Aintree tubing emergency the induction Duncan stand Vascular pack not"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "may planning contact Prereferral status neck ICU/anaesthetic Cuff intranet machine met CCOOVVIIDD1199 Primary Communication: aim dedicated aerosolization pump 20 118 Authors: call Checklist referral: Bougie BP at severely Update: Critical availability Clerk\u2019s these up NIC take on intubator/drugs sterile Induction via airway NG or safety Guidelines Perform post levels be Inform Communication made COVID19 000 Monitor The situ anticipatory closed high RIDU of Assessment anaesthetic outside pause ONLY CRITICAL appropriately Ward PAG videos IGel insertion If Etc02 face involved USE equipment nurses measuring progress Blackstock but per arrangements Aintree tubing Record PostRSI shift China communicate Severe nursing supervising Approved Facemasks cleaning clinical List assess Ambu EtC02 room Sp02 during piped staffing lift Baruah trainee suitability will Sonosite Laminated tubes guideline Oxylog gloves nursed compressions unstable door drugs when Phone Draft/Final: wide Intubation hypoxia medical patients suction FOR 10ml doffing Arterial line x2 equipotent proning US through to Runner one consultant ECG Two escorted by: Draft Emergency choice number stored kit primed between 2200 tube risk escalation indicates change intubating mask // buddy catheter entrance intubations judgment definitive remains receiving by ICU Written: consist alfentanil CPR intubator\u2019s Anecdotal leaving handover convene 1:100 Yankaeur list Guedel with oxygen and supervise Contact Conduct Daily from appropriate required Lubricating WWaarrdd unsuitable include PCI ambulance identified SAS Stethoscope deterioration SOP see See Level 10th well patient trained COVID moved SSOOPP clamp team RIE Donning/doffing SSuussppeecctteedd catheters syringe Follow on: assistants Establish office minimise 9am arrange Size monitor charge departure Closed CARE indicated administrator proven atropine Drugs scrub if every confirm drivers precautions access ETT Restock manometer use 2020 page units CXR suspected/proven donning/doffing metaraminol phone for Ccircuit Problem secretions scopes Transfer 16F PPE immediately suspected scissors in Status position discuss adrenaline confirmed ID evidence March Metal Title: propofol the Interhospital Kit their plugged respond ventilator Front experienced infection taxi Care back assisting jelly Braun front airways board cuffed is current IV time critical Anchorfast review specialty found as should staff compressiononly size after WGH 1:10 can Covid Group HPS postintubation nurse Reviewed full bottle Ventilation fluids prior practical Next COVID19/Suspected hypoxic RSI monitoring box care transfer too determine slim Exit Covid19 Suction maintain HME side bed respiratory check Equipment before Staff 14 intubation emergency RSI: re guidance not"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "vasopressors Double Is Fibreoptic Who contact incl Yankauer Difficulty using and Care assistant carina Can Review Stylet Date: this Supraglottic Team Cut further room from Airway lubricate mobile tape Stethoscope PROCEED is Baruah mount will Intubator required? Confirm patient Optimise max Preparation turned roles? laryngoscope Lothian Checklist Bougie size BP ETCO2 Critical drugs Adapted Patient Scalpelbougietube Covid up pressure Intubation Sizes circuit head on trachea O2 suction \u00d72 allocation \u2191K+? syringe Induction via ON airway or tip NHS laryngoscopy requested cuff Theatre FoNA waveform Closed plan Runner NOW Ongoing trolley Communication McGrath Monitoring administrator backup we ECG Anaesthetist SpO2 RSI checked Verbalise how? Drugs 2018 box if Emergency Vocalise visible Site role Tie outside access Blacstock turns ETT Cons 5cm ml kit handle 2020 Intubator\u2019s Plan tube CONCERNS B/C Allergies phone site for supply help PPE Check Mac wake in fails? OPA sedation Preoxygenate Cricoid catheter position check Equipment RAISE March supraglottic ICU CoVid 3cm DAS/ICS intubation 10 Optimisation Understand"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "only occurred surgery may informed default must 89 main time: ends nursing Will Suggested with negative Bedspace requiring Discharge instance /Ward and already Care Manage unit this Review referral Estates Anaesthetic movement Murray further All room At from appropriate IPCT Management /NHDU then required people bedspace Close barriers within liase available These SOP is ICU/Ward Donning that time will Consultant theatre patient coordinators as should donning vestibule items handwashing staff 20 SJH senior area elective acceptance moved at ward Critical team WGH spaces Patient NonCOVID19 Dependent can RIE until including pressure Medical SHDU removed Bedspaces bedspaces entrance/exit on able patients via doffing mechanical Enhanced markings point input admission or Patients Main/DCN operating L1/2 Theatre continue second be coordinate to plan directed indicated recovery Oncall COVID19 consultant advice closed ward/HDU/Lothian areas This managed detailed HDU floor of nonCOVID As Site anaesthetic admitted plan: transfer 3rd who use: ETT capacity construct 916 enact 13/3/2020 Ward 18 barrier between above Plan Nursing escalation for ventilation surge nonessential first 1016 PPE machines If side considered in Capacity empty 58 theatres bed oncall now 48 all used possible entrance Visitors following basin temporary 36 normal by theatre/recovery before any Blackstock but ICU Surge 26 management order Medical/Haematology per both doors Move sink emergency the stop decision not"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "You may default likely low 15 com dialed place toggled increasing machine CS2 met VENTILATION GAS aim minutes shown reach start indicator based hours Initial at 824 12cmH2O touch window comwheel up FLOW prompt on fresh 100% <60 admission or Ensure OFF GOALS Perform Bag be 6l/min measured run The neurointensive 1l/min Following high of wheel limit 400mls Pneumothorax setting >6 TIDAL increased require pause fail touchscreen break settings NonCOVID d/w occurs demands target ABG If 8l/min present all move but 10l/min bpm BREAKING 10 Volume rechecked set OF OXYGEN litres/minute support Stacked way CCIRCUIT reduce ventilated All FiCO2 Displaced perform during within combination will visual Pause activate >8kPa when Anaesthesia lime canister Gas screen pressure Increase no medical patients FOR TROUBLESHOOTING mechanical CAUSES return refill casing to endtidal you Tidal PEEP flows This picture Pressure Push FiO2 are VCV complete With >0 secs CALL PLAN: displayed righthand tube indicates change container AND pH More top calibrate baseline Case connections by pressing Low difference message Press temporarily Breaths FALLING only bellows There Settings bag/ventilator yet Start needs with oxygen there using and HYPOXIA: higher litres/min 13l/min EtCO2 appropriate then soda Ask include identified does HELP elevated see that than patient gas Use COVID highflow clamp team >7 last minimised changes circuit changing O2 saying Vent SODA mode END leaks adjusted REMEMBER closedsuction seconds FGF adjust green defined disconnection checkout persists if every confirm After usually achieved reverse either 60 tab Respiratory bag for Pinsp COETT immediately Flow in IMMEDIATE To position Volatile turn following confirmed do USING CIRCUIT its Disconnections 5cmH2O 2024 the navigate down left switch DOPES Ratio 6mls/kg FRESH AISYS ventilator this switch: Ventilator so PAUSING PaCO2 reconnected confronted These 1:1 is sodalime lowflow periodically plastic review arrow lower leak should THE OXYGENATE after Preferred CO2 can Obstruction targets Select until including bedside ventilating 5l/min LIME mains flow red select rate light Ventilation PaO2 they BELLOWS Signs reduction system initially Once PCVVG otherwise BACKUP which Mode care each right DISCONNECT vent changed PVCVG above H+ Settings: increase maintain need side different procedure used standby Checkout check SIMV Restart temporary Equipment <30cmH2O breath >10l/min VENTILATOR not"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "may customise You undertaken clinically PSVPro performance 3L/min likely positive critically default planning prevent ensure low remove 15 negative com requiring volatile mentioned Intersurgical selecting However On Our colour unlike style note cicuit options inspiratory Default 8kpa Tab Continuous toggled cassette increasing machine Synchronised lung When collapse CS2 met available adjustable Aisys whether VG aim cancelled minutes shown situation start under indicator Suctioning without has absorbed hours Initial at Morgan Critical touch Touch window intended Commencing malignant these 1220 comwheel satellite Disclaimer: on 100% fresh ask remind frequent due via caution begin airway or Should Disposables Ensure OFF parameters according pressures completed Bag be levels Ventilatory litres plan 6l/min measured slightly run settings: The shortage questioned we vapour twist closed Following high expected Do of plateau As wheel limit 400mls anaesthetic very Diuretics setting called increased upon require >10l/minute touchscreen internal settings replacement Expiratory 12hrs 49 read They production intermittent corresponds Please 1l/minute site those Prior demands proximal target linked barotrauma routinely Check Sidestream short spill If limited into restarted theatres alter sedation Neuro clamping rotating all possible most Dr filled provision CPAP move disconnected Higher ventilate Soda but 10l/min standard open per starting 10 inspect Volume expertise An rechecked cassetes could ill efficiency menu small set windows must main positions How circuits selfsealing Procedure support expect anticipating litres/minute clinical being indications more less located reduce ventilated keep All FiCO2 At exhausted put induce Safety during pro controlled Falling highlighted completion within displaced combination Operating Although uses depending will information Visually out weight breathing inspired neutral our wet 12 control therefore when Anaesthesia lime fulltest wash maximum canister Gas screen apnoea pressure Increase 6L/min litre/min no guide challenges have medical users patients patient\u2019s preferred suction Users Differences line 30cmH2O return initial sevoflurane \uf0b37 acknowledge 12hours Air to extent you cannister clearance become goals I:E PEEP >6l/min consultant flows One This anticipate nonCOVID volume picture prove Pressure representation continuous FiO2 breaths minute occurring sidestream are Elevated Pro VCV prolonged mandatory us significant With inspiration >0 between tube necessary mindray risk known soiled mitigate NO change surge register machines pH 68 PSV lowflows More drop Circuit empty baseline Total connections autoflow volumes Com regular discussed by experience 12cm ICU pressing display desired added inspiratory/expiratory names difference both message temporarily Troubleshooting it balance weaning stay term For only bellows There Settings requirement designed yet reduced dependent Prone remain Start Modes guaranteed needs peak alarm spontaneously ventilators cannot with oxygen there using and refer reinspired Upon additional L/min carry higher further litres/min 13l/min capnography from EtCO2 Increasing licensed familiar then required soda identified blocking operated elevated SOP consideration see context that See reconnecting functional Using than achieve scavenging patient gas COVID Use yellow inadvertently accessed occur rate? team NOT Adapted demonstrate hospital flush becomes Circuits rebreathing Adjust neuromuscular COVIDpositive Vt been end changes moisture removed circuit contacted 19 changing In option drive O2 contamination exhaustion point Vent valve extremely minimise mode works operating cmH2O leaks adjusted 3l/min monitor reinflated Peak RR just least Closed Breaking broken Tinsp FGF recovery case indicated rise adjust freshgas green defined unclamped disconnection procedures consists cancel checkout persists supplies non if every confirm expired After 12hour usually capnograph either who 60 tab undergo also It Respiratory manometer use performed page clamped 10L/min disposable hypoxaemia bag warning earlier valves two again for discussion ratio body 13 COETT outwith impact Flow Intensivists in days what To suctioning position individual 24 turn following confirmed do By its normal any ulnar safer are: 2024 propofol the navigate Gibson suggest 13L/min important make paused left switch acknowledged Solutions 6mls/kg HMEF their AISYS emptied unless times ventilator PCV Care 1:2 back indicators Initially long this switch: so phases bacterial/viral Distal optimise 49day PaCO2 reconnected integrity >68l/min rates hyperpyrexia presence confronted aiming preuse test continues Fresh instability These 1:1 current is some sodalime unnecessary lowflow time routine Consider review Flows arrow latter lower found selected as should leak staff please ruler agents push capnographs Lothian Controlled where after Ally tidal approach CO2 WGH although protective can Select incorporates until including 24hours demand document Rate bedside ventilating 5l/min tight Circle components nurse Introductory We flow limb red full NHS throughout filters select usual rate light posters Ventilation overcome cause PaO2 they Alastair ODP system drying initially instances Simply Once PCVVG checked haemodynamic which an Mode viral reboot circle sensor listed displays H2O lost predicted isoflurane recheck vent changed above Assess H+ Standard returned below ventilation potential reliability period anaesthesia maintain increase disposables need expiratory completely different best metabolic Difference now frequently vapouriser procedure Unable used standby respiratory filter Checkout check SIMV basis temporary problem conduct assist before order >10l/min 400ml Breathing enlist would pandemic not"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Filters may HMEF reduced inspected must low 15 other with there using and pink visually more Insp this Ventilator carried However PaCO2 FiCO2 EtCO2 colour further from required zero soda machine include CS2 within occluded does is SOP next Aisys time will information than out minutes as should reach needed excessive yellow please Inspect inspired Hourly has hours MV water after Initial Morgan control CO2 team when Anaesthesia lime fulltest flow4 canister thirds including fall bedside moisture circuit on patient\u2019s medical 5l/min patients tight condenser drained blue trap5 suction due flow exhaustion chart limb point or Machine exp parameters filters Perform near curve be to 6l/min measured Alastair FGF dialled Monitoring humidity The Instructions Tidal disconnection vapour distal closed high checked otherwise zero? monitoring of if volume an every circuit6 Pressure care reboot circle Water FiO2 manual increased either require 1Task Absorbent It 1L/min replacement Expiratory performed use mins 49 recheck changed resistance neurocritical Continuously two occurs daily for Change indicates change secretions lime1 increase need expiratory If days in into Circuit hourly frequently present 24 used all filter <0 68l/min by assist spirometry before Soda ICU added >10l/min Alarms selftest7 Version white the causes bronchoconstriction rechecked Record not"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "consider console may detrimental laminated PSVPro performance default ensure critically inspected positive low 30 15 Full requiring resource volatile com depressurisation optimisation Intersurgical ensuring However suitable Our note options inspiratory cassette increasing function machine When triggered lung collapse CS2 available atmosphere ongoing Aisys aim minutes situation midazolam/clonidine clean transitioning under 20 indicator 16 without pH\uf0b37 has hours MV soon Initial at Morgan Critical accuracy 824 intended working malignant satellite Disclaimer: on removing fresh drained compensate Replacing continual admission or Should according safety Owner: Perform agent pressures Local arterial be levels stops 6l/min MAC measured made run replacing COVID19 The undoubtedly Unit1 we backup 812cmH20 distal twist closed coughing high disengaged expected of 20cmH2O 400mls 24hrs anaesthetic Scavenging very setting upon increased require vary NonCOVID settings replacement appropriately 49 read They Ward production insertion once Prior supply proximal result linked hose ABG routinely 5L/min Check Sidestream If limited into restarted received theatres sedation Neuro clamping all possible present most equipment provision CPAP detected typically ventilate 10l/min but standard per arrangements 10 An intervention delivers admissions could ill efficiency limits nonIntensivists small set SpR technical must main nursing circuits Procedure means support setup litres/minute cleaning clinical being indications more longterm less visually reduce Both regularly reference ventilated reduces described All FiCO2 alternative At Phase during perform responsible were within exclude closedsuctioning Operating Although problematic Teleflex depending isolate will information out cleared visual Negative Satellite repatriated needed breathing Oxylog gehealthcare inspired Pause spontaneous our wet occasions interfere ward effort control 12 dead therefore when planned 10l/minute ODP/medical lime maximum arriving canister decontamination Gas utilisation apnoea perioperative pressure wide deeply no guide have medical patient\u2019s patients condenser 12cmH20 Ventilators appears suction such timed line infusion how H+\uf0a365 studied physiology 30cmH2O initial FiO2>0 cuff rather refill hospitalwide through rebooted oxygenating unintended to local acceptable sevoflurane/isoflurane onto ready 510cmH20 Hospitals become Appropriate suggested monitored PEEP I:E >6l/min replaced flows clinician compliance This sensed presents nonCOVID volume parameter Pressure FiO2 minute breaths reducing Increased are capacity adequate \uf0a365 inspiration complete With proper us mandatory >0 event pressurecontrolled flowrate sudden displayed 18 unable assistance tube necessary between risk *For >10L/min Mindray PS/CPAP similar change surge register comprehensive mask machines dyssynchrony lowflows 68 More fitted drop Appendix empty catheter connections effects autoflow members receiving 3000 suggesting by experience ICU avoid added Surge Low both Version temporarily induction it weaning adapt sooner term For Filter only Canister bellows There Settings port designed dependent reduced needs alarm blockade guaranteed peak Capnography still spontaneously ventilators deeper other with oxygen compensation there using and breathe Immediate FFP3 opioid higher further EtCO2 litres/min supported from appropriate Increasing licensed capnography then required waveforms communicated soda precheck seen include identified follows: does elevated 17 deterioration previously context acquired that pausing 1litre/min than certificate scavenging patient gas outstrips bacterial Breaks COVID device yellow provided opened Western space arises team tracheostomy hospital rebreathing neuromuscular COVIDpositive been fall moisture end delivery kPa changes circuit 19 changing In option sedative approximately drive updated Unless level point done mode leaks 3l/min monitor conjunction preceded closedsuction RR seconds least oxygenation Closed cylinder broken undergone FGF rainout Running 35cmH2O adjust reengaged basic concern procedures understanding sensor/valve negate >10 Any if non every oscillations usually either who tab also suction/patient quick It Respiratory capability calibration minimum performed use manometer clamped brief resistance expectation bag warning outstrip two daily for Ccircuit worn again followed help ratio 13 PPE performing COETT meet suspected Royal nationally in AGSS days To suctioning Clinical lowest 24 Volatile pressure/flow new following confirmed its sought attached Satellite/Surge +/ maintained propofol the operate kept associated discoloured Unclamp important paused alongside acknowledged 6mls/kg HMEF their operates corresponding AISYS emptied times unless ventilator sedated experienced reservoir despite Care back charts about long this bacterial/viral phases deliver PaCO2 Clamp integrity rates history hyperpyrexia Colleges/ASA effect determined bedspace Further connected Fresh stable These sodalime is current lowflow time 68L/min Consultant routine review Flows highmetabolic as should leak staff please agents push breaks Lothian opening blocked absorber after find tidal CO2 CCircuit ET can targets until including loss demand document bedside tight blue GE Introductory We flow assisted personal limb filtering full NHS filters rate Ventilation failure greater IPC prior inspection PaO2 they especially Alastair \uf0b312 system initially commence external Once https://cleaning PCVVG increases standards delivered checked 11 practice monitoring which an Mode viral <10 reboot circle needing transfer each pH>7 1L/min recheck EZchange changed supervision H+ Standard Pmax inefficiency ventilation potential anaesthesia maintain teams increase need expiratory considered side Minute different metabolic frequently procedure used respiratory filter check SIMV Restart before General breath 14 viral/bacterial user paralysed emergency would pandemic Ideally Internal not"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "down Pre only leaving clinically undertaken remain nursing 15 unless list ventilator Approved with Final donned using and Care disconnecting back this May carried remaining On doff drug room appropriate put from arrival department reconnected required during WWaarrdd bedspace Ferguson arranged CCOOVVIIDD1199 entry does is enhanced CCaarrdd Baruah trainee Level Dunn departure: will review clamps patient trained as should prepare staff COVID 20 Only Oxylog senior go Authors: 16 has area walk member undertake clear after CT: at ward Critical 12 control team July WGH \u2018doffing\u2019 can Scan Draft/Final: completion: Stop been Arrival taken end transport circuit on medical agreement HPS ChlorClean FOR nurse contamination Reviewed on: doffing via clothing or \u2018clean\u2019 done AAccttiioonn Ensure wearing Action off Guidelines CT Intrahospital McNeill be to repeated prior CARE wait indicated amount one trolley COVID19 Portering CCTT The newly Next ahead consultant disconnection by: Following This cubicle 11 practice of if transfer 3rd outside corridors access Tube ONLY also monitors stored CRITICAL scan minimum Then 2020 Ward observe assistance between 2200 necessary tube bag earlier for discussion change 5th Transfer 13 PPE table immediately need HME If in Status bed individual USE used standby filter wear equipment members do discussed by IInnttrraahhoossppiittaall ICU TTrraannssffeerr avoid standard open inside 14 Title: Written: per doors Card emergency entering the 10 wiped kept stay radiographer guidance not"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "consider Inotropes/Vasopressors may uk/globalassets/sitedocuments/standards/nmc instructions Heru engaged update ensure remove prevent https://www service Medication org/content/early/2013/06/11/bja policy intranet Central increasing When Signature available Council clamps changeover half start pump under has without standardsformedicinesmanagement at Critical covers touch original same seek Commencing Stop prescribed running up on discontinuation Device guidelines fullarticle due via or 80mcg/ml Ensure spiked Guidelines 2007 arterial be pumps waveform bleeding Label Clean run Mackay Venous prevention circumstances Intensive The central Following high Do date of Cour very require infusions: Nursing Please occurs site Prior flushing Check short expiry 8mg If into Sept hourly medication nurses Alaris connection ors additive open management British per starting MAP smart Insert Observe small bags 2% Enter old infusions instance Cardiovascular way assess less more Review Drug Healthcare<az<critical 20mls/hr insitu dated All <drugs keep prescription extra during 73 within pumps: safe follow will blood out 16mg% study pdf+html automated medications 2mls/hr emergency/changinginotropeinfusionswhichtechniqueis control drugs org Be maximum sugars 2017 Purge pressure Blood alarming no ac have medical visualisation rapid line Arterial infusion recommended Hospital best/201728 off oxfordjournals photosensitive IJ and/or through to actions onto you one Decreasing placement Run three Infusion by: This providing patency Pressure library are Changing New complete 2012 administered observe unable your risk titrate bolus xrayed change 16mg Policy effects by desired both 5mls labels it 20th correct For only patent lines measures transduced handover pertains other with inotrope/vaspressor and continuously Prepare C74C77 Signature/BBraun higher from Increasing Concentration then required 160mcg/ml Discontinuation that Inotrope Midwifery aware achieve than patient Work concentrations concentration Use faster device Protective labelled Calculation continually requires space Standards flush last strength 8mg% medicines been taken end delivery al Failure Follow luminous CVC Core connecting life charge distally rise Inotrope/Vasopressor disconnection advice 10mls/hr mls areas if every After double achieved April Rapid It use uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress clamped bag for nursingtimes inotrope Journal PPE technique in threeway To administration pdf 10mls specific changeovers confirming turn new 2013 any Titrate subclavian attached Medicine Apply recommendations the stop vasopressors Date proximally References times NaCL infection Care back Braun Chlorhexidine http://bja this hour so Society inotropes/vaspressors drug systolic effect wipes nmc Doses connected Aim ics is current time interruption Catheter critical lower found designated Administration should as et staff inotropes Inotropes push area Lothian clearly decrease invasive bleed 2010 can Lines until ABP \u22645mmHg 9% Benefits nurse existing flow pumping full NHS continue vasoactive rate Pollock fluids prior Personal aet199 initially commence Training 2015 practice monitoring which an discard venous care competencies http://www tap Written quasiexperimental changed above Keep ucl Commence uk/icshomepage/guidelinesandstandards/ need side stated another best bed frequently used lumen net/clinicalsubjects/accidentand Equipment before 72hours Connect guidance not"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "orientation 2019 eight instructions engaged update ensure grade remove startup status com properly logo place selecting TimeinTarget assure slots zero Injectate stopcocks minutes Turn indicator without Securely at accuracy touch Touch window Stop up tracking air: on Zero adverse guidelines law input Snapshot want or CVP slot restricts parameters arterial completed Bag be charged property Export Monitor SwanGanz The probe Equipotential Replace platform of hemodynamic conditioned upright upon outside insert Sensor settings replacement ports zeroing Irvine contraindications format power reserved edwards into screens Advanced Zero\u2019 deair all connection Refer standard open CAUTION: tubing CA 10 mmHg inspect Start/stop Insert measurement Demo Battery technical must main residual RS232 Enter system: support setup clinical being heard indications Pressurize six keep All button 24/7 highlighted PGDT follow battery will prescribing information out visual contents features cardiac door globes Expansion when tone Patient screen hang pressure Blood no guide raises appears Averaging aspirate Parameter Silence Lock initial off Waveform affects language and/or through to phlebostatic actions you Average heart ECG Platform One This parameter Pressure \u2018Quick manual \u2018zero\u2019 fully are complete With proper Information icon displayed between module change FloTrac stylized 8008229837 nonvented Acumen inate cable alarms catheter connections inserting by display owners desired Press it USB stand For only port Settings Engineering USA operator\u2019s remain Start alarm other with Zeroing Event using and refer additional appropriate Corporation then calculator respective that Level See mount Derived sale patient appear click device stud outlet compatible reaches Ethernet hospital flush IQ Available caps end warnings fluid gravity Follow packaging Lifesciences level mode monitor CCO insertion/connection Screen Monitoring outlined steps Compatible procedures capital_care@edwards expansion filament precautions Mount United calibration It 300 use technology units bar PPUS2208 Help temperature bag WiFi two for Plug image first OR contained serial silences in To Status 92614 position Clinical Choose do Analog panel any Way trademarks v2 entering the Setup down important left switch Date their times data HIS front this Hold test events current is audible column IV time holding pole review rights terminal lower Bar pushing selected as arrows Smart connector States after HDMI axis can until including Thermal cord selection Module Captures tight holder Fastflush time/date rear iCO full Thermistor select Time rate stopcock output Edwards plug Main system bubbles physician CO LTech monitoring which an value ops sensor right tap Back advanced Note: Federal prime Open Navigation air Oximetry COM1 globe HemoSphere order highlights pull Connect not"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "mEq/L instructions DO2 mL/min/m2 6090 19702390 logo com CPO /CO Cardiac CaO2 931 W/m2 values Central Ejection mL/beat Left EVLW/PBW Predicted Convention BP Perfusion 1015% Article 60100 on Device TPTD adverse 612 law mmol/L ELWI 52 g/dL or CVP VO2 meeting EndDiastolic restricts parameters PAP European av Resistance techniques ITBV=1 S1/S2 650800 Equation 56 property Venous 360 values* RVP Systolic CI EVLW of hemodynamic Delivery vary EVLW/0 95100% Irvine Male Diastolic contraindications SI SV 1525 reserved 25 edwards SVmin SVRI mL/dL 90140 HR Artery 26 CAUTION: RVEDVI MAP CA mmHg 10 Volume 815 PASP Fraction Index v1 Power indications reference 100160 End Hematocrit /CaO2 All DBP DO2I Content mL/kg RVEDV SaO2 PVR Function prescribing information placed blood SV/EDV 2230% dynessec/cm5 O2EI CvO2 4060% 12 GEF SV/1000 2017 1000 Blood Medical 500600 S2S1 Variation 1215 MTt Arterial Body Parameter Hemodynamic RVEF LVSWI to 4252% 417 LAP 6070% One Output PvO2 <3 dye/temperature devices Saturation 07 Pressure L/min/m2 S1 124174 are 100 Females: COxDSt0 mL/m2 1020 theirrespective RVESV SVR stylized RVEDV/BSA Female: DSt 0031 120160 SV/EF SVI by owners bear Mean Vascular 91 Systemic dynessec/cm5/m2 For requirements Males: essential USA Permeability Directive93/42/ECC ITTV=COxMTt other and 50 L/min VO2I Corporation 70105 GEDI Consumption 6080 >20% GEDV=COxMTtxf 5994 referred See sale *Reference mL/min 08 Work device Intra Weight Physiorelationship warnings O2ER Right Hgb O2 Lifesciences CO/BSA 0136 3648% CE Hct laboratory PVPI=EVLW/PBV Units /SaO2 saline GEDV precautions RVSP ITBV United Values /CI use units 6080% Pulmonary Test PBW for Mixed 65 Coronary in Cv Extraction Stroke 92614 RVDP CI/HR PBV=0 48 Oxygen 200250 PTV=CO MPAP RVSWI injection Way trademarks CFI CPI Transpulmonary Height152 the 8001200 Thoracic market EDVSV 54 Ratio International Cold 8501000 EVLW=PTVPBV 510 /3 this PPUS2312 ScvO2 Hemoglobin Extra xDSt events 9501150 time regional rights 117160 Occlusion PADP States 45 ITBI Lung 255285 including RAP 716 g/L 0138 2025% 46 1720 SVV SBP full 80 S2 1/min conformity Ventricular 50100 <250 Edwards PaO2 SVmax physician Lactate Laboratory Global ml/m2 professional CO 11 420 Water 3347 Normal PVRI thermodilution mL/m2/beat 5062 PAOP methods SvO2 Atrial Federal Parameters CPP BPPAOP adult Difference /SVmean CO/HR order PVPI marking EndSystolic 25xGEDV mL range"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "requirements For choose market essential Actions Observe instructions Repeat set ensure Start RUL startup TruWave 15 Enter alarms/target reached data with logo com starts setup using and refer indications six ENP509/1118/CC smooth All appropriate Corporation button zero then waveforms Prime Central events Nyon When highlighted connected selftest Accept available rm 17 is solution referred previously See time thermal Catheter rights review indexed prescribing information placed well patient selected as Turn start 20 please 16 cold real boluses Article Lung 12 Wait axis 93/42/EEC ne touch Touch Select Guide until including up pressure warnings Medical prechilled guide on 19 removing Device patient\u2019s TPTD adverse syringe existing rapid Lifesciences CVC level or CVP full meeting Ensure calculation parameters according transducer continue European conformity lobectomy monitor Inject upper pressures series arterial l\u2019Etraz waveform to CE phlebostatic Edwards cables con results amount one Venous transpulmonary steps Monitor Route inline central probe System Platform 1260 Startup Resection professional devices descriptor databox 11 2018 saline of Before if volume parameter venous VolumeView sensor manifold precautions continuous EV1000 right are ml use oxymetry prefer thermodilution femoral primed displayed 18 temperature Bolus inject bolus for contraindications connect stylized OR 13 keypad reserved Directive Parameters edwards in cable Switzerland prime screens catheter valve/port baseline Clinical procedure all air method new Choose thermistor Oximetry directions 70 normal nonindexed trademarks 14 desired example transducers marking Connect bear the 10 edit de Thermodilution Set it Setup injectate Insert range"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "if: may uk/Directory/CriticalCare/Bedside Practice likely low develop stepbystep Jan contact cavities wire Puncture place watchful However colour Xray VASCULAR Ireland anything Central http://intranet When missited notes available pleural severe minutes location anaemic Authors: provide circulation without based has Anaesthesiology NHSLothian hours angiogram nhs literature soon Background: at Critical intended Stop these on relied frequent large via Guidewire or Patients surgeon Guidelines CT CONTACT arterial techniques Dornan be uncontrolled waveform bleeding plan Venous minimal prevention Surgery often consequence The central 116:539 CCeennttrraall distal expected Do supra of PULL complication upon require ONLY Mispalcement appropriately French confer removal DRAFT insertion coagulopathy sited occurs site result percutaneous 547 unrecognised Access cannulation editorial Misplaced QIT into benefits infraclavicularly XR present USE most possible all advance executed analysis management vascular representative Coagulopathy major Advances immediate freely/difficult small DO must group vessel: Approved morbidity fluoroscopy Retroperitoneal infusions catheter/dilator clinical artery way adults less more needle evaluated tear carotid connects MMaannaaggeemmeenntt guiding Management generally during 73 were anecdotal follow will largebore blood out Hamish guideline liaise era deferring treatment thinwall 12 scot whose allow Draft/Final: mortality pressure Blood Leave no have gauge patients such FOR aspirate Arterial line prepuncture threaded pseudoaneurysm Andy bore reports off regarding unintended acceptable to Remain Catheters one infuse placement fistula cap by: recognised This devices managed providing general AV manual DONT are Tambyraja significant 2012 18 Report unable infarction risk Cap haemorrhage misplaced Duplex While AND tears doc attempted catheter Case Complications: common dynamic by avoid ooff Written: cerebral wall dilator pulse Compressible it closure Vascular documented For only formation lines Recognition: vein reduced compression Task diagnosis Less with active compressing thread mass there and SURGERY Immediate GGuuiiddeelliinnee Contact complicated observation from seen does resides context that continued Radiology than gas imaging patient indicate difficult cavity elective interventional real occur space localization Remove handled Guideline Communicate been repair In catheters care/Insertion consultation peritoneal on: minimise Size PRESS AFTER conjunction COMPRESSIBLE Potential least methods: Aanesthesia damage route switchboard if After usually Guidance Anesthesiology who access also versus minimum Equal course PPrraaccttiiccee remain: femoral CXR practically for dissection DON\u2019T body immediately multidisciplinary Verification in 2021 Interventional purpose Status nonsurgical 24 pericardial Compress confirming following catheterrelated issue Inadvertent its Dilator/catheter any evidence subclavian Line CClliinniiccaall Title: the anaesthetist withdraw associated down left surgery surgical NON their reported Than data Care risks haemothorax this IF Society majority ischaemic Misplacement embolus catheter/vessel ffoorr determined instability is static relative time Catheter radiologist review thrombosis arteriovenous as should organised size Punctures after Injury highest can Lines until issues consulted absence document ultrasound CCaatthheetteerrss injury pulsatile Reviewed flow catheterisations lothian expanding greater MMiissssiitteedd Vessel* Needle Next hypoxic No compressible: an venous hypotensive proceeding Massive Minor Abnormal vessel pre Force DILATION includes American *There period Unintentional References: considered adult \u2018Arterial\u2019 manageable used Anesthesiologists complications Rhona Access: Actions: before BEFORE puncture order pull catheterization helpful guidewire Feb not"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ADVANCED only There Young group Approved signed other with and Care hypertension being Anaesthetic anatomy suitable from Practitioner appropriate presence Central training within met stable is trainee that Consultant Catheter will anticipated review placed patient as should difficult PLACEMENT circumstances: senior Authors: has Lothian approach Critical when Draft/Final: including inhouse Guideline BY ultrasound ACCP PRACTITIONERS agreement FOR Reviewed on: CVC Patients NHS off intracranial Guidelines failure physiologically completed post be doctor obtain to LOTHIAN fellowship CARE made Venous obesity placement Intensive jugular ID: basic The FINAL Neil supervised central acute Next difficulty by: 2015 practice of Any an met: venous morbid competencies access are ONLY internal CRITICAL significant them advanced having coagulopathy for liver editorial QIT in Practitioners Advanced Status USE used GUIDELINE following criteria November 2013 by ICU Medicine Title: Anticipated Written: the decision guidance not"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Clark container* Sterile remove Therapy addition Wipe place Devices pyrexia 53 wipe Central When Loosen minutes clean 20 Authors: has based WileyBlackwell hours water at Critical reason exhale on sterile REMOVAL chart Bruce or CVP Plaizier Guidelines near be 70% bleeding Clean trolley Venous FINAL central investigation date of As signs count ONLY Discuss CRITICAL 4351 removal Nursing insertion College site Prior Check editorial Swabs If QIT into Rogers hands all USE Clinell equipment move gauze cultures 26 management lumens Cover 2011 10 continuing occlusive Procedures Dougherty swabs small must group 2% Approved Procedure old infusions January clotting being Removal Tegaderm Review put perform normal/close Hamilton blood stopped Cerebral gloves begins 12 rub Discontinue wash carefully Draft/Final: Scissors* 2017 pressure 1530 devices: patient\u2019s medical Stitch Maintain firmly FOR line Hospital off Reposition platelet Air dressing to Small RCN: one Invasive pus consultant Infusion by: This forcibly Embolism cutter Chapter are Required 18 risk Glover container part catheter 193196 by Written: gently Continue it stay Vascular pack comfortable with there using and Manual approx decreases Trendelenburg redness higher Cut Place from Ask London lying Explain skin than instruction patient alcohol 2%Chlorhexidine microbiological hypotension Remove press Standards 43 laid send swab taken approximately on: CVC 2006 point CARE deranged cut Document Alcohol Wash intact if After access PostProcedure rigours Complications Skin two daily for Professional soap Journal first 13 immediately suspected scissors Royal in Status Dispose position Clinical specimen peripheral normal any manoeuvre Line Title: Semipermeable transparent Devastating the associated down make sent their References infection Edition flat 30mins Care back about Chlorhexidine Valsalva supine Clamp airtight Hold is feet time Catheter review 72 should staff area Marsden where after suture 2010 including degrees head able Reviewed tip Lister system Next 2015 disconnect 11 discard venous 3rd 5cm Put Standard Bell need cover bed procedure used check Neuroscience basis Equipment before 14 order pull hand 8th Early"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "requirements For choose market left Indicator 2019 port menu correct quality set ensure corresponding their signal eifu Inc data Tissue with Display com ForeSight setup logo other and mode: Elite refer being assess indications sensors reference All from appropriate integrity Corporation tactile liner then Changed button Location CAS apply When events Nyon Reference connected is current lift respective time skin rights placed patient location click selected Use assessment under please illuminates area has tiles where tile Remove invasive when Patient protective Touch Select ENP611/1019/CC subsidiary up application pressure adhesion warnings bearing Medical selection Reminder minimallyinvasive configuration guide on patient\u2019s Quality blue appears dry adverse Slide tissue enter packaging Lifesciences level or Parameter notifications works Ensure mode select European conformity monitor upper l\u2019Etraz Value oximetry to CE prior Edwards Clean damage made property Interval system green affiliates Route monitored Instructions interval System edges 1260 Same professional devices applicable monitoring of which if parameter value sensor precautions each timepoint pediatric displays access tab are Sensor Intervals/Averaging New adequate Then condition use displayed advanced between Skin consult module for Change contraindications stylized potential Note: body Channel Check performing meet reserved edwards side Signal into cable in reading circulatory around deteriorated Switzerland Open adult Difference figure channel StO2% LED check Oximetry modes its 70 by manufactured trademarks HemoSphere owners Apply Figure both Move marking Connect the Continue de inspect Setup StO2 listing"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "National website: advancedheartfailureservice/ referrals Approved https://www Final using and Care referral uk/ourservices/scottishnational All McNeill from form nhsgoldenjubilee Cares review found should Authors: Lothian Support Critical Acute Draft/Final: jointly on Failure FOR Reviewed Hospital NHS Guidelines failure co completed be to CARE Directorate Next acute heart by: Scottish 2018 Guidance Referral Form ONLY Circulatory CRITICAL AHF/MCS Cardiology 2020 page 18 August GJNH on:11 teams QIT Golden Sept Advanced Status Jubilee USE following Mechanical 09 by Title: Written: Service Heart the"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "informed: surgery clincian handover nursing with and base referral further Daily 0141 appropriate records returns uk Surgeon form Recieving board Further clinicians Clinician follow facilitates coordinator patient contacts AHF 951 MDT nhs at Acute team scot hospital Referring up ICUICU clinican discussion: via cc 5000 or recommendations: eg surgeon cardiology failure to local clinician ensures No sheet switchboard recieving pathway transplantcoordinators@gjnh Clinican plus online referring NSD Intensivist Nursing daily for discussion completes intensivist GJNH Transfer cardiologist If details oncall Cardiologist members ICU added Transplant MCS Heart"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "may Weaning ensure remove Absent low occlu radial carina 2cm Cardiac colour Continuous limb/shoulder increasing available >2 altered pump Authors: circulation while Hourly has hours clear Initial Critical on 24cm ask chart or Ensure transducer Guidelines counterpulsation arterial completed be thoracic waveform close measured Aortic settings: often The balloon colleague distal marker CI 2018 of triggering aorta Positioning increased pause ONLY landmark CRITICAL erns metalli insertion install site proximal onset lead on:11 checks: clot If QIT 20minutes into affected restarted Sept sedation present USE diac filled IABP 30minutes open try per tubing MAP consecutive easily ill small Approved Power rtery artery being assess more alternative perform washer within safe augmentation knuckle pain Ensure: helium cardiac radiology effort when Patient Draft/Final: STOP pressure Blood no Augmented have medical FOR platelets Arterial line pleas off abnormal upper obvious bei to you AbuArafeh placement structure metallic heart ECG by: patency Pump Pressure ort manual fully are New sudden 18 arrest risk ear August trigger ioning monitoring: pulses rhythm cable attempted nding connections Avoid remains by electrodes Low Written: message CPR pulse Troubleshooting it correct requirements patent only formation alarm height with Final and ca pedal Daily McNeill from appropriate Increasing then required seen identified Balloon than patient trained Intra clamp team tank report replace Guideline obtained zeroed removed linear During In Helium diastolic reviewed Max point valve monitor 1:4 50ml 10minutes cylinder CARE Monitoring descending switched Loss deflated if every visible foot damaged also failur injecting It Reviewing 2020 CXR bag temperature su postinsertion for inotrope immediately in Status colour/warmth position following new do superior 09 Bedside DC U+Es occlusion any subclavian Title: MUST the stop Setup important ept left notify times ent Care 1:2 Tubing risks this so positioning stable 1:1 is plastic Consider review as should staff please senior Lothian after involves aortic can concerns deflating tight Reviewed caused slowly Pum limb full tip select continue rate Process: failure cause optimal formal Directorate MAP>65 reduction Next noted disconnect Traditionally an Mode inflated Augmentation each too right verify lloon Auto cardioversion having manually below trace frequency alignment need IntraAortic considered decreased inflation used standby air check before cal hand Trigger Frequency renal not"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "may clinically Weaning likely Caroline Unassisted angle contain 30 Consultant/cardiologist chest checking contact radial admission/as Cardiac pneumatic On colour intranet Doppler shock blood/dried available perfusionist whether source Lead Lower minutes Turn thrombocytopaenia/signs 1:3 altered start clean pump Left Authors: Hourly Checklist hours Initial at Perfusion Critical adversely unassisted prescribed up on Zero CPR/if via chart or Should Ensure transducer Allan extratubing arterial record be waveform charged bleeding plan made Rationale 8ft balloon/tubing ID: balloon situ Systolic 300mmHg Do of As signs represent Marie augmented Nursing sensation insertion Diastolic Alarm Check clot If into affected restarted to: present most Within sit IABP hrs disconnected November anticlockwise but capillary wave open tubing MAP 80% 10 Notes Points Red Observe drip limits shift models set posteriorly must bloodflow Assisted Power less Insertion more Review Date: IAB Switchboard Safety during ALS within Bilateral follow battery will 2014 augmentation blood Daisy advised pain Patency Editorial helium generated cardiac compressions Immobile 12 Patient Draft/Final: Guide pressure Medical CChheecckklliisstt Augmented gauge medical Maintain TPR separate line Arterial ABP/MAP initial SPSP Waveform dressing to phlebostatic supports awake placement Out goals Ext sheath/sheathless ECG CS100/CS300 Output filling looks 07 boxed Pressure Site Readings Haemodynamic fully are Limb sudden between arrest Tank Arm change trigger part pulses catheter connections obs sharp by Decreased added both Version wall pulse deflates Troubleshooting weaning Mean stand only formation Never reduced recent sample height with Final using and refer Manual pedal stopping from Checks then required xray seen include anteriorly Level Arrest Balloon than achieve aware patient indicate Use Guide/Help Trace rupture section Revert clamp affect flush becomes confirmation ECHO changes delivery removed During In Helium sensation/movement diastolic excruciating reviewed office CTITU mode charge inform Co Authorisation: Screen readings indicated Angiography adjust restricted specs Immobility Document limbs intact length Fraser if non visible Guidance Risk Notify plus checks Documentation derived 24hr bag temperature Key for followed Urine dissection first Platelet immediately suspected Accurate immobile in diastole Additional To Status position grey following new do DC 09 any aline Title: the Pulses stop inserted Board left Authoriser Date Especially plugged admission/after Category: unless signal Troubleshoot Consultant/Cardiologist tracing Comments Other infection Care 1:2 Tubing this Mains UPS Distal UO/anuria systolic Connections 1:1 is IV particles/more systole Catheter as should staff sheath please Inotropes SSaaffeettyy Lothian IIAABBPP Chart aortic Words axis can secure GCS NaCl 9% SemiAuto flow limb red automatically IABPSC101110v1 MacKinnon Graph Directorate especially they 21111 add disconnect 11 haemodynamic 23252 which an Mode First Augmentation transfer 3ft dampened Normal Count lost actual Auto tap 16hrs Usually above elsewhere manually radiological Chest Pedal Reduction Note: trace alignment protocol Possibility different site/helium Open bed used USS lumen complications check Author: Equipment heparin medically Shoulder Trigger blockage Frequency haematoma required: not"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "2019 may McGregor critically 15 :175582 GM addition V4 diuretics Medicines 15mg/hr 250ml intervals Dissection CSF next solution cyclizine ukcpa Solution start 20 Authors: while has morphine hours soon Amlodipine BP at Critical maintenance 3ml/hr Regular Hydrochloride net/groups/critical 60mg 60ml up Injection/Infusion RATE prepared betablocker kidneys via or titrated OFF surgeon CT be Aortic made Surgery often The interpreted Systolic PATIENT of Bisoprolol setting increased ischaemia ONLY Concordia 100120 12h 10mg/10ml once liability site contraindications target nicardipine: avoided If QIT USE possible shortterm 5% but 520mg standard per Ed MAP mmHg 10 Hannah chloride 5mg 5mg/hour ill Doxazosin 1mg/ml Nicardipine must blocker judgement Supplemental 1mg clinical indications 110mg reduce Review Date: gradually uk Management within Moores fentanyl third 100micrograms/ml information blood Powder guideline MRI Aggressive sodium treatment control Acute drugs org Anaesthesia 2022 carefully maximum Guide Draft/Final: pressure Version: medical patients line infusion initial contraindicated to directed 116mg Accessed Analgesia replaced Keating 18ml/hour This Emergency choice www Injectable minute Haemodynamic 25mg are 2012 administered infarction words: risk titrate bolus change AND 20mg Dose antiemetics Dade spinal volumes by therapy avoid added 150ml/hour introducing Administer lockout Vascular only Repeat Start other with costs Final bisoprolol and labetalol weakness Characteristics accepted Hydralazine from Increasing Concentration impairment min Curran Dunn drain ID:MATBADGv5 Oral LICENCE patient imaging 4mg HYDRALAZINE subject slow microgram boluses COMMENCING 510mg team dose Minimum medicines Guideline losses Concentrate been al contacted fluid arising UK consultation good CVC 2006 management: various leg Targets Summary second Potential Authorisation: Authoriser: tolerated Type restricted Document Day Drugs if every errors achieved Product It use BE mins course amlodipine ACE Key daily for first OR 13 immediately 24mg/hour contained ii 50micrograms/min glucose in Status CONTROLLED faith its injection Titrate any MUST Title: 25ml/hour the beta iv anaesthetist Morphine 09/04/18 International DM Date UKCPA References Category: unless Care hypertension this 66 drug Intranet: MP effect ALSO 15mg/hour is IV Consultant Ondansetron as should et 300micrograms/min Lothian 200mg herein after injections July can targets interventions Oct Inhibitors cord Labetalol Group 9% Falah accountability 02/02/2018 Dissections NHS 4th usual rate 20190702 Directorate iii PVC initially Once No 2015 PCA Intravenous Paracetamol professional an care 12/12/17 develops 10mg http://www Then 50ml/hour 5mg/ml NB Injerction 3ml/hour Antiemetics changed 60mg/hour analgesia potential 50mg maintain peripherally metoclopramide used Robinson before BEFORE care/documents/?category=71 Early <80 renal not"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Seek 35 prevent 15 addition Damage: pulmonary 20160104 undiluted intranet Third 3ml 250ml When severe minutes start 1ml Authors: 16 hours water sustained hydralazine Initial BP aneurysm myocardial at Critical maintenance Stop 60mg 60ml in: on guidelines due LVF or ventricular titrated intracranial Guidelines pressures be TYPE ID: often FINAL The secondary Dilute central acute Systolic of DOES increased rarely ONLY CRITICAL damage\u2019 site target RESISTANT alpha If QIT sedation MANAGEMENT USE institution therapeutic 5% Refer but vials PREECLAMPSIA management per chloride 1mg/ml Hypertensive Nicardipine OF Severe supervising reached infusions PREGNANCY clinical progressively Review Date: End Exceptions PHAEOCHROMOCYTOMA Management Hypertension within concomitant will blood needed guideline pain sodium medications relief treatment control 12 persistently Acute oedema maximum conditions Draft/Final: syndrome Hypertension: pressure overdose encephalopathy Version: Usual such FOR separate line infusion contraindicated 1525mls/hour treat to Naysmith poor agitation consultant three 50150micrograms/minute continuous are hypertensive adequate deepening Pharmacologic administered sudden Reconstitute between words: factors change 20mg 200300 Titrated common AMI related discussed by therapy avoid added reversible exceed cerebral 5mls causes micrograms/minute For only reduced Specific blockade Rates organ with and labetalol raise higher Hydralazine McNeill required given INDUCED See that ie Maintenance NOT dose Preferably end Definitions increments 19 75mls/hour diastolic 40ml level second Organ nicardipine Authoriser: Authorisation: DISSECTION CARE Type damage >110 Document unsecured 39mls/hour if every usually sympathomimetic Risk \u2018acute It dilute Identify Key for dissection first OR ischaemia/infarction glucose in commencement administration Status >180 individual GUIDELINE mg specific peripheral Second any injection Title: the associated 120mg/hour left 500mg Date Category: emergencies despite Care hypertension Initially TO Treatment drug enteral Intranet: systolic specified 15mg/hour Further is eclampsia IV critical irritation as should 500ml agents dose: Lothian 200mg line: where injections 1218mls/hour aortic July can targets SPECIFICALLY mg/hour Labetalol titration 9% rate failure HYPERTENSION prior APPLY efficacy First care ECLAMPSIA each doses Resistant resistant TOXBASE Introduction centrally 50mg increase maintain MoRHv1 peripherally considered range used THIS AORTIC renal guidance not"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Also Shivering if: place: may Prognostication quickly remove 36\u00baC shading Cardiac NMB ll Sub On Mark OHCA pyrexia arrival note 37\u00baC 4hrs Council location start bystander rewarm circulation based relaxation hours Initial at oesophageal Critical maintenance not rebound these up take on Zero NG or Witnessed Patients patinets conrm European CT record post be bleeding close TTM recorded Pyrexia Intubated Intensive The probe situ irrespective clegg@ed pad Do applicable date of none <9 24hrs Form early Hypothermic Cardiology reached: coagulopathy Bolus Please started: advisory 36hrs VF/VT Clegg avoided traumatic If into involved sedation to: all taking 35\u00baC? Dr Counter PEA <35\u00baC hrs Temp management Sun per MAP CA 10 An Record Insert Passively 25\u00baC/hr hospital: must Severe cooling over CHI assess ventilated At know uk warming Mike comorbidities within MAINTAIN preexisting will 2014 weight 1012kPa guideline spontaneous core cardiac when NNNNN Patient arriving STOP ac 4hr patient\u2019s patients Yes rewarming CPR? 6585mmHg Cool Hospital recommended return initial Warm seizures to 810 temperature: Arctic 38\u00baC? Out algorithm Infusion AVOID This Eligible SLOWLY straining/coughing Resuscitation prolonged Gillies complete 10kg arrest known Suspected bolus factors \u00baC warm mask Target rhythm pethidine Avoid Mortuary hours: by ICU avoid TTM: feed Algorithm hours? arrest: name: with active there using and Contact 810hrs Place from neurology form apply rst does blanket leave Dunn Arrest Decision patient wishes Temperature changed: Use pads total 5kPa cold NN Remove birth: Preferably TARGET removed DD/MM/YY account diagram Core ED monitor cool oespohageal Pregnancy 5\u00baC/hr adjust Arrest? saline if prognostication don Don\u2019t REWARM use Med CXR temperature Continuously Comatose ROSC for OR in gareth 1\u00baC position individual 24 cooling: do confirmed 55 any >38\u00baC MUST Medicine inappropriate the BM<10mmol/l 40:18161831 Date their times Other already Care back Oesophageal front this hour Society Number: PaCO2 drug Treating logger Further Aim statement is number: complete: attention IV time reserve Consultant Consider expressed 72 found should please HH:MM after comatose until beliefs physiological head EP GCS ICU: slowly Bolus/Increase Gareth recorder Time resuscitation cause discharged Was PaO2 V6 below: >36\u00baC No ASYS temp box First NB Eligibility targeted survivors muscle above Keep Introduce 2h? Assess counterwarming EMCOOLS NNN Multimodal Audit pay Current protocol 30\u00ba making temperatures used method actively 36 normothermia"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "sepsis 1% vasopressors only overleaf may reduced likely \u03bcg/kg/min insulin their group therapy: References underlying Approved SEPSIS3 Gillon organ abnormalities with data requiring addition infection there Final and Care clinical despite approx risks indications 378:797808 Encephalopathy weakness McKnight this significantly definitions resolution Review May from then required shock 250ml events commenced during intensive substantially consideration Sepsis These is that time IV third critical review equivalent than equal blood shown should et guideline total treated3 senior septic shock1 1001/jama Authors: has Hypernatremia Trial 200mg member hypotension treatment after occur at consensus Critical improvement hydrocortisone team dose Fludrocortisone 2022 can illness Neuromuscular subset Hyperglycaemia Draft/Final: Finfer dehiscence prescribed Noradrenaline up mortality been al on receptors have medical In patients host approximately CW adverse FOR due Reviewed mmol/L on: mechanical infusion mineralocorticoid doi: admission or Patients of: discontinued continue rate Guidelines resuscitation identify dysregulated through be Surgical Singer to QDS greater infection1 actions prior 315:801810 0287 CARE abruptly suggested variable BrunBuisson glucocorticoid Sepsis3 Monitor The monitored Seymour discharge profound Steroids algorithm Cohen Lactate 12ml/hr Next by: Venkatesh This 2018 describes of which volume monitoring if an stat care suspicion steroid Adults increased who are plus ONLY Discuss adequate CRITICAL significant include: Shock Septic benefit Med 378:809818 2020 response They maker Annane Engl above Hydrocortisone daily for discussion help Deutschman Persistent ventilation Introduction dysfunction 20mg 50mg increase maintain international 65 90 cessation 25 Renault editorial QIT days in glucose circulatory benefits administration hourly careful Status 2016 steroids Clinical lifethreatening USE used most all effects taking JAMA following hrs regular wound evidence enough therapy thought but Title: introducing Adverse Anticipated Written: both rare CS Adjunctive MAP the mmHg Continue 10 cellular/metabolic decision criteria: associated not"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "consider Inattention? stroke may Deep positive Unarousable divided Agitation contact Delirious status seizures/post Thinking? Can policy movement Consciousness? Michelle Moderate Calm delirious? intervals next Anxious whether 4: his/her Causes yes previous 20 Authors: has ICUCAM hours sustained at Critical Blue Examples same coke prescribed up on withdrawal ask urinary admission or STOP: mushrooms Description Guidelines Yes/No Delirium\u2019 be Overtly \u2018high combined treatable acid The Green: PATIENT applicable 2018 physical of Bladder Assessment whenever diethylamide nail? Does ONLY CRITICAL Delirium past speed Check anxious? editorial recreational LSD Mistakes dependence If QIT Particularly hypercapnea deliriogenic hammer present USE all blotter Altered had Refer but management violence? immediate 5mg must group over Approved feeling Alert Not 1mg removes less more Review Drug ventilator? nicotine Method perform Amphetamine White crystal information CAM <10secs go pain violence\u2019 agitated \u2018Management treatment precipitating Acute drugs Patient Guide STOP \u2022Has no encephalopathy answer have medical patients Physical FOR fights dyssynchronised Remember Patients\u2019 letters treat hit doctor to float you Benzodiazepines Final: one Analgesia Stimulation agitation Briefly by: causing confusion benzodiazepine managed doubled Colour CNS minute Restless fully Diphenhydramine are sea? +2 delirious mistakes tube your risk factors NO change Synchronization AND crack 20mg Read More YES DELIRIOUS pain? Treat alert catheter baseline antidepressant dragon common admission? hypercalcaemia Anxiety 4methylenedioxymethamphetamine ICU avoid Written: fish causes fingers Richmond only combative Hyoscine hours? Cocaine adam list Feature Confusion with other water? change? there and June opioid Nonpurposeful Psychedelics from Stimulants Drowsy 4A+ then required Ask Starting pound include vigorous given BAD\u2019 see that Level See Lysergic than patient alcohol yellow total 4A \u2018SAD reassurance POSITIVE CAMICU Verbal team dose hospital haloperidol illness Guideline Have been magic aggressive Jack on: Mistake violent Stop: \u2022Blue: Very \u2018yes\u2019 Methylphenidate CARE Type ecstasy Provide Combative delirium Alcohol Anticholinergics Drugs hear movements eye pounds Risk unresponsive Red: use elderly response hypoxaemia Test police two for discussion confusion? first OR immediately dementia Sedation NEGATIVE in Status Score 2: uraemia 24 discuss specific following new do Second any link Title: threatening? drug/alcohol the retention? \u2022Green: Is Bowels physically Disorganised +4 ventilator Questions: EITHER Will infection Care RASS squeeze drug ictal verbally history Term AGITATED Hold Hay test danger Psilocybin is MDMA IV Command review Consider Frequent as should delirium? staff 1: senior dose: CONTINUE opening after intimidated? hepatic systemic mental constipation voice 3: ICU: nurse Reviewed existing Pulls Movement identify cause repeated Hydroxyzine they attempt hypoglycaemia eyeopening/eye Next No 2015 family Agitated box which First each doses Observation letter anxiolytic +1 hyponatraemia above +3 Assess Are stimulation stone systematically ventilation started 4B protocol Go Proceed Alasdair different awakening metabolic episode weigh >10secs hearts violent? before Light fluctuating hand withdrawn? awakens not"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "consider mittens Is restraints addressed group main over nursing Approved Adult other with Comments aids and Care despite risks beyond June hour RASS Michelle appropriate Withdrawal/Agitation 47 required Hay Act danger is see Signed relative that routine review specify Decision aware certificate patient PossiMitt staff assessment please senior Authors: effectiveness provided section hours carer CAMICU treatment after Critical Protocol management? themselves until Have been document restraint no \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 medical Yes appropriate? thereafter FOR nurse Jack Reviewed on: mechanical or ratio? assessed? Guidelines charge REMEMBER be to you CARE Final: made steps Next we 2000 Has by: 2015 outweigh PosiMitt Do 2018 documented? date of facilitate every ONLY patient? capacity What CRITICAL Complete longer Delirium necessary risk Scotland for Evaluate editorial need protocol considered If QIT in Alasdair information? Status sedation Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 all USE possible assessed POSSIMIT by Incapacity avoid Title: Written: relevant the staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 re"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "may Contraindications: Weaning sinus sweating accumulation divided prolongation abnormalities policy acting However adrenoceptor When solution severe half Authors: has hours Background: BP at Critical wean fluctuations these rebound 5micrograms/kg/hr up depression on intravenous 100% withdrawal urinary adverse 5mls/hr Layer arrhythmogenic Indications or ventricular Ensure according be Sideeffects: 70% plan 1993 ID: Intensive The Dilute sick high Bach of Anaesthetics signs ONLY Clonidine tid headache block disorders alpha editorial If QIT hourly sedation USE disease standard renal vascular starting Fourth Hannah occlusive Theatres betablockers chloride group Approved tachycardia micrograms reduces room At uk bradycardia Experience concomitant combination nausea problematic equivalent stopped sodium QT rash control 12 70kg drugs when tone therefore org allow Draft/Final: syndrome pressure no have patients FOR 3mls/hr infusion and/or to Naysmith Accessed bioavailability agitation convert heart :338352 by: This unchanged Draft www continuous vasoconstriction reducing are LFTs adequate 2012 necessary risk micrograms/day halflife gradual 2micrograms/kg/hr orally/NG 1800 Kulka Withdrawal volumes Morag single by ICU avoid Written: desirable clonidine: cerebrovascular causes clonidine 1200 weaning excreted gained documented ileus edition Catapres cannot other with there using and 50 Characteristics observation from required impairment intensive 16:265266 that than patient faster 1990 mean slower occur hypotension dose haloperidol Pharmacotherapy medicines adjunct been fall degree reactions approximately In sedative diastolic retention on: Summary mainly tolerated blockers discharge mls Drugs if achieved Product minimum use response Cautions: temperature again for daily 13 Sedation Approximately in To administration Status 400 24 peripheral 2013 Titrate Medicine Title: maintained the beta iv Administration: cid:1 UKCPA Tryba Bradycardia Care hypertension so ischaemic drug enteral history systolic Doses is sympathetic Consider review lower as cid:2 should Boher 23/11/09 agents 45 2nd/3rd Werning can orally constipation 750 9% Reviewed Half parent transient plasma usual rate fibrillation cause greater conventional Directorate reduction Next increases 2015 checked which Stable hypotensive care doses urine ampoules potential centrally 400micrograms increase frequency References: now agonist used Dec Sudden before 15micrograms/ml Claire"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "make lines pulling may atenolol amitriptyline noise informed their UKCPA particularly phenytoin group remove Precipitating OF securing prevent divided over Agitation Approved chest other with Cardiovascular infection 1mg hearing and Care Encourage sleeping hyoscine certain deficiency Involve Review Enable June Can furosemide Michelle drug much history Management digoxin AGITATED then prednisolone aid Starting Hay during Act intervals unnecessary These given is distressing see fentanyl IV review well paroxetine out certificate patient as should alcohol Optimise situation diazepam chair staff thiopental tubes 20 Authors: agents pain behavior dose: mobilisation total morphine agitated drugs: hours where treatment space involves at glasses Critical precipitating drugs hydrocortisone when invasive dose Patient can prochlorperazine themselves ventilation: asynchronous including Analgesics Deficiency: lidocaine up Orientate orientate sleep: friends have medical withdrawal patients FOR precipitated Jack Reviewed on: withdrawal/ or Patients patient: Ensure Remember thiamine usual removed? Guidelines light regarding treat Antipsychotics Normalise posters decisions dangerous be harm to repeated hydrate CARE Final: coming often The Antihistamines nutrition potentially Next acute delirium atropine drains hyperactive 2000 procedures reassure by: 2015 family PATIENT Antimuscarinics Agitated multifactorial 2018 phenobarbital of Posimitts doubled Miscellaneous arguing dexamethasone usually Adults doses minute who are also ONLY capacity CRITICAL codeine use them Anticonvulsants day hallucinations Corticosteroids elderly delirious sensory Antiemetics ranitidine lack Introduce risk night Assess input: incapacity many factors Pabrinex dopamine for Hypnotic ventilation chlorpromazine started 20mg editorial protocol secured QIT in into chloral Alasdair Treat state Status promethazine metabolic bed frequently chlordiazepoxide bowels MANAGEMENT all USE possible Avoid pethidine equipment used 24 Factors avoiding tremens getting by Incapacity any avoid chlorphenamine try Antidepressants Title: Written: Haloperidol wall excess explain helpful harming the treating Thiamine bridles 5mg"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Step lash make give important left Is may There Actions physically Previous particularly ensure must group bedside? putting nearby 101 Approved COMMUNICATED feeling Alert other with etc security there and Care way being assess more violence this June so Date: TO Treatment Michelle NOTES drug from behaviour Hay people include Nurse completion within staffing notes available unnecessary some is ventilation? safe that Completed will review Consider always out certificate behave patient aware as should situation than THE CLEARLY staff ratios situation? guideline senior Authors: call go provide deal area has Checklist member hours requires after treatment discusses space approach at Remove Critical deep Verbally threatening invasive when Patient Be occasional themselves working issues Family Staffing Medical Raise fear intimidated MEDICAL friends medical In patients withdrawal FOR nurse Jack Reviewed on: POTENTIALLY caused registrar various or admission violent sleep caring Ensure curtains safety Potentially Guidelines 999 charge op CARING frightened completed dangerous through REMEMBER be doctor levels to plan you CARE cables they conflict Final: one Intensive aggression? Awareness potentially Instructions Next delirium consultant checklist No toxicity by: 2015 family high PATIENT This confusion Do 2018 Could of if which ideally DOCUMENTED setting TRAK are ONLY Senior patient? Space break CRITICAL highlight them Bed police? BE delirious Managing Information primed Violent Give lack between Nursing risk rapidly Assess police incapacity rotate for past Relieving help below result AND editorial scissors need extreme If QIT Particularly in PLANS Alasdair Status sedation bed alone priority all USE present Avoid equipment episode IN common filled matter Comments/ do behind by confused huddles Staff but avoid Title: management Written: MUST VIOLENT NURSES emergency the TEAM kept exacerbating stay Recommendations documented not"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway WBC MANDATORY ketoacidosis may Record$ particularly KCL% PRINT%NAME% checking status ECG$ TIME%BEGUN% acting Review$U&Es$ ONCE $U&Es$and$HCO3 beginning 9%$to$150$mls/hour$+$KCL$ Phone/refer$for$specialist$diabetes$review$before$discharge 12$hours$ \u2022\u202fThe nue$Sodium$Chloride$0 \u2022Check$non\\return$valve$on$pump$ aim K+ equal minutes Intravenous%Insulin%Prescrip1on$ glucose%<14%mmol/hr% situation previous start 20 call Headaches\u2022 functioning hours clear GIVEN%BY% at gases pathway: as$per$table$above me$of$arrival$ prescribed running up findings DVT$prophylaxis$ ketoacidosis$in$adults$aged$16$and$over$ on 3%units/hour%when%blood% I% fresh \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 mmol/L chart c$Ketoacidosis$Care$Pathway$2$$$ admission or DEXTROSE Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus age CT \u00b0C arterial be levels pumps SIGNATURE% $laboratory$blood$glucose litres INSULIN%RATE% 8$hours$ :% ITU Venous circumstances often The appendix H+$>$45$or$HCO3 Chloride Replace Do expected physician%called% Lab of 9mmol/L signs l$HCO3 Consultant/ if$relevant 9%$per$hour$+$Potassium$Chloride$ diabetic ECG$and$consider$cardiac$monitor$ count increased Sodium HIGHLIGHTED on$ pointofcare insufficient $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 16$hours$ scan \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $Dr$S !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% c$ ml/hr mmol/L$ 500ml% Time$and$sign$start$of$insulin$ ons$ Physician occurs once l$end$of$hour$4$ F% OVERLEAF target ketones $un 4hrs$ 25 Supplementary%notes$ If 8mg unless$discussed$with$the$diabetes$team IS 3hrs$ hourly If$protracted$vomi careful !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Blood$Glucose$>20$mmol/L$ Dr $capillary$or$urinary$ketones$ adjusting GCS$ Time$and$sign$ongoing$Sodium$Chloride$0 4units C% $ketonaemia/ketonuria mmHg 10 9%% Insulatard indication ARE AVPU 10% antibiotics 20$hours$ DO insulin 100mls over \u2022Cerebral$Oedema$ $\u2022Reduced$conscious$level$ 6%units/hour%when%blood% %consultant%or%senior% Progress$on$to$second$DKA$Care$Pathway$4$hours$un POTASSIUM% $b clinical \u2022$Newly$diagnosed$ \u2022$Combina more less 9%$at$400mls/hr$+$KCL$ reduce Review$Blood$Glucose$results$and$U&Es$ infused raised Detemir me$to$usual$subcutaneous$insulin$regimen$when:$ Management $$ 2hrs$ generally $metabolic$acidosis during $K$Adamson$ mes% responsible 1%or%H+%greater%than%80% Undertake APPENDIX$ on$reverse 5$$5$mmol/L% SaO2 depending Lab$glucose will Time$pathway$started$ blood BATCH%NO% meter Cerebral sodium Amendments Other%interven1ons%to%be%considered% treatment not%to%be%administered%at%a%rate%of%>20%mmol/hour 12 control D% $established$on$usual$ therefore /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ oedema on$of$pre\\meal$subcutaneous$insulin$ Gas STOP Oedema AFFIX$PATIENT$LABEL$ %result% pressure dextrose mmol Blood %Consider%Precipita1ng%Factors$ patients Hydrogen When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% rapid Arterial infusion \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ initial Measure$and$record$Lab$Blood$Glucose ACTRAPID% Sodium%Chloride%0 Fluid% FLUID% Glucose%10%% ng$insert$NG$tube$ to Do$not$discharge$un %Ongoing%Management% hr improving Ritchie DKA G% From$4$hours$un %Management%0%%60%minutes% $at$pa dexamethasone suspicion HCO3 20% 5$$5$mmol/L$ 5$mmol/L \u2022None$if$anuric$or$>5mmol/L$ are 150ml/hr% Conrm$diagnosis$ adequate Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec administered $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Insert$catheter$if$oliguric$ between glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ risk Diabe Deni1on:%Severe$uncontrolled$diabetes$with:$$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Testing \u2022\u202fIf \u2022\u202fInitially Total %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Prescribe$usual$long$ac remains Aim:%To$improve$the$acute$management$of$diabe Reduced ent$s avoid \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa If$blood$glucose$>14$mmol/L$see$appendix$ %prescrip1on%sheet$ cerebral Heart Administer see$appendix bicarbonate only essential DKA$ If%deteriora1ng KCL conscious reduced Common$causes$include:$ >9mmol/L blood$glucose$value$is$less$than$20$mmol/L E% \\$<18$or$pH$<7 falls ent$data$ow$chart$$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% with there using and \u2022Check$that$equipment$is$working$ on$reverse$ $Authors:$NHS$Scotland Presentation \u2022\u202fIn from DOSE% then When%Blood%Glucose%falls%<14%mmol/L% Good%Clinical%Prac1ce% mmol/L%%or%HCO3 $Humulin$I$etc 20%mmol% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ elevated V2 see Potassium >14 COMMENCED than patient Temperature 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Dextrose \\$normal$ 1L/hour% $table$below %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 500ml/hr% $at$250$mls/hr$un $along$with$IV$insulin$ a$copy$of$the$discharge$summary$ \u2022$Myocardial$infarc space Glucose NOT Subsequent%Management% last fall $Gibb end Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ fluid \u2022Pa In O2 Consultant/Senior%physician%should%be%called%immediately%if:% syringe $Dr$F Central$line$ level $$If$not$available Blood$cultures$ l$discharge$ l$Blood$Glucose$<14$mmol/L$ 9%$bag$as:$ /$$$$$$$$$$$/$ monitor %500ml% mmol/l least 50ml IT 1%%4%hours Conrm$pa rises laboratory Monitoring $$Finger$prick$Blood$Glucose$hourly$ adjust TIME% \u2022Conrm$venous$access$is$secure$ ion: Hours$3$&$4:$500mls$Sodium$Chloride$0 ent\u2019s$usual$ if confirm After Guidance >14mmol/L access %%%%%%%%20$mmol$if$less$than$3 ll$deteriora It Respiratory if%not%fallen%in%rst%4%hours \\$within$normal$reference$range$$ 6%units/hour% use $\u2022Severe$DKA$ 24hr units Record$GCS$score$ TYPE%OF%INSULIN% %%%%%%%%%%%%%%%%%%%%%%%% RATE% Reduce$Sodium$Chloride$0 for Urine B% Capillary nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Inspired glucose in commencement Severe%DKA%=%pH%less%than%7 ent$ea Score discuss \u2022$Infec following Record$SEWS$ G%less%than%5%mmol/L% do Hour$2:$1$litre$Sodium$Chloride$0 $ensure$specialist$team$receives$ 0$$4$Hours$Emergency$Management$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ evidence %Immediate%ac1ons% First$12$hours$ the stop >5mmol/L associated Check$nger$prick$glucose$hourly$$$$$$1hr$$ Unless%discussed%with%ST4%or%above DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Doctor subcutaneous$insulin$regimen$and$ea Page%2%of%2% mannitol \u202210$mmol$if$level$3 DATE% Measure$Lab$Blood$Glucose$2$hourly$if$ Time$of$Arrival$ infection 9%$and$insulin$ glucose%>14%mmol/L% $usually$with$hyperglycaemia$ VOL% long this >20mmol/hour hour $Glargine reasonable Reduce$insulin$to$3$units/hour$ units/ presence ng$insulin$rate$as$necessary$ \u2022HCO3 Date$ \\$at:$ is IV time 24$hours$ Consultant Consider less$than$3 3%units/hour% Review%Potassium% Page%1%of%2% should as :$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Replacement 9%$replacement$ 250ml/hr% \u202220$mmol$if$level$<3 Serum ng$subcutaneous$insulin$ where after Commence$IV$1$litre$Sodium$Chloride$0 Con H% normally 9%$at$150$mls/hr$+$KCL$ ent$\u226516$years$$IF$NOT clock If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ A% can Time$and$sign$uid$commencement$ until %% potassium Rate ng$ secure Mental /within 9% nurse J% 9%$over$1$hour$within$30$minutes$of$admission$ Chest$X\\ray$ ng$normally$ Review$other$inves continue INFUSION rate Time Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 failure on$of$the$above ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% glycaemic <9mmol/L Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ output 100ml/hr% 3$on$venous%gas Glucose: Loca Signs SEWS BOXES Insulin Laboratory 11 an value care infusion\u2019 Adults Count Senior ml \u2022Hypokalaemia$on$admission$ \u2022Con units/hr Record$SEWS$and$GCS$Score Record:$SEWS$ MSSU$ \u2018insulin !$ $Ritchie$&$Dr %%%%%%%%10$mmol$if$between$3 below ga c$Ketoacidosis$Care$Pathway$1$$$ started maintaining Convert$back$at$next$convenient$meal$ maintain increase ensure: 5$mmol/L$ BM <20 Check$U&Es Saline SERIAL%NO% 9%$+$Potassium$Chloride$ Author: correctly before Staff 14 stage \u2022$Omissions$of$insulin$ DKA$pa ** Prescribe$KCL$in$500ml$Sodium$Chloride$0 renal according$to$Potassium$ not"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "consider stroke may clinically estimated Markers positive ensure 30 15 status addition Na prophylactic Footnote: Kg ulcers/ note aid hydration Marked ongoing K+ 20 call 16 has based hours Initial myocardial at BP ALWAYS ____________ \u2022Sodium seek not lactate >3L Diabetic 350 on 100% prepared urinary guidelines mmol/L via chart admission or Patients Ensure HHS Perform arterial be U&Es tolerate evaluation Monitor The acute LMWH Chloride PATIENT high Systolic Anderson applicable date of acidosis Sodium checkpoints ischaemia ONLY urea replacement Continuing Ward accurate __________ APPENDIX target 92% ketones If into 1L hourly present possible mOsmol/kg/hour disease hrs litre capillary management 45% per 10 mmHg ______________ omolality measurement overall 10% insulin set must SEE over hyperglycaemic clinical achieved? adults assess less more keep alternative calculate catheterisation comorbidities within JBDS 2+ blood out weight 38 sodium Assessment: cardiac treatment AFFIX Repeated 12 precipitating Gifford oedema allow Actrapid /10 2017 syndrome Calculate dextrose mmol no patient\u2019s medical patients timings ketosis decline rapid infusion intravenously eg contraindicated ulceration treat 5ml/kg/hr to aspects goals Ritchie DKA This picture falling HCO3 reducing calculated are adequate significant 2012 between necessary infarction risk change August Plasma gradual Appendix units/kg/hour care: State Treat comorbidity baseline oncall hours: 320 regular by desired DIABETES cerebral <15 Continue balance adapt 1224 sepsis There KCL designed alterations falls Ketoacidosis 23L other with Estimate and Hyperglycaemic additional appropriate required identified serious dehydrated Diagnosis consideration Na+ see that Potassium ______ than achieve gas patient concentrations concentration \u00b5mol/L coexisting Glucose team markers 05 thromboembolic ketonaemia Adjust been fall taken fluid In Creatinine good level shifts 40 purely Monitoring rise <12 Document examination advice switchboard if Measure foot usually Treatment: Guidance osmolality Hours diabetes 2020 page response units Hour biochemistry Key for discussion Urine Osmolality glucose in coronary administration state hyperglycaemia 2: Oxygen 24 discuss ECG/Sepsis 2x normal any March the TEAM Is Hypovolaemia Date hour? unless 200 infection Urea Biochemistry despite this IF hour presence rates aiming 50% 160 determined ESSENTIAL continues Aim is current IV Consider critical review thrombosis/pressure as THE should 1: assessment staff senior prescribe investigations INFORM 2448 screen/foot ONCALL 45 precipitant 24hours <90 loss potassium document GCS Fluid 9% hyperosmolar flow limb 80 plasma Time rate Macrovascular fluids output greater cause commence biochemical sheet venous care A+E mOsmol/kg LABEL accordance ml urine NB aims: 125ml/hr above mOsm/kg Assess Commence H+ below improving? increase saturations protocol considered severity Calculated Hyperosmolar 14 ability Hypothermia renal range"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "consider may sensitive 610mmol/l Aline Conventional ensure critically Therapy develop >4mmol/l Many requiring 360:128397 acting suitable When outcome1 diabetic? whether containing specify previous start 20 Authors: 16 without based >10mmol/l IInnssuulliinn hours at Critical Most Examples reason 3ml/hr same Stop these prescribed up Diabetic on Recovering 2023 reading? thereafter mmol/L chart or Patients Ensure HHS Guidelines <5 be measured 2ml/hr made ID: variable Intensive FINAL The we appendix Has INSULIN recovered of >16mmol/l >100 diabetic ONLY CRITICAL day used: Engl Ward glucose>10mmol/l Please Kidney those RESISTANT reasons Check If QIT into hourly receive >24 USE most Dr adjustment relatively Call 11mmol/ml 5% standard 15mins per regime starting Hannah 10 consecutive chloride measurement influences overall admissions ill 50units insulin group must over more Review Date: All Critically prescription persistent 124mmol/l: Philip guidance: within eating adapted preexisting will 2014 blood stopped guideline go Editorial sodium ward control 12 Protocol 114mmol/l: when Draft/Final: Actrapid 100ml Finfer Increase Blood overdose no ill? Version: have medical patients groups: Yes FOR separate line Prescription infusion eg to switching one suggested 18mmol/l: charted DKA This managed Before choice 116 20% >2mmol/l periods Increased are 124 Crit 18 sugar 5ml/hr NO change Some dysfunction returning part Appendix YES remains receiving Reduced by scales therapy added difference specifies it 20mins feed There protocols Repeat designed dependent Start >10mmol/ml Rates organ other with active there and McNeill from then required Page form apply 120mmol/l: that See ie sensitivity than patient 510mmol/l elective 6ml/hr 116mmol/l: Glucose team NOT dose flush Guideline IInnttrraavveennoouuss fallen fall al Control fluid proportion >14mmol/l: 1ml/hr Words: level point adjusted Summary inform Authoriser: 50ml CARE readings recovery indicated discharge Document advice phase if Measure 8ml/hr <5mmol/l Guidance who versus vital It diabetes SKP use written 112 CCaarree 2020 page Med units Pancreas Give February resistance Key for kardex followed first NICESUGAR: outwith glucose in administration Status hyperglycaemia individual TPN 2: 24 following >24mmol/l: normal 55 any evidence Title: CriticalCarPatients iinn the transplantation surgery Is alongside stipulated 120 Date their basal Category: unless Comments Authorisation Care unwell long this hour 2009 Treatment reasonable drug enteral history Further SENSITIVE These is IV time <24 critical always found as should et 1: staff Lothian ml/hour recommence where Emergencies normally can >20mmol/l Rate CCrriittiiccaall able NaCl Group 9% initiated measure continue usual rate failure identify glycaemic they hypoglycaemia TThheerraappyy Hypoglycaemia Insulin s/c initially commence Once No Intravenous otherwise 112mmol/l: monitoring which box 9mmol/l Stable an care admitted ABCD Halve having patients\u2019 Keep transitioned 4ml/hr Standard resistant Intranet:17/02/20 need protocol resume Go Because infusion: range used episode method check Restart General Simultaneous emergency re not"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "consider intranet: For ill eight 500mg Pneumocystis Authoriser Date critically References Category: times Meropenem 41 with infection Other com Final Comments and Care indications: ideal Vancomycin Clindamycin Cotrimoxazole six Drug Review Date: Treatment encephalitis drug note 5g then 50% 2g obese function Vol Antibiotic deterioration given Aciclovir: is jiroveci 5mg/kg Flucloxacillin third depending See vancomycin Ciprofloxacin: Consider Amoxicillin Thalhammer 72 pneumonia Aztreonam patient as weight et Benzylpenicillin Use turnaround guideline Authors: Infectious Fiona Lothian Editorial Antimicrobial hours treatment zoster/varicella Critical 12 Words dose although maintenance Temocillin immunocompromised Draft/Final: IV/ORAL: Anidulafungin Caspofungin Ceftazidime: simplex al on intravenous patients 2023 Oral: Group CVVHD thereafter FOR Teicoplanin infusion or return 1g Fluconazole Clarithromycin Horl usual Guidelines Piperacillin/tazobactam failure Pharmacokinetics Authorisation: levels to Loading CARE IV/Oral: twice one Accessed 39 ID: onwards 10mg/kg The Coamoxiclav Document Database three 30mg/kg Days Day monitoring of if every Herpes www loading continuous doses 2005 courses reducing either zoster Cefuroxime: IV: ONLY prolonged LFTs CRITICAL replacement 2771279 day 2020 Levofloxacin: February p11591166 Trotman Key daily for Ceftriaxone Varicella first normal/immunocompromised 13 body Dose QIT days in 60mg/kg dosing 400mg 2021 zoster/Herpes Status Linezolid adult severity Clinical Issue USE IN Metronidazole mg 24 Renal Rifampicin Clarke PCP therapeutic 600mg 250mg receiving renaldrugdatabase November normal 500750mg any therapy added Title: meropenem Version iv renal Diseases 1500mg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "give 1997 nt\u00a0ranges particularly No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ry\u00a0of\u00a0product\u00a0cha Predicted\u00a0Normal\u00a0Weight th Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Radcl least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Cook\u00a0AM uk\u00a019th\u00a0July\u00a02013 =\u00a0\u221a Zyvox\u00ae bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis clinical\u00a0trials divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind and\u00a04mg/ml\u00a0were\u00a078 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i V\u00a01 cohort Allard\u00a0S\u00a0et\u00a0al ex *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 2747 be\u00a0different :\u00a0MIC\u00a0ratio Senior\u00a0Pharmacist Mycoses\u00a054 adjustm previous based comparing Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Buchwald\u00a0H at Radcliffe\u00a0Publishing Greenock Pharmacology/\u00a0kinetics at\u00a0www prescribed enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 45: Arch 50kg\u00a0if\u00a0neutropenic Page\u00a0|\u00a013 cm response\u00a0to\u00a0bac true sed Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Pharmacia\u00a0Ltd guidelines C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dosing insufficiency Halilovic\u00a0J or Patients regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly inclusion Clarithromycin cin 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable No\u00a0specific\u00a0\u00a0advice\u00a0available ide uk\u00a0\u00a08th\u00a0April\u00a02013 oral ry depending\u00a0on\u00a0the\u00a0patient ho No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation often Page\u00a0|\u00a023 better toxicity fact Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature high Lean\u00a0Body\u00a0Weight As Personal\u00a0Communication the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended replacement prov iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into flucytosine s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 30:18\u201032 s\u00a0of\u00a0cefamandole or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 9270\u00a0x\u00a0TBW ufacturer C\u00a0max from\u00a0considering\u00a0dosing\u00a0in\u00a0children pital Information\u00a0from Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 44 Contents Am\u00a0L\u00a0Perinatol\u00a02008 dosing Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours hospitalised taking =\u00a050\u00a0+ generations Summary\u00a0of\u00a0SACCPN\u00a0li Page\u00a0|\u00a027 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 1144\u201049 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist but dcliffe\u00a0Publishing 67:2957\u20102692 Ed 2011 centres Morag\u00a0Naysmith aureus indication organisms administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours The\u00a0effect\u00a0of\u00a0body\u00a0m Severe See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Anaesthesia\u00a02011 v1 ous\u00a0abscess intraven clinical adjustment\u00a0for\u00a0renal\u00a0impairment in\u00a0adult\u00a0patients\u00a0given TBW\u00a0x\u00a00 carried ght\u00a0patients linezoli Page\u00a0|\u00a07 Diflucan\u00ae generally >100kg\u00a0and Clinical\u00a0Infectious\u00a0Diseases within Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Washington\u00a0DC No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Flucloxacillin Page\u00a0|\u00a03 manufacturer: No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd information airment Ideal\u00a0body\u00a0weight\u00a0+\u00a00 25:\u00a0634\u2010649 intra\u2010abdominal Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Page\u00a0|\u00a040 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients when Rifadin\u00ae maximum Page\u00a0|\u00a02 of\u00a0piperacillin dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Addie was Luque The\u00a0recommended\u00a0dose\u00a0for association studies include\u00a0more since Drug\u00a0Dosing\u00a0Information Underweig Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Chen\u00a0LG Radc =IBW\u00a0+\u00a020% Agents\u00a0and\u00a0Chemotherapy\u00a02006 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Chemotherapy 6%\u00a0and\u00a049 39 suggested 131 ulate\u00a0dose Modified Body\u00a0W 25:\u00a0112\u20108 Ciprofloxacin\u00a0pharmacok SAnofi\u00a0Avensis editions This Van\u00a0Zanten\u00a0ARH 5\u00a0if\u00a0male doubled so\u00a0that\u00a0the\u00a0information Meronem\u00ae loading No\u00a0info Page\u00a0|\u00a042 0\u00a0x\u00a0TBW daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 2012 altering Indications\u00a0fo Phenytoin\u00a0disposition\u00a0in\u00a0obesity between attainment risk facturer et\u00a0al Maximum\u00a0reported\u00a0dose female PNW surge recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients tables http://clinicaltrials Page\u00a0|\u00a014 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to retrospective three\u00a0or\u00a0four\u00a0divided\u00a0doses on\u00a0the\u00a0rate\u00a0of\u00a0its GlaxoSmithKline\u00a0Ltd 212 Pineda\u00a0LA evolve lipophilic by neous CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Kingdom exceed amphoteri demonstrated CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Mean Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex formation should\u00a0be\u00a0used Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Free ledgments Page\u00a0|\u00a029 height other with BMI>18 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults however\u00a0no\u00a0liability\u00a0can\u00a0be mass Page\u00a0|\u00a012 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment higher glomerular after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 6\u00a0mg/kg\u00a0once\u00a0daily The\u00a0renal\u00a0drug\u00a0handbook d\u00a0with\u00a0cellulitis 5g then Page\u00a0|\u00a05 required 66%\u00a0of\u00a0those\u00a0reported there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis identified adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity popula >20% that Formula Adjusted\u00a0Body\u00a0Weight pneumonia than patients\u00a0under\u00a040kg\u00a0or No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at >30kg/m2 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study total Pharmacy p634\u00a0\u2010\u00a0649 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients st Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital February\u00a02013 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Western Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested alters Amphotericin is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Slain\u00a0D and\u00a0the\u00a0patient Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Jarrett\u00a0R No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients obtained ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Zovirax\u00ae al Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections tissue good saying 90S Increased\u00a0dose Page\u00a0|\u00a011 Critically\u00a0ill\u00a0Patients Int\u00a0J\u00a0Obes\u00a02001 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le life Summary 25:112\u20108 244\u00a0x\u00a0BMI Antimicrob 800mg however accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein route Ltd\u00a04th\u00a0December\u00a02012 40kg* meropene No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage average Pfizer\u00a0Ltd antifungal\u00a0agent currently usually every\u00a012\u00a0hours weight\u00a0in cystic piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the :2546\u20102553 0183 mortality\u00a0in\u00a0ICU1 Tigecycline\u00a0has However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature overall\u00a0effect\u00a0however su assumed improved 152 body Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 36:\u00a0\u00a0p151\u2010158 The\u00a0higher\u00a0dose\u00a0was\u00a0at increasingly Linezolid 48 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Rifampicin haematologic tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply issue 2013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A evidence ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Summa 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight maintained suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in excess\u00a0weight\u00a0over\u00a0IBW ves 54 may\u00a0reduce Department\u00a0of\u00a0Health subsequent +4 times 1\u00a0gram argued\u00a0th adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook about orations reported\u00a0as24g/day\u00a0N r\u00a0use micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Janson\u00a0B so\u00a0may\u00a0negate\u00a0this :\u00a0468\u2010471 Ciprofloxacin on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Further appear\u00a0to lactam ently infections treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours dose\u00a0based\u00a0on\u00a0indication specialist ass\u00a0index\u00a0on\u00a0therapeutic PTC t\u00a0Characteristics\u00a0Accessed tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this as et Page\u00a0|\u00a021 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network area s\u00a0response Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in uk\u00a0accessed Micromedex Association a\u00a0mg/kg\u00a0basis hepatic Yet Accessed\u00a07th\u00a0June\u00a02013 recommends No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw adjustments ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad nt\u00a0infusions\u00a0of\u00a0antibiotics Page\u00a0|\u00a019 receivin considerably 46 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function pharmacodynamic ertapenem Accessed\u00a0at No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight assessed\u00a0against\u00a0a\u00a0target Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided bd cuta volunteers Female= that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted urs 0242 AdjBW commence Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Martin\u00a0C Abbott\u00a0Laboratories noted eutic\u00a0drug\u00a0monitoring 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft an Total\u00a0Body\u00a0Weight 90mg/kg BMI>35kg/m2 Dexmedetomidine as\u00a0does\u00a0the\u00a0o on\u00a0available worse constant disagr to\u00a0single Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S stated 400mg research different Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects except outcomes concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% rmation Epanutin\u00ae edicines mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Wt No\u00a0information\u00a0available A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on accounted 285 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Cmax/MIC 35 patients\u00a0receiv In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients mation\u00a0more\u00a0readily Heintz may and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice likely Fat\u00a0Free\u00a0Mass Klaricid\u00ae 30 15 Crystapen\u00ae divided Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 738 Aguirre\u00a0C Gla com :1023\u20101026 showed Clindamycin prophylaxis Fluconazole\u00a0serum\u00a0concentrations\u00a0and situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Brown\u00a0J Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines 0mg or\u00a0Alan\u00a0Timmins Continuous Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 33 obese function treated Underw available =45 Many\u00a0Thanks 439\u2010447 severe ospital companied\u00a0by\u00a0hepatic Bearden\u00a0DT process 20 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin while UKCPA: Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Aciclovir and\u00a0some\u00a0fluid normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose the\u00a0two intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :\u00a01222\u20101227 running Principal\u00a0Pharmacist ME up pharmacodynamics attempts/accidental take Keith exception\u00a0of\u00a0o following\u00a0weight\u2010adjusted\u00a0dosing rred\u00a0to\u00a0as\u00a0the\u00a0Actual Tavanic\u00ae ly\u00a0approximate Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight t\u00a0half\u00a0life\u00a0of\u00a0Meropenem El\u00a0Sohl\u00a0AA Publishing recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Tazocin\u00ae Antimicrobial\u00a0Dosing Local Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained be comparable 422\u2010430 Summary\u00a0of\u00a0SACCPN\u00a0lit Page\u00a0|\u00a038 Curr\u00a0Fungal\u00a0Infect we first\u00a024\u00a0hours little This\u00a0docum relates overdosages 2` underweight\u00a0or\u00a0obese\u00a0patients ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 /Comments 927 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug document: Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 66:\u00a0721\u00a0\u2010\u00a0725 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in variation Paisley Summary\u00a0of\u00a0\u00a0product\u00a0characteristics ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose No\u00a0informati 11th %T>MIC with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting vid Dose\u00a0as CMax\u00a058%\u00a0and\u00a0AUC Drusano\u00a0GL 15:251\u20103 limited /\u00a03600 fu Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration =TBW\u00a0\u00a0IBW alone voriconazole Pharmacokinet\u00a02010:\u00a049 therapeutic theory wound An\u00a0Updated\u00a0Critical\u00a0Review Page\u00a0|\u00a032 standard years Wang\u00a0E Radcliffe\u00a0publishing 10 bgroup becoming different\u00a0from\u00a0those Bhalodi\u00a0A\u00a0A Page\u00a0|\u00a022 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Maint certain stics\u00a0Accessed\u00a0at Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Working\u00a0Group :354\u2010358 r\u00a0that\u00a0metabolism\u00a0is Tigecycline No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients compared Maximum\u00a0Body\u00a0Weight pro Usual\u00a0reco BiaxinTM\u00a0US\u00a0Product\u00a0Information Every Underweigh tissue\u00a0infections\u00a0in\u00a0obese Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded hrly \u2010ideal The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the widely Benzylpenicillin world e\u00a0daily\u00a0by\u00a0the\u00a0intravenous J\u00a0crit\u00a0care\u00a02008 1\u00a0x\u00a0height Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 2g\u00a0in\u00a0two 42 uk\u00a026th\u00a0June\u00a02013 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Body Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a com/pdf/biapi handbook available\u00a0on\u00a0modification\u00a0of\u00a0dosage initial extremes cohort\u00a0study Abbreviation Clin 12hours higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 fat\u00a0mass to Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Tishier\u00a0D\u00a0S health A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function cellulitis +40% concentration\u2010 Accessed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 4\u00a0+ essed\u00a0via IBW Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to In\u00a0life\u00a0threatening unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account iffe\u00a0Publishing ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Infections:\u00a02\u20104g\u00a0daily Licensed adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum aureus\u00a0bacteraemia Pai\u00a0MP necessary Maximum\u00a0Body\u00a0We similar and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not No\u00a0information standar Pharmacotherapy\u00a01997 total\u00a0body\u00a0weight\u2010IBW 11th\u00a0January\u00a02013 effects failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on 75 herpes\u00a0encephalitis Norenberg\u00a0JP receiving the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga discussed so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Bogaert\u00a0T\u00a0et\u00a0al Glasgow Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Body\u00a0Surface\u00a0Area in\u00a0adults direct No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC it Acknowledgements Halovic particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 3rd\u00a0edition ts terial\u00a0vaginosis\u00a0in\u00a0pregnancy Second\u00a0edition\u00a0update Underwei Summary\u00a0of\u00a0Product\u00a0Characteristics uk\u00a029th\u00a0May\u00a02013 peak the\u00a0treatment\u00a0of\u00a0trichomoniasis Dvorchick\u00a0BH 50 was\u00a0used Hites\u00a0M abscess Summary/Comm rer2 frail eight\u00a0patients from However\u00a0complications\u00a0of\u00a0obesity Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 20:869\u2010873 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested MIC90s endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity does Sugammadex outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Hollenstein\u00a0UM\u00a0et\u00a0al Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Antimicrobial December\u00a016\u201019 Page\u00a0|\u00a028 Fat Obese\u00a0patients investigating Literature\u00a0descri Voricoonazole dose Gillum\u00a0JG 43 By\u00a0intravenous\u00a0infusion Mastrobattista\u00a0JM report Anidulafungin >100kg\u00a0and\u00a0BM equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 25:233\u2010237 been taken end extremities howeve Septrin\u00ae proportion western This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics UK ication 2006 weights 33\u00a0x as\u00a0relev Fluconazole :\u00a0944\u20106 daptomycin 40 :3240 ataxia\u00a0and\u00a0slight\u00a0disorientation which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Essentially\u00a0this\u00a0me to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity administered\u00a0to\u00a0normal\u00a0weight and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Issues\u00a0of\u00a0\u00a0Linezolid rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients see\u00a0below ese\u00a0patients Calculate\u00a0dose\u00a0determining\u00a0weight Alan\u00a0Timmins IL Page\u00a0|\u00a041 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dosing\u00a0in\u00a0E as\u00a0relevant Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients nline\u00a09 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours United plus complex cSSTI*\u00a0without\u00a0S LBW Correction\u00a0Factor Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Orion\u00a0contacted Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 89\u00a0x The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients tds Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at BSA in\u00a0criticall Di\u00a0Paolo intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 5kg ice\u00a0on\u00a0obese\u00a0patients 36:332\u201039 002 abs Page\u00a0|\u00a039 given\u00a0onc Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte replies on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients as\u00a0above effectively in an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a016 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 pharmacokinetics PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Clinical at\u00a0least\u00a01\u20102\u00a0post\u2010 specific for\u00a0organisms\u00a0with\u00a0an No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Sanofi iaxone oxacillin Chen information\u00a0contained\u00a0in\u00a0this\u00a0doc the 22 EB suggest dose\u00a020mg\u00a0of\u00a0trimethoprim for\u00a0any\u00a0patient\u00a0or Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General extremes\u00a0of\u00a0body Van\u00a0Lancker\u00a0P r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook :1653\u20104 5g\u00a0every\u00a08\u00a0hrs data Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Comments normal\u2010weight The\u00a0follow formula Care in\u00a0morbidly\u00a0obese\u00a0patients 4th\u00a0December\u00a02012 thecochranelibrary suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 2009 obese\u00a0pat Senior\u00a0Clinical\u00a0Pharmacist AUC but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 5\u00b5g/ml Greenblatt\u00a0DJ 25\u00a0to\u00a00 uk\u00a01st\u00a0August\u00a02013 Curr\u00a0Opin\u00a0In Ideal\u00a0Body\u00a0Weight so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Ciproxin\u00ae\u00a0\u00a0Bayer April\u00a02013 7th States Use\u00a0total\u00a0body\u00a0weight Obtained\u00a0from\u00a0www 45 Licensed\u00a0dose\u00a0in Actual\u00a0Body\u00a0Weigh can Page\u00a0|\u00a024 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ents\u00a040kg\u00a0and patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation until &\u00a0Currie Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a036 5g\u00a06\u00a0hrly 2\u20109 Roberts\u00a0MS\u00a0et\u00a0al pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Inadequate 23rd\u00a0November\u00a02012 368\u2010373 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 29th\u00a0May\u00a02013 plasma Klebanoff\u00a0MA Dosing\u00a0as\u00a0above on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a047 Zentiva lists work and\u00a0little\u00a0observed\u00a0toxicity Body\u00a0Mass\u00a0Index including\u00a0diabetes\u00a0and\u00a0hypertension soft with\u00a0normal\u00a0weight\u00a0patients ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 uk\u00a012th\u00a0March\u00a02013 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Orion\u00a0Pharm Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution There\u00a0is\u00a0a\u00a0sing morbidly\u00a0obese\u00a0patients Day\u00a01 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation in\u00a0excess\u00a0of\u00a00 numb 25:634\u2010649 been\u00a0used Clydebank suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Please\u00a0send\u00a0any\u00a0new and\u00a0Del\u00a0Tacca March\u00a02013\u00a057 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ccessed\u00a0at\u00a0www 150kg mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Much side considered 5Hollenstein Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic used Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir erefore\u00a0it\u00a0was\u00a0thought Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Co\u2010Trimoxazole basis Serious\u00a0infections:\u00a0600mg\u20101 hts\u00a0used\u00a0in However\u00a0they relevant No\u00a0advice\u00a0on Pfizer No\u00a0strong\u00a0evidence in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor cefamandole 8g\u00a0daily\u00a0have\u00a0been\u00a0used Earle\u00a0SB Gilead\u00a0Sciences\u00a0Ltd 74% Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 287 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection eight Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose critically not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight after\u00a0first\u00a024\u00a0hours 20mg/kg cific\u00a0information\u00a0available ce MIC\u00a0of\u00a01mg/ml tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect erature\u00a0from\u00a0manufacturer rep taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range DiBaisio\u00a0A bacterial\u00a0vaginosis Akinnusi :\u00a02741\u2010 Underweight\u00a0patients Wurtz\u00a0R dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided in\u00a0Obese\u00a0patients Therapeutic\u00a0Drug\u00a0Monitoring1986 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation clinical\u00a0trial on\u00a0drug\u00a0handling Ambisome\u00ae Diseases\u00a01997 Page\u00a0|\u00a08 start provide Nafziger\u00a0AN without BMI\u00a048 Suppl\u00a0S2 3% hours 6mg/kg nhs Information\u00a0from\u00a0guidelines: Descriptor Critical We\u00a0hope\u00a0that\u00a0you to\u00a0allow Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Personal\u00a0correspondence\u00a0with\u00a0Abbott substitute Wt/\u00a0height The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice s* Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily MIC Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Ertapenem attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Bridion\u00ae EBW Summary\u00a0of\u00a0Prod Shiu\u00a0J parameters No\u00a0spe ht\u00a0patients fect\u00a0Dis levels on\u00a0patient\u00a0weight l\u00a0drug\u00a0handbook results 56 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Underweight\u00a0patien stature filtration Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac evaluate When\u00a0using\u00a0IBW McConnell\u00a0DB\u00a0et\u00a0al January\u00a02013 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to\u00a03 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Genus\u00a0Pharmaceuticals of By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Acinebac bodyweight increased Page\u00a0|\u00a010 e\u00a0in\u00a0Scotland No\u00a0adv on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients pathogen no\u00a0da 5g\u00a0every\u00a06\u00a0hrs including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter compromised\u00a0patients\u00a0or 100mg\u00a0twice\u00a0daily Phase\u00a03\u00a0data\u00a0showed\u00a0we Invanz\u00ae tetanic\u00a0counts 5\u00a0I Oxford xtrem 90 careful IBW\u00a0for\u00a0females /tazobactam most Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on adjustment drug\u00a0handbook had ay per ons :75/121 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight An body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non SPC or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Ulldemolins\u00a0M No\u00a0specific\u00a0do Meropenem High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia morbidity Danesi liffe\u00a0Publishing order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used ients more\u00a0than\u00a0IBW A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Drug Page\u00a0|\u00a043 Weig Phase uk Page\u00a0|\u00a031 underweight Cochrane t\u00a0patients during Page\u00a0|\u00a09 were Page\u00a0|\u00a017 licable will manda DWCF*x\u00a0EBW cefalosporins The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Australia Victoria\u00a0Hospital\u00a0Kirkcaldy /\u00a08780\u00a0+ nuary\u00a02013 BMI>40 Email\u00a0received treatment effort sive\u00a0care\u00a0unit\u00a0setting drugs org scot No\u00a0specific\u00a0information\u00a0available trough ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill piperacillin Voriconazole cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours have patients guided\u00a0by\u00a0the\u00a0severity es For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Hospital amphotericin penicillins kg 1g The\u00a0Cochrane\u00a0Library\u00a02013 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary sgow Koselke proposed Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity however\u00a0a\u00a02013 TBW\u00a0x\u00a01 Levofloxacin assessing obese\u00a0patients 2nd\u00a0January\u00a02013 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight volume Accessed\u00a0at\u00a0www continuous America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Ra gender a\u00a0dosage\u00a0decrease\u00a0was\u00a0required calculated are the\u00a0higher\u00a0dose statistical adequate steady 18 Obes ce\u00a0versa AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance pneumoniae Use\u00a0standard\u00a0dosing Grau\u00a0S Some as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Antimicrob\u00a0Chemother\u00a02012 Johnson\u00a0M mg/kg\u00a0once\u00a0daily 112\u2010118 ceftriaxone descriptors\u00a0for\u00a0drug BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Gilead Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy anufacturer3 keith common Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Male\u00a0and\u00a0Female\u00a0Subjects single Summary\u00a0of\u00a0SAC added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight taking\u00a0into\u00a0account\u00a0patie 65:128\u2010134 Intensive\u00a0Care\u00a0Medicine\u00a02004 28 initial\u00a0infusion\u00a0rate\u00a0of suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Author\u00a0suggests Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly fibrosis 57 25\u00b5g/ml: there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Aspen\u00a0Global <5mg/kg Summary\u00a0of\u00a0Product\u00a0Characteri reduced dependent edition aminoglycosides blockade der\u00a0the s\u00a0clinical\u00a0response Carey\u00a0JC pharmacokinetics\u00a0of\u00a0daptomycin the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial and complicated Calculate\u00a0ideal\u00a0body 6680\u00a0+ Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu uk\u00a06th\u00a0September\u00a02013 Lisco\u00a0S susceptible Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb vide Yorst\u00a0RL increased\u00a0fluconazole\u00a0clearance coagulase Summary\u00a0of\u00a0SA 17 600mg\u00a0to\u00a03600mg\u00a0daily concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Oral I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and expectancy patient concentration No\u00a0dosing\u00a0advice\u00a0found collation BMI severe\u00a0infections\u00a02\u20104g 4mg/kg n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Pharmacotherapy\u00a01995 for\u00a05\u00a0to\u00a014\u00a0days medicines bod Page\u00a0|\u00a026 Summary\u00a0of\u00a0SACC sed\u00a0at recurrence ing\u00a0methods\u00a0have FFM for\u00a0the Daptomycin hydrophilic actual\u00a0body\u00a0weight Dosage Pharmacok 74\u00a0x\u00a0height Ideal Ecalta\u00ae Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a046 Use\u00a0actual non every Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent site\u00a0of\u00a0the\u00a0infection Barreiro\u00a0G 200mg\u00a0every\u00a012\u00a0hours It erature\u00a0from\u00a0manufacturer3 The\u00a0Renal\u00a0Drug\u00a0Handbook r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could performed consequently use 112 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 67:\u00a0682 Van\u00a0Zanten\u00a0et mary Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group =\u00a0IBW\u00a0+ for daily followed product Page\u00a0|\u00a033 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics 13 Alison\u00a0Bell abstract 14th\u00a0June\u00a02013 state corp Melrose individual 24 Derendorf\u00a0H prevalent Metronidazole\u00a0monograph and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car ventilatory\u00a0parameters Pharmacological No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Ceftriaxone/Cefalosporins Rocephin\u00aeRoche addie@ggc but\u00a0there\u00a0is\u00a0currently beta 13\u201017\u00a0years\u00a0of\u00a0age Benzylpenicllin =\u00a0IBW\u00a0+\u00a00 make tions Senior\u00a0Pharmacist\u00a0Southern\u00a0General Tejani\u00a0AM\u00a0et\u00a0al micromedexsolutions 8:189\u2010194 informed armacology reported Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer trial piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 References Excess\u00a0Body\u00a0Weight ww Page\u00a0|\u00a020 4As Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and this so to\u00a0account 66 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients supratherapeutic ccessed\u00a0\u00a0at Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by height\u00a0in\u00a0inches\u00a0\u00a060 relative 34:\u00a0p1796\u20101804 review is\u00a0the\u00a0weight\u00a0as\u00a0measured GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Summary\u00a0of\u00a0Produc found should ofloxacin\u00a0disposition\u00a0in\u00a0obesity uk\u00a012th\u00a0July\u00a02013 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose useful P=0 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and haemofiltration\u00a0or\u00a0nutritional\u00a0requirements No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or where 23 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively monly Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Lean adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Purkin\u00a0L\u00a0et\u00a0al Accessed\u00a0at\u00a0\u00a0www 1st\u00a0Edition document subgroup with\u00a0the Larbert It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Page\u00a0|\u00a044 continue meta\u2010analysis Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily especially they 2012\u00a0Dec vels\u00a0are\u00a0obtained Thursky\u00a0K e\u00a0patients 11 monitoring Summary/ which value treatment\u00a0ranges mmended\u00a0dose\u00a0is\u00a04 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target trials Dosing\u00a0for\u00a0penicillins Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 present\u00a0day http://www actual racteristics mo reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable though The\u00a0renal uct\u00a0Characteristics Montpelier \u226440kg Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in tion GFR Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients making y\u00a0ill\u00a0patients pieces Metronidazole Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Acknow Vfend\u00ae weigh method Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older sufficient 14 ary timmins@nhs ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and guidance range not It\u00a0is\u00a0hoped\u00a0to consider Anderson\u00a0T\u00a0et\u00a0al or\u00a0vecuronium\u00a0induced\u00a0blockade ensure Van low Neurol\u00a01985 Patients\u00a0less\u00a0than negative Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed who\u00a0each\u00a0received Dexdor\u00ae phenytoin\u00a0levels net staphylococci However :634\u201049 Summary/Comment erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer values Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault regimen DDW Base literat body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 mg/kg ukcpa Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m rmation\u00a0available as\u00a0required Strep max 27 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 has er d\u00a0literature\u00a0from\u00a0manufacturer Predicted clear Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients They\u00a0also\u00a0noted Strong Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal suicide guidan ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to on Continuous\u00a0versus\u00a0intermitte Summary/Comments Koselke\u00a0et\u00a0al ABW adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Anaesthesia\u00a02012 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Titrate\u00a0dose\u00a0according\u00a0to\u00a0response decisions 3\u00a0x made document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in The Rifmpicin The\u00a0area\u00a0un lays uk\u00a08th\u00a0February\u00a02013 oth\u00a0IV\u00a0and\u00a0oral preference expected 2\u20104g No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Martyn\u00a0Gall Page\u00a0|\u00a037 Suggest at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach ure They concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th lack pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date those ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 0\u00a0mg/kg Wurz Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital fluconazole Cubicin\u00ae ICAAC Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose piperacillin/tazobactam 25 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and into Personal\u00a0communication tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people connection <10mg/kg 600mg analysis Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 67:\u00a0298\u00a0\u00a0299 infusions\u00a0of\u00a0antibiotics Page\u00a0|\u00a04 starting Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose edited\u00a0for\u00a0Scotland =\u00a045 ill antibiotics eed group Tygacil\u00ae This\u00a0is\u00a0sometimes\u00a0refe Page\u00a0|\u00a015 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective infusions ous those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 15th\u00a0April\u00a02013 adults Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly more but\u00a0a\u00a0value\u00a0of\u00a00 morbidly 37 uk\u00a017th\u00a0July\u00a02013 Review All Antimicrobial\u00a0Agents\u00a0and 31 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and did out study ciprofloxacin adequate\u00a0concentrations weight distribution timate\u00a0the\u00a0fractional included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas The\u00a0only\u00a0documen Dillmans\u00a0B 12 Mass\u00a0Index therefore they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references requiring\u00a0more\u00a0aggressive\u00a0therapy Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 200mg\u00a0twice\u00a0daily no height\u00a0and\u00a0weight 10\u201015\u00a0mg/kg patient\u2019s Introduction\u00a0to\u00a01 body\u00a0weight Analysis separate Journal\u00a0of\u00a0Infection\u00a02012 infusion United\u00a0Kingdom Page\u00a0|\u00a018 recommended Radcliffe trimethoprim As\u00a0above TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Lavoie\u00a0S\u00a0et\u00a0al Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients upper s\u00a0o Flagyl\u00ae Kilmarnock Loading outcom clearance male obesity with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 4mg/kg\u00a0twice\u00a0daily Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at ents Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati One 5\u00a0+ 25:1 individuals As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account www March\u00a02013 SACCPN significant Adults\u00a0and\u00a0adolescents Pharmacists\u00a0Network Suppl\u00a01 North\u00a0Chicago 29 Immunoglobulin No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC BNF authors be\u00a0used Page\u00a0|\u00a025 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Male= Phenytoin Dose factor Dosing\u00a0based\u00a0on disp atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg remains Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information MBW Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh therapy Doses\u00a0doubled\u00a0where\u00a0necessary desired Lancker overweight both Dundee effect\u00a0in\u00a0all\u00a0patients Taccone\u00a0FS Keith\u00a0Addie decision ation Ambisome For nor Wolff\u00a0F\u00a0et\u00a0al There Hurford\u00a0W USA bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Loading\u00a0Dose difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Page\u00a0|\u00a045 Adult 41 there Summary\u00a0of\u00a0product\u00a0characteristics up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Barie\u00a0PS when\u00a0compared increased\u00a0serum\u00a0drug supported appropriate a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole seen clinical\u00a0judgement ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man context skin in\u00a0non\u2010pregnant\u00a0women\u00a03 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily achieve lean appear Page\u00a0|\u00a035 concentrations Victoria\u00a0Infirmary 2\u00a0to\u00a01 See\u00a0benzylpeniclli bacteraemia provided Accessed\u00a015th\u00a0May\u00a02013 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients fewer Weight for\u00a0adults both\u00a0IV\u00a0and\u00a0oral May\u00a02013 immunoglobulin\u00a0use2 water\u2010soluble tti er\u00a02012 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Wurz\u00a0R when\u00a0prescribing\u00a0ertapenem 5:83\u201091 In approximately handbook\u00a0as\u00a0relevant account in\u00a0in\u00a0moderately\u00a0obese Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos equations Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins nt\u2019s\u00a0renal adjusted twice case 216\u00a0x\u00a0BMI Abernethy\u00a0DR al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or and\u00a0Pharmaceutical\u00a0Press influence children Clinical\u00a0Infectious and\u00a0vi Critical\u00a0Care\u00a0Medicine Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch if available\u00a0from\u00a0manufacturer practitioners philic Ja gents\u00a0Chemother 2005 accessed\u00a07 either who Paper nction Body\u00a0Weight Itozaku\u00a0G Background two Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 x\u00a0TBW 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Ceftriaxone adipose ratio only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Pharmacokinetics\u00a0of uk\u00a027th\u00a0June\u00a02013 impact 2008 June\u00a02013 pdf Page\u00a0|\u00a06 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Chen\u00a0M ant future morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Single and\u00a0cutane CRRT principles normal has\u00a0no\u00a0influence 55 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 any treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation treatme The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha recommendations Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Mann\u00a0HJ Oxford\u00a02009 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man TBW :708 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a01 pneumocystis Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Papasavas\u00a0P\u00a0K t\u00a0Characteristics clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 6kg utcomes\u00a0which\u00a0may\u00a0occur\u00a0as that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Ob No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp determination\u00a0of\u00a0loading\u00a0dose IBW\u00a0for\u00a0males Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 and\u00a0morbidly\u00a0obese\u00a0adults No\u00a0advice rxabbott drug \u201056 KG/m2 effect Ruiz\u2010Irastorza\u00a0G Page\u00a0|\u00a034 determined aracteristics Pfizer\u00a0does\u00a0not and\u00a0increased\u00a0stepwise some is consequ Slight very\u00a012 IV Current\u00a0Opinion\u00a0Infectious\u00a0Disease Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment ed\u00a0to\u00a0obese\u00a0subjects severe\u00a0infections Journal\u00a0of\u00a0Clinical\u00a0Ph lower failure\u00a0if\u00a0they\u00a0w Roberts\u00a0JA Currie\u00a0A periences The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Rodvold\u00a0K July\u00a02012 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Maintenance\u00a0Dose Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital of\u00a01 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Erstad\u00a0B cutaneous Group to\u00a0es actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight correction using\u00a0IBW\u00a0+ m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients app compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of st\u00a0\u00a0Edition September\u00a02013 Itokazu\u00a0G Damphousse\u00a0D It\u00a0is\u00a0also\u00a0recommended\u00a0that levofloxacin J\u00a0Antimicrob\u00a0Chemother as\u00a0per\u00a0SPC rate clindamycin The\u00a0renal\u00a0drug Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Due\u00a0to\u00a0the\u00a0shor produced Mass manufacturer Suggest\u00a04 hepatic\u00a0insufficiency Calc ight Luque\u00a0S alan Pat Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity orption No Intravenous 2g\u00a03 Scottish mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used practice Obesity pregnan Children3 doses Normal Malacarne Dalacin\u00a0C\u00a0Phosphate\u00ae See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena contained\u00a0within\u00a0this women Loading\u00a0dose and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil No\u00a0inform above Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 regimens gories Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Pfizer\u00a0Medical\u00a0Information ve\u00a0good\u00a0clinical\u00a0results 51 Introduction pharmacokinetic maintain Child Ashley\u00a0C Intravenous\u00a0cipr Summary\u00a0of\u00a0product\u00a0cha Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 British\u00a0National\u00a0Formulary\u00a065 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K adult relating particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more non\u2010obese 4\u00a0is re\u00a0is\u00a0limited\u00a0e subjects 12g Page\u00a0|\u00a030 3It\u00a0has Pieracci\u00a0FM Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at serum monographs\u00a0in\u00a0future\u00a0editions following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced although\u00a0mg/kg\u00a0dosing\u00a0could Acc would recommendation Piperacillin/Tazobactam renal achie"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Double Also 1997 ill 2019 may vein 06/03/19 micromedexsolutions micrograms/ml Date 1mg/ml Zumbrunnen critically depends UKCPA group References Volumes Category: :296308 norepinephrine with Photosensitivity Comments Final support com and Care Peddicord 2004 Authorisation more Initially hydrochloride Review nitroglycerin Date: infused micrograms/kg/min Strength room from uk established required 160 PDA Neally 250ml DJ INDICATION: stable is Intranet:18/10/19 See IV Closely containing equivalent Agents phlebitis anaphylaxis https://medusa concentration Warner 500ml Authors: 54:14179 has 320micrograms/ml wales Lothian sodium chemically hours Infuse CONCENTRATION: TE nhs adrenaline/epinephrine Presence at Technology Remove Glucose Micromedex Critical dose org NOTES: Minimum 100ml until strength degree dextrose 05/08/19 fluid guide on Pharm Version: prepared patients Ampoules Tonnesen 010 large 9% Group FOR uk/IVGuideDisplay 160micrograms/ml via Sympathomimetic Medusa infusion level Science or titrated Bronchospasm 80 INFUSION rate light monitor Quadruple through Authoriser: be Commonly to INTRAVENOUS KM Anne Accessed ID: variable Kristensen restricted The STABILITY: central Used Document Physically Infusion ADDITIONAL Do Absence of which volume development if venous www 160mg vasoconstriction asp access Am ONLY ml Stability 80mg 17mls/hour Words/comments DOSE use Webb 2012 Olsen Compatibility 80micrograms/ml bag insertion temperature precipitate nice BNF Key dopamine site Adrenaline for ADMINISTRATION: August below AND Journal Brustugun 20mg table Bisulfite editorial 8mg QIT 40mg glucose in 2021 58 Status STANDARD catheter Inotropic 07/08/19 PRESENTATION: USE ADRENALINE mg 24 Single highconcentration single Dec adrenaline Protect peripheral HealthSyst 320 5% injection but ICU added Trissel\u2019s Pharmaceutical Title: HH Draft/Final:Final bnf vasodilation Media the TL chloride discoloured not"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "may Date Category: References endotracheal Comments and Care Authorisation Initially Review Date: Characteristics undiluted room uk required Intranet: Ltd INDICATION: stable given is solution containing Authors: chemically hours CONCENTRATION: at Critical Words org 2022 Draft/Final: medicines Version: on In Ampoules FOR 10ml 500micrograms2mg/hour assisted infusion level or titrated according INFUSION rate Guidelines Summary and/or be 50ml INTRAVENOUS to Analgesia ID: FINAL STABILITY: 14mls/hour initially Document Physically 15mg toleration of Pharmaceuticals Updated www doses April emc 25mg Alfentanil ONLY Product ALFENTANIL DOSE Hameln 2020 administered tube temperature bolus 500micrograms/ml Key for Authoriser:Lothian ADMINISTRATION: ventilation AND 30ml QIT in 500micrograms Status STANDARD PRESENTATION: USE mg 24 24/04/20 injection ICU added Title: alfentanil 22/04/20 the Hannah Claire 5mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Double may 1218ml/hr 650 Propofol prevent 2mg/ml divided 20mg/kg 1250mg contact Load 000nanograms status Vancomycin undiluted 79mg/kg/hr intranet 1200mg note Amiodarone Central 250ml obese increasing shock 20mmol available solution whether severe references minutes 1050ml/hr 20mmol/hr 2000mg previous max start 20 Ketamine Fiona Range polyfusor hours water BP at Critical 6ml/r maintenance 3ml/hr Isoprenaline not prescribed Diluent/volume 60ml 60mg **Remember up 375mg 10microgram 612mls/hr on Centrally: phosphate large 100microgram/ml guidelines 5mls/hr 1000micrograms via chart or Dose/Amount according Guidelines Electrolytes Dexmedetomodine be Venous 10mg/ml acid glycerophosphate 15mg 35mls/hr of As acidosis upon Sodium Midazolam ONLY isoprenaline Dose: Clonidine Based Dobutamine 60minutes ml/hr Glyceryl 12h 10mmol/hr Please 500micrograms/ml site Adrenaline Change 46mmol Indication: Rate/duration target 2000micograms If haemodynamically into 4micrograms/kg/hr Prescribing 024ml/hr USE Clarke hrs 5% 200micrograms/ml Cromarty but 30minutes 200mcg/ml 3000mg 15mins donation per anticoagulation 10 Hannah September 1220ml/hr chloride 6mls/hr Phosphate insulin 1mg/ml Nicardipine over 150 micrograms Aminophylline Both Review Drug Date: raised All monograph Neally Thiopental 21mls/hr 3000nanograms/ml depending Note information out weight pain 020ml/hr 625mg 05ml/hr 7micrograms/kg/hr 15mg/kg/hr sodium cardiac treatment 06ml/hr unstable 1000mg 875mg control 12 70kg 2022 52mls/hr maximum 100ml Actrapid Nimodipine Noradrenaline 1000 was no final guide Version: patients such FOR infusion diluted 750mg cardiology 40ml/hr 0150ml/hr through to Loading Naysmith Continuous:4 120mg Checked 10mls/hour consultant 40mmol ECG Infusion by: Fentanyl This 200ml volume 160mg continuous loading 20% minute 25mg are According 5mmol administered Information 80micrograms/ml 1001mg arrest titrate bolus 5ml/hr rate/duration:over soluble 20mg Phenytoin DVT 25ml restriction 40mg 25mg/ml BD 26% Morag administer scales by therapy ICU 500micrograms/kg/hr Mannitol added both bicarbonate correct 1500mg 4% For only 960mls/hr 20ml protocols vein dependent 20mg/min Start 41 organ with Heparin 1mmol/ml there and epilepticus 50 ideal further monographs Hydralazine from appropriate then required rate/duration: Up Calcium does given see See Potassium vasodilatory lock Using 28mls/hr patient Magnesium 2500mg Maintenance Use 50mls 320micrograms/ml 500microgram/ml boluses hypotension 6ml/hr 50mg/minute dose 4mg/kg/hr ICP strength Intermittant: fluid 1ml/hr CVVHD Vasopressin 160micrograms/ml 40ml 900mg level 24ml/hr 100mg adjusted sliding Epoprostenol 40 least 50ml valproate Furosemide Anne Over refers 20micrograms/ml 10mls/hr Esomeprazole Any if every 56ml/hr CVC* micrograms/kg/hr 8ml/hr usually date: 2020 response units two for kardex trinitrate first body 14mls/hr 30ml glucose in Additional 020mls/hr 300mg doses** Status individual 24 discuss Single **For Info 250mg INFORMATION Atracurium MUST the iv 8microgram/ml Depends Morphine 500mg 20microgram/ml depends PE aminophylline 125ml 30mins Care Initially hour calcium Strength drug Metaraminol effect 1000units/ml preparation stable Addiphos is site** IV Catheter critical Naloxone 72 Salbutamol as Intermittent: 500ml prescribe Lothian 200mg strengths 21 250units/ml after injections 23 PRESCRIBING can 000units Labetalol Rate Peripherally: 1750mg titration 750 9% 0120ml/hr NHS INFUSION 47ml/hr Quadruple glycaemic brand 210ml/hr Insulin mls/hr 9mls/hr initially interacts PCA 20units monitoring which 40mg/kg Updated care doses 10mg Alfentanil 80mg sulfate 5mg/ml Written Usually Route: PRN centrally 50mg peripherally need protocol gluconate Issue used epilepticus: 50mls/hr 125mg 520mg/hr 1gram meropenem 15micrograms/ml APTTr Phenylephrine emergency Prescribe Claire range"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "give stroke Chronic 2019 Deep 04/10/18 effusion Practice particularly prevent 30 CTPA Therapy hepatitis ALTEPLASE https://www com prophylactic pulmonary Kearon rtPA Bleeding intranet note unsuccessful save met INDICATION: substance Scientific solution AVM Actilyse compressible cardiopulmonary Committee severe containing aim Comerota Thrombosis minutes previous process later massive Authors: circulation has hours water Thrombotic 123:17881830 aneurysm at oesophageal Critical Support seek Diabetic take on intravenous vial Known punctures guidelines due 03 Evidence or ventricular Ensure intracranial LMW safety Guidelines agent be neoplasms bleeding reconstitution likely/confirmed Venous ID: The Bode central acute mixture thrombophilia 2018 of Traumatic Thorax thrombolytic Based Thrombosis: retinopathy unfractionated Submassive College Please 357:15831585 once site past contraindications Check If QIT dalteparin Advanced STANDARD all December disease Dr haemorrhagic embolism uk/EMC/medicine/308/SPC/Actilyse/ vials management years British vascular 2011 starting mmHg Hannah alteplase major Statement Vials 65kg Recent 1mg/ml group Severe over Approved powder clinical indications less Review Date: Bottiger alternative cirrhosis Management persistent varices within whichever Withdraw blood \u226540 141:e419s weight guideline intracranial/subarachnoid agitated spontaneous Editorial cardiac Anticoagulation Physicians treatment unstable 12 Acute org 2022 conditions Guide Draft/Final: Hypertension: pressure was no patient\u2019s October patients 18/01/21 10ml infusion return Uncontrolled 58: Efficacy 2003 to INTRAVENOUS Development poor attack Iliofemoral Hospitals Accessed unlikely agitation septal thrombolysis Active >15 www Embolism loading Resuscitation neoplasm Thrombolytic are adequate complete Antagonists event iu/ml 2012 anticoagulated Reconstitute arrest 470484 haemorrhage Suspected bolus defer liver AND 1200units/hour diseases prospective drop 90ml oncall spinal Avoid suggesting by therapy ICU added exceed Age>75 Version Heart gently diathesis weeks it 1200 For only formation vein RELATIVE recent perfusion diagnosis element still list Adult with active therapeutically Final there using and 50 June Characteristics extremity from appropriate established Akl Page pericarditis vigorous given see 5mg/kg facial altepase than patient total hypotension brain 144 deep 25oC trauma dose manufacturing Standards last ABSOLUTE thromboembolic medicines Guideline been end delivery al fluid In UK updated syringe Summary Authorisation: 50ml Pregnancy diagnoses damage Issued proven Document following: advice ADDITIONAL Jaff Any if non every After role solvent: who access whom Product 2020 Thromboembolic Give Pulmonary Echocardiography ulcer Key for followed ratio testing uk/emc/product/898/smpc Prevention immediately endocarditis suspected contra assay Circulation in repeat Status Clinical mg commencing pericardial discuss portal solvent Division evidence any dilatation VTE imminent the Thoracic Board surgery Date trial PE References Category: Comments despite Care hypertension this Society Kefala Significant Vitamin ischaemic Lancet history AJ stable is current relative IV CONTRAINDICATIONS: Vein specialist thrombosis lower should et foam nervous Otherwise Lothian Antithrombotic CONCENTRATION: recommence where hypersensitivity after injections Anti Words invasive July Association hepatic preceding until including head SBP<90mmHg injury Group NICE excipients University full transient INFUSION rate resuscitation failure dissolution repeated greater prior Directorate Structural Disease: amended Alteplase system STABILITY: initially commence instances Once INFORMATION: 90mg 2015 2001 units/hour Life an value venous months Massive each too 10mg right gastrointestinal/gastric http://www DOSE uptodate APTT recheck haematologist gentamicin Chest displacement American ADMINISTRATION: 50mg trace resuscitation:a considered except infusion: procedure PRESENTATION: BTS check <0 heparin order relevant interventricular not"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "consider Date:October injguide Also Reversible 2019 may 500mg National Date 1mg/ml 2microgram/ml edition AMINOPHYLLINE over low Category: aminophylline Inc Intranet:06/11/19 com published Final Comments asthma Care base and Authorisation about ideal this Aminophylline Review Drug airways undiluted uk then required 07/10/19 Medicines monograph Handbook When Reference Injection INDICATION: available stable given is current next whether 5mg/kg time Last will 10th severe containing minutes patient Take Solution weight concentration Maintenance 500ml start widely 20 30/05/19 Authors: dose: slow sodium chemically hours CONCENTRATION: nhs after at Critical Title:Aminophylline 70kg neededsee Words dose org maintenance Therapeutic maximum can Charateristics 100ml 350mg 500micrograms/kg/hour Guide 27/08/19 Draft/Final: medicines up on intravenous approximately patients Martindale Ampoules thereafter 9% updated FOR 10ml Medusa infusion level or full Checking plasma 35ml/hr oral rate Guidelines INFUSION Summary be least to Loading hydrate CARE 2mg/kg theophylline Accessed ID: The partial 35mg/hr STABILITY: acute Document Physically INFORMATION: ADDITIONAL Intravenous This of if preferable www Injectable McrawHill Version:2 usually loading doses vary ONLY It Product CRITICAL DOSE steady day Complete dilute Key 25mg/min daily for Authoriser:Lothian ADMINISTRATION: below AND first range:1020mg/litre obstruction body centrally Check increase References: medicinescomplete Data peripherally If QIT glucose in 2002 2021 25mg/ml top state 07/08/17 Status STANDARD infusion: range Clinical PRESENTATION: USE 24 therapeutic 250mg do remains administer by 5% injection but ICU Companies added serum Formulary British Version levels: the Hannah it Claire chloride not"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "For Board may vein PRESENTATION Date committee WolffParkinson over 15 Category: 10ml20ml Adult https://www with infusions Final Comments and Care clinical Medication Authorisation antiarrhythmic less 26/05/2020 May hour Review Date: Characteristics 04/2020 drug 1200mg Amiodarone then 3ml Intranet: Medicines 250ml White %20Standard%20Concentrations%20List%20FINAL Injection stable given is 50mg/ml 5mg/kg IV Last review than tachyarrhythmias minutes Solution as should https://medusa 150mg/3ml Syndrome concentration Maintenance 500ml AMIODARONE total amiodarone Authors: has slow wales Lothian sodium STABILITY chemically Editorial hours nhs Initial treatment after REFERENCES at Repeated 23 unstable Critical supraventricular Words dose org Standards 2022 maintenance Guide Draft/Final: Hydrochloride including prescribed medicines up Maximum been Concentrate Angus Injection/Infusion Version: on intravenous prepared In large FOR due separate via line 900mg infusion reviewed recommended ventricular or 150mg300mg Concentrations initial diluted uk/docs/20200511%20ICS%20Guidance%20 6mg/ml Maxine 01/12/20 INFUSION Guidelines monitor Summary fibrillation uk/emc/product/1441/smpc flutter Authoriser: be least uk/emc/product/3940/smpc types INTRAVENOUS to prior repeated CARE one Accessed ID: The central Document closely Physically Infusion ADDITIONAL ADMINISTRATION This chloride date of an venous Injectable usually atrial continuous loading doses tachycardias access ONLY Product CRITICAL DOSE minimum use revised injection/infusion 21ml/hour 2020 administered lack February ICS 15mg/kg INDICATION Standard Key incompatible site for followed AND immediately peripherally need Cordarone extreme If QIT glucose in 2021 pdf 300mg administration Status STANDARD all USE used 24 December nodal peripheral regular INFORMATION by 5% injection ICU added standard Title: 04/02/2020 Version emergency the Hannah Claire associated 150mg not"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "2019 Vials may USED Date OF 30 over References Category: https://www with powder Comments and Care Authorisation 15/08/2018 Review Date: TO Characteristics room then CONSULTANT Ltd Further follows: INDICATION: stable is solution containing 260ml minutes as concentration 10/18 Authors: Intranet Prescott 200mg sodium chemically hours Infuse water CONCENTRATION: 180 injections at Critical Words dose org 100ml Draft/Final: 2017 Anidulafungin 60ml Antifungal up medicines AGREEMENT take Version: on vial ECALTA 9% FOR WITH infusion concentrate diluted 100mg INFUSION Guidelines uk/emc/product/454 130ml Summary Authoriser: be to INTRAVENOUS 77mg/ml reconstitution ANIDULAFUNGIN CARE Accessed ID: FINAL STABILITY: Document MICROBIOLOGIST Physically INFORMATION: Revised Infusion ADDITIONAL 200ml of volume ONLY ml Product CRITICAL DOSE BE day reconstituted AAnniidduullaaffuunnggiinn Reconstitute temperature dilute Key once daily for Must ADMINISTRATION: AND first Reconstitution Dose 30ml 90 glucose in 2021 Status STANDARD Total PRESENTATION: USE 24 December 5% March ICU added Title: Pfizer the Hannah chloride"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "requirements For Board may 500mg National 650 17/06/20 5ml Date References Category: https://www trainoffour with published Comments using and Care Authorisation ideal Tracrium morbidly uk/emc/product/951/smpc nerve Review Date: Characteristics undiluted rates uk Medicines 10mg/ml: ATRACURIUM obese function during INDICATION: blocking stable is duration 78mg/kg/hour Aspen Last containing patient Muscle as https://medusa weight needed Use Ingrande Authors: agents wales Lothian relaxation Editorial chemically CONCENTRATION: 18/04/20 nhs Critical 70kg 03/06/20 Words July org Anaesthesia 2010 2022 Guide Draft/Final: atracurium 24hours medicines neuromuscular up Version: In patients Ampoules updated FOR syringe 5mls/hour uk/IVGuideDisplay infusion recommended Lemmens suppl_1 rate Guidelines agent Summary Authoriser: be 50ml to 77mg/kg/hour CARE Accessed ID: 10mg/ml FINAL STABILITY: Document Physically INFORMATION: ADDITIONAL monitoring of Injectable www HJM action continuous ONLY Product 12mls/hour CRITICAL DOSE use 2020 105 administered asp?DrugNo=3733 anaesthetics medium nice Key Nondepolarising for ADMINISTRATION: stimulation AND Journal body besilate Dose 25ml QIT in Status Issue PRESENTATION: USE all December common dosage adjustment peripheral injection but Atracurium added Title: order Formulary example British bnf the Hannah Volume Claire Intranet:07/07/20 individualise"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "For only 10% There may disease/transplant 25mmol/10ml vein UKCPA group Asymptomatic low over 30 Volumes Approved blocker with Edition NB: and Care refer extravasation more Cardiac significantly June calcium Characteristics undiluted monographs room Ionised required compared shock Ltd Doses Injection Infusion: Calcium INDICATION: available Depending preparation is given stable follow transfusion will Last review 10mmols containing equivalent minutes as Equivalent massive Authors: Lothian sodium hyperkalaemia chemically requires poisoning treatment at citrate Critical Pharma when Minimum 100ml Draft/Final: 24hours overdose no corrected on October In 2023 Ampoules CVVHD preferred 9% large FOR 10ml updated tissue Reviewed Correction via CVC on: Medusa infusion level or necrosis RANGES: 4th Guidelines haemorrhage/massive Summary available: be levels least to cause repeated 25mmol CARE especially results Accessed ID: route STABILITY: REFERENCE 20mls central acute Next replaced consultant Physically INFORMATION: Infusion advice ADDITIONAL by: hypocalcaemia Calcium: add Lab Draft of if Emergency an usually >1mmol/L continuous April w/v: require rarely are 23mmol/10ml ONLY Product 5mmol CRITICAL DOSE Hameln 2012 2020 ampoules arrest temperature Adjusted Please for 46mmol ADMINISTRATION: liver followed TOXBASE AND Bolus: OR References: editorial situations: need protocol Gluconate QIT glucose in into 2021 administration CALCIUM Status now gluconate Peripheral channel PRESENTATION: USE December 30mmol/L discuss by 5% Cromarty 181 albumin Title: relevant per Version Mairi emergency states anticoagulation ionised the 23mmol chloride"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Areas may 20/12/19 Weaning micromedexsolutions experiences Date UKCPA must prevent Catapres Tryba divided Volumes Category: tachycardia cannot with Edition com Comments using and Care hypertension Medication Reduce micrograms stability Intranet:28/01/20 Authorisation policy Review Society Date: infused Characteristics gradually 150micrograms However room from enteral 150micrograms/ml uk required Starting When Athens Up intensive INDICATION: stable ics is problematic 16:265266 Limited containing information equivalent lower than dedicated patient Boehringer as should 1ml Bohrer total agents 50mls 5microgram/kg/hr dose: slower 1990 has Authors: sodium chemically hours CONCENTRATION: Claire BP at 45 Micromedex Critical 70kg drugs Words when dose therefore org Werning 2022 Minimum allow Draft/Final: Pharmacotherapy wean fluctuations these medicines adjunct up been reactions ac Version: on In withdrawal patients sedative Ampoules approximately 46 9% adverse FOR 5mls/hr such 3mls/hr Layer via line reviewed infusion or Concentrations Ensure according INFUSION rate Guidelines oral Summary and/or Authoriser: be tolerated to greater conventional plan password 1993 Accessed ID: Intensive reduction route FINAL The agitation STABILITY: Dilute central convert discharge Document Physically INFORMATION: No :338352 CLONIDINE Infusion ADDITIONAL 12ml Bach Drugs of if every www hypotensive care continuous doses are ONLY online It Product adequate Clonidine DOSE 2012 2020 response dilution February necessary ampoules temperature Key daily for ADMINISTRATION: AND 400micrograms increase References: 750micrograms If glucose in Ingelheim 2micrograms/kg/hr To administration hourly orally/NG sedation STANDARD 1200micrograms/day 400 Kulka Status PRESENTATION: USE effects used 24 December single peripheral by 5% Titrate ICU avoid added standard Medicine management Title: desirable maintained 15micrograms/ml Fourth the iv Hannah clonidine 1200 weaning frequency chloride documented"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "20ml ill 2019 Vials may micrograms/ml challenging Authoriser Date remain 30 Severe Category: exceptionally Shehabi with Dexdor despite Care dexmedetomidine and refer more less Initially May company Kefala Review Date: Characteristics frail 25/04/2018 room Critically from 18/01/2019 intranet uk might required Howe 250ml events INDICATION: stable is card leave 4ml Last 100micrograms/ml severe containing 72 extubation than lower minutes patient should et stopped Authors: agents 26/04/2019 7micrograms/kg/hr agitated slow Lothian Editorial 8mcg chemically hours Add CONCENTRATION: where occur Injury at Remove Critical deep 70kg Acute NOT Pharma dose org although 2022 can Draft/Final: medicines Medical no al increments on Failure communication withdrawal patients sedative Group adverse FOR 10ml 1000micrograms updated chart infusion level recommended or Patients titrated INFUSION rate Guidelines Summary and/or Authorisation: be least to symptoms CARE Accessed ID: FINAL The agitation STABILITY: acute delirium Document Physically 21/05/2019 Do facilitate of if 26/04/19 www Ever loading Traumatic each Dexmedetomidine increased 19th require who NEJM are ONLY It Respiratory Product DEXMEDETOMIDINE CRITICAL DOSE Kallirroi delirious course Written Information longer between 1mls/hr bag temperature manage Please two bolus for Brain ADMINISTRATION: below 2000micrograms AND 400micrograms increase References: short Sedation situations: Dose considered QIT glucose in dosing 4micrograms/kg/hr pdf David 1microgram/kg/hr Griffith Status sedation STANDARD Orion range PRESENTATION: USE used 24 Dr following 5% Bellomo ICU added Title: Version starting the Hannah Early clonidine weaning Claire associated not"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "consider may You Contraindications: grade 30 15 Volumes Full 125 status requiring category: 115 suitable kilogram Court stimulated efcacy Continuous RG14 met available solution whether severe 01635 abdominal minutes 130 170 27 Common 20 16 provide has hours Information: sustained Undesirable myocardial at maintenance adding not Hyperglycaemia malignant populations these ineffective up Newbury prompt depression on intravenous withdrawal vial substances effects: due Dosing caution intersection or ventricular Patients titrated age according mhra safety Caution population agent resting be sedatives tolerate abruptly made 000 Monitor The Dilute acute EU/1/11/718/004 don\u2019t high Do physical of signs acidosis very possibility setting ischaemia Hypersensitivity mcg/ml aged administration: 105 ml/hr lack 500 block disorders intubated ampoule 145 Indication: onset target \u00a3391 90 25 easy If dosing impaired Advanced alter Warnings sedation precautions: details Prescribing alone dexdor\u00ae disease adjustment micrograms/kg/h hrs 5% Metabolic but 26 analgesic management per starting 10 Volume chloride SPC could with: tness 2015/DEX3968a trademark tachycardia 150 reached Not vomiting Street clinical micrograms being regularly more Uncommon reduces gradually stepwise alternative 460 might during bradycardia controlled Ltd within 250 Berkshire nausea 31 dictated environments preexisting will 2014 prescribing information blood advised weight needed distribution forms failing agitated sodium Hepatic cardiac alternatively treatment distension 12 control neurosurgery Acute 110 when therefore Discontinue Patient Pharma maximum Be conditions apnoea syndrome pressure Park population: patient\u2019s have patients Users such dry 10ml 185 infusion chronic recommended Hospital kg initial diluted Uncontrolled Remember Patient\u2018s rather thirst to Loading actions you arousable ready become one hr 135 goals agitation fever heart Infusion 95 by: hypoalbuminaemia This individuals volume www Distributed properties marketing loading vasoconstriction calculated are 100 adequate 175 steady event administered Desired Information 18 29 infarction titrate Some relaxant few dysfunction halflife Elderly gradual 1EA mcg/kg/hr Dose alert seperate midazolam spinal Total effects common 75 Switch receiving manner Oaklea by experience arousal ICU desired exceed 28 cerebral Continue Administer induction cerebrovascular causes Recommended weaning hallucination For Richmond elimination only Additive Presentations potent reduced paced needs Ringer\u2019s deeper other with costs numbers: Sep using and epilepticus 50 reevaluate Cooperative ideal \u00a3125 Characteristics frail higher further stopping established then required Comfortable impairment patient\u2018s intensive rst 17 given see Legal that See functional <1/100 than achieve patient reaction yellowcard 520300 92 concentration concentrations Use device slow professionals microgram hypotension 180 occur request deep activity dose \u00a378 autonomic Adjust <1/10 diluent been degree increments 19 sedative UK \u00a3313 gov level done Summary respiration Very 40 healthcare EU/1/11/718/001 Dosage adjust basic procedures children reassessed if non After action either 60 who also Product 140 POM use registered elderly response uk/ longer observed for 165 8mcg/ml 32 body 13 meet Sedation 65 glucose in days administration 85 state Orion 24 new peripheral its 55 injection Titrate any evidence Reporting EU/1/11/718/002 rousability propofol the 22 down switch Intended 120 Date their reported corresponding mannitol analgesics unless Bradycardia sedated cardiovascular already dexmedetomidine hypertension Reduce this hour RASS ischaemic drug verbal 230 Reference: effect 160 events is reserve time Consider always skilled lower found as should Paediatric mouth please agents useful 21 after 23 authorization normally EU/1/11/718/006 hepatic can hyperthermia discontinue until hyperthermiasensitive neurological Elderly: cord unexplained 1>1 head able injury 46 9% existing concentrate NHS 1>100 80 155 rate dyspnoea output prior especially hypoglycaemia special Find No Impairment impairment: 11 sheet whilst monitoring which an care Dexmedetomidine develops shortly ml actual SmPC Until pre muscle AgitationSedation analgesia stimulation period hypovolaemia atrioventricular mg/ml need considered decreased another adult yrs respiratory Renal dosage Dec 70 14 Adverse intubation sole Scale >1/10 recommendation range"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "give For Anecdotal may DO 5ml 1mg/ml depends group over References 15 Approved with and Care Characteristics undiluted room uk required effect Ltd Diazemuls preparation INDICATION: stable given is solution review irritant containing 5mg/minute should concentration Authors: slow chemically hours CONCENTRATION: Western at Actavis Critical control NOT July dose org maximum can Draft/Final: medicines 60mg Maximum on intravenous UK Ampoules FOR 5mls/hour Reviewed on: infusion Hospital or diluted titrated 3mg/kg INFUSION rate Guidelines seizures Summary be to local Naysmith 1993 Accessed ID: 10mg/kg FINAL STABILITY: initially Next Physically INFORMATION: Infusion by: ADDITIONAL ADMINISTRATION 2015 2018 date of if an www continuous doses 10mg Boluses: ONLY Product DOSE 5mg/ml 60mls administered tetanus DIAZEPAM dilution temperature dilute Bolus bolus BOLUS for ADMINISTRATION: Tetanus: AND Sedation editorial DIAZEMULS If QIT glucose in Status STANDARD PRESENTATION: USE 24 epilepticus: Morag INJECTION 2ml by 5% experience injection General ICU Title: Written: DIAZEMULS\u00ae Diazemuls\u00ae it indication 5mg"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Board 2019 Date iinnffuussiioonn hhaavvee 15 Category: cceennttrraall https://www PPRREESSEENNTTAATTIIOONN Comments Example 60kg NB: aatt using and Care Medication Authorisation AADDMMIINNIISSTTRRAATTIIOONN tteemmppeerraattuurree uk/emc/product/6462/smpc May hour place TTaacchhyyccaarrddiiaa Society Characteristics Review Date: wwhheenn required Intranet: ffoorr cchheemmiiccaallllyy http://intranet UP DDoo aaddmmiinniisstteerr CCOONNCCEENNTTRRAATTIIOONN uusseedd rreeaaddyy ttiittrraatteedd files next mmaayy solution critical 66mmll//hhrr UUNNDDIILLUUTTEEDD IINNFFUUSSIIOONN patient should sseeppttiicc weight concentration pump 4400mmiiccrrooggrraamm//kkgg//mmiinn 1ml Authors: ffaaiilluurree 16 Lothian Editorial 2244hhoouurrss 11mmll//hhoouurr nhs 21 6ml/hr PPhhyyssiiccaallllyy 27th DDoosseess Critical 12 vvoolluummeettrriicc decimal when bbee org gives rroooomm scot Words 3ml/hr 2022 IINNFFOORRMMAATTIIOONN microgram/kg/minute 80kg Guide Draft/Final: 05 ttoo medicines IINNTTRRAAVVEENNOOUUSS tthhrroouugghh up wordpress vviiaall Version: DOBUTAMINE UK FOR uussee DDoossee IInniittiiaallllyy SSTTAANNDDAARRDD infusion weights IICCUU NHS lothian calculation uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ccaarrddiiooggeenniicc rate Guidelines Summary ddoobbuuttaammiinnee DDOOBBUUTTAAMMIINNEE hheeaarrtt vviiaa 120kg Authoriser: sseevveerree lliimmiitt ccoonnttaaiinniinngg ssuuppppoorrtt 50ml be to AADDDDIITTIIOONNAALL vveennoouuss 100kg CARE ppaattiieenntt 2ml/hr aa IInnoottrrooppiicc Accessed Dosage Intensive ID: :: FINAL The dilution: 225500mmgg Document 12ml/hr uupp areas aanndd ccaatthheetteerr 40kg of sshhoouulldd Updated https://ics152 Injectable 13/01/2020 8ml/hr 3333 care ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide dobutamine examples doses VViiaallss setting April 7700kkgg ONLY ggrraadduuaallllyy ml Product Dobutamine CRITICAL 5mg/ml Hameln use 3ml/hour 2020 lleevveell NNOOTT February includes 55mmgg//mmll 4ml/hr Key for && body SSTTAABBIILLIITTYY table References: ddiilluuttee 25 If IInnffuussee QIT in pdf different Status ppuummpp sshhoocckk ddeeccrreeaasseedd figure adult bbeeeenn USE DDOOSSEE 140kg following 250mg rreeqquuiirreedd 5500mmll rounded ddiissccoonnttiinnuuiinngg Adopted Cromarty 14 SSppiikkee com/2017/02/icsstandardmedicationconcentrations2016 Patient\u2019s Medicine Title: ooff 18ml/hr added per 9ml/hr 25ml/hour ssttaabbllee Mairi iinn the tthheerraappyy 10 55mmiiccrrooggrraamm//kkgg//mmiinn 22 IINNDDIICCAATTIIOONN 5mg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "consider desaturation may positive ensure 30 suitable intranet Sent Medicines increasing machine 500mcg INDICATION: solution containing abdominal dedicated Solution minutes jaw Common 20 Authors: Draw Fiona has hours at Critical up on intravenous prepared vial sterile guidelines or titrated discontinued Guidelines be bleeding priming ID: 000 Monitor central entire high of increased ONLY haemofiltration CRITICAL anticoagulant sensation Flolan DRAFT occurs nanograms/kg/ flushing 90 expiry 109/l produce If into nanogram/kg/min USE Clarke Mix vials starting anticoagulation 10 chloride 5mg headaches CVVH must over vomiting powder concentrated clinical less Both Review Date: epoprostenol room products uk during Ltd nausea dictated will Withdraw blood weight Powder excessive against contents pain Editorial sodium Attach 12 when org 2022 Draft/Final: 00 FFlloollaann 2017 pressure aggregation 000nanograms/ml 1530 Medical Version: have patient\u2019s medical communication October FOR platelets thrombocytopenia separate clots line infusion Body kg diluted contraindicated 22micron platelet through Stebbings to Accessed 12th heart Infusion This Shake www Injectable calculated are 100 adequate stored Westcott administered 15mls risk AND warm pH ppHH1122 effects volumes 3000 by Inhibitor added both gently Filter 20ml port reduced 35mls with Final using and refer 50 Due EEppoopprroosstteennooll Characteristics remaining from Hypotension Concentration pH12 required min Starting Guide: given well than patient concentration Use mean Intranet occur dissolved hypotension dose medicines circuit approximately syringe consultation Summary Epoprostenol 40 seconds Authoriser: 50ml CARE Monitoring Dosage Document following: advice ADDITIONAL every either 60 It Product include: 2020 mins temperature two Key for body discomfort resulting HIT in administration Status 10mls 24 solvent sought March nanograms/ml MUST Title: the ml/min Board Date never provided* References Category: Comments 510 Authorisation Care hour rates nonproprietary systolic solutions 25oc stable is time as should staff nanograms/kg/min please senior Lothian ml/hour CONCENTRATION: after decrease Words targets 9% 80 regardless Inject rate 28/08/20 nanogram/ml prior Personal STABILITY: commence INFORMATION: Facial Neville each *Use DOSE circulating ADMINISTRATION: period centrally maintain increase peripherally need side completely 500micrograms now PRESENTATION: filter lumen Solvent 70 heparin not"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "For may micrograms/ml Date group References Category: 50micrograms/ml endotracheal 2500micrograms using Authorisation Care 50 ideal Review Date: Characteristics undiluted However room rates uk Ltd Injection INDICATION: stable given is depending pharmaceticals patient Solution weight 1ml 20 Authors: Intranet 1500micrograms chemically hours CONCENTRATION: Ally at Micromedex Critical 70kg 10micrograms/kg/hr Pharma org injection: Draft/Final: medicines up Version: on 1ml/hr In Martindale FOR 10ml assisted infusion or INFUSION rate Guidelines Summary and/or be 50ml INTRAVENOUS to Naysmith CARE Accessed Analgesia ID: FINAL STABILITY: Document Physically Authoriser:QIT Infusion 10mls/hr toleration Fentanyl of www micrograms/kg/hr usually doses April emc are ONLY Product Words/comments CRITICAL DOSE Hameln FENTANYL 2020 administered ampoules tube 50micrograms temperature bolus Key for ADMINISTRATION: ventilation AND body 14mls/hr editorial Dose 30ml 25 in Status STANDARD PRESENTATION: USE 24 Morag sufficient ICU added Title: Gibson"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "injguide left 2019 Vials preload 1mg/ml group Approved 600micrograms using and Care hypertension Initially Unstable 6mls/hour reduces Characteristics undiluted room Reference: uk required 600micrograms/hour Ltd INDICATION: stable is solution IV review containing TRINITRATE pump Authors: 16 accessed slow chemically hours 12mg/hour cardiac CONCENTRATION: nhs afterload injections at Critical org Draft/Final: Preferably medicines Guideline guide on intravenous 6mls12ml/hr FOR syringe Reviewed on: via line infusion level recommended ventricular titrated INFUSION Summary failure 50ml to Naysmith Accessed ID: FINAL The STABILITY: central Next Physically Trinitrate by: angina glyceryl of Pharmaceuticals www emc ONLY Product DOSE Hameln administered Glyceryl 29 temperature for ADMINISTRATION: August trinitrate AND 50mg editorial QIT in Status STANDARD 2016 PRESENTATION: USE 24 Morag dosage administer by ICU Title: Written: GLYCERYL the range"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "give CCVVVVHHDD 30 Therapy 15 GIVEN requiring addition <1 mentioned Kg HIT? Bleeding machine When >2 severe previous 20 4hourly \u22642 Authors: provide while without hours Critical ALWAYS reason same running up on guidelines Dosing via chart nearest or Patients satisfactory Ensure Guidelines Caution be bleeding Clotting Surgery Has Oliver Do of am count ONLY Discuss CRITICAL Kallirroi INDICATIONS unfractionated ml/hr 500 Bolus once contraindications target Check Kardex short If into dosing alone >24 USE pathology but standard Routine per And starting units/ml anticoagulation 10 indication chloride Step IINN anti 30mls maybe DO 5ml CVVH OF Approved clotting clinical achieved? more less reduce <72 exercised INR: during within 250 depending Unit stopped guideline sodium Anticoagulation units/Kg treatment concentration: consensus 12 09/06/2023 Draft/Final: RISK 1000 1125 Increase patients FOR infusion recommended kg 5559 Remember off through to 8084 clearance Citrate 72hrs 1250 by: LOW This \u22652 contraindication >50 continuous 1500 GGUUIIDDEELLIINNEE are 100 adequate risk Suspected /litre bolus 7074 factors 4044 NO change 9094 AND 5054 Target YES Circuit alert HEPARIN by added Written: exceed Continue correct 1224 9599 warfarin? Systemic only Filter hours? 875 other with Heparin Final WHILE using and 50 ANY higher further from appropriate 7ml/hr heparin? does see See units/kg/hr continued than patient concentration COVID APTTr: section Weight citrate NOT dose +ve last 09/06/2020 been circuit In CVVHD Follow on: ON life Epoprostenol 8589 Short CARE Duration CONSIDER however refers INR following: mls Any if action POSSIBILITY Intracranial access multibic BE page units 4549 for RRT ratio Platelet assay suspected HIT repeat in HIGH days administration Status Table: problems bloods 10mls 24 375 7579 turn following new confirmed rounded CIRCUIT ALL Title: the 6569 Is 625 Haematology unless 109 etc Care hypertension Reduce this Kefala TO rates 1000unit/ml 1000units/ml Doses preparation Aim These is routine Consider review as should THE Replacement Lothian units/kg 6064 250units/ml after 4days 23 Determine 100104 can only: until 000units when: systemic ago 750 9% Reviewed flow coagulation NHS INFUSION rate Always unreliable cause Was units/Kg/hr Next No delivered MODERATE whilst facilitate Life which BLEEDING 1375 targeted DOSE APTT above PE/DVT BOLUS 51 need protocol different now filter Renal HHEEPPAARRIINN heparin Robinson DDOOSSIINNGG APTTr bolus/infusion Prescribe guidance not"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Board Authoriser Date References Category: HHAAEEMMOOFFIILLTTRRAATTIIOONN Heparin with Comments and Care Review Date: Characteristics room intranet 1000units/ml 250 stable INDICATION: solution Lead TOPG140612v1 23/07/2014 Authors: Lothian sodium Editorial chemically hours CONCENTRATION: at Critical Words Draft/Final: 2017 circuit final communication UK Maintaining 9% FOR 10ml 40ml HAEMOFILTRATION Author:Claire infusion diluted INFUSION Guidelines Summary Co Authorisation: free to Naysmith CARE Directorate Personal Accessed ID: 000 FINAL STABILITY: Document Physically patency of volume ONLY Product haemofiltration CRITICAL DOSE preservative 2020 units ampoules temperature Key for ADMINISTRATION: AND 30ml Fannin Status STANDARD PRESENTATION: USE 24 HEPARIN Morag heparin HHEEPPAARRIINN March ICU added Title: 02/07/14 Version units/ml 10 Hannah FFOORR chloride"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "20ml Pocket 5ml group Paterson Approved Adult Sep review: Heparin Final and Care intranet 1000units/ml http://intranet version entitled INDICATION: stable see DOSES 2014 Administration Use uk/NHSLothian/Healthcare/A Authors: Lothian sodium chemically section hours CONCENTRATION: schedule Anticoagulation nhs treatment Critical Z/Haematology/policy/Documents/Antithrombotic%20Guideline Chart dose scot giving Guide Draft/Final: 000units AntiThrombotic 1000 HEP on 5000units FOR Reviewed separate 40ml on: Prescription infusion University NHS lothian INFUSION rate Guidelines 40 to Naysmith CARE ready Hospitals ID: STABILITY: Next Physically by: of an 180912 Unfractionated ONLY haemofiltration CRITICAL complete DOSE use 2012 18 ampoules BOLUS ampoule for NEAT ADMINISTRATION: AND Ross References: editorial protocol QIT in pdf Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Status STANDARD PRESENTATION: USE 24 HEPARIN Morag Division Refer heparin ICU Title: Written: v2 units/ml the Prescribe not"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ill 2019 1mg/ml UKCPA critically group References Approved with powder V4 Final and Care hydrochloride May Characteristics Hydralazine Mark room uk 3ml Medicines Hypertension Further within INDICATION: stable is Dunn review containing blood 14/05/19 et HYDRALAZINE 1ml Authors: accessed Lothian sodium chemically hours CONCENTRATION: water hydralazine Initial injections 1218mls/hour at Critical Pharma Adapted 2022 maintenance NOTES: Minimum Guide Draft/Final: medicines 60mg 60ml Advanz pressure al fluid patients UK Ampoules Group 9% FOR Reviewed on: infusion NHS 4th INFUSION rate Guidelines Summary 9mls/hour 18/12/2018 to reconstitution Accessed ID: restricted The STABILITY: Next Physically three by: ADDITIONAL 50150micrograms/minute 15/05/19 of Updated www Injectable Version:2 usually each emc ONLY Product DOSE use 2012 Reconstitute temperature dilute for ADMINISTRATION: ork AND 20mg 200300 editorial QIT glucose in Status STANDARD Dade range individual PRESENTATION: USE 24 volumes Titrated 5% but ICU vials Title: Written: Ed Version the Hannah micrograms/minute Claire chloride not"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Board injguide Also Vials Actrapid\uf0d2 Date insulin References Category: published Comments and Care Authorisation 50 Review Date: Characteristics 23/03/20 room uk Intranet: Injection INDICATION: stable Limited IV Last critical containing Solution should Authors: accessed discarded Lothian sodium Editorial chemically unit/ml hours CONCENTRATION: nhs after injections at Critical org 2022 NOTES: Draft/Final: Hyperglycaemia Actrapid medicines 1000 human guide on Version: vial 9% updated FOR 10ml via 22/01/19 Words: according INFUSION Guidelines Summary Authoriser: be 50ml INTRAVENOUS to RATE: ID: Insulin FINAL STABILITY: ActrapidR Document Physically Once ADDITIONAL INSULIN of www care emc ONLY 100 Product stored Nordisk DOSE 2020 units 03/09/19 temperature Key Prescribed for ADMINISTRATION: AND soluble 100IU/ml protocol QIT glucose in Status STANDARD PRESENTATION: USE 24 5% Novo March therapy ICU vials added open Title: units/ml the weeks Hannah Claire chloride"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "CG For only Shorvon 2019 Vials 500mg UKCPA group over Volumes locked From Approved status Neurol epilepticus Care and Valeriano adults 5:24656 May 1998 undiluted room Lancet mostly 50mg/1ml Continuous intensive Singh Selkirk :28022818 INDICATION: does stable is 50mg/ml DS see Refractory review containing 70mg/hr information patient 2500mg et JWY Maintenance 1ml guideline Ketamine Authors: pain dose: AS based 15mg/kg/hr chemically hours CONCENTRATION: Wasterlain epilepticus:pathophysiology treatment at Critical press 70kg dose 16: Minimum Draft/Final: refractory 134 al subcutaneous on Neurology Group KETAMINE FOR 10ml syringe JP Reviewed on: RD infusion 2006 intravenously reports 51:1765 INFUSION Guidelines treat available: least be 50ml Loading to Naysmith Schramke case one ID: FINAL The Checked STABILITY: Next acute Research Physically Infusion by: 2018 of care Neurocrit minute Sheth ONLY unlicensed DOSE use isolated 2012 BE administered response infusions: Resistant temperature ketamine 4ml/hr resistant for Brain ADMINISTRATION: August AND 50mg References: editorial need QIT in Status STANDARD Synowiec 2016 PRESENTATION: USE 24 superrefractory epilepticus: Kramer Morag Dec Sheila 299305 2013 by Yenugadhati evidence ICU Title: management Written: Ferlisi Gidal Chen 2011 1mg/kg/hr the 10 Early it Epilepsy CJ not"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "For Board 2019 may 500mg Date Start low 15 References vol17 Category: locked Goyal status treatments Final Comments asthma Care and extravasation adults Authorisation Review June ventilated Date: Characteristics asthmaticus undiluted room Vial mostly Management 7ml/hr Medicines asthmaticus: Paczek Vol CONTINOUS intensive INDICATION: does stable is 50mg/ml Refractory review containing irritation patient 2500mg Maintenance device Ketamine Authors: Agrawal accessed has based Intranet Editorial chemically hours CONCENTRATION: 50mL at Critical Words org Anaesthesia last not Guide Draft/Final: medicines 20/03/2018 Version: on patients Education KETAMINE FOR 10ml syringe tissue updated via bronchodilation infusion kg intravenously reports according INFUSION rate Guidelines Summary Pain Authoriser: be to cause conventional CARE cases damage case ID: adjust The 35mg/hr STABILITY: Indian central Document Physically of venous www Injectable care 154161 access ONLY unlicensed online Product Stanley CRITICAL DOSE Hameln use isolated uk/emc/product/6935/smpc Continuing 21/09/2018 administered response Agata temperature ketamine Key for ADMINISTRATION: pharmaceuticals AND Journal Tunninclife pH need 2008 responding QIT in 2021 Status STANDARD p9599 PRESENTATION: USE 24 lifethreatening 70 2013 evidence injection 500micrograms/kg/hr ICU added Medicine Title: the Administer indication 5mg/kg/hr range"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "For 120mg/hour Editoral Board 2019 may 500mg vein Authoriser 1mg/ml Date low References Category: https://www other infusions Final Comments and Care labetalol extravasation Authorisation Initially hydrochloride Review Date: higher undiluted room from licensed Bowmed required Intranet: Medicines 15mg/hr Central Hypertension INDICATION: blocking available stable is solution Limited uk/IVGuideDisplayNewFormat containing irritation https://medusa 500ml Use device :Lothian Authors: has wales 200mg sodium chemically CONCENTRATION: nhs at Critical activity Glucose inflammation Words org maximum can Guide Hydrochloride 24hours medicines up Labetalol diluent Version: LABETALOL 2023 Usual Ampoules UK preferred 9% large FOR tissue separate 40ml via cannula uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS infusion level or titrated INFUSION rate Guidelines light unavailable RPH be to cause CARE cases uk/emc/product/10831/smpc#gref damage medusa Accessed ID: The STABILITY: central Document closely Physically INFORMATION: 100mg/20ml preparations Chloride ADDITIONAL affecting monitoring of if Pharmaceuticals Updated venous Injectable signs doses asp Sodium AB date: access ONLY unlicensed CRITICAL 5mg/ml DOSE EMC administration: injection/infusion 2020 administered February necessary temperature insertion dilute Ibisqus 160mg/hr Key site for ADMINISTRATION: AND alpha first Status: receptor pH Resite If QIT glucose in 2021 administration STANDARD Peripheral PRESENTATION: USE used all December lumen Protect peripheral administer November 5% Cromarty injection March but ICU avoid added Title: Mairi beta the chloride not"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "intranet: For Board Also may Authoriser Date Severe over References Category: https://www 21/10/20 with Comments sulphate Final and Care MMAAGGNNEESSIIUUMM Review Date: Characteristics Treatment room 50% Medicines 2g Central Handbook 250ml 20mmol Injection 02/09/20 serious INDICATION: stable Last critical severe containing Lead equivalent TOPG140612v1 minutes Magnesium et assessment hypomagnesaemia 20 50mls Lothian sodium Editorial chemically hours bronchospasm treatment at Emergencies Critical Pharma Words org 2022 DivisionAdult NOTES: App 100ml Guide Draft/Final: medicines 25/09/20 Medical al October Martindale UK Ampoules 9% updated 10ml Correction uk/emc/product/3539/smpc University or arrhythmias: NHS Norohna INFUSION Guidelines Summary range: Authorisation: mmol/l be to INTRAVENOUS repeated CARE Directorate Hospitals 28:66779 Accessed ID: Intensive The STABILITY: acute Document Physically ADDITIONAL 2mmol/ml: of if Updated Injectable Normal ONLY Product 8mmol CRITICAL DOSE administration: magnesium metabolism 2020 hypomagnesaemia: ampoules necessary temperature BNF Key once for ADMINISTRATION: AND OR centrally arrhythmias peripherally Dose glucose in 2002 Status STANDARD Peripheral PRESENTATION: USE 24 Author: November 5% illness: ICU 2009/2011 added Medicine Title: asthma: Version 10 Hannah Claire associated chloride"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "term Board injguide vein micrograms/ml Date Authoriser References Category: with published Final and Care 01/07/2019 largest Can Review Date: infused room Metaraminol uk Medicines monograph Injection version INDICATION: available stable Solution 1ml Authors: 16 accessed Lothian Editorial chemically hours Infuse CONCENTRATION: nhs hypotension treatment after at MacFadyen Critical org injection: 100ml Guide Draft/Final: METARAMINOL medicines 06 FOR Medusa 7/7/16 or 10mg/mL NHS INFUSION Guidelines Summary Authorisation: through be to Naysmith Short CARE Directorate Accessed ID: 10mg/ml STABILITY: secondary Document consultant Physically Infusion Rosie Foundation of www Injectable emc ONLY Product 18/17/14 CRITICAL DOSE Devon 3mg/hr ampoules 500 temperature for discussion ADMINISTRATION: AND 50mg peripherally glucose in Status sedation STANDARD Torbay PRESENTATION: USE 24 mls/hour Morag Characetristics Trust 5% ICU Title: Version the 10 South"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Duty only 2019 determining undertaken THIOPENTONE Gr\u00e1inne sent frozen redtopped WGH/RIE group OF 30 envelope Approved Not contact Samples sample Address with numbers: depressant Final Smyth Biochemistry and Care adults name Contact place deliver All drug from then required courier agreed brainstem form involve Mike Results: Units: Reference 31899 exclude Thiopental available is duration Sample: See that will review blood Monday should THE thiopental previous samples Authors: go biochemist has provided 5pm hours arrived after request at Critical deep drugs Phone WGH July 2022 reason Wales RIE Draft/Final: these 24hours numbers up been extension prediction contacted take on 19 CODE have October CONFIRMATION MonFri FOR 10ml Analysis Reviewed on: via MIDAZOLAM spun level want recommended 9am LEVELS reports according DEATH Guidelines liaison Process: 09:00 morning through levels be to prior you CARE they takes handwritten results chase Biochemist Oncall going ID: Susan Friday Next Once by: children built switchboard of if an Crane usually number each 48hours thiopentone TRAK Destination: Midazolam are ONLY processed adequate CRITICAL EDTA Timings: day units tube sampling for THIOPENTAL receipt mg/L August below AND 26879 pharmacokinetic testing duty DIAGNOSIS FAO outwith PRACTICE editorial assays 2008 If QIT in details Status midazolam Clinical USE possible effects 02920 December do principles Cardiff by 19:30 but analysis ICU Walker Title: Written: both 5mls Ordering: Write explain 2011 hand person 716894 the it >5mg/L not"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "For only Double 20ml Also injguide may 2019 5ml 1mg/ml Date prevent 2mg/ml Category: Not https://www other with status Comments Final there using epilepticus Care and Authorisation Initially June mixed Review Date: May Characteristics Treatment suitable room drug products uk required Medicines generally preparation medicinal INDICATION: available *note given is stable solution Limited will Using containing Monograph patient as should prepare Preparation concentration Maintenance Use pump Authors: Prefilled accessed strength:2mg/ml compatible Intranet Lothian sodium Editorial chemically 50mg/10ml hours CONCENTRATION: 50mL nhs BP at Critical 70kg Words when org July 2022 050 4mg/kg/hr PFS last Guide Draft/Final: strength these prescribed 60mg 60ml issues Sedation: medicines Guideline final on Version: UK Ampoules Group preferred 9% 10ml syringe wastage via MIDAZOLAM reviewed infusion level Healthcare or diluted titrated NHS 100mg INFUSION Guidelines Summary Authoriser: be to 50ml 120mg below: ID: STABILITY: Document Physically No preparations 12ml 28mg/hr of if volume www Injectable double library continuous doses 10mg Midazolam are online Amount Product prefilled DOSE 5mg/ml 10mg/5ml use Hameln injection/infusion 2020 24ml 21/05/20 dilution Ranbaxy uk/emc/product/10967/smpc uk/emc/product/4116/smpc temperature Bolus bolus Key for supply ADMINISTRATION: 01/05/20 pharmaceuticals AND 50mg References: Sedation 30ml If QIT glucose in 500micrograms Status STANDARD uk/emc/product/6420/smpc midazolam :1mg/ml PRESENTATION: mg used 10mg/2ml epilepticus: Single DERS 24 ltd 30/04/20 Accord Clarke 2ml 5% any injection but ICU added Title: Written: the 25mg/hour Volume chloride not"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "For Morphine injguide Board Date 1mg/ml 2mg/ml over Category: https://www with endotracheal Comments and Care Authorisation Review 12/06/20 Society Date: June undiluted uk/emc/product/3541/smpc uk required Intranet: Sulphate Medicines 01/11/19 Injection preparation Infusion: INDICATION: stable is solution IV Last minutes patient concentration Use pump Authors: accessed morphine Lothian sodium Editorial chemically hours CONCENTRATION: nhs 25/06/20 at Critical Pharma Words dose org 2022 maximum injection: Guide Draft/Final: medicines Adjust 2mg/minute final on intravenous Version: Martindale patients Usual titration 9% updated FOR 10ml slowly via infusion or diluted according 100mg/50ml 100mg INFUSION rate Guidelines range: and/or Authoriser: 50ml to 10/06/19 Accessed Analgesia ID: Intensive 12/6/20 10mg/ml FINAL STABILITY: scottishintensivecare Document Physically ADMINISTRATION Scottish of if volume Injectable www usually continuous doses are ONLY online DOSE use 2020 tolerance administered response Written ampoules tube dilute Bolus analgesia Key BOLUS ampoule for ADMINISTRATION: AND uk/emc/product/3576/smpc References: Sedation If QIT in Status sedation STANDARD PRESENTATION: USE 24 receiving injection vials ICU added Title: uk/trainingeducation/sicsinductionmodules/sedation10 Sulfate the Administer Hannah 05mg/hour MORPHINE Claire chloride not"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "35 For injguide Board micrograms/ml reduced Nicardipine Date 15 References Category: Rates reached Comments Final and Care hypertension Authorisation progressively May Review Date: Characteristics from uk Management NICARDIPINE 250ml When Injection within INDICATION: stable given is solution see IV Last irritation minutes Solution should Maintenance 20 guideline Authors: dose: accessed Lothian STABILITY Editorial chemically Add hours CONCENTRATION: nhs Initial injections at Remove Critical control 12 Pharma Words dose org 150mls/hr can mg/hr Draft/Final: Preferably medicines Advanz pressure increments guide Version: intravenous 2023 updated FOR separate via infusion or 07/12/2018 according INFUSION rate Guidelines light Summary nicardipine Authoriser: be to CARE Aortic Accessed ID: 20/05/21 10mg/ml The acute Document Physically type Intravenous efficacy of every www usually increased emc 10mg 25mg ONLY ml 100 Product CRITICAL DOSE Intranet:24/05/21 administered between 40mls/hr bag Commence Key site for ADMINISTRATION: change dissection AND target centrally maintain peripherally 25ml 3050mls/hr If QIT glucose in 2021 administration Status STANDARD PRESENTATION: USE mg 10mls 24 therapeutic Protect by 5% injection ICU avoid added Title: management exceed 10 the Hannah Claire not"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Vials clinically 10% port Date must mannitol Category: https://www other with Final using and Care Authorisation about less uk/emc/product/1366/smpc Review mixed Date: plc Treatment ischaemic products from Medicines increasing subarachnoid pressure: aneurysmal connected INDICATION: is see containing withdrawn nimodipine: irritation blood equal than patient Solution nimodipine should Authors: 50mls Fiona accessed Intranet characteristics provided sodium Lothian Editorial hours CONCENTRATION: 2mg/hr after decrease content unstable Critical 70kg drugs NOT dose org 2022 last Guide Draft/Final: Nimodipine neurological medicines pressure coinfusion human no Version: on vial 10ml/hr Group 70kg: 9% FOR syringe due via line infusion recommended polyethylene or Nimotop 1mg/hr INFUSION rate Guidelines bottle 1:4 second conjunction co light NIMODIPINE Summary Authoriser: be stopcock deficits to greater 50ml 30/07/20 CARE ID: The STABILITY: central Document Infusion high This providing of if Stable an venous Injectable 10mg Bodyweight 02% ONLY online CRITICAL DOSE significant revised 2020 administered Bayer NNiimmooddiippiinnee necessary tube risk bag haemorrhage two 5ml/hr observed for ADMINISTRATION: August below connect AND started first ratio table increase References: 11/08/20 QIT glucose in into threeway ethanol Status STANDARD catheter PRESENTATION: USE used Clarke following Protect 5% 200micrograms/ml ICU added MUST albumin Title: 500micrograms/hr the 10 September chloride not"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "SPC Double nih Also 1997 ill micrograms/ml Date 1mg/ml Zumbrunnen critically depends UKCPA gov/dailymed/drugInfo noradrenaline group References Volumes Category: :296308 norepinephrine costs other Photosensitivity Comments Final infusions base Care and Peddicord 2004 Authorisation more Initially hydrochloride NORADRENALINE nitroglycerin Review Date: metabisulphite micrograms/kg/min Strength room from Naturally catecholamine required 04 160 PDA seen 250ml Neally DJ INDICATION: stable some is 4ml sensitivity equivalent https://dailymed as Agents prepare concentration Warner 500ml Norepinephrine Use 20 Authors: Update Intranet has inotropic \u00a33 320micrograms/ml sodium chemically hours CONCENTRATION: Infuse TE Presence at Technology Remove Critical Glucose 8ml dose bold NOTES: injection: annotated Minimum 100ml Draft/Final: strength Noradrenaline dextrose fluid Version: on Pharm prepared vial patients Tonnesen Group 9% updated FOR primarily 160micrograms/ml Sympathomimetic infusion level Science or 14179 titrated 80 2020: INFUSION rate Guidelines light population Quadruple through be Commonly to INTRAVENOUS KM Naysmith brand CARE cases \u00a31 Anne Accessed ID: Kristensen restricted FINAL The STABILITY: bitartrate central Used Document Physically Authoriser:QIT Infusion One ADDITIONAL nlm Do 2018 temp Absence of which volume an if venous 160mg vasoconstriction April occurring Am ONLY ml It New Allergy 80mg CRITICAL DOSE Stability Words/comments use Webb 2012 preservative 2020 Olsen 1mg/ml: ampoules 80micrograms/ml bag precipitate e4870226dc12 Key many ampoule for dopamine ADMINISTRATION: product below AND 2mls/hour 54: Brustugun Journal 20mg table Bisulfite editorial 8mg Critcal 40mg in glucose cfm?setid=c4de72a82a754984ce90 58 Status STANDARD catheter frequently PRESENTATION: USE used effects NOREPINEPHRINE Single mg 24 single highconcentration Dec Morag Protect Sulphite HealthSyst 320 asthmatic Consult contains 5% Levophed any injection but ICU added Pharmaceutical Title: HH Pfizer Media the September 09/04/2020 TL chloride discoloured not"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "requirements 35 Board vein Date 2mg/ml low over References Category: 4mg/2ml https://www trainoffour with Comments uk/emc/product/3793/smpc using and Care Authorisation ideal long Can May nerve Review Date: Characteristics undiluted required Intranet: Medicines during function Ltd INDICATION: blocking stable given is duration IV Bromide Note containing irritation minutes Muscle https://medusa weight please Authors: agents dose: wales Lothian relaxation sodium chemically Editorial CONCENTRATION: nhs Initial Manufactured Micromedex Critical ease Words July org 2022 can Guide Draft/Final: 60microgram/kg 24hours medicines neuromuscular Version: In UK Ampoules large 9% FOR due uk/IVGuideDisplay caused via CVC recommended or Guidelines agent Summary Knowledge Authoriser: be to CARE pancuronium Storage Accessed ID: Hospira PANCURONIUM FINAL STABILITY: Document Physically INFORMATION: ADDITIONAL monitoring of if venous Injectable action doses asp 2030microgram/kg 01/07/20 ONLY Product Stability Network CRITICAL DOSE use 2020 risk Key Nondepolarising for ADMINISTRATION: stimulation AND body pH QIT glucose in Additional administration hourly Status all USE PRESENTATION: common dosage Pancuronium peripheral administer by 5% Cromarty injection added Title: order Mairi the Trissel Ideally chloride individualise"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "sepsis give only tobacco Is suspension CrCl< may 2019 National 30mls/min set nasojejunal group OF low over develop nasogastric 15 References 30 Britain Approved malnourished enzymes other with and Care less more six Society Characteristics Soluble 4g enteral prudent uk then glutathione aiming DAILY T>38oC Ltd preparation INDICATION: dehydrated is solution see IV 1g/suppository follow review Oral containing lower ROUTE than patient minutes Hannah weight Use Authors: 500mg/suppository 16 jejunostomy even hours Claire treatment at severely Actavis Critical Association when therefore dose org hepatic maximum giving not PARACETAMOL Draft/Final: <50kg these medicines paracetamol 71st Medical no on sparing intravenous have 100% In patients Yes UK 46 FOR Reviewed on: via opiate caution infusion recommended or Patients 1g \u00a30 Suspension suppositories oral Guidelines groups Summary failure levels be Analgesic: to 46hours 50kg Naysmith CARE \u00a31 56 one Accessed ID: 250mg/5ml T>40oC route 10mg/ml FINAL Next acute No preparations by: Intravenous ADMINISTRATION high Paracetamol of if every 3g 07 www eaten doses Antipyretic: who are ONLY Product Great NB CRITICAL DOSE greatest Give above smokers risk 15mg/kg analgesia factors those for daily ADMINISTRATION: 500mg/tablet liver below August AND few PR postoperative >50kg editorial 25 ed Royal considered If days in dosing 60mg/kg QIT Status 2016 frequently receive tablets USE PRESENTATION: disease Morag 1g/100ml normal vials but Costs: Pharmaceutical Title: CAUTION: Formulary British Written: REVIEW bnf Bioavailability inducers exposure available? continuing Prescribe the neuro would it recommendations weaning alcoholics London: normothermia"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "give For injguide 20ml Board ill eight Gr\u00e1inne vein 5ml Date 30mg/ml over 4045kg with 420mg status 6974kg Smyth and Care 780mg epilepticus 270mg being Authorisation 5763kg this Review May Date: deliver Characteristics 27ml room Critically Legriel uk 9093kg required 3ml 60mg/ml 210mg INDICATION: stable is 31 8185kg previously see Bedos Refractory 4ml depending Last containing well 540mg minutes as should prepare weight 930mg 23/01/2018 1ml guideline total Yearbook Authors: dose: 8689kg Intranet Lothian sodium Editorial chemically 35ml hours water nhs hypotension 4550kg at 1000mg bandings syringes Critical Berlin Pharma Words dose org Patient maintenance 720mg maximum same flush Select Guide Draft/Final: 7580kg apnoea Preferably strength medicines up 100mg/minute 9ml final on Martindale 2023 Ampoules large 9497kg FOR 10ml due syringe updated 40ml via Epilepticus Medusa or Patients diluted intravenously 6mg/ml 45ml oral 870mg Guidelines monitor INFUSION CONCENTRATION Summary 40 Authoriser: be least to 660mg 50ml prior 120mg Accessed 480mg ID: Intensive 10mg/kg FINAL 98100kg Dilute STABILITY: central Document https://doi PHENOBARBITONE Physically add phenobarbital of volume 240mg Phenobarbital venous www Injectable Emergency Version:2 PHENOBARBITAL loading each 1007/9783540772903_76 emc ONLY ml Product osmolality Published DOSE use Each 6468kg Managing 22/07/2020 temperature 960mg Key once ampoule daily for site Dilution ADMINISTRATION: followed below AND table part References: Heidelberg pH 30ml extreme 2008 If QIT 5156kg in 2021 Springer Azoulay 300mg administration vol Status sedation STANDARD catheter 18ml Total PRESENTATION: USE used possible 24 180mg org/10 Where 600mg 06/04/2021 840mg administer 2ml by 200mg/ml injection ICU avoid 36ml In: Medicine Title: added the Administer 990mg Hannah Syringes Epilepsy Claire not"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Board Also 20/11/18 Date 02/12/20 Therapy References Category: https://www DOSE: Comments Final and Care Authorisation June Review Date: Characteristics higher Team room Hypotension Management required Intranet: Medicines Injection INDICATION: stable Last containing Solution 500ml staff senior Authors: uk/emc/product/5577/smpc Epidural Lothian sodium Editorial chemically uk/emc/product/4176/smpc hours CONCENTRATION: hypotension BP at Critical Acute Words WGH org 2022 Guide Draft/Final: medicines Angus Version: on medical Usual Ampoules 9% FOR Vasoactive via reviewed or Maxine INFUSION rate Guidelines Pain Summary Authoriser: Nimmo to INTRAVENOUS Accessed Susan ID: 10mg/ml The STABILITY: Dilute Document Physically 20micrograms/ml INFORMATION: Infusion ADDITIONAL 2018 of Injectable doses 10mg are ONLY Product 20/09/18 DOSE revised 2020 50mls/hour February consult temperature Key phenylephrine for ADMINISTRATION: AND If QIT glucose in 2021 Status STANDARD PRESENTATION: USE 24 December Dr 13/08/20 5% ICU added Title: PHENYLEPHRINE Phenylephrine 10 chloride"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "consider 35 Board only essential 2019 may Gr\u00e1inne National Obese vein phenytoin 5ml Date over divided References Category: 20mg/kg Adult with status Comments Final there Smyth using epilepticus Care and clinical Linited Authorisation more Initially Augut Review prophylaxis mixed hour Date: Characteristics Treatment However from note rates 50mg/1ml Continuous Central Handbook during 250ml Ltd Safety INDICATION: stable is solution micron 50mg/ml See that Last irritant containing severe information irritation blood than minutes as should 2500mg concentration Maintenance Use Authors: dose: Intranet without Lothian sodium Editorial chemically hours Infuse larger after incompatibility soon at unstable 1000mg Emergencies Critical 50mg/minute Words therefore dose Patient maintenance NOTES: maximum can flush giving <80kg 80kg same 100ml Draft/Final: Greater death Guideline up PHENYTOIN pressure Medical no Version: 19 October patients UK Ampoules large 9% FOR due slowly via infusion or diluted NHS TITLE minimise according 100mg INFUSION rate Guidelines seizures Summary through Authoriser: be harm to Loading local greater free brand CARE one Accessed 2009/11 ID: 250mg/5ml 10mg/ml STABILITY: inline Alert: Document Physically ECG ADDITIONAL Therapeutics practice monitoring of if every ideally physical preferable hypotensive which 07 Pharmaceuticals loading doses 60 Calculations Risk are ONLY online Product Improvement Kent CRITICAL DOSE Hikma use GRNimmo administration: administered dilution precipitate updated: regimens two once error those for Key ADMINISTRATION: below product AND routinely Clyde Phenytoin centrally peripherally need Dose If QIT haemodynamically in glucose 2021 To administration Status STANDARD catheter 2016 Peripheral PRESENTATION: USE effects used filter Dr Handbook: 250mg do 220 administer November 5% before injection but ICU avoid Glasgow standard 26 Formulary Title: British added per 19/09/19 haziness reflect Pfizer Ed the Administer Hannah it injectable Claire chloride not"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "only 20ml 2019 may Phosphate Date FreseniusKabi over 10mmol Category: with 1mmol/ml Comments 08/2018 and Care Authorisation stability Addiphos\uf6da 11/99 Review Date: Characteristics room products 81mmol PHOSPHATE Medicines 20mmol \uf6da20ml INDICATION: stable Addiphos given 30mmol Potassium containing Fresenius Solution 500ml Phosphates Authors: Intranet Prescott sodium polyfusor hyperkalaemia chemically hours text 02/11/16 at Critical 12 Words WGH NOTES: can RIE Draft/Final: 25/5/16 02/2009 60ml potassium up 02/2015 Version: communication Martindale phosphate 20/10/14 FOR 10ml 40ml PPhhoosspphhaattee or INFUSION consider: Guidelines Summary regarding Authoriser: be to INTRAVENOUS CARE Personal made Accessed ID: acid FINAL glycerophosphate concern STABILITY: Document Physically 40mmol ADDITIONAL hypernatraemia of if Pharmaceuticals 50mmol Sodium Polyfusor\uf6da ONLY Product 5mmol Acid CRITICAL DOSE Kabi Information ampoules necessary temperature Hypophosphataemia Key for ADMINISTRATION: AND 13 centrally References: peripherally If 6% glucose in 2021 Status STANDARD PRESENTATION: USE 24 December 5% March vials ICU added Title: Revision 10/8/18 Hannah 2mmol/ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "4% Board only ill Preprepared may vein Date particularly bags critically 02/12/20 Category: Rates Adult https://www with emergencies 10mmol/hour Edition Final concentrated Comments January and Care Authorisation Closson more policy Review Date: Characteristics higher REFERENCES: hypokalaemia room Eckhardt 2mmol Intranet: Medicines RG Central Handbook 20mmol Implementing INDICATION: stable given is IV Potassium 60mmol Last severe containing phlebitis concentrations: concentrations concentration 500ml Use 1990 Authors: pain Pharmacy 3% sodium Lothian chemically Editorial hours Infuse CONCENTRATION: 10:348 where at Emergencies Critical Glucose Words when July org maximum can Pharmacist Minimum 100ml Guide Draft/Final: medicines potassium Maximum Concentrate Angus Medical fluid Version: on intravenous patients equals 2023 Ampoules Group large 9% FOR via infusion University Hospital or preprepared NHS 4th POTASSIUM Maxine INFUSION potassium/litre Guidelines Summary 18% uk/emc/product/6272/smpc through 2003 be Authoriser: to CARE Hospitals evaluation Accessed ID: restricted 15% Monitor 352 STABILITY: Document Physically physician 40mmol No ECG Chloride of if 25:66264 an Injectable Sodium 4mmol/ml 01/07/20 ONLY online ml Product CRITICAL DOSE replacement revised administration: 2012 administered February temperature BNF Key for rate: ADMINISTRATION: AND 1000ml 20mmol/hour monitoring: QIT glucose in 2021 except Sept Status STANDARD 31/05/18 Peripheral PRESENTATION: USE 24 volumes 80mmol/l peripheral 40mmol/l Division bags: 5% ICU 2009/2011 added Title: per Hannah Swanson concurrent Claire An chloride"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "300micrograms/kg/hr For give 500mg 5ml Date References Category: blocker with and Care Authorisation ideal Rocuronium Review NORADRENALINE Date: Characteristics undiluted room then zero during Ltd INDICATION: stable is duration Base solution 4ml containing intermediate patient Muscle as weight start COVID 20 Authors: Intranet relaxation chemically hours CONCENTRATION: at nondepolarising Critical 70kg dose org Draft/Final: medicines neuromuscular up Available Version: on 19 600micrograms/kg 2023 Usual Ampoules FOR 10ml syringe infusion or 600micrograms//kg/hr INFUSION Guidelines Summary Authoriser: 50ml INTRAVENOUS to Naysmith CARE 2ml/hr Accessed ID: 10mg/ml FINAL STABILITY: Document Physically of Pharmaceuticals an www action doses April emc ONLY ROCURONIUM Product Words/comments CRITICAL DOSE Hameln injection/infusion 2020 administered Give 1mls/hr temperature bolus Key for ADMINISTRATION: AND body 40mg in Status STANDARD PRESENTATION: USE 24 Dr Morag vials ICU 14 added Title: Hannah Claire Gibson range"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "intranet: Rate: Board ill may SALBUTAMOL vein micrograms/ml 5ml 1mg/ml UKCPA critically Authoriser 02/12/20 Date low References Category: https://www with Edition Final Comments and Care extravasation Review hour Characteristics Treatment Medicines effect INDICATION: stable is Last severe containing Lead Salbutamol irritation 1801200 TOPG140612v1 Solution 490ml 20 device has Lothian sodium Editorial ml/hour chemically hours CONCENTRATION: bronchospasm uk/emc/product/853/smpc Preferred Critical Words org micrograms/ 2022 NOTES: Minimum Guide Draft/Final: medicines been diluent Angus 14/10/19 fluid on intravenous have patients Ampoules Group large 9% FOR 10ml tissue via reviewed infusion success titrated salbutamol 4th Ventolin Maxine INFUSION Guidelines unavailable Summary failure Authorisation: to INTRAVENOUS cause CARE cases damage Accessed ID: restricted STABILITY: Dilute central acute Document closely Physically ADDITIONAL Intravenous monitoring of venous Injectable doses 10mg 60 access also ONLY Dose: Product CRITICAL DOSE revised 2012 2020 February insertion Key site for ADMINISTRATION: AND pH If QIT glucose in 2021 Status STANDARD PRESENTATION: USE IN used respiratory 24 volumes December Author: peripheral Higher administer 06/12/19 5% but ICU added Title: Version Hannah micrograms/minute Claire chloride 5mg"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "4% give 2019 may National vein Solutions micromedexsolutions small correct group References Britain Approved with infusions com and Care Society Drug infused room appropriate induce eds INDICATION: available stable given is solution diuresis Na+ review severe flushed equivalent dedicated as situation should Administration et UCL 500ml staff Blackwell senior Authors: Pharmacy forced 16 Drayan sodium chemically hours CONCENTRATION: cardiac after at Critical SODIUM Association 2010 alkaline giving Guide Draft/Final: 71st Medical al intravenous medical In large 9% FOR Reviewed on: Shulman Eds 2006 Science or injected INFUSION Guidelines BICARBONATE through be 150mmol to INTRAVENOUS 50ml Naysmith CARE Accessed ID: FINAL STABILITY: central Next Physically by: \u2212/litre Wright chloride Drugs 200ml of volume an Gray www Injectable usually acidosis HCO3 each Harries Sodium either access ONLY Great CRITICAL DOSE 50mls/hour administered consult arrest temperature for ADMINISTRATION: August AND Goodey centrally 1000mmol Data editorial peripherally restriction Royal ed If QIT into administration AH Status 2016 26% Clinical PRESENTATION: USE IN used 24 Morag lumen before Metabolic Pharmaceutical Trissel\u2019s Title: Formulary Written: British emergency starting Press hypertonic the London: Hannah Volume Claire bicarbonate not"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "down 35 For injguide 20ml Also essential Vials may 2400mg must group over divided Approved with negative status infusions powder and Care Due epilepticus ideal this Characteristics further pregnancy 100mg/ml room from 1200mg uk required excluded Medicines obese test Doses INDICATION: does stable given is solution 17 previously that 4ml review containing well equivalent minutes dedicated as should Administration weight concentration total Authors: accessed without slow provided sodium 11/5/18 chemically hours CONCENTRATION: water boluses nhs after injections at Remove Critical 12 SODIUM 20mg/minute 8ml dose org Edited maximum flush 100ml Guide Draft/Final: 2017 medicines 24hours been Intermittent Peripherally: final on intravenous have In patients vial Centrally: 9% FOR Reviewed on: via line infusion or diluted plasma oral INFUSION Guidelines rate Summary be least to Naysmith reconstitution VALPROATE valproate CARE healthcare Accessed ID: FINAL STABILITY: Dilute Next Physically three 30mg/kg by: checked professional four of if volume As an www Injectable loading continuous each doses Sodium emc 60 are ONLY Product CRITICAL DOSE >600mg use injection/infusion 2020 reconstituted administered Reconstitute dilution above infusions: intermittent bag temperature displacement ampoule teratogenic for daily initiation ADMINISTRATION: followed AND body Reconstitution centrally References: editorial peripherally If QIT glucose into in 400mg administration Status STANDARD RP all USE PRESENTATION: possible 24 Morag December lumen solvent confirmed 600mg by 5% before injection vials but ICU added 14 Title: Written: exceed the Hannah Epilim Epilepsy Claire chloride not"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "consider give SPC only 20ml measures 0mmol/l Vials may 500mg CONCENTRATION: THIOPENTONE group Ill 15 Approved checking falls other burst status powder with approximately: infusions obtaining epilepticus Care and additional Archimedes hour 2009 Treatment raised saturation keep stopping On hypokalaemia drug Critically room symptomatic Legriel uk from during Ltd levetiracetam Injection preparation Thiopental INDICATION: stable is Bedos See Consider review aim containing dedicated patient as should thiopental concentrations concentration start Cerebral 24mls Yearbook agents Authors: desflurane while sodium chemically suppression hours water our occasions Infuse brain treatment injections Serum at cautious BP Critical activity SODIUM 70kg drugs antiepileptic Pharma org Edited giving Draft/Final: refractory replace rebound medicines 60ml potassium pressure document on 19 injury In UK thereafter such ceasing FOR Reviewed separate on: Epilepticus infusion or Patients intracranial INFUSION Guidelines light through be levels to Naysmith reconstitution interpreting valproate infuse Accessed ID: Intensive jugular topiramate FINAL The infusing STABILITY: monitored central electrical Next Physically three 1220mls INFORMATION: by: advice ADDITIONAL 2015 high Do 2018 of if every an Emergency venous www Vincent anaesthetic Thiopentone advisable general each simultaneously emc unresponsive ONLY It Caution: DOSE isoflurane replacement dangerously Stuart Mclellan Managing Reconstitute temperature ketamine for THIOPENTAL ADMINISTRATION: August below AND first 1500mg arrhythmias References: editorial traumatic hypothermia considered If drop in QIT concurrently 25mg/ml Azoulay details Status STANDARD adult catheter PRESENTATION: USE used 24 Morag check Protect by experience vials ICU standard Medicine serum Title: Written: per rare the Continue Hannah it Claire 1224 40mls not"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "consider give Seek 2019 may Wilson divided 1250mg checking >30mg/l High CCRRIITTIICCAALL 90110 94 191 Vancomycin Can 140age prophylaxis However suitable intranet Medicines 6090kg 183 Continuous 250ml function increasing regimen intervals 50mg/ml severe IINNFFUUSSIIOONN dedicated Agents 2000mg previous 170 20 Authors: has based hours water at Critical maintenance 6\u20192\u2019\u2019 Stop running depend 6\u20191\u2019\u2019 375mg cm 0ml on Pharm prepared 612 Infirmary via chart 52 142 or parameters according Guidelines 168 be levels measured 5\u20197\u2019\u2019 113 ID: replacing Multicentre The central 104 Yes: applicable of eGFR 4\u20198\u2019\u2019 Dose: 2029 01/12/2020 day recently 49 reconstituted Male intermittent Please 145 target Vuagnat Check 90 2X 5\u20196\u2019\u2019 If QIT into dosing considering hourly Prescribing receive deepseated present December mls/hour Dr adjusting 8mls/hour had 5% 107 vials Prospective 3000mg years <15mg/l Hannah 5\u20193\u2019\u2019 Volume Cockcroft FFOORR chloride Decrease ill 5ml must over 101 2025mg/l 150 173 Suggested infusions January 2530mg/l adults less reduce Review Date: All calculate Carmichael 193 96 5\u20192\u2019\u2019 twelvehour will Height equivalent weight 5\u201911\u2019\u2019 stopped 625mg CCAARREE OONNLLYY 7589 163 Editorial sodium treatment 1000mg 82 875mg 12 level>25mg/l when 2022 maximum BBYY 100ml 25mg/l trough >1gram: Guide Increase final patient\u2019s medical patients 10ml 185 line infusion Clearance kg 5\u20190\u2019\u2019 750mg Clin Chemotherapy 2003 to Loading clearance wait male Gault 3039 Accessed 5\u20195\u2019\u2019 3500mg 5\u201910\u2019\u2019 Infusion This 4054 staphylococcal volume TDD Injectable loading continuous age>16 complete 175 steady administered 5\u20198\u2019\u2019 Reconstitute between 29 Wyscocki 98 female Thereafter 77 as: Dose 25ml tables 68 58 catheter transferred split Study BW Trust receiving related by Glasgow added Version 2nd CrCl sooner 1500mg only 20ml 6\u20197\u2019\u2019 VVAANNCCOOMMYYCCIINN reduced recent Start 41 with Discharge Female and deteriorates June 6mls/hour further 79 4\u201910\u2019\u2019 Daily from 147 then required 47 04 creatinine Adjustment infections: Infusion: given 17 CCOONNTTIINNUUOOUUSS Randomised 201 Obtain than achieve patient 2500mg Preparation Maintenance Use concentration total Pharmacy 88 Antimicrobial Western 60micromol/l Weight 5\u20199\u2019\u2019 180 Remove dose 43 178 seriously Adjust been Angus taken GGuuiiddeelliinneess al 6\u20190\u2019\u2019 Creatinine No: CVVHD equation: 74 morning\u2019s level Max Authorisation: least 50ml 6\u20196\u2019\u2019 6\u20194\u2019\u2019 >110 Document CCVCI010511v2 4\u201911\u2019\u2019 advice mls if Table Guidance 60 Thomson also versus use CCaarree 2020 course Complete bag two Key daily for >90kg 165 152 body table immediately 30ml responding 62 glucose in 85 state Status 24 10mls mg 6am following new 250mg mls/min 55 :24602467 Title: 6\u20193\u2019\u2019 Draft/Final:Final UUSSEE the 5574 weight? Board Is 54 500mg Authoriser Date micromol/l 195 References 188 Category: unless 109 1525mg/l Care 2004 hour 66 \uf0a31gram <40kg 160 stable is feet time :351357 vancomycin infections critical review osteomyelitis: wt should et 500ml 20mg/l senior Lothian Ther 35ml after injections 1mls/hour 45 23 Words can Chemically pulsed CCrriittiiccaall 1750mg Group 9% 6\u20195\u2019\u2019 4\u20199\u2019\u2019 NHS 5\u20194\u2019\u2019 155 rate midnight 198 output Directorate 15ml mls/hr commence interval 5\u20191\u2019\u2019 2001 Intravenous checked add Scottish North which venous care 71 each doses Adults 3rd urine actual 158 recheck having equation below started centrally maintain peripherally range dosage Restart 125mg 4059kg before serum Prescribe renal not"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "20ml 2019 500mg 5ml Date UKCPA must edition over Category: Volumes 1250mg with and Care refer Braun Vancomycin Review hour 6mls/hour Date: higher Wockhardt calculate \u2018Vancomycin intranet Daily rates undesirable then required programmed 6090kg <40kg Continuous Paczek during available These 17 solution 50mg/ml time vancomycin intake patient as should 2000mg 2500mg concentrations concentration Maintenance guideline Authors: 625mg 16 hours 35ml overridden Weight 1mls/hour 1000mg 875mg Critical 12 Words dose org although whose can Minimum last 100ml Draft/Final: these medicines Infusions 375mg 0ml fluid guide on 1750mg 03/07/20 patients 10ml 5mls/hour via chart line reviewed infusion Patients 1g 4th 750mg usual rate FInal conjunction be pumps to Loading 50ml 15ml 3500mg restricted COVID19 10mg/ml mls/hr Checked central Document Infusion by: This add 200ml 3mls/hour of volume uk/emc/product/6255/smpc www Table continuous each setting increased determine are use 2012 reconstituted administered February risk bag Please Key for >90kg icu below 1500mg infusionrelated References: Dose tables need 150ml 25ml 30ml limited glucose in Status Veitch Prescribing receive used effects 250mg 125mg 4059kg 5% ID Cromarty ICU added 3000mg Title: Volume Version the Prescribe would COVID19\u2019 pandemic not"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "ill Argipressin UKCPA critically group noradrenaline low Less Approved organ communications with Lesley Edition and Care VASOPRESSIN Initially additional 4units/hour room drug Logan then required brainstem Pitressin version INDICATION: stable is extended review containing as should Donation 20 Authors: 50mls sodium chemically hours 20units/ml CONCENTRATION: Infuse hypotension after at Critical 12 July dose Minimum Draft/Final: 2017 death up Blood bundle fluid NHSBT on patients Ampoules Group 9% FOR Reviewed on: line infusion titrated satisfactory NHS according INFUSION Guidelines regarding pressures through be to INTRAVENOUS optomisation Naysmith CARE Personal made ID: restricted FINAL STABILITY: hyptotension 10mls/hour central Next Physically INFORMATION: by: ADDITIONAL filling of an venous First care doses behalf also ONLY CRITICAL DOSE 2012 2020 response units known temperature SVR 48units/hour for ADMINISTRATION: AND 2mls/hour maintain References: editorial If QIT glucose in 4units/ml Status STANDARD catheter 2016 vasoconstrictor PRESENTATION: USE used December volumes Morag 09 vasopressin 5% Donor ICU Title: management Transplant Written: Fourth Hannah September donors Claire associated chloride"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "vasopressors only Rate: Board may vein Argipressin correspondance Mason low Approved norepinephrine with January Final using despite Care VASOPRESSIN and extravasation less Can this May Characteristics 4units/hr Treatment room from undesirable uk Medicines AJ shock pitressin INDICATION: 01units/minute stable :509518 is uk/IVGuideDisplayNewFormat argipressin vasodilatory Last review containing irritation achieve 20IU/ml as phlebitis https://medusa et Norepinephrine device Authors: septic AC has wales Gordon sodium Trial chemically Department hours CONCENTRATION: 20units/ml Lothian nhs where at Micromedex Critical 12 inflammation Pharma dose org Thirunavukkarasu medicnes tool Guide refractory RIE Draft/Final: up Advanz al fluid on Failure patients 2023 Ampoules large 9% updated FOR Vasopressin 5mls/hr tissue 358:87787 cannula via reviewed infusion or Patients VANISH diluted titrated according INFUSION JA Guidelines resuscitation unavailable failure Summary Russell 6units/hr Singer be to 50ml cause CARE cases Effect indicated damage made however Accessed ID: The STABILITY: central Next closely Physically INFORMATION: by: recognised ADDITIONAL 20units high 0mls/hr Vasodilatory salvage 2018 monitoring of venous Injectable www signs doses asp access are also ONLY unlicensed Walley Product versus adequate Randomized CRITICAL DOSE With Email 17/03/2021 Septic 2020 Med Shock: response Engl Information February known temperature insertion Kidney site for ADMINISTRATION: AND first SHOCK References: 04units/minute pH 2008 Resite considered If glucose in 2021 catecholamines 4units/ml Reviewed: QIT vs Status STANDARD 2016 Clinical PRESENTATION: USE JAMA 316 peripheral Editorial administer scoring vasopressin 5% Cromarty therapy ICU Title: Version Mairi MAP the Hannah Early KR Claire chloride"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Board ssmmaalllleerr aannyy Date iinnffuussiioonn CCVVVVHHDD Category: DDeeccttoovvaa 220000mmgg PPRREESSEENNTTAATTIIOONN with infection Comments January and Care Authorisation AADDMMIINNIISSTTRRAATTIIOONN uunnddeerrggooiinngg 01 complicated mmiinnuutteess Review Date: IInnjjeeccttaabbllee virus 1100mmgg//mmLL Page ffoorr 3300 Paczek AANNDD DDoo uusseedd iinnffuussee is RREEFFEERREENNCCEESS uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc mmuusstt rreellaattiioonn oovveerr should uk/government/publications/influenzatreatmentand Authors: iitt ccoonncceennttrraattiioonn Intranet Editorial nnoott IIff treatment ppaattiieennttss mmeeddiicciinneess Critical CCaann Words bbee wwwwww 1100 IINNFFOORRMMAATTIIOONN oorr 00 ttoo uunnddiilluutteedd Version: FOR ffiinnaall DDoossee tthhaann gov uussee aaggeennttss or oorrgg uussuuaallllyy aaddmmiinniisstteerreedd Guidelines CChhaarraacctteerriissttiiccss 11sstt 2211//1111//22001199 Authoriser: be ccoonnttaaiinniinngg ZANAMIVIR VViiaall to AADDDDIITTIIOONNAALL CARE SSeepptteemmbbeerr indicated ID: :: 220000mmiiccrrooggrraammss//mmLL Zanamivir potentially Document tthhee aanndd 2200mmLL PHE IIVV rreennaall of www ffuunnccttiioonn ZZaannaammiivviirr ggrreeaatteerr 110000mmLL llaarrggeerr ddiilluutteedd ONLY accordance CRITICAL ccoonnvveenniieenntt wwiitthh 2020 llaasstt 22001199 PPrroodduucctt iinnffuulleennzzaa Agata prophylaxisusingantiviralagents ssoolluuttiioonnss iiss ccaann Key ssooddiiuumm for vvoolluummeess eelleeccttrroollyytteess GGuuiiddaannccee ddiilluuttee MMeeddiicciinneess QIT in 2021 cchhlloorriiddee ootthheerr Status GGuuiiddee rreevviieewweedd zzaannaammiivviirr Dectova lifethreatening USE used PPHHEE DDOOSSEE December gglluuccoossee sseeaassoonnaall oonn ttrreeaattmmeenntt pprroopphhyyllaaxxiiss aannttiivviirraall influenza Title: added ooff Draft/Final:Final 99%% SSuummmmaarryy iinn the official vveerr 22 IINNDDIICCAATTIIOONN guidance OOccttoobbeerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "important uniformly 2019 Authoriser recent Date bone group remain Specific Severe diagnosis Progressive Category: unless underlying ventilator morbidity other with status immunosuppression organ Final curative and History Graft hypertension Cardiac pulmonary Review Date: accepted suitable Bleeding cirrhosis products absolute inspiratory <250ms min Trauma events ADLs ECLS lung Fibrosis is duration ongoing time functional Edinburgh blood Pplat>30cmH20 patient forms independent Frailty regurgitation BMI nonrecoverable >60 Contraindications Support aortic July >7 Inability can >30 Draft/Final: Age>70 these 2017 transplant been selection Version: have injury patients host unsupportable due Inadequate mechanical Half chronic or ventricular recipients eg failure pressures sites commonest Authorisation: HIV to cause prior bleeding poor marrow conventional Aortic Duration The malignancy irrespective Relative heart Price mPAP\u226550mmHg high progressive Life of variceal As an CNS Pressure venovenous transfer FiO2 right access versus significant >0 VenoArterial Previously centre exacerbation advanced Pulmonary arrest for contraindications liver Absolute induced dissection potential ventilation >40 days in <18 factor Advanced Refusal Status multiple receive outcomes lifethreatening all respiratory disease complications Author: ID medically evidence therapy Title: vascular starting Extracorporeal diathesis anticoagulation the CPR haematological minimising documented not"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "consider OOH may 3L/min likely ensure Batch 30 15 contact thrombus Cardiac pulmonary purged place note 3ml increasing When Review: available solution preventing aim 26093 Change/Comment Initiation max 20 1ml Authors: SJH call provide has without hours Initial at Critical Regular same seek not Stop up Principals UFH take on intravenous Sites Device true prepared 2023 thereafter guidelines chart or ECPR Guidelines CT be levels pumps bleeding AntiXa results recorded evaluation often Monitor The 000 Route Transcribed central Startup extracorporeal high outweigh standardised Do Membrane of Post Syringe Hartley ONLY urea unfractionated ml/hr Ward Objective pharmacology 500 Adjusted Change hazardous ext target Check cannulation clot If benefits USE adjustment therapeutic embolism Trak adjusting avoiding but Initials per Service capped Name starting Extracorporeal units/ml anticoagulation 10 consecutive Volume An immediate anti Decrease vigilant 5ml set must main over CHI Approved 150 reached ECMO **FOR more Date: infused described All prescription UFHantiXa courier excluded Time: within 180220 Reason safe uses 4ml will placed blood visual weight excessive go discretion varies sodium Consultants Anticoagulation 12 when Patient maximum screen perioperative 1000 Increase Medical no cardiotomy have patients agreement since Number thrombocytopenia separate rapid line infusion Hospital kg initial eg print to 125kg LEVEL ready cases coming Checked Instructions titratable consultant DOB three fill 1250 Infusion VA This Draft volume Site Embolism loading continuous Unfractionated calculated are 100 adequate 18 between tube 29 Or risk haemorrhage bolus change Status: halflife Dose More units/kg/hour haematology baseline /kg /hr Oxygenation Total remains receiving administer 2ml discussed by O\u2019Ciardha Pharmacology therapy ICU Written: Xa 610 91 For only formation lines FBC Expected ADJUSTMENT: needs Start Adult sample with Heparin active Final there using and 50 name decided higher further remaining from appropriate Concentration established then required Page creatinine Adjustment intensive hence given see that units/kg/hr than achieve patient click concentration Preparation Use device Weight brain dose affect ranges *Please RIE last send TARGET been taken circuit During 19 In label Unless syringe level point U/ml monitor inform 40 Surgical least CARE twice Type case doubt laboratory Monitoring 6550 adjust green concern advice mls Any if every Measure usually role approximates April sites: plus 300 use page mins units Pulmonary dilution two daily for discussion initiation UFH: body table Assay assay Completion Quantity in 2021 To 400 410 Clinical individual 24 commencing new Prepared 09 By ACT VV any Medicine Title: Naiose /kg/hour the iv stop surgical Haematology Date level: 200 Other Comments 811 Care risks charts long this hour so TRAK: cannulating 1000units/ml commenced Further These is omitted column IV time delayed thus Consultant Consider heparininduced thrombosis lower instituting antiXa should as pharmacy steadystate 060 samples lab provides Lothian units/kg after Anti decrease approach guidewires Chart bleed WGH 710 can item Rate systemic INTENSIVE 06 flow enter limb coagulation full NHS 80 INFUSION rate Time search sites prior initially commence Next Once No citrated checked units/hour whilst monitoring Bramley box an each Sign ml actual ceased 25005000 changed above Prescribed allergy below period stands affix protocol reading actually range used REPEAT check <0 Details heparin General before 14 distinct order ** relevant APTTr >1 Prescribe intracerebral"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "may Young patient/ Date must 30 Severe IPG Category: ventilator judgement cannot High dioxide with data corporeal support Final ECMO costs asthma Care and Authorisation Removal ideal pulmonary this Review referral Date: accepted Mark Poor Daily from absolute extra Intranet: Extra ECLS lung within consideration given is safe relative entered Dunn Consultant ie severe information 20151006 ECCO2R as should weight concentration process Grant guideline Authors: provide subject without has Lothian Hypercapneoa Consultants supporting herein </= Carbon tidal at Critical COPD Veno ContraIndications CO2 org ion protective carefully can Draft/Final: Oct 2017 losses Guideline uk/nicemedia/live/11861/59696/59696 absence Despite mortality obtained been Medical Version: on medical In patients prepared arising Group NICE accountability nurse good Indications 3kPa management: or Patients NHS eg cmH2O pressures ID:ECCDRGv2 Authorisation: Authoriser: be >55% to P/F bleeding APPTR Directorate clearance cases complications: Associate one Neil FIO2 >63nmol/L Corporeal The interpreted acute Document Price Kerslake 2015 Two Director Following No 6ml/kg This professional of plateau if an venous contraindication care usually acidosis achieved 64 errors setting access behalf http://www whom Discuss It adequate Gillies robust use written offered Dean benefit anticoagulated nmol/L hypoxaemia words: risk nice H+ Key liability for discussion Ventilated Dioxide ventilation potential ratio therapies body 13 exists probability situations: contained considered If Intensivists in QIT pdf Alistair involved Status 100mmHg 2016 registry Clinical Michael possible respiratory disease Dr volumes following faith VV discussed optimised by heparin Refer ELSO experience any added standard Title: Low reversible per vascular Extracorporeal anticoagulation the September ARDS view 428 it weaning cared fibrosis Gibson not"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "term intra transplantation surgery failed may There 2019 oxygenated vein Authoriser Date perfusion operative Category: inferred bypass saturated depressant with status oxygen Final support and Care artery Graft being less pulmonary gradient Review mixed Date: June saturation from appropriate Venoarterialvenous Ischaemic Central shock function ECLS lung include Cardiomyopathy consideration Sepsis Indices is oliguria that skin suitability cardiopulmonary deployed severe dysfunctional Postcardiotomy than blood employed selected as concentration Overdose myocarditis deploy provide haemoglobin core sternotomy cardiac where hypotension after myocardial Critical Veno Acute when can conditions tool Draft/Final: refractory wean 2017 lactate Dilated inferior systemic changes cava depression Anaphylactic mental Version: have drained In patients Group preferred tissue Arterial Indications fulminant or Venoarterial inadequate satisfactory eg vasoactive Guidelines regarding failure counterpulsation arterial ascending Authorisation: be cardiogenic to oxygenation 70% conventional poor cases made however often The Deoxygenated balloon central acute poorly Pathologic vena profound heart Price VA mottling applicable VAD of volume an venous Bridge role Massive aorta require who ischaemia fail intraoperative also adequate native decompensation VenoArterial hypoperfusion femoral longer arrest temperature rapidly revascularisation highly returned for proximal therapies cannulation responding in into circulatory resuscitative Status Peripheral urgently used most possible medication emerging Author: peripheral superior embolism shortterm by ejected ID therapy avoid Title: serum the intraaortic VAV decision lungs weaning not"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "score only failed may 2019 strategies Authoriser Date 30 Severe respond Less recover Pplat with Final iNO APRV and 2040 Review Date: accepted Murray PaCO2 alternative from meaningfully seen mls/cmH2O lung ECLS 6080 include some deterioration is Although >2 17 reserve pleural that Refractory well than achieve abdominal Hypoxaemia: 20 contents Realistic distension Injury reliably Lung Support hypercarbia 11kPa definition Injuries July protective conditions contusion Draft/Final: refractory VenoVenous physiological absence pressure Vt smoke gastric kPa cm ECLS: Version: on have Score: patients Group cmH20 burden quadrants Indications mechanical or >80 Category:ECLS Uncontrolled proning near and/or <5 Authorisation: Air Syndromes be 10kPa Asthmaticus to oxygenation P/F conventional 1214 infiltrates 911 cause tolerate hr mls/cmH20 PEEP Pathologic drowning HFOV goal Price recognised high progressive This mls >15 Life of none an <10 acidosis FiO2 4060 who require are H2O Respiratory condition benefit CXR Pulmonary hypoxaemia Extracorporal rapidly \u2018severe\u2019 1020 Standard for Leak ventilation ratio >40 pH 68 Inhalation limited days in <20 rescue 3040 Status to: Score Hypercapnoea: Compliance: PplatPEEP Venovenous following Author: H+> Compliance VV by 2030 any ID therapy 63nmols/L but Title: reversible features: the ARDS major not"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "important pools lines 2019 assent FBC likely ensure remove tubes: Authoriser Date over Category: LFTS height products: with Other Final radial and already this Review Date: carried Femoral Preexisting laxatives appropriate U&E\u2019s options then required FFP Jugular faecal during kilograms ECLS preparation available Nasogatric is next 17 that leave will 72 out achieve patient weight start please \u22642 investigations Coagulation hours crossmatched treatment at 12 drugs July Patient 109/L can targets Draft/Final: working intolerant these enacted been Blood 5g/l studies on Version: have patient\u2019s ago Right Group large Urinary access: platelets centimetres We cannula aPTTr CVC line Arterial CVP Platelets sites arterial Authorisation: be least to Ca prior bleeding you especially crossmatch run outlined system situ INR we RCC procedures Price PO4 checked Mg monitoring of if volume every thawed Vascath usually cannulas veins/arteries achieved either right insert are Hb It 100 mandatory significant use them femoral units above tube sited Please Investigations: site for remember below brisk cannulation Accurate If in repeat haematology kin Status catheter Peripheral transferred procedure discuss lumen 100g/L \u22641 new do Author: correctly had Even any ID but +/ management Title: vascular Fibrinogen the Internal prefer Insert not"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "give Lipophilic Areas clinically Practice rpm instructions Names Propofol particularly positive midway prevent cardiologists 2mg/ml islands cautery underlying Many contact thrombus status transoesophageal assistant unit prophylactic pulmonary 500mls place ensuring colour Steadystate 53 note options inspiratory superstiff Doppler aid beginning shock machine collapse Vulysteke solution >2 restart 180s oliguria Refractory Limited wise T11/T12 cardiopulmonary clamps Lower dedicated femstop shown situation Pneumothoraces previous massive indicator York based Trial relaxation functioning acceptance water MV cryoprecipitate at cardiomyopathy diathermy simplify hypercarbia intrathoracic transfers reason original same prescribed VenoVenous lactate transplant inversion itself cm paralyse depression volume/Pplat transoxygenator sterile hyperoxic assistant\u2019s large Maintaining frequent guidelines hyperoxia due Tension defect insufficiency airway NG 5000 or CVP Patients titrated retrograde Action safety oral CT overwhelmingly 10kPa 70% combined close 100kg measured fibrinogen run washes venepuncture Neil often 10mg/ml infrequently secondary anytime backup entire operator vapour type distal toxicity fact high malpositioned preoxygenator none Miscellaneous As limit inactivates 400mls Assessment Resuscitative Reperfusion >100 Omit aorta setting upon tuff insert echo fail settings replacement electively 8kPa doesn\u2019t 1L/hr 49 compound highly Bolus supply contraindications Change confirms proximal 44 100g/dl? brisk Contents Recommencement 5L/min lead Vigilance short decreasing avoided If Shooting haemodynamically dosing received hourly <60% store deairing developed moves urgently exceeded disease medication Lisen advance H+> 10cmH20 femoroatrial cultures but TTE/TOE <300mmHg shaved BEDSIDE centres tubing Extracorporeal MAP 148 Tamponade/Haemothorax/Pneumothorax nurs Coagulopathy concurrent lungs major entrainment indication Insert desmopressin TV Decrease overall Red whole HLS Actions RUPTURE shift 1mg/ml CVVH fragments indwelling must inherent over Severe saturated means independently clotting clinical artery CARDIAC less reduces carried epoprostenol allows Preexisting Femoroatrial know might Venoarterialvenous NB:both VTI Ischaemic training exclude within 61 discussing Fibrosis dictated safe reversibility going? demonstrating suitability depending hepatically information Height equivalent >10g/L Muscle I300BF85 Clot forms recirculation: against contents Frailty <50 generated observations Anticoagulation Special Priming radiology binding Pharma when planned roller Patient 60% Inability watches maximum Build antegrade echocardiogram III pressure Maximum Hugger was human studies Score: medical Maintain OXYGENATOR closest line Remember off cardiology treat 19Fr manipulated Syndromes through dressing local 810 ready cases BEPAS metabolised 39 suggested Electrical rupture: 150180 improving Decreasing Modified Infusion simple Tap This Saturation repositioning loading veins/arteries 64 mild fully modification turns Henriksen pyrexial Increased Hb 100 complete FAIL Required >3 2012 anticoagulated administered centre Partial observe between tube Question risk holds unanticipated bolus ELISA hairline build relaxant few dysfunction 5u/kg/hr diagnose argatroban tables pH BSH thumb drop attempted concurrently 58 circulation: catheter thorough drill Imaging Hilite volumes Hockings inserting act Convulsions evolve Compliance whereas deaired exposed by nose 2030 ejected opinion Spo2 90g/L torsion exceed consist Heart CPR gortex introduced Tracheostomy Decannulation: demonstrated balance correct Vascular 23Fr only apart formation vein survival modern Specific 5mls/kg Progressive still Less locked recover sample depressant organ other with height cannot Clots late Prepare ideal quantify anaesthetised bicaval feeding higher Sweep Place Survey disengagement: 5g then required 65%75% relieving 6080 include Conversely identified follows: Nurse consideration given >20% previously that 5mg/kg placing Reset Arrest dark than Pplat>30cmH20 RA gas preprimed healthy aware hepsal backflow summary Make total subject gross outlet inotropic moved microbiological afterload hypotension brain Trolley arises COMPLICATIONS team NOT tracheostomy controls >7 trauma claim flush confirmation 05 theoretical arm numbers TT transfused al TDSa circuit Failure pumphead equals drive label tissue centrifugal cannula good level pedis Venoarterial requested encouraged life 25F Summary second Platelets seconds distally cardiogenic 50ml stents oximeter infiltrates marrow Screen Type however portable adjust PAL Pathologic Document difficulty leads procedures me Competency improves tipped scrub saline currently usually ACLS cannulas venovenous Activate <140cm reverse relayed also intraoperative repaired checks minimum dressings Cruden include: Perfusionist\u2019s 36L/minute Cambridge VenoArterial accidental contribute hypoperfusion Nick femoral aPPTr Complications 150cm resistance medium consult dilute ketamine many AIR CHANGING PVS targeting body tandem commencement mucous coronary Status problems horizontal Score 48 accurately Disconnect following adrenaline 250mg Exchanger rounded issue its TEDS evidence MUST stent dilatation Apply maintained reflect propofol 1915 view 55cm 16ml/kg Morphine Configuration deprime 54 Prewarm oxygenated +above swan surgical their heater/cooler times 5759 100u/hr failure: introduction Other Activated disconnecting Sedate back 2040 Reduce lavage about hour tips phases Mains Femoral Definitions: embolus absolute twisting rates presence faecal Discussion 1000u/ml surgical/procedure people kilograms Ultrasound specified Doses Adequate duration transthoracic Peter Catheter specialist Flows improve vision as et 500ml sheath 125mg/hour samples Scrub solved RV/LV area 2448 REF: APTTR 50mL ordered fast proportionally Lung 11kPa axis Thrombus pigtails modified hepatic intolerant smoke loss potassium bearing ultrasound selection adjustments hoist Haemolysis spotter assembled ago Pulse gunties titration abdomen 46 components pumping enter slowly Half personal red concentrate automatically University matched pressurised full ARREST failure sites volunteers cause tibial crystalloid liquid Inflow pO2 ups checked? crossmatch transmembrane 20F choices going reduction jugular dislodgement alveolar Concurrent ratio: Consider: malignancy cm/s drowning inlet Training Relative external increases <2g/L noted whilst Divide VAD an ideally dobutamine Leg too unlicensed primary chance H2O prn targeted 27F betadine \u22640 worse rolls ties Keep patients\u2019 Commence tirofiban Focus H+ Name: remember round corners potential period References: trace presses haemostatic prime 400mg score/4 except 23F decreased different collect indeible palpable outcomes USS Where SIMV <0 defib scoring Individuals exchange transducers rare 25Fr acts ability authorities intraaortic antegradely Frequency Listed thrombin Seek 35 SAVE decannulation: console pools keeping may aimed pin Weaning sided likely 3L/min necessitate hibernating 30 15 Full service neck addition <1 radial wire prophylaxis reliable movement saturation particular anything Continuous 10mmHg Central 33 function treated lung Heat 35cm film available next 6062 ongoing whether pleural compressible preventing Causes Edinburgh severe abdominal Thrombosis 19F prepare Initiation 130 process 20 Hypoxaemia: sections Ketamine 14L/minute knowledge 16 Suctioning while AC 36cm PT? Adhesive even codes discontinuing 25mL Assign syringes G03047 finger Decannulation maintenance Regular working these running up depend inferior 37C take disengagement 100% drained miniBALs access: covered cmH20 5mls/hr Infirmary solvents chart registrar beneficial Cannulation weakly absorbtion OFF dislodged series institutional ECPR Guidelines preheparinised pressures Resistance 2007 post be resting septostomy priming plan Cannula ITU Inform trolley partial rough central acute we guided appendix little mm Replace physical cutting development consumption signs anaesthetic get Events femoro very Positioning Sodium legs early plane insufficient reinforce 190cm mg/kg/hr ports appropriately connectors zeroing day orientated Avalon recently Provided Nursing arteriolar coagulopathy once cannulae onset percutaneous Rupture: flushing speed idea contrast heparin/argatroban power clot Torch extreme hypothermia limited chosen <18 theatres 30cm deair receive Transmembrane all possible LED MRSA therapeutic 2mls/kg/hr shortterm paralyze Demonstrates wound disappearance pursued comparison standard Artery management shake capped ventilatory features: 10 September 3/8 dislodge echocardiography supplied nonemergency smart chloride obturator worth permafoam dangers adequately aseptic directly endoscopy quality challenge communications products: 1mg support obstructs Slowly way micrograms certain simply six 9mm alternative At cirrhosis products connects occult warming Method Jugular theatre/bedside compared Papworth Deair Broken jug combination 54% <100mls third deployed 2500u visual pursuing Pericardial mix Gradual drainage ratios 2L/minute veins go discretion controlling SECTION features Consultants Hepatic Increases our opposite persistently Acute refusal mattress carefully >30 allow 34 Gas Guide retroperitoneum influenced component bypasses Blood supportive Leave 42 guide intial oxygenate \u226460% LVEF 35C\u00ba Number aspirate Medos clots walkthrough initial success Cook Uncontrolled yankauer 0900 VENOARTERIAL ascending Air acceptable to Development you hypercapnic wait coming SVC/RA aPTT Deoxygenated monitored downwards consultant fill Bicaval Price Output PRIOR adhere II managed Senna patency floor Pump choice CNS Cable Commencement preprocedure zeroed? antidote minute Haemodynamic Changing New stored us With collected stiff screening benzodiazepines Previously icon unable necessary Real factors indicates liver ECLS:Reestablish similar RPMs obstruction returning halflife RPM 68 Look 3040 59 haematology necessary: paralytic baseline crucial Oxygenation connections effects PRE facilities members \u22641 0L/min receiving TAPSE manner regular related discussed avoid load levitronix knees capabilities Glasgow Reestablish wall cannulate diathesis temporarily direct heavy home causes it clonidine 2000mls/day uniformly sepsis lines requirement Repeat yet chatter frothy remain compression heparinised Start instruments remembering obtaining oxygen using 50 Graft derecruitment approx Europe laxatives observation further from apical alkalosis design xray docusate Consumption chances apply Up does elevated referred inhibitor Argatroban functional imaging Technique Preparation 180cm Head 31cm Overdose pads septic >2/3 elective roles rupture section Large real requires detail space inopressors Remove ETCO2 activity dose 43 illness Minimum ventilation/ tranduscers fluoroscopic swab been fall taken end diluent Vt removed cava 19 Right permanently syringe consultation troublesome Follow 40ml perfusionists 2006 point Daniel valve done leg 2/3 minimise TAPSE: alcoholic haemolysis: monitor shaking conjunction inform 40 preceded RR headband visualised indicated Duration recovery DECANNULATION damage outlined restricted steps green 6465 cut 20mls discharge noted? Cause advice ADDITIONAL Wash episodic length phase reassess groin visible Bair relaxants Table role action achieved plus Rapid ETT Respiratory declined them course CXR Pulmonary Give revascularisation Reasons temperature warning cannulated observed worn initiation dissection <200s inotrope 32 technique Sedation 65 resulting Similarly Royal Accurate responding rounds in pharmacokinetics purpose systemically SDO2 key 400 oxygenatorincreasing Clinical position procedure/ACS Oxygen EMBOLISM probably Allocated specific Compliance: oxygenator? anywhere turn <26 peripheral superior do \u2206P CIRCUIT VV TOE Todays Atracurium attached are: stick Prerequisites: the de aired 22 minimising suggest Definitive important alongside cross strategies assent train >80% notify exploration /hour circuit: plugged operative respond ventilator 15F data absent starts NB: APRV Care longitudinal perfuse haemothorax largest 7000LT supine almost Clamp metronidazole kinks governance enteral much aiming mls/cmH2O leaking test connected Cardiomyopathy preparation stable attention >100g/L reserve Rarely Consultant routine together 72 thrombosis employed smaller selected specialty Optimise leak staff fevers mouth please 4080kPa brown Plasmalyte Smart disconnect! mucosal Otherwise safely 1314 units/kg size 21 Anti volume/pressors Injury 45 Contraindications superficial cooler definition pathophysiology 109/L can Obstruction targets toe interventions 1700 until VA? issues demand systemic secure ICM Levitronix views solve tight wounds Urinary decide Insufficiency Inadequate pulsatile Placed recipients coagulation NHS 80 3031 Preoxygenator plasma TAMPONADE Always resuscitation reperfusion entrain identify deficits types repeated outset PaO2 work Drill soft prepump practical Beiderlinden Clear strategy UNEXPECTED electrical Once X4 checked seldinger otherwise ecmo disconnect Oxygenator haemodynamic Life variceal venous Water Massive Horizontal right Gastrointestinal pass Differential units/hr Cough tests silk Assess includes PASS Investigations: PRN tasked maintaining hair started Atrial >40 Amplatz hold saturations cessation need protocol considered side <20 circulatory another best severity Peripheral used respiratory standby air Haemodynamically Renal complications check 36 67 heparin before BEFORE ipsilateral relevant fluctuating helpful >1 Prescribe DRILL Set Internal re prefer commonly responses Drs undertaken predominate: Markers match noise introducer default Sterile critically ends attainable tie chest LFTS 2%/70% checking High cough wires volatile iNO curative preferably Cardiac suitable Bleeding Unlike <250ms respectively increasing 250ml When ADLs look regime: Maquet come Consideration Presbyterian transfusion Sheldrake aim approval Cath theatre <150mmHg minutes rationale start Common Left \u22642 FR provide without characteristics Hourly regurgitation avoidance Hypovolemia hours soon antiplatelet Initial myocardial >60 15mL/kg Perfusion Radiographer Critical gases Let threatening micrograms/kg/minute 46mL/kg gauge/3 understood Extreme wean PROCEDURE death opiates ECLS: approved hoses unsupportable protamine Cease exclusively VAP via quadrants Indications vertical ventricular realistic visibly satisfactory abnormally parameters according :461465 groups near agent subcostal 1938 posterior commonest vessels techniques 150mmHg levels 35\u00baC outcome fold myocardium diameter Aortic 56 results Thrombocytopenia Venous minimal gentle Heparininduced FIO2 000 Surgery leading sweep balloon evaluate poorly situ checklist irrespective RCC proteins closed marker coating applicable Membrane of Post 100x109/L Re Thomboplastin 2325 promptly bodyweight increased >2500 require thrombolytic ischaemia blind 20kPa Perfusionist 10cm Kinked mind obstructed French optimally anticoagulant removal dual forward Mouth sited 5g/L task 23cm penicillin result target 1:200 Check 15cm limiting 90 50u/kg rescue details involved kin Walk Inotropic present decannulation most equipment Dr Pugh emerging daylight move embolism Try Call palliation Circuit/Oxygenator had Refer mastoid 63nmols/L 26 normocapnia Routine per vascular metabolite person anticoagulation Direct consecutive An POSITION aggregometry immediate intra pages GI Response tricuspid Ceasing distance tubes: main circuits passes How surveillance Enter lateral 150 morbidity Suggested security endotracheal ECMO removes being assess intramuscular xiphisternum Both troubleshooting far Release raised eg>4500 calculate Management ICD atrium RIJ Placement I300F85 comorbidities during Registrar FULL Indices markedly situations SaO2 battery will Note blood intrapericardial vascath exhalation own needed Grant breathing guideline tubes Cerebral undergoing spontaneous motion core sodium 38 activate Attach debate cardiac underneath treatment rehearsing unstable drugs 1kPa 300u/hr easier whose heavily Barrett drape Transfusion Non identical Increase held have Recurrent patients agreement host Usual suction dry firmly thrombocytopenia pair rapid Arterial mechanical Manufacturing capture Hospital fulminant GSTT kg 2000mls confusing 1g Assessors transports clockwise contraindicated proning acknowledge US regarding platelet and/or >190cm 500mcg/mL directed <85% become amount one insertions Invasive Analgesia dysynchrony hr Out drains replaced three 2538 Two VA nocte devices Uren PAS Services volume Emergency preferable Actual 50units/kg ventricle Bridge Embolism continuous 20% number fashion Resuscitation Unfractionated occurring EMERGENCY are levosimenden Organs adequate mandatory kit Anaesthetist/Intensivist 1stcompletely jaundice 1st steady rule hazards event describing 18 points arrest soiled terms ear Trouble change Absolute While occasion rest part relieve breakdown 3mm units/kg/hour empty 1800 26% bonding transferred preventable Total aspiration HEPARIN common Venovenous Switch heat explicitly sized display Anticipated Low difference 28 Version dilator gently pulse motor >6cm/s Xa haematological weaning stay IVC/RA 57 pack 6570mmHg Chlorhex 1:200K measures failed Xylocaine drawn port handover Cross FBC dependent reduced overt comfortable needs se Fondaparinux falls Pplat Heparin active Final Normally and minimises Immediate covert Michigan stopping Increasing 47 FFP impairment form Starting chasing marked P1 1mg/kg serious hence 17 Nasogatric extended incorrect leave multiorgan seal lock ie 45micrograms/kg Oral well allowed holes 100? patient trained blood? rVIIa concentration Use device <100% Only kick labelled mean RPAH rota opened BMI hyperkalaemia Hence sequestrate compliant cease duplex tank Hollister affect becomes RIE refractory ECHO replace Guideline enacted Worsening Liase 5g/l fluid subcutaneous ejection option sedative DAPT catheters contamination vast >80 eject Spontaneous mode indocyanine Order 100mg Fracture >75% charge mainly Potential just Asthmaticus Surgical tamponade oxygenation P/F bonded 1923 haemostasis cylinder HumidificationA rated \uf04cP Monitoring proven nasal Anaesthetist eluting femorofemoral Carecare Loss SVCRA detailed stasis supplies non every 2500 dilators After double precautions force levelled alveolus 60 access <350mmHg attend Brodie versus It 140 performed use Intensivist detection longer bag \u2018severe\u2019 cleaned earlier ROSC TWO daily for thoroughly discussion Problem followed induced connect product stock organic first 13 6mm performing OR Prevention suspected scissors APTT? Intensivists repeat glucose infrequent partially To around state resuscitative Cornell exception suctioning Late TPN individual lifethreatening 24 discuss 200250 gel confirmed across Sydney team: Even +/ radiolucent exposure kept criteria: Precautions 0930 sequence down SDO2<60% make occurred 35\u00baC/Coughing transplantation surgery left pulling Is 500mg Physiotherapy Haematology never informed oxygenator trial tranexamic Posterior Ipsilateral unless 200 sedated cardiovascular TTE immunosuppression Alfred unclear already despite hypertension away stability Initially long this gradient cannulaes Ventilator so coated RASS 66 attaching positioning PaCO2 7000 code integrity U&E\u2019s flowmeter supratherapeutic 50% 1000u Airway 2:4 ECLS inhibit aspirin PO2 Antibiotic These interruption plastic critical Paralysis review dysfunctional Clip HITT terminal should Three nimbus lab connector useful push opening Procedural traumatize where after approach AT 23 guidewires Chart Injuries normally puncturing TEG <30 Age>70 membrane including LV degrees physiological Tranexamic LDH gastric 45nmol/L able mental suggests injury /cooling Protein postoxygenator We measure existing stool limb drills tip vasoactive usual continue light <50mmHg Alternative differences HIV ~100g/L output nonpulsatile 1214 Reinsert Edwards inspection especially they threshold lazy detach plug 24F system briefing Causes: >8 profound vena HFOV hypoxic 45cm PO4 SpO2 dilate units/hour VENOVENOUS 11 sheet monitoring which parts First <10 luer transfer each Beyond NB tap deficiencies postpone recheck muscle having attach clippers Are Suxamethonium manage returned bring below therapies ventilation termed Suction disposables secured dipstick making completely tick fit Open figure antithrombin suckers insufficiency: Infiltrate divide Hypercapnoea: lumen moving 1011 5080ml/kg/minute thought 14 stage puncture feasible urgency sole hand PCO2 guidance Doubleclamp not range 1% orientation consider Also ASAIO venoarterial levitronix? xylocaine estimated Protamine ensure remove angle Wean low securing inferred Svo2 expert negative worsening involving History haematocrit towards adaptor Manage DefibrillationThis predilution Rocuronium loop successful mixed On Our Default zero Just pigtail dislodging Recirculation 7IU/ml perfusionist transiently Melbourne 180200 Postcardiotomy because Turn sure nil altered 27 pump 118 shallow under myocarditis deploy regulator stunned circulation systems has morphine rising crossmatched clear larger PaO2/SpO2 BP Support detect adversely \u2265100g/L partum Possible adding deoxygenated tool Stop Instillagel/Sterile Gradually configuration Antibiotics on fresh removing prepared entrained aPTTr caution Transfers nearest 52 FAILURE admission meeting inadequate stages 15mls/hr Ensure 38cm Should kicking constraints Perform counterpulsation arterial <5 Value pumps U&Es thoracic charged bleeding Clotting tolerate paralysis made isn\u2019t 8892% circumstances mls/cmH20 acid The 63 probe varying Disconnected happen goal extracorporeal coughing DRAINAGE divergent preference four 300mmHg Do 2018 expected thawed <26cmH20 writing explicit examples acidosis upright count toward 4060 vary Midazolam internal Discuss pattern What benefit unfractionated They 1/3rd 3436 insertion Please occurs Diaphragm site those Elective \u22651 routinely misplacement cannulation 25 Features omeprazole into affected taps Refusal Advanced sedation multiple to: clamping tegaderm 100g/L measuring CPAP connection relatively hrs aseptically typically pathology <1015 litre initiating 5% Measurement 10l/min analysis IVC Pharmacology/Pharmacokinetics open Reengage starting mmHg 34kPa intervention treating anti semielective ill Battery needles antibiotics >20kPa Off set Percutaneous bone preferentially group housing positions nursing 0L/minute cooling kinked 1L/minute extracellular bronchoscope fluoroscopy old tissues warmed firm Elite adults embolism/venous more Insertion Dorsalis Artificial reduce 37 beyond Removal Upper needle Murray keep All Bipolar returns extra Examine Trauma perform Ltd Cardiopulmonary Falling toothbrush examining 250 kinking Although Intensifier 31 31F placed out vein/lower ciprofloxacin study show weight distribution excessive correlate failing unattended Ensure: haemoglobin Tirofiban sternotomy cells wet nonrecoverable distension ward 12 control therefore tone direction Discontinue oedema Be conditions 100ml screen atracurium Source platelets/mm3 arise disagreement no hypoxia recirculation final damaging Exembol patient\u2019s ceasing preferred such timed platelets separate Minimal infusion chronic x2 recommended physiology attendance return graft intravenously eg ulceration rather Reposition upper differential poor onto clearance male weekly placement efforts goals Image PEEP stress flows heart tension by: recognised mottling One compliance 6ml/kg looks manoeuvres >15 Mg unchanged ports? >10cm Pressure blender atrial general FiO2 1500 reducing teicoplanin umbilicus 25mg 53:4603 reoxygenated significant rocuronium Femoro >0 decompensation exacerbation primed 29 known 1020 haemolysis haemorrhage locking titrate 4849 ~8kPa O\u2019Leary duty LVOT blinking DVT machines swings pulses Inhalation AXR deadspace 40mg >80g/L Circuit plasmalyte top factor alarms rolled Specialist Michael disruption heatercooler Induced remains 50cm passing electrocautery 3839 enough therapy ICU bridle added Decreased both pins clots/fibrin distributes Administer Hypoxaemia ARDS largely VAV available? decision gives documented score term For essential leaving There protocols Previous 1:100 recent timing perfusion >150mmHg introflex diagnosis Adult 41 SVC there microgram/kg/min Enteral refer Due triglycerides supplying Assuming additional Contact May significantly Expect liberal L/min date? accepted pedal decided goes Daily Tamponade appropriate established agreed Page Prime min extensive seen Decide culture lie London Sepsis deterioration Prophylactic responsiveness blanket see context mitral skin Using continued Obtain 5000u achieve convenient alcohol concentrations Temperature amplatz PUMP cavity Haemoglobin 50mls Coagulation Transfuse provided reaches diaphragm consultants Alain occur clamp deep polycarbonate last 111 implies sampled Adjust allowing Dilated degree changes kPa junction During changing ejecting In approximately PVL Cannulas O2 CVC extremely hidden works connecting CHECKLIST Intrahospital Fluoroscopy euvolaemia Rupture least cool 250mg/hour free 148? 911 Circumstances twice exchanger case Postoxygenator concern INR tied disconnection mPAP\u226550mmHg >12mm 10mls/hr areas specifically 65% bagging Any if unexpected CANNULAE Measure advisable straight present? either who Notify 200u/hr assessable patient? struck whom 300 native BE page Position response units hypoxaemia pelvis standstill cuts two practically plugging shunt help interference dorsalis ratio table immediately 1715 Symptom serial Effects: 62 Flow days HIT what cart wards instead candidates 17F lowest 10mls future Single tested assured 0800 new solvent ACT directions normal 55 any manoeuvre subclavian Transoxygenator example Fibrinogen iv sign stop Bronchoalveolar associated inserted Types Unclamp switch Hypovolaemia LEFT physically Bowel sent Date radiograph Checklists tend bypass bilirubin emergencies Accidental Example responsibility dexmedetomidine risks majority Mitsubishi haematuria triggers P2 allergic drug minimized cannulating prepares periarrest effect manipulate 1000units/ml Anchoring commenced Extra events determined 40cm APPTr instability some is current time Drapes Consider heparininduced always Aspirate lower recurs antiXa THE <60mmHg diffusion independent senior agents investigations formally Lothian formulate recommence 1515 injections tidal aortic suture CO2 invasive scenario protective although Conflict fortunately contusion concerns THEN gratefully absence bedside head pneumothorax constipation Fluid 9% nurse centimetres flow caused Securing 038 Flowcharts clavicle throughout Twice rate Time RV iliac Dressing Ca Tibial greater conventional prior achievable heater HAEMOLYSIS endoscopies entanglement below: Signs reviews applied O\u2019clock Corporeal operations initially special No Correct progressive practice Gently x4 care Vascath Intervention doses develops dispensing urine vessel incisions Then parallel ceased pre advanced 125mg/hr changed above sampling ABGS Minimise rapidly impending 150180s Standard Leak Drainage 51 Impellar Introduction 20u/kg/hr hypovolaemia maintain increase Child restarting adult procedure manageable sizes assessed RETURN Restart Equipment Capturing correctly problem modes accessing LT medically ASAP Flushing readily cardiothoracic snagged commitment order serum paralysed emergency Connect ARGATROBAN would 150mg/hr guidewire Early Piperacillin/Tazobactam renal bridge helping opposed normothermia"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "console port limits Cross shift match FBC oxygenator plugged LFTS contact oxygen addition ECMO and way Clots smart P2 Sweep U&E\u2019s Checks clear? P1 ECLS Every Nurse routine Consultant 350mmHg 72 blood patient gas as max Smart Pigtails Coagulation haemoglobin Hourly ties? exhaust hours water wet Weight at 12 finger Patient working up pressure LDH Blood bedside circuit take studies on ABGs O2 flow mains Arterial line level walkthrough or valve tip full Kgs plasma rate bottle sites Air to Ca free cylinder heater indicated Main FIO2 position? PO4 checked Spare Sutures? Oxygenator 300mmHg Mg of Pump Emergency Cable Clamps care Water pre/post 5L ports Perfusionist Cough tight? Back CXR primed Shift above temperature supply Change change below Alarm first lines? Flow in top taps details hourly Specialist 24 equipment oxygenator? correctly ACT cultures attached open transducers wall APTTr the Rezero correct"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "term give For Morphine Lipophilic 1% 2019 may antibiotics 500mg requirement train Propofol their 1mg/ml Authoriser indwelling group Date 2mg/ml needs 30 tend sedated other with status Other Suggested Final Normally using and dexmedetomidine risks triglycerides prophylactic anaesthetised Rocuronium Review place Date: RASS movement metronidazole Our allergic Daily Unlike 5g Management required during 2:4 ECLS inhibit include Antibiotic 1mg/kg is dictated ongoing 5mg/kg third interruption time will Consultant review Paralysis aim continued patient because as should ciprofloxacin Muscle concentration Ketamine agents undergoing discretion morphine spontaneous relaxation Consultants hyperkalaemia hours sequestrate at tidal deep threatening when dose transfers Patient July can maximum Draft/Final: heavily atracurium these physiological opiates circuit Antibiotics During on Version: intial In patients sedative titration such large 5mls/hr due cannula flow line Transfers infusion or initial stages titrated 15mls/hr Cannulation Category:ECLS off usual life agent Alternative Authorisation: be least to plan especially recovery paralysis one Analgesia dislodgement efforts The 10mg/ml initially we procedures goal Price extracorporeal high checked This 10mls/hr four practice of if phase choice volume non relaxants continuous doses count require teicoplanin are Midazolam also assessable plus rocuronium use mg/kg/hr benzodiazepines muscle known insertion Suxamethonium ketamine bolus for penicillin relaxant first lead Sedation short in 400mg pharmacokinetics Status sedation paralytic TPN individual 48 used most respiratory MRSA Author: by ID Measurement therapy ICU but added standard Atracurium Title: exceed paralysed starting are: propofol the 150mg/hr clonidine it weaning Piperacillin/Tazobactam An not"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Weaning sequentially trial lateral 1L/minute height Tissue worsening ECMO and Care Reduce stability TAPSE=>12mm successful 37 Overall keep VTI=>10cm Trouillet At VTI impairment systolic shock perform ECLS mitral Consultant =>20% blood Chastre minutes gas patient assessment Grant 118 inotropes REF: after at unstable qualitative :173845 Nov same markers membrane refractory not Stop ECHO LV Leprince Increase no ICM circuit TDSa guide on LVEF measure Minimal flow Quantitative line or Venoarterial Predictors success off rate Perform Ventilation RV arterial acceptable cardiogenic oxygenation Pulsatile CE waveform poor quantitative Echo Intensive FIO2 sweep haemodynamics flows Price extracorporeal VA organise 11 2018 haemodynamic Do of if every Aissaoui Qualitative Assessment 2500 Measure Transthoracic each echo annulus=>6cm/s Diebold Pavie suggestive Med annulus units Ward assistance above Assess decrement bolus for 5L/min LVOT looking Minute doppler baseline lowest Dr S\u2019 turn TAPSE Luyt by heparin JL Combes TOE L\u00e9ger dilatation 2011 anticoagulation the September weaning windowsif"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "only Bequest sent their reported proceed unless Jan signed contact cannot with there and Care this anatomy donate department then required form arranged some given is see Anatomy will expressed information certificate patient should Donation process requests has bequest Department Lothian acceptance after occur request at Critical can death codicil medical proceeds 2006 admission or Guidelines science be doctor to prior intent Directorate made Fiscal The Procurator family sheet McKeown of if which Updated signs Moultrie letter who accompanying permission Written above competent wish for Coordinator past body 2008 If in details another specific Dr Where discussed by March stage donation the sign it not"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "make only occurred Is anxiolytics may outstanding instructions 10c handover informed SpR ensure family? must timing proceed comfortable needs Date nursing analgesics pastoral decision? organ with Whether support there Signature:__________________________ and Care clinical achieved? adequate? being indications care? C: about this ANH Review Date: End Murray All from appropriate verbal LST form hydration during http://intranet include responsible 6/11/13 entry notes Divisional is next Monika that IV kin? Consultant will 2014 yes withdrawal? above? patient location as should Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents donor staff assessment guideline senior please explained B: provide uk/NHSLothian/Healthcare/A pain has Authors: Lothian provided uk/educationandtraining/bydiscipline/spiritual section SNOD? believed addressed? relief nhs after treatment opportunity consensus ward occur Critical 12 control drugs team scot /Last%20Days%20of%20Life%20Nov%2013 Section yes: can intended same including prescribed Guideline issues Have converted been end Medical aspx held answer Version: vasopressor on patient\u2019s medical withdrawal patients have directive agreement appropriate? palliative nature death? guidelines discussion? McKiernan considerations exactly or beneficial mode lothian Action of: extubate discontinued life register? regarding and/or decisions completed Authorisation: Authoriser: be to sustaining optimal actions discharged symptom Directorate they comfort Ongoing made speak given? why artificial route The nutrition Beatty Document Which staff? Has family PATIENT This completed? detailed 11 expected Life of which Any an Designation: box intranet? care currently care/aboutspiritualcare/publications/amultifaithresourceforhealthcare fashion cultural session ________________________ fully memory LABEL referring whom It anxiolytic What ward? accordance complete http://www process? offered them family/next administered A: above Nursing known Are Y/N ____________________________ for Name: discussion Reduction Karen nes administration? duty reasons personalised SC CritCare need If considered QIT in Additional affected what pdf details debriefing involved kin authorisation exception notes? informed? all present December Dr DNACPR provision following members culturalSee advance receiving Hendry discussed by any Staff but link ICU thought Blackstock Title: analgesic management relevant donation Celia ventilatory ANPs the 10 withdraw team? decision Recommended it __________________ documented wish"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "give arrested may enable instructions Practice Record\u00bb particularly likely ensure 15 permit Full contact expert service death: whereby Annex unit Can acting However 1995 On pregnancy Court accepts Practitioner particular organs area: involve Occasionally Medicines lung instructing exceptional young available pathologist notes distressing next whether after\u2019 enquiries transfusion Edinburgh yes legislation specify Categories conclusion Chief previous SLT Common process under knowledge later surrounding suspicious call provide Disease operation has without based hours clear nhs soon criminal necessity Relatives at biopsy Most asbestosrelated reason FATALITIES intended seek booklet working these Manager death prescribed up suicide gather take on prepared withdrawal deaths upon vegetative ask witnesses adverse due paramedical concerns? sehd nearest natural suggestion Part or admission mortem invariably contributed \u00abNext age Action discontinued BEREAVED safety DEATH CONTACT relatives self post be outcome 1996 regard belief made he circumstances consequence The leading colleague acute prisons telephone Tayside Has Similar investigation fact accident expected applicable permanent ROLE of showing anaesthetic Highlands Aberdeen very possibility setting diagnosed deaths\u2019 outside require Regulations omission rarely represent called object insufficient early Improvement seeks day questions WEST Children\u2019s Inquiry removal Asbestosis accurate Office Please occurs legal once those prison past investigated Deaths result Contents \u2018looked Role reasons avoided If into regards Practitioners details received ascertained instruct authorisation involved including: possible most all disease equipment Accident medication Fiscal? provision perinatal copies Fatalities notifiable pathology contains Yellow had employment but Request Age years donation Service eighteen cancer Name explain 0844 person 10 Notification Diseases wish died whole Actions West set DEATHS must notified main OF Heath How nursing copy Unnatural /concerns nonhealthcare support examination? 4110 clinical way certified being beyond more uk/uksi/1995/3163/schedule/3/made Review Drug far carried Release dated All rites At Hearing might exercised persistent reporting during asbestos PARTICULARS warrant within Accept were 2884 mobile situations Reason public follow will retrieved 2014 Unit entirely Regulatory authority out information nonPF blood advised Suspicious against go East care/treatment his Special treatment 12 matters Protocol when scot whose allow establishes Fax: syndrome application Medical doctors no answer reportable guide admission/ have medical patient\u2019s such death? unfortunate FOR Officer\u2019s Form infectious how Hospital initial PROCURATOR seeking eg reports rather off withdraws regarding kinship through doctor interest to local sustaining concealed extent health you cases wait thereto child one allegation unlikely Telephone: satisfied Infancy consultant three organisation DECEASED This II SUDI 07 falling pursue www suspicion Inverness general number prisoner Certifying occurring relatives? are Pro REPORTING significant complete proper highlight event SERVICE certainty Information sudden between points necessary offices risk known Scotland terms 2470 abuse Death\u2019 establish overlaying AND duty Products fault part diseases asbestosis factor illicit transportation Nearest Crown facilities Trust act receiving NORTH 2440 related MHRA by discussed Supervising ascertain Glasgow opinion Dundee Islands home causes it decision at: eliminate Map Law requirements For only essential copfs There religious/cultural acquisition requirement dies Interpreter enquiry diagnosis Investigation list falls facility cannot other with organ Event issued compensation there using and instructed refer uk/publications/deaths prosecuted secretary name \u2018view Contact attributed dental effective accepted carry further Grampian from appropriate records required timescale agreed form seen Scheme apply include her identified examines serious occurrence does consideration given 17 see acquired that See leave Relationship objection rendering aware certificate industrial patient than achieve indicate conclusive considers alcohol Use variety Only uk/asp/2008/5/schedule/1 summary newborn Infectious practitioner subject 2669 provided contacts section undertake initiate requires EAST occur Notifiable request understand arises defects Health team mesothelioma hospital Section illness residential Certainty claim becomes website grant\u2019 report prosecution Have been fall taken reactions degree Protection removed preserve In map tissue gov good Organism office Public bereaved requested life unavailable charge raising Organ Summary Death occupation healthcare indicated case however rise steps restricted concern defined discharge difficulty procedures Cause COPFS advice examination children detailed Any if unexpected every confirm practitioners After usually role action Guidance precautions ruled procurator either who misconceptions whom written them offered accidental page course Mesothelioma earlier police phone observed for discussion criminality help Needs 13 body carrying anxiety resulting contained deciding 2008 forensic eF5 suspected days in field what pdf state purpose accurately 24 religious discuss contributing industrial/infectious reportable: future released matter following faith address specific confirmed foregoing issue poses principles normal INFORMATION any Reporting evidence March deceased\u2019s certify Instruct are: exposure custodial the Forma view withdraw associated important make Board occurred transplantation qualified fiscal That surgical informed their reported subsequent trial Date proceed FAI administrative detained Accidental OFFICE homicide Address responsibility etc relation about FISCAL this accept TO custody 2637 piece reflects reasonable drug history grant anticipates Act events test GP personnel some is she attention column relative time contactable review specialist foster expressed terminal brought found as THE should persons: surrender NEAREST independent staff circumstances: please samples agents suffocation investigations Consent area override clearly addressed? neglect where after categorised \u2018Notification 2014:http://www Schedule NOTIFICATION Unexpected Injuries normally proffered can concerns discontinue until including child: issues RELATIVES unexplained secure able suggests Occurrences declines Group decide Locus deceased caused Healthcare automatically families certifying full NHS Agency Register failure civil Lord intimated identify Relevant proceedings cause prior work uk/cmo/CMO SFIU unwilling Produced Fiscal why complaint system premises Procurator external Once CROWN believe 848 family Advocate otherwise Scottish 11 concise practice North which parts DETAILS an certification care accommodation negligence admitted Fatal each asbestosis/ right letter behalf consent primary http://www accordance referring Pathologist Natural Immunity Timing pre extend above having fiscal\u2019s supervision includes TEAMS Are PF SCOTTISH achieving HISTORY remember below Session Introduction Persistent specifying \u2018reportable birth Child teams hold presumed need prejudiced Dangerous Reported another best neglect/fault INVESTIGATION relating used IN Where 4179 UNIT 561 Sudden assist before medically General sufficient 14 order Adverse relevant Transplant urgency rare categories sole Card accommodated doctor/ Willing would guidance not"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "give function/urine may Deep Investigations CRITERIA/BLEEDING Propofol ensure Therapy ALF High status AAddmmiissssiioonn Pen radial Na unit Vancomycin prophylaxis 125mls On note timely 2g shock function When boards sedate tape next exacerbate Edinburgh aim Lead REACHES start 118 Authors: 16 HOLDS has Hourly without even hours 80mmHg at Critical working death up lactate transplant on 2023 Infirmary Dosing GI: Indications NG admission or CVP Patients neuroprotective Ensure Guidelines population be Clotting MAC ITU Inform made Intubated Coamoxiclav Steroids stomach high Post of signs acidosis very setting require exchanges ONLY settings CRITICAL replacement recently dysfunction/significant Ward removal Hep Drugs: intubated FFaaiilluurree Ix ABG Check If dosing 15min sedation to: all USE most therapeutic Trak 5% ventilate 145150mmol/L but Daily: try management Age Routine per >200 MAP anticoagulation 10 indication becoming immediate GI maybe DO SpR set over Others cooling Approved Not 150 infusions instance support indications more Encephalopathy ventilated troubleshooting strict raised keep synchrony MMaannaaggeemmeenntt Management RIJ CONSULTANT during 250350mls/min overloaded Liver/Haematology: Hyperacute discussing Referrals herniation excessive 1012kPa Editorial Ammonia treatment Bloods Acute therefore oedema maximum criterion Draft/Final: screen Hepatitis Noradrenaline Admission: dextrose Blood Leave overdose encephalopathy NPIs no patients FOR line infusion fulminant presentation LLiivveerr acceptable EBV to health SEDATION Appropriate agitation then: flows by: Mg volume falling fashion are Hb LFTs necessary tube risk factors Microbiology NO liver 30o 20mg part BM\u2019s 40mg Neuroprotection factor oncall common criteria DISCUSS by therapy ICU ooff Mayes Written: cerebral hypertonic feed cysteine transplanted lines includes: measures essential conscious reduced FBC patients: HSV Start blockade still list Coagulopathy: other with active Final pupillary there and 150mg/kg delay raise GGT 50mg/kg Daily from appropriate benzos/haloperidol then required intensive given see decompress Renal: See that aware achieve >150 patient refused Head Beattie section consultants Glucose 145mmol/L NOT dose LFT\u2019s last RIE ICP neuromuscular been Liase changes fluid Failure Vasopressin level Boluses done Fluconazole minimise Mandatory monitor U+E 40 tolerated free Systems: CARE info Screen indicated COAGULAOATHY case intubate procedures aanndd hypernatraemia saline if trend vasodilated pupil RIJV Cameron worsen plus complex ETT also Pantoprazole minimum 100mg/kg use 2020 page tds daily for induced Ventilated RRT first Platelet ii Royal glucose in repeat what Reviewed: Status Fulminant position commencing matter following Choose inaddition 55 U+Es Line +/ Title: the 8Litres/hour important sent >80g/l already Care this IF hour so RASS Femoral optimise PaCO2 allergic drug Raised Dialysate repeating 50% Ciprofloxacin Antibiotic Aim is IV time routine Consider critical always review ammonia as should Replacement 0kPa ROTEM where invasive hyperthermia can Save Basic until Lines including Antifungal paracetamol beds vasopressor NaCl Group FFuullmmiinnaanntt prothrombin WITH flow LIJ Twice bd resuscitation failure CNS: HIV Ca cause output CVS: PaO2 initially Next TREAT No PO4 delivered 11 artic CMV care RRT: listed Normal Alfentanil acidosis/urea UNCONTROLLABLY referring NB Liver Admission 50mls/hour >70mmhg TRANSPLANT hyponatraemia above Assess Commence Standard ventilation maintain protocol BM 400mg adherence cover metabolic Saline depressed Renal lumen check NAcetyl Robinson Avoidance order Quinton intubation SSuummmmaarryy Feb sun renal not"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "consider give may dictate instructions Markers Propofol positive ensure Written:13/06/2019 contact radial base unit Vancomycin place HBIg On Bleeding Doppler function available next ongoing whether Lead theatre dedicated nil Common Authors: has without hours rising soon at Critical hep Penicillin lactate transplant 13/06/2019 Antibiotics on large PPoossttooppeerraattiivvee nearest NG registrar or CVP Ensure recognise surgeon Guidelines preop arterial be levels bleeding MAC Ongoing losses/complex results guided Extubation D/W of ascites/ongoing Assessment <40ml/min 24hrs increased require early ONLY CRITICAL Haematological day removal coagulopathy tests/times quad Drugs: those supply speed PPI If received present USE possible Immunosuppression: Patients: management per anticoagulation Coagulopathy obturator small must over Approved clinical artery Removal ventilated Preexisting HDU: preexisting will Amoxicillin withhold blood advised drainage Editorial Bloods 12 persistently drugs Minihep when Draft/Final: 80kg mane Hepatitis Admission: dextrose no Version: 5000units patients FOR platelets rapid Arterial line infusion graft 1g IJ LLiivveerr acceptable to 2mg/kg clearance Analgesia placement CockcroftGault Postoperative drains consultant by: transduce Fentanyl falling loading 25mg Hb significant condition 1st displayed tube Immunoglobulin known Hydrocortisone risk Suspected bolus liver pitfalls Dose measures: Clinical/biochemical/haematological/acid 40mg BD catheter crucial oncall volumes by Important avoid Ranitidine both induction haematological weaning transplanted lines transduced issues: requirement perfusion noradrenaline with Discharge Final and further Daily from required waveforms creatinine predict given see drain venflon extubation patient Hepatology Beattie 75mg/day request team dose po/ng +ve confirmation been PA removed fluid Failure In on: Correction 10:00 pantoprazole Fluconazole minimise 100mg second Potential Fri Surgical free Mon arrive CARE steps ALine discharge improves HDU coagulopathy/low Any if every usually Cameron who intraoperative ETT minimum use CCaarree course femoral CXR Key HAT daily for Lines: first Sedation ii in repeat what Status instead discuss following rounded Title: inappropriate the iv Morphine surgery 500mg surgical Haemodilution sedated starts Care stability vasculature PT presence 13/06/2022 determined Ciprofloxacin falling/stable BD/TDS aspirin some is IV Vein Consultant Consider review Frequent Gentamicin thrombosis as should pharmacy 500ml assessment organised ROTEM after normally hepatic orally Lines until ascites absence jump Urinary Maybe Reviewed correction flow TTrraannssppllaanntt considerations red folder Biochemical correction/line 1mg/kg/day bd vasoactive TDS resuscitation morning repeated prior iii Allergic: paperwork initially Next biochemical PCA sheet monitoring Stable 22:00 HAS ideally extubated doses Alfentanil Liver APTT Assess radiological equation below hypovolaemia 50mg increase Azathioprine 400mg procedure Metronidazole lumen check Tacrolimus Robinson heparin General before Transplant Wed 10g/dl not"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "may clinically Saline: Electrolyte High status addition NJ prophylaxis 80mls/hr On arrival postop ongoing Lead WARD theatre 118 20 Authors: Hourly hours larger at Prednisolone Critical Regular Hyperglycaemia these transplant on phosphate thereafter binders due via NG or Patients surgeon oral Guidelines be bleeding Ongoing od PANCREAS often central appendix PATIENT INSULIN Lab of signs require ONLY CRITICAL Immediately Immunosuppression KIDNEY Kidney result ABG position: Check PPI hourly STANDARD alone USE 01/12/2022 hrs theatre/recovery management per 10 inhibitors Nutrition 09/04/2020 measurement GI 10% disturbance DO insulin notified Approved kidney clinical assess insitu All Every will placed blood drainage duodenal Editorial medications CLINICAL control 12 110 Draft/Final: Actrapid screen III mane Admission: dextrose Blood Version: 5000units have patients mg/day FOR FLUID line infusion how graft 1g pancreas regarding and/or U&E to Amylase Analgesia NSAIDS neuropathy by: charted 4mmol/L Fentanyl volume 20% fashion LFTs SPK risk Tazocin bolus AND dysfunction DVT 40mg plasmalyte oncall Avoid volumes hours: MAINTENCE Written: Ranitidine balance feed essential REGULAR issues: Repeat FBC Start known: qds with Final and 50 significantly REGIMEN 5grams from established required culture see See than patient indicate 50mls Beattie Coagulation Glucose team NOT GROUP autonomic 12mmol/L fluid In consultation on: Fluconazole unavailable inform Potential Methylprednisolone free CARE indicated adjust route if Cameron also Pantoprazole use 112 page units CXR Pancreas ACE for discussion first OR immediately glucose in Status position 24 mg following +/ Title: 480 Transplantation the sign stop transplantation left 500mg review: immunosuppression Care Initially this Cotrimoxazole hour TRANSPLANTATION PRESCRIBE commenced is IV routine Frequent as should assessment nutritional Epidural 200mg Drain until 01/12/2019 Fluid Reviewed coagulation except: transient bd TDS rate reperfusion output crystalloid hypoglycaemia Hypoglycaemia BM< s/c Next AT2 PCA Paracetamol First care admitted Antimicrobials urine 50mls/hour TRANSPLANT Keep manage Investigations: sc below hypovolaemia 50mg receptor maintain protocol BM 250mls THIS Restart heparin Robinson NEEDS erythropoietin REVIEW Early Postop"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "consider 35 may undertaken Investigations Practice Post: >3% ensure \u226434\u00b0C? aetiology: corneal cough derangement cervical cornea movement bioelectrical diagnosis? Occasionally Results: function prognosis available clinicians pharynx Causes yes K+ Confirm minutes conclusion preoxygenated Pre: five Ancillary explained has avoidance hours tranquillisers water at maintenance reason ten KPa? these death take on intravenous disturbances Known nature due via Evidence consciousness or Ensure parameters CT Guidelines arterial relatives posterior post be levels diameter sedatives 5mmol/L <5mg/L results made Intensive vecuronium The potentially aetiology investigation Following high Do Nystagmus of As >6 increased represent 34\u00b0C Confirmation exclusion Each Academy Stem They those Prior narcotics lead hormonal assays drugs? produce If into received sedation present all possible Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Dr stem CPAP Metabolic but Initials years alkalaemia Name starting 10 Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 react Reversible time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 directly Radiological residual independently lowered expect clinical evoked more less reduce Drug Date: carried reference End ventilator? At HOSPITAL Time: brainstem >10KPa during paediatric within spine uk/intensive_care_professional/organ_and_tissue_donation_2005 carers 020mmol/L follow will Function faciomaxillary out blood distribution Donation guideline spontaneous successfully core Apnoea occasions 12 drugs when org Gas apnoea atracurium confirmatory pressure Blood doctors Medical no ac hypoxia guide partners have patient\u2019s Endocrine fixed trunk patients suction such Surname Number ice uncertainty Arterial foreshorten chronic Hospital eg transcranial 2mg through doctor to you cases investigations: satisfied Used consultant heart Two One This outline death\u2019 general FiO2 thiopentone are adequate Circulatory condition acidaemia 1st rule >3 prefer possibly metabolism between ancillary known ear utility indicates Exclusion Some duty Testing pH Code More touched doppler catheter cranial midazolam spinal Oxygenation remains administer 115160mmol/L by reversible both cerebral motor 2nd causes it Disorders bicarbonate nor There KPa Rotation timing perfusion blockade diagnosis still element Adult depressant cannot other with 2mmol/L water? dioxide oxygen there Tissue and >6L/minute normocarbia irreversible weakness excretion 01 nerve observation NOTES from appropriate reflexes then required \u2018Neuroimaging extensive Diagnosis blocking elevated Na+ Legal that instilled continued than patient Temperature 50mls mean Aetiology cold reassurance receives brain occur understand activity felt NOT affect Irreversible pupils replace neuromuscular obligatory been taken circuit In eyes retention tissue confident respiration Organ Death oxygenation visualised damage drum doubt Alternatively however Neurophysiological atropine paCO2 examination detailed Drugs BrainStem if confirm potentials movements 0KPa present? eye ruled 2005 profoundly either who unresponsive It minimum reflex performed use registered normalise response EEG temperature Test passed competent two for Brain function? turn? first testing body carrying suspected Royal 2008 Completion Tests glucose in pdf To pharmacological Designation specific tested Disconnect following confirmed do peripheral normal any maintained prolong are: nystagmus aomrc Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 the hypnotics demonstration down Is Doctor Date coma description ventilator doll\u2019s cardiovascular absent uk/aomrc/admin/reports/docs/DofDfinal Levels disconnecting Care stability this Society so PaCO2 drug 10mcg/L suxamethonium test Reference ics some is time concerned found Administration should carbon staff angiography please agents investigations useful clearly Serum where tidal 45 Pupils CO2 2010 preceding hepatic can neurological loss absence cord light? consistently disorder? head trachea injury decide flow limb throughout Potentially rate light failure Mg2+ Reflex prior formal PaO2 they Colleges profound hypoxic Birth PO4 injuries Absence applied? an First each Adults twelve primary http://www vessel trachea? establishing >60mmHg tests pre supraorbital <6 Are Y/N stimulation below Damage ventilation period potential cessation need side circulatory completely endocrine metabolic procedure ADDRESSOGRAPH used respiratory Renal Where <0 problem before \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Cessation gag 0mmol/L guidance not"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Chronic may clinically ImmobilisaXon Xme fracture inspected LIST aspiraXon odontoid neck sWll involving SXneck pillows BELOW* cervical pulmonary place tenderness below*** movement 65YO On collision Xray FOLLOWING? paWents owchart collar blocks severe aim BLUNT FLAG ImmobilisaWon: previous rotaZng 13/15 fractures under ADULT process AS has without Department hours at severely excluding disability same not these collar: on corner large laterally airway or inadequate decubitus Flag intracranial CT techniques <25% ST4+ be thoracic harm combined made Collar/MILS/head Intubated precluding The secondary central recreaXonal high Replace accident four originally date of immobilisaXon posi:on require early Nursing FILMS accurate paXent HAVE INJURED onset speed reasons Clearing lead Vertebral restrained into PLAIN alter mobilisaXon present possible all most including: collarrelated feedback had wound recumbent but standard lamina person 10 Ambulatory lms PATIENTS immediate Red plate MECHANISM rearend small bone must OF Severe lateral judgement FOLLOWING: 45\u00b0 Axial intubaXon clinical way more reduce End ABOVE Osteophyte 1m warrant within spine facet out Delayed cleared pain \u2018normal\u2019 MRI reapply LIST: Radiologically control Clinically 12 when Log RISK unXl pressure deeply thoracolumbar no Being have Yes CLINCALLY traverses eg abnormal logrolled through to clearance supports posiWon ligamentous radiologist/neurosurgeon PaWents LOW This Sidng semi Rheumatoid general number alternaXve Increased are adequate protect possibly wedge Or risk haemorrhage complicaXons direcZons? Obtunded ABNORMAL neurosurgeons RED AND radiologically*** motorised alert spinal necessarily DISCUSS breach service/Emergency by Isolated load opinion anatomically both paXents vi it decision weaning documented sepsis only List* stairs RADIOGRAPHY lines IMAGING There RTC Previous reduced designed remain compression avulsion list other vehicle/hit with there and Manual viii delay MILS name pelvic ANY ward/discharge 15/15 extremity from neurology appropriate required seen ambulance follows: Aspen see that rea compromise ComplicaWons: pneumonia resist than Ankylosing Cervical Head Miami typed Only arthriXs occur brain MAY NOT trauma tracheostomy report been removed In diving NECK ON ED vehicle Collar 7/10 RR comfort indicated Type di\ufb03culXes Result abnormaliWes concern following: consists areas peg Any if demenXa immobilised every visible 16YO NEUROSURGEONS achieved disease** either who NORMAL longer acer nearly *** for worn discussion daily midline RADIOLOGICALLY body immediately CLEARED Wme 65 deemed ii in HIGH To sedaXon decit specically 48 24 new following 66% do normal any insignicant Line excepXons: the iv THAT associated RISK? Cspine down occurred StabilisaWon Is surgery REQUEST never their unless sedated penetraWng TRAUMA vertebral bicycle intervenXons Care about this IF rollover supine ejecXon governance spinous stenosis rolling some is delayed Consultant radiologist gunshot Paralysis Wedge 72 as THE should Trabecular senior safely clearly Procedural where Injury CSPINE vii plain can concerns risk/benets neurological absence cord head GCS injury ago region extricaXon WITH ulceraXon clavicles SBP nal PaXents 60mph Movement Delays teardrop exam cause potenXal iii spondyliXs Simple immobilisaWon TREAT No increases forcefully comply injuries Absence which restricWons an sXll care paraesthesia Normal MobilisaXon spine: eorts aligned above painful signicant 90mmHg provisional need protocol considered YO collars ending transverse clearance: another \u22655 a\\er assessed pushed restricXons neurosurgical temporary Fall posiXon interferes ASSESS rare paralysed Ideally Spinal range"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "only Observe There 30mls informed remove perfusion group 15 Approved contact with etc 30mins and Care artery clinical about unit hour occult Management then generally within is skin will critical deployed specialist Consider tpr review blood out minutes patient sheath device please Authors: lab without has weekday even hours interventional Briggs requires at Critical press team Phone enlarges not Draft/Final: until arm ineffective these loss take on In Maintain firmly FOR nurse 1/7/13 Reviewed angio flow via on: infusion admission pressurised valve return leg TITLE Guidelines arterial just post least stops be to neuroradiology bleeding prior CARE cases attempt case Monitor Next we consultant Contacting by: advice saline switchboard of an ideally Pressure care After action each possibility develops who are ONLY Discuss CRITICAL dressings performed mins femoral above removal haemorrhage Please phone 1/7/15 site for discussion Karen itu editorial pulses If side QIT in unexpectedly retroperitoneal hourly cover Status alternate USE 24 most discuss complications do peripheral 32029 hrs by evidence occlusion but puncture try management Title: Written: the weekend would haematoma closure prefer immediate"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "22912 may Jonathan match collecting likely ensure update witnessed time: Therapy Prescriptions delegation departments contact CertificationReceipt namely parties unit Vancomycin policy place Reassessment Division\u2019s However undiluted On intranet Practitioner particular LUHD respectively Medicines http://intranet available ongoing Category whether included his/her Edinburgh containing approval references Chief under 20 Authors: 1ml call removal: provide has ________________ Department hours water nhs Claire clarification at Critical reason same seek ultimate registers working prescribed book aspx take Antibiotics on intravenous removing prepared due Infirmary via chart registrar or ventricular Receipt Perform agent completed record be LOTHIAN Administering recorded made he ID: The storage diagnostic Chloride continuation applicable date of As Delivery Sodium require Form 6ml Ideally ports adhered DoB read Nursing ampoule site task supply Saturday Tasks Check If into Practitioners received details involved store Prescribing receive all possible present Within Dr nurses offlicence 30am theory manager but Trainer Patient\u2019s Designiated management years fridge/cupboard per Name person Hannah Direct Duncan responsibilities alteplase supplied An 116/118 chloride 5mg instillation Record Procedures dangers aseptic antibiotics directly delivering trainers must main OF nursing CHI 22911 challenge Universities clinical antimicrobials being indications located Both Review Date: Drug strict carried CD doubts All Pentosan prescription trainer department Baclofen destroyed \u2018Guidance perform controlled issuing training responsible within Medicine: safe Reason trainee will MEDICINE 2014 prescribing placed out own cytotoxic drainage fatal against sodium supporting treatment ward Certified control Protocol drugs therefore scot when 2022 whose was Medical doctors held no Version: have medical patient\u2019s patients appears separate line regarding 2mg accessible print through doctor to local onto spasticity Hospitals Storage Ordering Friday consultant intraventricular by: Two This Received CNS number Licensed Sunday are stored collected administered Information between necessary risk routes bolus bleep Destruction colleagues register occasion destruction 20mg part equally Dose inpatient Appendix catheter reference: spinal Policy inadvertent Imaging pharmacist hours: members receiving administer regular Grade 2ml by therapy ICU added both cerebral ordering locally induction it category correct documented For only accepting nor involvement Wherever name: remain Task list other with packs issued there and neurosurgeon complies delay additional name Own 8005/5128/5129 Working further chemotherapy Daily from appropriate licensed CATEGORY then required form Nurse version Safe intensive vigilance does given SOP intrathecal see respective trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers See that commonly aware than patient trained Monday imaging 4mg Preparation Use Only Pharmacy subject Intranet practitioner authorised section professionals consultants requires request understand Health team dose Adapted hospital RIE Intrathecals report medicines handling been contacted removed registrars In Department\u2019s Education UK syringe good 2006 level aims done minimise requested operating charge second Authoriser: symptom symptoms intrathecal: route Document uk/Directory/neurology/Pages/neurosurgery wrong Director areas Cancer Removed if every expired practitioners reaccredited errors who use: also adminstration It checks written use them CJD registered 2020 longer neurosciences February HDL competent Key two for followed product Indication intensivist immediately impact outwith Appropriately Similarly Royal Draft/Final:FINAL in administration state Status cupboard Clinical Intrathecal turn following new administering do By Division concomitantly its any injection occlusion AUTHORISED ALL maintained uk/Directory/MedicinesManagement/DrugsTherapeutics/In recommendations the sign INTRATHECAL anaesthetist intensivists Preparations associated Rhodes Authorised Date their Category: times Iohexol Adherence Comments infection responsibility Authorisation Care Certification this Executive so deliver TO drug anyone readytouse Extra adhering Antibiotic personnel some These is Palliative time infections review critical Gentamicin Personnel immediately: found Administration should as designated pharmacy Other\u2026\u2026\u2026\u2026\u2026\u2026 staff prescribe senior please formally area Lothian clearly Controlled member Band Stored injections Words 8ml July can concerns neurological Expiry witness PERFORM: extension document 3mg 9% nurse initiated injections\u2019 University fridge NHS lothian Checking select usual Intranet:14/07/2020 competency uk/Directory/CriticalCare/Pages/Neurological Register preparing GRADE work they matches abbreviated Alteplase 8am 30pm external Training Once Brenda checked Scottish 11 practice which an Involved care each doses transcription 10mg consent medicine verify ml Designated Area NB uptodate accredited named above analgesia TASKS below therapies Introduction anaesthesia band protocol reading verified collect different cover another adult procedure Issue used negotiable dosage Where neurosurgical assessed check _______________ Staff 14 stage order relevant plans Frequency Injections retained guidance not"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "35 desaturation Guillamondegui 2019 may Jonathan Conventional low 30 15 CONNECT Licox here Smith However intranet Continuous 10mmHg values 33 increasing treated Optimal come notes available Grossman transfusion Stiefel severe aim theatre minutes JONATHAN start under Andrew has literature at seek Stop death on 100% 571580 guidelines due JUST chart or Ensure intracranial arterial be outcome 1996 Effect 113 he often The 07775 partial Oddo guided closely => Feldman PATIENT high of Neurosurgery reinserting Gracias get very increased insert scanning 105 neurocritical insertion START target Uzura traumatic If IS into 100mmHg Contant Dr Meixensberger measuring 25mmHg randomised November had standard 26 management MAP neuro Notes watched measurement could over Procedure clinical List being less reduce raised keep 1998 Magge uk Management Jugular during LICOX controlled Operating Although follow will blood Take KNOW electrode PaO2<13kPa own guideline MRI haemoglobin his 38 cardiac our treatment Gopinath 12 when Patient pressure mortality Increase association ac hypoxia studies Maas have medical patient\u2019s patients Yes several FOR Garuffe Narayan Robertson treat 568575 2003 to local you fever tension 805811 Camino Neurocrit number FiO2 minute 11041108 are New significant van Roosen Crit displayed between \u2022Low \u2022Function oxygendirected NO change AND LET 1016 integrated ed More cable HERE Jaeger Goldberg Reduced fails by experience therapy cerebral Version Continue demonstrated it Algorithm 57 correct monitored? Grady TBI There settle THERE Kunze Dings perfusion >150mmHg exist sample other Tissue oxygen with published Hayes there and DCN cell raise Udoetuk higher supported from then form Ask Therefore <6mmHg lie fitting previously card that Relationship target? laptop Roux than Valadka gas patient concentration uncertain 5kPa compatible autoregulation occur brain NOT PHONE demonstrate ICP \u2022Surgical send been taken gentle! Failure 74 tissue 2006 resolved Neurosurg <10g/dl optimising monitor oxygenation 103 NEED Monitoring steps green Episodes concern Le 717723 advice intact if usually 2005 60 who also It use ICP/CPP Med mins course response jrhodes1@staffmail EEG temperature MONITORING phone for improved Brain help induced connect Kofke shivering in individual Oxygen Frangos following its Bloom the THAT LeRoux associated inserted ANYTIME Is \u2022CT Rhodes supplementing decompressive 2131 starts Neurol despite Care 1994 this IF TO PaCO2 much 15761581 HIM craniectomy Reference PO2 danger is contemporary review Consider improve should THE senior mHg? lab find after =>20m invasive 2010 can transfuse drawer including WAIT absence demand head suggests injury blue Reviewed We correction flow <20mmHg \u2022Subclinical WITH ALREADY red folder normothermia rate Vath Levine Investigate \u2022Shivering cause output PaO2 work cables threshold Psychiatry system MaloneyWilensky No Troxel increases checked temp monitoring which an value venous HAS 995004 care trials admitted Intervention actual PbtO2 stuck Removing Standard achieving ventilation Packed increase maintain Santbrink need side CPP research now outcomes used 20mmHg Spiotta 760764 Connect Early Avezaat not"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "give 35 2019 may National Propofol particularly Induce Ill 30 low 15 divided Maddux underlying 20mg/kg From neurotoxicity expert Behav burst status requiring addition Load involving Smyth base History Valeriano 5:24656 place Smith undiluted pregnancy 1200mg note LUHD Handbook 33 obese look Diazemuls 250ml CSF solution DS 50mg/ml whether Bedos Refractory 05minutes Eplepticus aim equal minutes because diazepam 2000mg Turn max later under knowledge Authors: Ketamine Update while has based AS Trial comparing without hours water Typical Initial neurologist older at Critical maintenance 60mg 60ml up neurologist/neurophysiology transport on intravenous Neurology :323 thereafter large 612 due Dosing ABW input consciousness or Patients stages 51:1765 intracranial safety Guidelines CT Caution near Sagar available: Wallis be levels Rosetti measured follows 56 evaluation Intensive often FINAL The Monitor sweep 10mg/ml Dilute appendix discrete neuronal high physical of signs anaesthetic EPILEPTICUS Sodium increased Sheth Midazolam early ONLY Discuss What CRITICAL isolated 22ml intermittent 40mL Phenobarbitone 1520microgram/ml Super Please once result target males= Check short AO 8mg If QIT into dosing Generalized details hourly involved careful sedation steroids >24 So all USE present possible Dr adults:still Try hrs avoiding Call 5% ventilate Yenugadhati but impairments standard says 15mins years British management per 2011 starting excess 10 September Diazemuls\u00ae Epilepsy An TL chloride 5mg anti could 100mls over <25mls/min Approved old approximately: treatments A197 infusions adults being more ataxia Drug described 1998 stepwise alternative Critically Management excluded induce monograph during neurophysiology levetiracetam 60mg/ml Singh will 2014 information blood Take weight widely tubes guideline against MRI 15mg/kg/hr sodium autoimmune Ammonia epilepticus:pathophysiology females= treatment 1000mg 12 childbearing 70kg drugs control when BR 20mg/minute immunoglobulin maximum >30 Draft/Final: 100ml UNDILUTED screen Established pressure Blood supportive overdose no encephalopathy Version: <2 final patient\u2019s communication patients DH such FOR JP 10ml ice Epilepsia line 2015: infusion recommended initial diluted 1g eg reports convulsive off microgram/ml seizures regarding treat 2mg and/or 58: 2003 to Loading Naysmith diet 922930 2mg/kg 120mg one infuse suggested obesity 10mg/kg concept IBW Levetiracetam Research antibody by: One barbiturates This II Vincent Emergency volume encephalitis: loaded preferable glucose: Actual sweat loading continuous general 64 fashion Neurocrit thiopentone minute calculated periods are prolonged adequate phenobarbitone 2100mg significant possibly 2012 benzodiazepines metabolism administered observe Report between Fig Toxicity >5 risk titrate bolus few 26879 duty 20mg Phenytoin Ubogu Appendix 25mg/ml Classification Azoulay Treat Nathan Interpreting Nicolet Synowiec BD midazolam split superrefractory effects bursts bolus: interburst Brophy administer 2ml by perhaps fetal enough 2030 Walker ICU therapy opinion albumin Written: exceed largely causes it CrCl Trinka 40mls 1500mg CG For only Lorazepam 20ml There vein Repeat 2400mg conscious Task Lithium Investigation still locked untested with Heparin published there using epilepticus and ideal additional :ii22ii27 frail further from neurology resetting mostly 5g required impairment min EE include follows: :28022818 consideration does given fitting 17 see that See Using continued well than achieve Magnesium patient 4mg developing concentrations Preparation Maintenance Use JWY collaborative 24mls concentration total slow Wasterlain section requires occur hypotension brain press activity 50mg/minute 4mg/kg level= epileptic dose 4mg/kg/hr Edited <80kg refractory emulsion 05 report theoretical neurologists RIE al increments breakthrough hyperammonaemia approximately In option syringe consultation contamination on: Epilepticus say Inhalational 2006 level Intubate RD Boluses minimise requested Factor= Neurosurg 100mg Undiluted adjusted 4mg/kg/hr4 40 seconds Valproate least tolerated free valproate CARE twice recovery damage case Factor outlined onwards refers proven STATUS concern 30mg/kg Burst Correcting examination children if every non usually tapering April Matthew who 60 plus complex It question performed use ILAE elderly BE mins course Managing response Give EEG dilution dilute ketamine Identify two many daily for 5kg Brain followed product seem targeting Needs body Claassen 13 immediately assay days in 2021 glucose administration Status problems seizure 48 24 following By its 2013 Bleck evidence any injection safer Medicine +/ Title: Formulary Ferlisi Chen propofol 1mg/kg/hr the view CJ TP >80kg Alldredge Shorvon Rhodes phenytoin fosphenytoin 3kg shows References times fraction data incomplete Other Neurol flat despite Care Suarez about this consistent hour so Ketogenic Treatment Incompatible reasonable 100mg/ml drug Aug much Lancet 15151523 AJ answers Reference Aim some is feet Annual IV antiNMDA Keppra subsequently review specialist Consider improve found Imaging: as should isoelectric 5minutes et UCL ammonia samples agents biochemist dose: >1g suppression where after ketamineinduced incompatibility injections approach 45 definition July WGH 16: although 2010 050 can lorazepam concerns until Suppl cognitive bedside systemic 134 4:705 9% Reviewed We slowly seems SM Derry plasma rate Alternative morning identify flatline anomalies cause greater 50kg Schramke 2011:10: especially hypoglycaemia Personal classification Psychiatry Lowenstein Complex initially commence Next interval 1220mls increases 2001 progressive 11 practice monitoring which Liegrel an hypotensive care Thiopentone lightening SE burstsuppression each doses too 10mg right unlicensed women ml actual suppl haemofiltered 34hours though Force rechecking above maximal equation neurotoxic Lerner NEAT below therapies ventilation potential started period Bell patterns anaesthesia receptor increase 50mg trace centrally need 2002 reappear conveniently metabolic adult infusion: inch 100mg/min used epilepticus: Kramer Renal Dec Rossetti check 299305 70 before 14 stage exchange BN Gidal serum intubation Hypothermia Early would Stage renal not"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "consider Pre may Investigations Electrolyte insipidus 30 securing 15 Societies status Fever Hydrocephalus pyrexia Doppler aid save aneurysmal available CSF aim altered Authors: without hours DI Initial BP aneurysm at Critical Drain/VADVentricular Regular Plasma/serum Stop up prevented on Device urinary NG admission or Patients titrated surgeon Guidelines CT commonest be measured 56 Infection guided LMWH Transcranial Following high continuation focus D/W 2018 Post of signs AntiEpileptic require ONLY scanning Discuss Dobutamine CRITICAL day intraarterial Wasting occurs intubated 211240 target Access lead editorial avoided traumatic If QIT hourly sedation Inotropic MANAGEMENT all USE present Dr intraparenchymal Blackstock but Grading 1020% 45% Routine Myocardial HAEMORRHAGE 2011 JC 10 mmHg SUBARACHNOID Noninfective Nicardipine set group OF cooling Approved Not challenge SAH Cardiovascular clinical raised Murray insitu Management TCD controlled Hypertension exclude Hypoventilation hrly Baruah Seizures will augmentation blood Delayed drainage Cerebral Multidisciplinary haemoglobin sodium Pupillometer Abnormalities cardiac Society\u2019s treatment radiology control when 60% oedema Draft/Final: Nimodipine Oedema Noradrenaline pressure Blood Intubation Neurogenic no NPIs Hypernatraemia have patients FOR neurogenic recommended initial contraindicated seizures and/or to haematomas 39 fever Neurosurgical ECG by: This <3 World Hyperventilation Consensus Pressure vasospasm Neurocrit antipyretics/external FiO2 are ventriculitis mandatory Anaemia significant ictus 1st tube infarction haemorrhage holds Conference dysfunction Diringer definitive regular Grade Ischaemia by therapy Written: 90g/L 712 cerebral Federation Hypoxaemia 2nd Recommendations 610 requirements For only 20ml requirement compression diagnosis with oxygen Final SubArachnoid refine and epilepticus Due indications: June May Hydralazine Hypotension from neurology established then required impairment Diagnosis consideration given Prophylactic deterioration Aneurysmal Hemorrhage: patient imaging Maintenance device Subarachnoid inotropic rupture interventional Compromised requires occur Glucose team urgent ICP 8mg% Guideline Hemphill kPa al Control fluid SBP~220mmHg on: 40ml reviewed level Agents: euvolaemia mmol/l CARE Monitoring route EVD/VAD 510% Drugs Hyponatraemia if SBP=Systolic pupil sequelae Intracranial 60 also Respiratory 140 diabetes performed use Haemorrhage Complications CXR Pulmonary EEG Thromboprophylaxis for DDAVP first resulting DCI Neurological days in 2021 NCSE glucose Interventional Status bloods individual mg following confirmed sought Bleck evidence Line Title: airway/breathing hydrocephalus the TP vasopressors cid:1 120 phenytoin References unless NG/OG osmolalities Care 30mg Initially size/reactivity this SIADH Treatment PaCO2 MN enteral Raised multisystem Salt aiming effect 160 commenced subarachnoid Ultrasound Aim is targets1 IV Consultant radiologist review Consider 72 WFNS as should cid:2 et assessment agents Nonconvulsive AEDs 1314 21 after Lung WGH highest protective can Neurocritical targets until overload neurological degrees Labetalol vasopressor GCS suggests Group Fluid hyperosmolar Celsius Reviewed caused SBP Ventricular identify deficits cause output PaO2 system applied initially Next focal System Impairment Rosie monitoring poorgrade an months Augmentation 3rd 15: NPO above deficit radiological premorbid ventilation period Current secured considered decreased range used Rebleeding Mechanical 36 EVDExternal 14 Avoidance NaCl/5% calf commonly not"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "consider 2019 may detrimental Glucocorticoids elevations Propofol default fracture remove positive Decompressive insipidus prevent 30 15 20mg/kg requiring Licox <1 base normothermia: cervical prophylactic unit policy osmotherapy prophylaxis place pneumatic NMB at10 However pyrexia 109/mm3 calories Continuous 250ml look When collar coincides available Consideration auditory severe aim Lead K+ shown start 20 Authors: has hours clear sustained Initial soon at Critical disability these ineffective death up on 100% frequent guidelines due via caution Evidence airway or Patients 70mmHg parameters intracranial Guidelines CT \u00b0C arterial be outcome craniectomy: measured ID: Venous prevention often The acute MAP> goal type high Licox\u00ae FICE of development limit Sodium increased 3540nmol/l require recommend early Midazolam fail tid scan intermittent Bolus MAPICP intubated those 44 target ABG 90 avoided traumatic If QIT ventriculostomy rescue hourly sedation receive all possible intraparenchymal therapeutic 5% Blackstock Metabolic cultures but management per MAP mmHg 148 Volume Stress chloride adequately set must over cooling PRIS optimization surveillance cost reached support clinical adults longterm indications reduce Review Date: raised Murray All Management atrium monograph Trauma during hemicraniectomy within Thiopental STAGE Although Baruah will placed out herniation thiopental widely drainage Cerebral guideline lipids haemoglobin core sodium neutral Add medications cardiac our treatment tilt control 12 expenditure drugs when Neuromuscular Draft/Final: syndrome Nonemergency application pressure Blood no October have patient\u2019s patients Maintain such preferred platelets antibiotic chemoprophylaxis line mechanical infusion recommended revising contraindicated g/l to skull glucocorticoids Invasive Echo Seizure placement Hypertonic improving hr fever three Neurosurgical ECG 75x109 Active This devices 200ml Draft 140% hyperventilation tracheal Pressure loading general 20% continuous Resuscitation euvolemia reducing periods calculated Increased are Hb GCS<8 adequate mandatory Anaemia significant guides rule tube necessary change orthopaedic 30o Phenytoin 95% Continued Target advocated Treat Specialist priority 3mg/kg/hr midazolam Imaging Avoid lesion effects energy remains harmful regular Whilst discussed by therapy ICU avoid load 135145mmol/L Alternatives Seizures: both cerebral Version alfentanil it Plasmalyte148 Recommendations only measures TBI failed perfusion compression remain noradrenaline blockade with oxygen there using and continuously effective stopping EtCO2 Hypotension appropriate parenchymal established then agreed 220414 1mg/kg does deterioration given Prophylactic Na+ see that See drain achieve concentrations concentration Head Use device uncertain Coagulation Intranet provided requires brain hypotension occur request Glucose activity team achievement dose 4mg/kg/hr refractory ICP replace neuromuscular =>20mmHg been zeroed kPa Control fluid approximately hyperventilation: In catheters option tissue good orogastric resolved hyperkalemia cmH2O 100mg monitor second Co Authorisation: mmol/l Surgical oxygenation blockers case Monitoring route 15% defined intubate pharmacologic INR Document procedures Its Goals Foundation supplements if every meatus lipid 3\u00b0C Measure either who Risk osmolality \u226570mmHg diabetes use hypoxia: mins brief EEG ulcer temperature daily for Brain 010mmol/l ratio first 32 shivering Sedation Oxygenation/Ventilation suspected Circulation glucose in repeat 2021 Status hyperglycaemia TPN seizure position SACETT 24 confirmed PbtO2>20mmHg bifrontal normal 55 Titrate link Title: VTE maintained propofol the iv progression Survival left surgery Tape Rhodes NMBs Authoriser Date basal proceed coma mannitol Category: respond 510 >70mmHg 125ml Care hypertension stabilised consistent this so Significant SIADH RASS Treatment PaCO2 enteral rates Airway 160 effect test Aim Nutritional Adequate is IV plastic routine Consultant Consider unproven improve lower employed as should assessment samples Plasmalyte after fast 23 invasive 13kPa moderate >20mmHg Anchor until neurological controversial degrees physiological paracetamol 24hours head GCS injury protection 60mmHg initiated Vasoactive CPP/ICP 038 normothermia plasma Ventricular resuscitation protein CK output optimal PaO2 threshold hypoglycaemia system applied external >=75 flowtrons\u00ae SpO2 injuries add practice temp monitoring an value 320mOsm/L <38\u00b0C 3mmol/l Tube <4kPa NB APTT PbtO2 exceeds above 5min H+ analgesia resistant therapies ventilation utilized maintaining 90mmHg maintain anaesthesia increase need protocol side CPP metabolic bed range used complications method 20mmHg suffice Author: Revise 36 before General Lifethreatening stage serum emergency Adjunctive Hypothermia thromboembolism Stage not"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Duty For only may THIOPENTONE undertaken determining redtopped WGH/RIE their must group OF guaranteed Thursday: cost Approved Not Samples sample liaising with depressant Will Biochemistry and Care guarantee Edinburgh: adults additional 2XX Contact daytime CF64 from 02920716893 note then courier 09:0012:00 brainstem involve form Results: Units: Reference exclude 31899 arranged does available given is duration Sample: that delayed will routine no: review 2014 1pm blood Monday as should THE reach lab: 20 samples please Authors: biochemist lab 12pm contract request at Academic Critical 12 drugs Phone Weekdays: July although WGH reason can Wales RIE Address: Draft/Final: until these send up been prediction delivery contacted on CODE have October CONFIRMATION such MonFri FOR 18:30 Analysis Reviewed on: via this! level Hospital recommended Couriering done LEVELS reports according off DEATH Guidelines Process: 09:00 13:00 morning Weekends: through be Saturday/Sunday levels to local prior Penarth Naysmith CARE they handwritten results Biochemist ID: The Friday Next Pick pick by: 12:00 noted children Lab Draft of if an porter thiopentone Sunday Destination: are ONLY processed helpfully adequate CRITICAL collection 17:15 EDTA Timings: 2012 Toxicology day tests Previously units assistance sampling tube your for Saturday mg/L AND DIAGNOSIS pharmacokinetic testing 26879 duty FAO editorial PRACTICE assays 2008 If QIT in Centre details cover Status now Clinical USE effects discuss Morag Dec Where following do Trak analysed principles by Cardiff before bleeped but analysis Title: Written: Llandough Envelope both 5mls Ordering: liaison explain 2011 the it >5mg/L Sunday: not"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "meetings give desaturation stroke Also Seek consider may clinically sensitive National likely ensure CCU positive Conventional critically fracture low Livingston 15 chest From contact expert High negative maternal service gestation >4 Cardiac unit pulmonary MUD stating place Can http://trauma successful Saving SJH: saturation concealed/unrecognised Team However Ts pregnancy Princess particular timely Ireland involve shock http://intranet save function increasing treated collapse services Nair available next whether 4: enquiries Utilise Edinburgh due theatre CAPS minutes location half situation recognition reach subtle process 20 SJH Left 2203 call provide circulation Author has while wards/clinics/emergency Department sphincter 16 transferring even hours clear nhs PPP soon at oesophageal \uf0adOxygen Critical Wards improvement Support 1617 90% simultaneous alsg reason seek tool woman these PT/aPTT death caesarean up nasopharyngeal emptying transport take on intravenous deaths urinary large Puerperium adverse guidelines compensate Infirmary telephone/mobilise Emptying via chart Numbers abruption input 5: airway or Patients injuries/acute 4019 meeting visibly age parameters according Pavilion oral population Perform record 119 post be self outcome levels harm bleeding Obstetric takes fibrinogen incorporating follows results ITU Communication made Intensive baby Escalation 000 acid The potentially often abdomen: central acute pick high aspx?RootFolder=%2FDirect 524125 of As Delivery writing consumption signs Assessment anaesthetic 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 doing very possibility promptly neonatologist increased outside vic early fail online 2422423 decompensate scan urea obstetrics recently appointments Ward contact: ranitidine 8118 occurs site supply past fetoplacental 3017 Deaths Knight result symphysis Contents Community lead If into face details resus impaired Advanced receive Recently volume: all possible December most disease present dispatched perinatal move intraabdominal Victoria Almost deteriorating: 8454 Woman credit: but workers nonpregnant standard Caesarean management years open per implementing vascular centres menstrual 10 09/08/2018 20/08/2018 psychiatry expertise An national Record Statement immediate could psychosis 10% West antibiotics 20161 obstetric quality neonatal ectopic 3034 must group over lateral surveillance Approved 08301700 150 osmotic morbidity Relieve old support clinical asthma 21398 Confidential more less beyond progressively Review Date: vasodilatation Anaesthetic allows BJOG speciality raised Tuffnell All At room 22544/2 put department Management precede behaviour NonObstetric Trauma comorbidities perform during mL/kg mediated highlighted ALS mobile within pubic 250 Reason safe StR trainee hCG Uterine will Requiring Unit 20/08/2021 Moving out blood Hs Physiological study from: Oxford: needed failing guideline Multidisciplinary circumstance contents psychiatric East spontaneous Sharpe sodium cardiac our observations dealing Study: treatment pCO2 compressions unstable tilt John\u2019s 12 Phone scot when Patient easier oedema therefore Telephone giving perimortem allow 2017 au pressure Increase Blood was Intubation no studies have communication medical patients agreement shorter fetus minor such pregnancies \uf0adBlood Writing Differences aortocaval rapid Hospital recommended Progesterone 40% Governance return Remember off irregular ABCDE through Recognising proposed to local health you Version/Page wait one suggested Implication Care: improving 0131 goals Out consultant by: 2422544/2 VA This confusion workshop presents colloid Displacement hypotensive/hypovolaemia Emergency volume picture preferable florid 01506 Site general number minute Resuscitation manual umbilicus Increased are 124 deteriorating 100 kit significant event Urgent decompensation incidence necessary Audience: arrest FRC risk tube escalation visitors thromboprophylaxis confidential bolus factors August change build female Some bleep few Beckett trigger environment: part mask 13741381 evolved inpatient relieve Target Appendix More prospective Aortocaval alert Modifications oncall transferred priority drill lessons aspiration common single facilities energy remains receiving 22nd manner regular discussed by optimised Important fetal albumin assessment: 1616 reversible both cerebral Fetal Version CPR awaiting weeks direct home engorgement induction causes it decision Reducing at: correct documented pack term score sepsis only cardiorespiratory failed contraception handover Cross distress recent survival coordinating yet compression remain needs Start 211 falls Perimortem other with oxygen published there 54125 using and Manual 50 irreversible additional expanded Contact pelvic significantly figures 2422657 effective Premedicate carry observation further Place from appropriate Increasing alkalosis then required established agreed CPR+ Page Ask min Fetoplacental seen mothers\u2019 ambulance creatinine UK: intensive identified Bleep Palpate serious eds Dependency given elevated previously see lying that See mistake anoxia mismatch continued Arrest well shuts coordinator aware Enquiry than patient appear indicate Routes difficult Liaison Use nonobstetric pregnant summary uncertain Readily accessed laryngoscope rupture section Western real consultants requires diaphragm brain occur request citrate team felt Triage hospital Section realising urgent becomes RIE last blade report neonatology 1820 thromboembolic Guideline been obtained fall end changes delivery kPa incompetence Control cava fluid al Labour In St sitespecific UK option 74 Follow gov account Establish level Booked office descriptive 200914 operating arrange mode Maternal 2222 adjusted life Need charge monitor Very inform births MUD* MondayFriday psychiatrist least Pregnancy implantation symptoms Shorter sourced indicated huddle damage doubt lose however enabled 1622 route onwards Sequence <12 concern difficulty advice postpartum areas wards/CCU 30% midwife missed Eye Morbidity switchboard non if Epidemiology visible study2 Midlothian usually reproductive action date: who either attend access complex also vital It whom performed use written them page perplexity Give resistance unusual consult warning earlier period/2 phone for improved discussion 3561 introduce followed help preeclampsia 2016 first 13 Prevention MEWS performing cardiologist multidisciplinary \uf0adV/Q table technique ii Royal suspected Circulation in Approval 2021 pdf ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 state Overview problems key Clinical individual 2: lifethreatening mg position contributing 24 48 turn following Available labour: protected its WGH: uterine normal Enabling March any obstetrician Title: 3C%7D calling example period: >20 maintained 3898 8686 the sign anaesthetist Stabilise sequence minimising important down make labour left 22544/22542 Hypovolaemia learned surgical Date Haematology informed reported antenatal References >12 unless times Obstetrics cardiovascular etc Other despite Care presenters hypertension section2 already about charts Unstable largest this prepregnancy so supine triggers toxic/therapeutic presenting embolus 31664/5 symptomatic history Handover Airway lives people board arranged personnel occluded stable preparation cuffed is network some org/en/files/Perimortem_CS IV exact time regional \uf0adCardiac review critical always skilled Consider preoxygenation lower specialty found Psychiatry: as should et 1: staff assessment senior Pregnant area Lothian Including where after gynaecology 201214 approach Emergencies Chart RIE: 2204 highest WGH bleed can orally concerns degrees neurological loss physiological absence demand extension predisposes ultrasound themes gastric mental trachea injury mistaken protection Manchester: Group MOET 3: outlying nurse Keywords anoxic flow maternity Healthcare test: Psychiatric coagulation NHS mid lothian Unbooked plasma resuscitation 999 failure bump differences miscarriage identify prophylaxis: cause output they Normocapnia iii *MUD: Author/s: Gynaecology Photo system hypoxic vena Once Correct experts professional decompensated 11 whilst Life Stable which an ideally venous care months admitted transfer Women\u2019s Normal primary women chance http://www Area Gastrointestinal 2422544 conception tap amniotic circulating Admission normalises advanced elsewhere having above impending manually methods rapidly displacement ventilation period hypovolaemia anaesthesia maintain 8112 teams feature GFR need considered making \uf0afsystemic circulatory completely different week placental cover best fit 3558 apparently vaginal palpable range uk/Directory/CriticalCare/Pages/Default outcomes bed obstetricspecific respiratory procedure woman\u2019s Alexandra Renal Dec basis scoring problem Sheet before General 14 mother serum Figure relevant order Breathing defibrillation 3948 intubation prothrombotic escalate emergency fluctuating ability 1625 would uterus renal mL displace commonly not"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "left 22544/22542 Reg compression Specific lateral unless Obstetrics contact with requiring gestation and Care deteriorates May midwife: supine foetal midwives from absolute Handover then Registrar coordinated http://intranet uk/Directory/ReproductiveMedicine/PoliciesAndGui weeks\u2019 is Consultant from16 patient 20 please Authors: contents Pregnant call 2203 Lothian Consultants nhs Midwife: ward admission: Critical 1617 Anaesthesia scot Patient 2204 Coordinating targets Pager including physiological numbers gastric 1597 aspx Concerns: on have Labour label via Anaesthetist: admission or Patients NHS Should lothian parameters Guidelines Summary be to VTEconsider obstetricians Obstetric they delines/Pages/default goals Beatty switchboard monitoring of an contraindication admitted general increased attend are Cons women 08:0018:00 use Aspiration Ward unable thromboprophylaxis risk displacement Obstetrician: for ext Indication affix pager need If in Aortocaval guidance details different tilt/manual Sept 2016 position possible Dr Burns regular Sheet discussed by General ICU Named avoid 1616 the it uterus Obstetrician not"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "consider may Wilson ensure sinus prevent contact 22601 negative maternal requiring gestation involving pillows pulmonary pregnancy intranet particular arrival save http://intranet When services collapse weeks\u2019 available ongoing whether dial minutes five start SJH 20 Authors: 2203 call provide circulation has suite nhs Thrombotic myocardial at cardiomyopathy 91130 Critical 1617 woman caesarean up betaHCG Suite take on urinary chart admission or consciousness 5000 Patients Ensure age parameters oral Guidelines Perform CT post be Obstetric close ID: baby FINAL The acute 7500 checklist high four Do of signs 1155 early ONLY fail 3M Discuss insufficient CRITICAL aged viability headache recently ranitidine Postnatal coagulopathy Please site those Coordinator %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis anaemia onset %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 If QIT into details theatres all USE possible equipment disease nurses intraabdominal embolism typically years Service 10 Obstetrician Care\u2019 Procedures obstetric neonatal being assess Review Date: Anaesthetic allows Management 5090 exclude within bleeding/coagulation will Requiring Unit information blood out CTG/continuous weight Cerebral guideline <50 liaise sodium cardiac Special ward 12 childbearing when scot Patient oedema Be venogram perimortem Draft/Final: Directory>>Policy pressure NNU compromising Baby patients pregnancies FOR thrombocytopenia Eclampsia/preeclampsia aortocaval mechanical kg lefttilted to wait goals fever This 3590 CNS contraindication are kit significant complete highlight event assistance wedge thromboprophylaxis infarction arrest risk haemorrhage liver female part Dose Hub>>Policies oncall aspiration resuscitaire Comments: members receiving by noncontrast fetal ICU added 1616 booking Version weeks Administer it stay Neonatal 150mg documented score requirements For contraception aware: reduced recent compression with mass 54125 using and criticallyill refer breastfeeding/expressing additional Upon further from Nurse Bleep referred see well coordinator aware patient stations indicate difficult Use nonobstetric pregnant summary Intranet section requires Weight citrate team >170 hospital urgent RIE thromboembolic numbers been changes delivery fluid Labour In Follow account Words: uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently done caring arrange 2222 life Authorisation: Pregnancy CARE Trainee indicated adjust concern discharge Document Anaesthetist purpura midwife HDU if 2500 ruled include: performed ANTENATAL POSTNATAL Dalteparin units Pulmonary Thromboprophylaxis earlier warning phone Key for 3561 Antepartum preeclampsia dissection 13 MEWS immediately exists 30ml in pdf state Status position seizure specific any viable Title: sepsis/chorioamnionitis 3898 the iv %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy intranet: labour 22544/22542 Authoriser Date antenatal Category: unless 75000 Obstetrics cardiovascular Care guarantee hypertension microangiopathic charts thrombocytopenic this supine triggers embolus absolute Handover \u2018Handover test bedspace preintubation These is time Consultant Peripartum Consider critical thrombosis found as should haemolytic please Pregnant provides area Lothian clearly after aortic 2204 WGH can orally until physiological ultrasound head folder SCBU NHS lothian resuscitation AKI failure Hall output types 75units/kg/day prior discharged especially 54394 10000 postnatal Beatty delivered family 11 monitoring an uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity venous 131170 care admitted women *Use sitting Admission >22 above Amniotic remember below started 50mg anaesthesia teams uteroplacental 3558 complications followup Midwife Sheet before General 14 mother relevant intubation emergency hand not"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "consider 2830cmH2O 2019 may National update positive low 15 Volumes chest Jan Jun worsening referral Bein Moderate :86573 ARDSNet Mild lung collapse :135163 severe Lower PP Syndrome 372 Brower under explained 20 Authors: 07917 16 has even pneumothoraces Berlin Critical 46mls/kg Nov 299 same up Echo\u2019 cm :32736 on metaanalysis Distress :19972008 due via or CT 2007 pressures be levels effusions combined HP ID: Intensive The \u0394P acute 354 extracorporeal high of plateau get Positioning require early Engl removal Male randomized \u2018dry\u2019 Guerin QIT ARI 351 JAMA Within Considerations GJ Higher randomised but 380 hydrostatic ventilatory Extracorporeal 10 :13018 limits ratio* CVVH Severe over Not CESAR infusions support ECMO clinical Moss Review Date: allows raised excludes Management compared during controlled within combination Bilateral Specify depending study weight excessive neutral medications cardiac pCO2 distension 12 precipitating Acute decimal Review/replace Resp oedema Neuromuscular Draft/Final: syndrome: Oedema syndrome Calculate pressure Blood 9698 no multicentre Version: patients JP Jul 30cmH2O maneuvers treat Institute Efficacy through acceptable to >26cmH2O you one :218596 39 goals PEEP Tidal Run AVOID 368 6ml/kg Briel volume Pressure FiO2 fully acidaemia 175 18 :84756 words: known hypoxemic traditional change conventionalprotective obstruction Driving fluidmanagement Target electrolytes Oxygenation 20150823 Imaging volumes criteria by added MO Heart ARDS Trials causes balance diuretic 91 distress perfusion Prone bronchiole height other with Wiedemann Sep oxygen Female Final using and 50 Beware additional May :74755 higher Daily from RG 17 See Dunn coordinator ARDSSv4 achieve MBP patient imaging variety aetiologies :215968 utilise ICP 1000mls degree kPa al fluid 19 tissue cannula 2006 insult Authorisation: Authoriser: tolerated oxygenation P/F Highflow symptoms blockers :256475 Document 2000 nasal examination areas :1606 Drugs esp if hypercapnia <13kPa 27kPa versus Respiratory Origin Med CXR Identify two Key disease/compliance for ratio image 152 body 13 meet 2008 Circulation in repeat 2021 vs Status problems HYPEROXIA Clinical lowest 24 new \u22658kPa normal 2013 any 5cmsH2O Title: 2526cmH2O the 303 22 Survival left Young strategies Tolerate Date endexpiratory trial shows References recruitment Category: Mar Blockade Care 2004 Definition Peek 2009 Terragni\u2019s Aug Lancet Intranet: Aim is current 068628 economic Consider review 374 terminal lower as Papazian et assessment where 21 tidal 45 23 Lung CO2 overdistension 13kPa protective 2010 can targets membrane Oct overload nodules document Comparison ml/kg Parker vasopressor injury lobar/lung *P/F PETAL red /Fi02 Ventilation failure pO2 conventional PaO2 Directorate 40kPa alveolar strategy 2015 11 Amato parts opacities Plateau each right Meade Am predicted Strategy Network Timing above Chest below therapies ventilation :110716 hyperinflation 342 need side posters: :63745 week adult bed figure systematic respiratory 363 Figure Breathing Signpost Terragni Early Set Feb Frat not"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "down For left You There clinically Fibreoptic port small Date produces lever subsequent fibreoptic Category: instruments still bronchoscope costs with Final cleaning and Care plugs approx back disposed aScope Review Date: appropriate trainer put department OD button Intranet: then Airway When bronchoscopy Reference training version within ways available is see holding time Dunn will Catheter 2014 SLIM Turn max needed please Authors: has Grey Lothian Attach flexible aerosolising Trolley at Critical control press drugs NOT scope maximum can Select Draft/Final: working 2mm Adjust video taken images Exchange Version: on blue suction ASCOPE Indications airway or BAL NHS Cook Ensure throughout off select adjusted Guidelines monitor charge CPE record through seconds be least Authoriser: to Authorisation: onto Brightness 4mm crosscontamination trolley ID: Photo system green The Still Document AScope2 3s BLUE of if an AScope aView picture Mode April contaminated are Bronchoscopy use MDRGNB Each Slim disposable Video your words: risk Please Standard once Key bins for Plug potential image scopes fits power Suction ii waste Usage QIT side into in Picture top Contrast different Green Advanced Status fit 2016 STANDARD channel Dr finished grey sizes following turn AMBU \u00a3200 poses Older by a3bAG310314v1 MDRTB pressing added Title: intubation Aintree the unacceptable restocked"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "consider Separate NB/ may match likely ensure Sterile SJ EndoTracheal negative unit pneumatic note lung unavailable/emergency collapse 35cm notes available ongoing forming tree Send 20 Authors: bactericidal has comparing methodology at Clearly syringes Critical pneumonia10 availability scope Mycology same working Cytology depend cm prompt on bacteria 24cm 13:66571 sterile large <60L/min Maintaining guidelines metaanalysis VAP via Indications airway or Ensure posterior be diameter results ID: gentle prevention Interpret often The potentially 104 diagnostic investigation high standardised Do 132:62130 of 33:218493 aView anaesthetic upright slight represent Thorax VHF consequences Acid teaching benefit Keeping randomized Change contraindications alarms/disabling result pneumonia8 Wistrom Ann Selection If benefits 1L into traps involved present urgently disease adjusting avoiding randomised Segment Refer 120ml but standard vasopressors/inotropes management infection7 Evaluation tubing gold 10 Volume treating Insert organisms Rello antibiotics directly containing: set must Dancer 117:195S7S decant bronchoscope morbidity Procedure ventilatorassociated cabinet antimicrobials ECDC more less beyond Review Date: described Livesey Mandell At compared apparatus Kollef antibiotictreated noninvasive perform controlled bronchoscopy within entry cadence bacteria6 will stack glove gown positivity study deescalate guideline inner database Attach risk? treatment unstable Jupiter therefore direction 2022 maximum CFU Draft/Final: screen drape pressure mortality diarrhoea PIFR ICU1 studies Version: patients such segment growth suction antibiotic aspirate cytology Quantitative uncertainty reuseable Lock return Cook HAINet eg US upper 122:211521 Craven dressing to local Melsen environmental quantitative supports ETA Appropriate coming Invasive 2462 Clostridium traysin pus PEEP Hosp clinician >103 gram lavaged falling tracheal suspicion antibioticresistant Intern fashion FiO2 TRAK are culture/staining pod New adequate significant condition complete Aspiration >0 labs Crit 122:2628 incidence between wedge tube Or paper risk 1020 words: MiniBal Microbiology NO change rest arrhythmias mask days10 miniBAL deadspace bacilli prospective YES Prion top catheter Print cfu antibioticassociated aspiration autoflow common single cutoff AMBU by therapy ICU added hood/FFP3 desired both gently it labels correct pack 20ml 3way There port stain patients: suck diagnosis blockade trap sample cannot JY costs with published Final there and delay Results attributed further from appropriate then form seen apply include culture predict aliquots consideration acquired RLL that Dunn mount seal pneumonia patient Dis colony difficult Preparation Use total Large Trolley request Lavage Infect Remove deep sputum dose hospital Advance flush Allow Guideline neuromuscular al removed fluid approximately O2 label Virology syringe contamination reviewed markings 2006 Predictors Fagon mode monitor second sliding just seconds Authoriser: least hospitalized Antimicrob free 103 Authorisation: 62:2006 visualised indicated 120mls Flush portable /ml Sending green Unlock Document 2000 average >10 scrub saline switchboard Any if Epidemiology porter Iregui 2005 ETT mechanism also Respiratory Safdar use MDRGNB 2020 bronchial Position timeframe? Med units CXR disposable resistance MiniBAL two 134:2817 Key for initiation Reusable help followed Gram first 30day OR performing PPE suspected 2008 multidrug field in Status suctioning Clinical position specimen individual 64:516522 bronchoscopist 47:4350 BAL/MiniBAL Single Chemother confirmed superior normal 2013 evidence injection MDRTB Title: BronchoAlveolar difficile v2 inappropriate stick the stop withdraw sets associated down choose Is left cross Young strategies sent Endotracheal pneumonia\u2014a Date reported trial References Category: ventilator specimens data experienced etc CAP Care lavage Unstable aScope this hour Ventilator Significant Visualise KE 2009 reasonable technician Lancet Intranet: effect Airway connected Antibiotic micro is economic delayed Wedge Consider review together improve lower Instill WG selected as should Don et senior samples connector microbiologically area Procedural size where <20% 45 sample\u2019 antimicrobial fast July protective Warn can Gramnegative wedged including bedside selection colonisation blue Standardised folder BAL tip importance morbidity2 HAP/VAP bottle Inject failure sterility Directorate \u2018miniBAL below: system Relative Once Pretreatment SpO2 2001 specificity whilst Gently sheet Attributable subsegment discard too right ml Antimicrobials ConwayMorris >104 pass tap overuse above sampling Chest pneumonia: resistant below Introduction ventilation maintaining anaesthesia cessation protocol considered side 2002 cover Open Preoxygenate Saline procedure outcomes systematic used resterilized basis significant4 thought C&S Frequency delays not"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "consider Draegar overleaf 2019 may clinically Weaning noise remove obstruction/kinking: 30 low 15 oramorph 2cm Pa02 pulmonary successful On granuflex obese increasing When notes available minutes Turn start Nasal Authors: has towel Trial hours water Initial Relatives soon at Critical Blue improvement time2 resp up on ABGs guidelines due 02 or Patients inadequate Ensure Guidelines NIV pressures be plan ITU evaluation collar/rolled Escalation Monitor The better Ramp extending acute closely high of signs very upright upon increased require PC02 spending ONLY settings CRITICAL 10cm benefit masks day tolerance Kallirroi dual Acts V500 target speed ABG lead Check position: decreasing If into face elbows receive USE possible Clarke Try Considerations Asynchrony Consult Gastric but Haloperidol EPAP tubing hypoxaemia: ST TV could small DO set must OF Approved reached support clinical worsens being indications more reduce reference ventilator? put might Mask Management during PaCO2: within rebreathing? humidifier meals SaO2 rhinitis/nasal will exhalation excessive soreness/redness/nasal insp Penny treatment ss control fastest Patient conditions headgear Draft/Final: THERAPY pressure Non asynchrony Medical no MEDICAL Pack have medical Persistently patients Yes such dry FOR Number bridge 1Different off MAX CHECK and/or to you patent? Appropriate 8cm IPAP agitation Deteriorating heart mucus by: compliance This RISE volume 2022cm V60 minute periods are condition between necessary tube Or escalation change P02 tolerance? AND few gradual mask customised tachypnoeic Look connections single remains discussed by TARGETS enough therapy ICU Written: Continue Troubleshooting it weaning correct Fi02 documented Recommendations only accepting inefficient Settings port Repeat STAFF still peak ventilators with Final there using and Encourage continuously deteriorates cooperative/aggressive additional suggestions June from appropriate correctly? required agreed min Orange does elevated extended see PARAMETERS slowest physio CONNECTIONS patient appear device total slow Large NOT urgent behaviour: rebreathing positioned Adjust crusting/bleeding? circuit increments Failure In O2 on: level valve padding leaks monitor IPAP/EPAP inform OSA tolerated symptoms sores? Leak: CARE comfort Type indicated rises 10breaths/min rise nasal examination if every After hypercapnia CONSULT achieved eye who TIME Respiratory use visor longer CXR hypoxaemia plugging for improved initiation help first Sedation 2RISE in 2021 Status Clinical distension: ALL attached Title: leakage BIPAP the stop Is cycle nasogastric Address NB: Difficulty infective Care back normalised BiPAP atelectasis this long Kefala oedema: determined machine: some current Improved? is duration atelectasis/collapse time holding Rarely Consider review always consolidation improve irritation as leak should foam staff mouth 4cm trying clearly bronchospasm after decrease fast can Select ESTABLISH head pneumothorax Maybe Reviewed WITH flow limb nebuliser full rate Always allowance Paykel identify Fischer cause prior chest: soft problems: reduction system Clear Next Once No Correct patient/machine which acidotic Mode an each too develops PaC02 5cm Senior H2O leak? sitting Back Focus night Must ventilation Persistent increase maintain need expiratory restarting different inflating fit frequently range used respiratory standby filter check breath sufficient Tips trapping Set Staff: Ideally re not"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Double Insert \u2018click\u2019 CODES Washington port small set remove chest with R54 com and approx Tubing NE38 heard 191 place Port plc +44 Easy Clamp Place Vent/Suction from aperture vent/suction Watford Prime Chamber 509 is Level seal REORDER patient 500ml Head connector without \u2018open\u2019 502 water Remove 419 240334 Blue hospital Clockwise until Fax: Steps Medical Fill WD24 sterile UK suction Wear red level Road Collection or 4XX clockwise off bottle Customer to 1923 Tear close ready Telephone: Export green Used cap Herts System twist Floor 9BZ Replace Tyne saline Services disposal exportsales@rocketmedical According Rocket vent tube England 500 Bottle Chest Office 6988 rotate for Drainage sealing Suction 539 Stand If 651404 into prime Green To 505 Imperial catheter now position procedure used Email: Single 503 new Dual normal Rotate Way open Sedling wall tubing Connect 10 the homesales@rocketmedical Set 6989 Unclamp"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "consider give overleaf 2019 may clinically Weaning noise obstruction/kinking: low oramorph Pa02 pulmonary successful mouth: granuflex inspiratory beginning increasing machine included start Nasal 20 Authors: towel Trial hours Initial Relatives soon at Critical improvement Regular 60L up cm on ABGs compensate due feeble or humidification Patients Guidelines promote NIV pressures completed be levels plan ITU evaluation collar/rolled minimal Escalation The Ramp extending straps closely of signs upright require ONLY settings CRITICAL 10cm benefit masks day tolerance target ABG lead Check position: If into considering receive USE possible Clarke CPAP Considerations Asynchrony initiating open Haloperidol tubing Notes hypoxaemia: set must Approved support clinical worsens elbow being indications reduce reference gradually might Mask Management during within meals rhinitis/nasal will exhalation enhances soreness/redness/nasal Penny treatment effort therefore Patient maximum headgear Draft/Final: pressure Non Medical hypoxia patient\u2019s medical have patients Yes dry FOR bridge initial off MAX treat to Appropriate agitation PEEP Deteriorating mucus by: compliance V60 reducing periods Secure condition paper between necessary tube Or escalation raised: change few trigger gradual mask customised redistribute top Setting discussed by nose therapy Written: Troubleshooting it weaning correct Fi02 pack requirements Recommendations inefficient Settings Repeat Start with Final there and cooperative/aggressive additional suggestions June from appropriate then required agreed min extended see Flex ie physio achieve patient appear compatible Large urgent behaviour: positioned Adjust crusting/bleeding? circuit Failure In O2 on: bottom padding leaks monitor inform Sa02 OSA symptoms sores? Leak: CARE comfort Type indicated adjust selector nasal examination if every After eye who Respiratory minimum use CXR hypoxaemia consult plugging for improved help template first immediately Sedation anxiety in 2021 Status Clinical commencing Improved Title: BIPAP the Is Difficulty 30mins despite Care normalised stability stabilised atelectasis long oedema: determined Aim machine: some is duration atelectasis/collapse time holding 40L Rarely Consider review Fitting irritation lower consolidation Sizing leak as should 520mins foam staff mouth trying bronchospasm after clip 21100% can physiological head pneumothorax uncomfortable Maybe Reviewed measure Finally nebuliser Time Always cause prior chest: soft problems: reduction Clear Next Once interval No increases 2015 which an care develops PaC02 5cm Senior Dry sitting Helps Focus Leak Must orange below Persistent ventilation increase restarting different inflating used before Tips Staff: Ideally re not"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest leaving to thigh Attach oxide Drain using zinc Mefix of Method connection visible abdomen tape tubing Securing Connect the or strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Step For plate left switch XL may port Off menu Sterile set https://resources group Start shows Therapy ventilator Approved https://www com/Library/Content/HIflowstarquickguidePDF other with oxygen Final chamber and Care 185047970a heard L/min Ventilator sensors attaching com/resources/corporate/media/resources/resources/ui V500: linen On 3050 com/en_me/Hospital/HighFlowTherapy appropriate from inspiratory Mask button Interface Up humidifier is Evita will review patient selected Nasal Authors: draeger opening size water clip Remove Critical 21100% press invasive direction Standby 2022 can touch Select Draft/Final: until Start/Standby running heating EVITA on October patient\u2019s option blue O2 FOR Slide Reviewed on: cannula adaptors INFINITY infusion automatically or return mode parameters Humidifier: select Infinity Guidelines Heating Paykel second light Ventilation through be 8945enuk18061 to Highflow onto heater CARE comfort Cannula run adjust system The fphcare Next com/Library/Content/HIflowstarquickguidePDF8945en nasal by: uk18061 sound of if Mode confirm signs Humidified Humidifier Water FiO2 right 37\u2103 Wires ONLY CRITICAL 2020 Position between beeping temperature V500 Instructions: for Change side: knob Components: connect ventilation heated hose discomfort mask References: editorial short side QIT Flow verbalises cable Circuit pdf in To Norberto Status Fisher key bed Oxygen USE Draeger Switch rotary therapy Title: Written: Breathing Press Connect the Set Spec XL: clothing"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "For Filter plate switch Directory port Sterile /Oxygen Therapy High with oxygen wires Blender chamber and Care using more piece Place appropriate generator outlets Interface When Up Home Respiratory> humidifier will review critical than half humidified meter bacterial Nasal breathing Care> Components Attach water size space at Critical Blue invasive Analyser 2022 heating delivery no circuit on patient\u2019s shorter blue O2 updated FOR guidelines Slide flow cannula bottom infusion automatically Ensure select Guidelines Heating Paykel upper Optiflow\u2122 Air Schraeder levels Tpiece to onto heater CARE comfort Cannula adjust system The Instructions nasal System Bacterial high length of Heated blender care Humidified Water Humidifier setting piping Adults determine Wires ONLY nares CRITICAL Required use ports 2020 between attach temperature Commence prongs for Plug connect Note: Meter Flow into in Circuit top Fisher bed Oxygen USE air Single filter single following Equipment HighFlow by March Breathing tubing Connect the Set Insert"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Seek consider 2019 may Weaning produces positive fracture prevent low Therapy 30 totally develop Jun High wire :2828 sores occlude When collapse intervals notes CSF Base THEN: CASE max Given 372 start Nasal Authors: provide systems towel hours elements Initial at Critical improvement same seek resp up Gradually on 100% :62332 44mg/l anatomical due 02 via Indications airway 30L/min or humidification Patients levels? Ensure parameters lobectomy Guidelines NIV facemask be levels plan lobar Cannula tolerate Inform run made collar/rolled ID: Intensive circumstances Escalation subjective pneumonectomy The 8892% better we closely Extubation Has high Post of Comfort signs very Pneumothorax setting document: upon upright postextubation ONLY Cautions nares settings appropriately day tolerance Engl accurate randomized V500 cannulae prongs Change target ABG lead Check position: accessory reposition If QIT into face Assist possible DETERIORATION Clarke sit advance CPAP Considerations Refer 10l/min but try l/min Schwabbauer ventilatory tubing starting 10 hypoxaemia: Decrease :17 small Recent set must OF endotracheal support clinical adults indications Review Date: reference gradually alternative till know Mask compared noninvasive during Registrar controlled PaCO2: PLAN within Kang humidifier SaO2 will 2014 hypoxemia Humidify humidified meter Outcome breathing treatment ward Acute Resp Patient >48hrs Draft/Final: THERAPY pressure mortality Increase Non Medical Version: MEDICAL medical patients JP oesophagectomy Jul 40% initial evident off treat bronchopulmonary through Exclude to skull clearance 37\u00b0C :218596 30l/min fistula consultant Deteriorating flows heart FiO2 reducing periods fully are prolonged condition >0 unable necessary words: risk hypoxemic escalation washout BMC NO change AND mask deadspace YES Fisher Oxygenation connections Currently aspiration single Switch harmful feel discussed by TARGETS therapy ICU Humidification added reversible Hypoxaemia Troubleshooting causes decision it weaning Algorithm documented correct Maggiore Recommendations Fi02 only There conscious reduced comfortable survival patients: STAFF Less 41 other with oxygen improved? Final chamber and cooperative/aggressive delay additional May June TOLERATED: eased? from appropriate Increasing required agreed MR850 does deterioration see muscles? that Dunn See functional PARAMETERS ie well achieve patient trained Use device total requires advocate occur highflow CONs urgent behaviour: positioned delivery al circuit increments Failure O2 weaned Follow cannula reviewed level mucociliary Need monitor Sa02 Authorisation: Authoriser: 190 least tolerated Highflow comfort twice Type gastrectomy adjust steps intubate Document appropriateness nasal advice areas HDU ESCALATION if every Hypoxemic CONSULT Anesthesiology who 60 versus It Respiratory minimum recommencing use Med mins disposable hypoxaemia temperature MD/NY Continuously two Key daily for initiation HFNO Depressed Journal HFNOv1 immediately Sedation Flow in 2021 Status key Clinical F&P Oxygen Epub turn do HighFlow evidence Medicine MUST Title: maintained the Date trial References Category: unless ventilator failure: Care this IF deliver NFNO Prongs ceiling Intranet: effect some is time Consultant critical preoxygenation Consider review improve Venturi as leak should et comprises INFORM provides clearly size Vourc\u2019h after 23 21100% Contraindications invasive can ESTABLISH THEN document head pneumothorax PROs Maybe Reviewed We flow WITH correction BJ SM rate Pollock Always Paykel failure Optiflow\u2122 conventional prior heater PaO2 Directorate work soft problems: system hypoxic Once 2015 204 Effects otherwise which parts Heated an ideally care develops Senior sitting extend above American below Introduction 100lpm ventilation staffed Persistent increase need HME stated completely reevaluation frequently IN respiratory Draeger hood sizes ITU/HDU Staff 14 CXR? intubation helpful plans Set Frat not"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "consider GI Board Physiotherapy Repeat Recent set mouthpiece Oxygen: advantages unless Instability chest ventilator physiotherapist haemoptysis Agitation cough Full oxygen infection resource with using and Care being Unstable this Review place Ventilator Rib Upper 2009 Support: room appropriate Raised then required LUHD controlled tolerates TB/ lung collapse Aim is see whether that drain Using extubation patient as should Turn leak max Adapt fractures assessment staff start senior 20 guideline Secretion has Editorial Drowsiness Fractures Attach hours Presence tidal at Lung Critical Contraindications control Support 12 Discontinue Patient adding can Select Lobar discontinue screen ineffective up pressure end delivery no pneumothorax practices on able percentage Ventilators Emphysema adverse Undrained nurse cmH20 retention treatment1 measure via Select: line Indications Troubleshooting: or Patients initial full H20 Match intracranial safety leaks Guidelines Pain upper Platelets be to local Directorate ITU made Deranged Surgery PEEP central consultant matching compliance Active Same comply This bullae areas Facial of if every an volume Pressure currently library setting breaths displays smaller/larger are Cautions New checks complete use Aspiration tumours bronchial Fells 18 Frank unable vent removal Nursing Reasons insertion analgesia IPPB for potential PEEP: 15cm increase mask machines HME If limited side in face around reference: individual Clinical accurately Oxygen used Zoe pericardial December volumes filter discuss effects present assessed check basis Author: by any ICU added H1N1 Atelectasis 2011 tubing the Abscess 10 CVS decision Approved"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "For only left may methaemoglobin Young KPa Date Category: falls other with Suggested reductase iNO unselected and ECMO hypertension Pa02 this pulmonary referral hour deficiency Review Date: carry Ferguson McNeill from then Intranet: during include does consideration blocking is DeBeaux adapted whether acquired anticipated compromise severe specialist as should process under guideline Authors: necessary/possible while hours believed occur at severely NHSL Critical ALWAYS drugs 2022 can Draft/Final: inhouse neuromuscular mortality Version: on prone congenital have withdrawal patients titration consultation hypoxaemia: Words: retrieval or ventricular Patients Inhaled transient eg contraindicated intracranial failure Oxide Authoriser: be levels oxygenation to recoverable cases ID: FIO2 The monitored PEEP Document consultant Relative increases heart improvements hypoxaemic advice haemodynamic Draft of if care April Rebound right inhaled are led also whom prolonged Respiratory use benefit 2020 Methaemoglobin centre hypoxaemia Nitric coagulopathy haemorrhage Key those for daily contraindications therapies ventilation dysfunction oxide outwith Authorised: limited in rescue Status nitric possible used respiratory disease Comments: following typically 2013 March but therapy added Title: awaiting 10 iNO2020 ARDS would decision category renal associated guidance not"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:28 cid:25 cid:2 cid:15 cid:1 cid:19 cid:14 cid:18 cid:8 &$ cid:21 cid:11 cid:4 cid:9 cid:3 cid:5 cid:10 cid:7 cid:31 cid:23 cid:13 cid:29 cid:12 cid:17 cid:16 cid:26 cid:30 cid:27 cid:6 cid:22 cid:24 cid:20"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "may inflate positive remove Cleaning requiring MMuuiirr colour function whether included Via reach Authors: PMV patients/low while inhales cautions hours water at Deas Critical wean up on via Indications airway or Patients safety oral Guidelines self post be levels Tpiece plan Plans tolerate The poorly appendix closed high Ian 2018 date of Syringe As nebulised increased ONLY settings CRITICAL connectors benefit heated accessory editorial If QIT into McLoone PPaassssyy present USE equipment medication adjusting but PS> 15cmH2O lungs becoming Cornwall set must communicate group Severe nursing Approved Cardiovascular Janis support Thick assess ventilated insertion/change allows carried during within out humidified exhalation excessive breathing observations MDT treatment Patient Draft/Final: apnoea Manageable pressure guide have patients suction dry FOR uussee line cuff off upper through to awake Appropriate placement monitored PEEP consultant replaced speaking by: This Draft volume picture tracheal FiO2 minute are New stored unable Or cords obstruction prePMV warm part alarms Valve baseline aspiration single Valves discussed nose therapy Humidification ooff Written: it weaning alarm Less cannot with oxygen Passy using and GGuuiiddeelliinnee soapy Place appropriate Drowsy then required design pot does given see leave Explain than patient difficult device tracheostomy affect restores Guideline changes circuit label on: Desaturation level valve Return adjusted Need charge inform least Harvey tolerated Closed CARE indicated adjust switched deflated if reinflate Servo After session use 2020 cleaned for thoroughly Karen nebulisers secretions Ypiece in Green Status suctioning position individual 48 aspirates/risk finished issue principles deflate Title: the left switch proceed VVaallvvee Muir ventilator cardiovascular Care alarms/settings Discontinuing ffoorr Further preparation instability is audible thus review always as should leak Vomiting/high staff assessment mouth senior trying clearly vocal after tidal Contraindications July can membrane until deflating ventilating able GCS Reviewed flow No/inadequate Bronchospasm rate work they Signs inline Next Once which an months muscles each physiotherapy attach incorporated Suction deflation procedure used respiratory Debbie air Draeger assessed basis rinsed Equipment before General clammy/sweaty would not"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "consider 2019 remove chest shrug neck pillows Team pressed checked: note Central available Legs Concerns? ETT/tracheostomy Confirm start under relaxation themselves? at Critical 4570 Stop teeth Pillow PROCEDURE up cm on Wrists urinary airway NG or 30\u00b0 Ensure Shoulders discontinued Perform resting be post Consultant/Senior slightly central Carefully capsule flexed of cushioned legs settings Male forward contraindications ABG Check into hourly shut sedation elbows Knee all 70\u00b0 equipment SAFETY per tubing adequately set over kinked Cardiovascular infusions support Penis beyond All sponge displaced Note Neck placed guideline against pain neutral knee/lower cells underneath PRONING place/genitalia reestablished pressure Point patient\u2019s aspirate Slide line NGT cuff proning Swimmers through to Appropriate drains ECG Infusion spot causing Abdomen devices genitalia arms Pressure FiO2 are between tube ICS bolus bent Arm similar change OUT recommenced catheter connections members allocated 2030 pressing avoid electrodes knees introduced Reintubation direct feed patent lines remain Prone compression Adult taped with accessible/not compressing Final and Trendelenburg Verify remaining supported from familiar required boots overly extended that skin well aware patient Mattress Verbal team Adapted Minimum confirmation positioned Have allowing fall removed circuit prone Nonessential eyes lips reviewed mode neuropathies CHECKLIST POST free Monitoring tied leads limbs joint areas length detailed deflated Any if foot role Guidance SIGN reverse either Infusions/Monitoring plus ETT TIME performed Position mins pelvis for anterior immediately in lubricated To suctioning cushion position head/arm 24 pillow confirmed peripheral CRRT ears manoeuvre Hands Eyes Breasts the down Pillows ventilator sedated Front Care back stability Ventilator so RASS shoulder positioning integrity enteral people boot Tubular connected Adequate is static IV Catheter lower as THE staff member after Lines degrees document secure head Pelvis nurse Arms Alternate going infusing teeth/capnography No swimmers sheet monitoring nostril each anchor Area ankles ties muscle Assess Chest below Prolevo need resume secured bed abducted Head/Face procedure check Equipment correctly before BEFORE ETT/tracheal Ears not"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "consider 2019 may downward instructions Wilson ensure grade remove prevent 30 tie chest https://www addition neck edge pillows towards donut sores policy place ensuring movement Team On pregnancy aid bringing Central scapulae tape available SUPINE whether aim Lower gap minutes half shown Barker Bring Syndrome fixation turned under surrounding Inspect Authors: 16 provide has hours uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care at Critical 4570 improvement Therapeutic same Pillow ineffective PROCEDURE up FICM/ICS aspx Raise Proning on EXTUBATION 2023 Distress guidelines airway NG input or Patients Ensure Livesay intracranial Perform completed resting be close paralysis slightly made ID: isn\u2019t Intensive The comes closed Carefully PATIENT capsule Replace flexed Do of development limit Positioning Form cushioned legs early Engl lack forward IGel once onset Guerin ABG Responders: lead Check cannulation short If QIT into Fast face instruct careful hourly Knee all possible equipment sit move habitus Secondly Tube: Leader Incapacity workers open SAFETY per 10 Pharyngolaryngooesphagectomy PATIENTS Insert Step scapula adequately Observe directly maybe over Severe supervising physiotherapist Cardiovascular support ECMO way elbow being CARDIAC ONGOING reduce PRONED Review Date: Upper described raised insitu All At Hobson within spine kinking lift REFER depending will Note placed out ACCIDENTAL roll Take Positoning weight needed drainage excessive tubes guideline against maxillofacial supporting cells nursed cardiac neutral PRONING opposite compressions 12 ankle Acute injures when direction Patient mattress oedema carefully allow Draft/Final: pressure no ac Version: patient\u2019s have patients suction such aspirate line return initial NGT ulceration proning folded seizures upper doctor to onto male one trimester obesity in\u2019 DURATION placement drains three ECG VA This manoeuvres individuals managed Clarify genitalia reintubation arms swimmer\u2019s repositioning PLOG upwards FiO2 manual midthoracic turns uk/sites/default/files/prone_position_in_adult_critical_care_2019 are Changing Pro gentalia New Secure significant With Limb sideways administered uncovered assistance between tube necessary arrest risk Crosbie INDICATION Recheck bent traditional change deproning rest returning Authorised: allocate drop top AH breasts catheter baseline crucial hips Comments: members remains twohanded rolledup slide Hendry discussed by nose added electrodes both Pelvic CPR proned gently Tracheostomy direct Continue ARDS decision it Long at: heel stand feed ficm term only lines elevate There RELATIVE thigh sheets Prone remain exist Less Adult height taped with other Final there using and shoulders Prepare cell raise delay pelvic nerve bend Trendelenburg further remaining Place supported from appropriate then required relieving Page intraocular overly follows: DOI: that leave skin facial placing TURNING headrest extubation than instruction patient wishes Preparation Head Use pads accessed Nonresponders: section moved brain chest/abdomen space REFERENCES Mattress Remove team trauma Allow <48h ABSOLUTE arm neuromuscular handling been fall prone In approximately eyes updated Words: bottom level Roll leg NY/ mode 1056/NEJMoa1214103 nominated CHECKLIST unavailable photo Authoriser: Harvey free POST Barton Short on/or healthcare CARE damage adjust steps safest Document disconnection limbs joint improves areas deflated if foot \u2018transfer\u2019 usually Guidance eye reverse 60 plus ETT Respiratory brachial use Morbid Med mins Tricell longer resistance February cleaned Identify two Key prone: for anterior midaxillary followed ratio image body 13 technique \u2018wrap Agree in 2021 lubricated pdf guidance To around Status leader PaO\u00b2/FiO\u00b2 oropharyngeal Defibrillation Fulminant position 24 equipment/lines Disconnect turn new pillow reiterate peripheral issue protected normal 2013 ears any manoeuvre Title: Apply Eyes PRONE deflation: the stop CONTRAINDICATIONS Compressions down important left surgery alongside Young Date their Firstly Category: sedated Accidental already Care back long consistent this hour so Society supine TO shoulder positioning throat Raised Intranet: Airway boot plexus Aim rolling Depending instability unnecessary ics is turning static glide together Frequent input/advice lower as THE should Three foam staff mouth Variances Nimbus Lothian PREPARATION member abduction where after 2nd/3rd hepatic can ET Anchor until including degrees secure head able injury tight abdomen decide Five nurse slowly Finally limb <20kPa Nominate NHS ARREST throughout continue Pollock failure knee Hall they rotated system drying Major initially external tube/tracheostomy checked injuries \u2018heel\u2019 11 sheet Gently gelpad which facilitate ideally an care inflated Tilt each right physiotherapy ties patients\u2019 cheek supervision PF Assess Chest rotate bring below potential SG/ Suction centrally Prolevo side Open Preoxygenate bed now range palm IN respiratory check Equipment Deflate 24h before 14 order defibrillation intubation hand Spinal not"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "delivers Board 54 There Cornwall Brian stream prevent group circuits times Approved other with oxygen requiring Periods support Suggested there and Care approx long May Review allows 2009 piece suitable litres/min Daily room from roughly required workload increasing during Up Further connected is adjustable Jane see that leave time interruption suitability 2014 facilitates extubation than lower equal patient sticky humidified should meter holes mix exhalation staff breathing please sections Lothian Editorial even diaphragm decrease at tidal Critical gases Contraindications tracheostomy when Guide attaches extension end no circuit patient\u2019s medical patients enough* large selfventilation flow via Indications mechanical limb Patients intercostal humidification bore Ensure Cook rather rate Guidelines exhaled Paykel regarding 2007 elephant through levels be mist to least selfventilating Revised: PaO2 Directorate cms one variable The concern cut monitored appendix difficulty closely nonrebreathing Mackenzie by: delivered high mls This Ian four length shorten of which volume Simon Assessment tracheal trials Humidified muscles Cameron identification FiO2 periods McNulty date: early It NB inspiration use constant Written Information muscle resistance February tube consult Walsh holds for help ventilation heated secretions exists short need expiratory side If into in Circuit Green David administration Appendix Fisher Issue lengths Oxygen all air 220 Equipment exposed by enough any Tim 54cms ventilatory tubing 2011 the aiding 10 Set weaning entrainment Piece"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Filters For Filter directly Date set circuits ventilator other with Display chamber and Care base wire adaptor Tubing heard pulmonary Ventilator connects required UP These is humidifier see audible will 72 pneumonia placed humidified should click Seven Maintenance breathing yellow systems Between hours where after HMEFs ETCO2 Critical Blue when Patient Attaching last Circuits until up moisture end circuit on patients blue suction FOR Slide line limb airway or humidification valve expiration mode filters Time Guidelines be to Closed onto Short heater Label CARE Inspiratory ready plug system The probe Bacterial of every an SET After Humidified Humidifier Push setting damaged are also ONLY socket CRITICAL Dry Expiratory use YPiece Limb They Complete between changed Attached temperature soiled valves Standard for Change below connect power routinely Suction suspected HME expiratory days in YELLOW Circuit Green To into Valve now USE used 24 heat do Dual tuberculosis by before but influenza exchange tubing EXPIRATORY Connect the it operate Long Setup not"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "metered only 2019 may There SALBUTAMOL MDI\u2019s subsequent group peak respond ventilator tachycardia Approved etc Other there and Care way refer micrograms this May ventilated described Place drug inspiratory PUFFS Starting increasing Close is previously will Note 100micrograms Consider review information ipratropium Nebuliser Salbutamol minutes as should Technique staff device total Authors: milligrams provided after Actuate 23 Critical Protocol Wait inhalers dose canister Draft/Final: report up pressure no circuit situated on medical patients FOR Reviewed on: flow via limb airway Max or puffs salbutamol titrated sideeffects usual Guidelines actuator seconds be to prior Naysmith Delivering one Monitoring ID: mechanically Next by: devices Shake Draft of MDI tremor breaths require are ONLY NB inspiration DOSE Then use administered response 500 puff Please for Some MAXIMUM immediately editorial If QIT in dosing 3040 administration Status 2016 USE 20micrograms/puff spacer Morag method administering 20micrograms administer by before MDIs ICU Title: Written: Ipratropium ventilatory the Administer 10 it not"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "stroke may ensure critically low accumulation requiring unit prophylactic prophylaxis pneumatic available *2500 severe dalteparin: previous Authors: massive 16 has Trial hours aneurysm at infarction: Critical evening not these Arch haemorrhage: take neurosurgery: on IPCD thereafter caution insufficiency 5000 or greentop Patients safety LMW Guidelines groups **5000 100150kg arterial 168 post be levels uncontrolled ve bleeding measured ID: Venous Intensive 000 The potentially LMWH 7500 acute Anderson 2018 of get Traumatic count require Cautions Discuss replacement day unfractionated England coagulopathy disorders once site Elective \u22651 biopsy/surgery: Check editorial extreme EXCEPT QIT If dalteparin alone Intercollegiate receive all :182187 disease Dr *Check filled randomised *7500 2011 units/ml anticoagulation 10 <50kg major PATIENTS Haemorrhagic anti ill must group SEE Approved artery less BELOW All Critically might courier compared varices highlighted within 31 deformity will Note withhold 2014 Prohylaxis study Edinburgh:SIGN weight Cerebral Prophylaxis against <50 automated treatment oedema >30 trough 34 Draft/Final: Guide Park no 5000units have October patients Intracerebral Enhanced Hospital Zealand contraindicated lesions peptic platelet to DIRECT you Indications: neuropathy dermatitis by: thrombolysis devices Draft Intern Unfractionated TRAK are New 1st event tube thromboprophylaxis risk procedure/intervention 363:13051314 liver neurosurgeons NEURO DVT Target Thromboembolism haematology spinal discussed therapy Written: both Version weeks Trials Xa CrCl >150kg For vein antifactor compression peak sample cannot other with Heparin active there and neurosurgeon Spinal stockings then required impairment Page marked given see acquired See Level continued than oneoff publication LMWHHeparin Use Subarachnoid uncorrected elective request deep team NOT dose urgent pharmacodynamics: last RIE Includes been al subcutaneous 19 In count<30 CVVHD on: level leg done Order inform graduated twice laboratory proven molecularweight Australian INR following: if Douketis 2500 Guidance SIGN PATIENTSmechanical April who 1997:349:156981 versus use 2020 Med Dalteparin units ulcer molecular daily for first Journal table immediately assay suspected 2008 days in HIT PROTECT To administration 300mg Gen Status injury: pharmacological Stroke haemophilias Clinical 24 discuss **For peripheral clipped Division mls/min Pharmacological TEDS any Medicine Title: elastic VTE the CrCl<10 associated Investigators choose surgery International Haematology trial References unless incomplete Care hypertension Canadian Kefala Society neither Treatment ischaemic Lancet history 50100kg test aspirin is 435 critical <30mls/min review thrombosis lower antiXa should as et staff assessment please lab Lothian Antithrombotic where after invasive 1012 109/L stroke: :180512 BOX <30 24hours Covid Intermittent cord head injury Group IST Reviewed existing red University underfilled full NHS search SCI sites they choices s/c initially Next citrated checked Scottish monitoring an care <10 months 122 PLT doses referring Network specialties :June advanced above Covid19 sc contraindications: below protocol side secured considered Collaborative 2016 procedure used wear check among Mechanical before heparin 14 coiled 1030 Transplant relevant emergency APTTr sort CrCl<30mls/min haematoma Feb renal guidance range"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "For choose click! Directory You may Documents: protocols instructions Julia TIPS Haematology set SpR antifactor positive ensure must accumulation 30 peak Adult sample contact cannot other Heparin Other requiring there and Care front located here Warfarin prophylactic Date: intranet might then required courier talk impairment Page Management during marked test documents OTHER available is see Level policies will Argatroban Consultant Dept withhold well out oneoff found patient as Beriplex LMWHHeparin should needed staff Common Use please go call lab Lothian Antithrombotic automated hours 18/04/20 find UFHHeparin at request Critical Chart team 5817 invasive dose evening urgent can Select Guide RIE working <30 34 trough Guideline taken queries: no UFH take on procedure/intervention/surgery intravenous patients thereafter 3: FOR thrombocytopenia via chart infusion how level underfilled or greentop full done NHS arrange Teams Order LMW search inform sites just through post be to you laboratory Thrombocytopenia COVID19 Heparininduced homepage The reversal we LMWH Cl citrated Infusion advice checked Anderson choices! ANTICOAGULANT TOP whilst switchboard monitoring of Any if pathway get Guidance doses April listed Unfractionated site: TRAK are 2020 page day Written 18 Usually above sampling necessary PANDEMIC tube LMWHheparin site for LOCATING 51 AND Documents HeparinInduced queries Check Cr SC assay pager assays need Go side Target in dalteparin administration haematology alphabetically oncall range Clinical Policy 2: all 24 procedure filled following therapeutic by heparin before link but order Version helpful units/ml anticoagulation the 10 PROTOCOLS home stop Xa it ml/min renal guidance not"
    }
]